
<html lang="en"     class="pb-page"  data-request-id="8e108fd5-643a-4b91-8ca7-ccb91b87987e"  
><head data-pb-dropzone="head"><meta name="pbContext" content=";requestedJournal:journal:jmcmar;journal:journal:jmcmar;page:string:Article/Chapter View;ctype:string:Journal Content;wgroup:string:ACHS website Group;website:website:acspubs;article:article:10.1021/acs.jmedchem.9b01313;issue:issue:10.1021/jmcmar.2019.62.issue-20;pageGroup:string:Publication Pages;subPage:string:Full Text"/></meta>




        <link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /></link><meta name="citation_journal_title" content="Journal of Medicinal Chemistry" /></meta><meta name="dc.Title" content="Discovery of Novel Aryl Carboxamide Derivatives as Hypoxia-Inducible Factor 1α Signaling Inhibitors with Potent Activities of Anticancer Metastasis" /></meta><meta name="dc.Creator" content="Mingming  Liu" /></meta><meta name="dc.Creator" content="Yuru  Liang" /></meta><meta name="dc.Creator" content="Zhongzhen  Zhu" /></meta><meta name="dc.Creator" content="Jin  Wang" /></meta><meta name="dc.Creator" content="Xingxing  Cheng" /></meta><meta name="dc.Creator" content="Jiayi  Cheng" /></meta><meta name="dc.Creator" content="Binpeng  Xu" /></meta><meta name="dc.Creator" content="Rong  Li" /></meta><meta name="dc.Creator" content="Xinhua  Liu" /></meta><meta name="dc.Creator" content="Yang  Wang" /></meta><meta name="dc.Description" content="In order to discover novel hypoxia-inducible factor 1 (HIF-1) inhibitors for the cancer metastasis treatment, 68 new aryl carboxamide compounds were synthesized and evaluated for their inhibitory e..." /></meta><meta name="Description" content="In order to discover novel hypoxia-inducible factor 1 (HIF-1) inhibitors for the cancer metastasis treatment, 68 new aryl carboxamide compounds were synthesized and evaluated for their inhibitory e..." /></meta><meta name="dc.Publisher" content="American Chemical Society" /></meta><meta name="dc.Date" scheme="WTN8601" content="September 26, 2019" /></meta><meta name="dc.Type" content="research-article" /></meta><meta name="dc.Format" content="text/HTML" /></meta><meta name="dc.Identifier" scheme="doi" content="10.1021/acs.jmedchem.9b01313" /></meta><meta name="dc.Language" content="en" /></meta><meta name="dc.Coverage" content="world" /></meta><meta name="dc.Rights" content="Copyright © 2019 American Chemical Society" /></meta>
        
        

        
            <link rel="meta" type="application/atom+xml" href="https://doi.org/10.1021%2Facs.jmedchem.9b01313" /></link>
            <link rel="meta" type="application/rdf+json" href="https://doi.org/10.1021%2Facs.jmedchem.9b01313" /></link>
            <link rel="meta" type="application/unixref+xml" href="https://doi.org/10.1021%2Facs.jmedchem.9b01313" /></link>
        
    
    

<title>Discovery of Novel Aryl Carboxamide Derivatives as Hypoxia-Inducible Factor 1α Signaling Inhibitors with Potent Activities of Anticancer Metastasis | Journal of Medicinal Chemistry</title>












<meta charset="UTF-8">




<meta name="robots" content="noarchive"/></meta>
<meta name="pb-robots-disabled">









        <meta property="og:url" content="https://pubs.acs.org/doi/full/10.1021/acs.jmedchem.9b01313" /></meta><meta property="og:title" content="Discovery of Novel Aryl Carboxamide Derivatives as Hypoxia-Inducible Factor 1α Signaling Inhibitors with Potent Activities of Anticancer Metastasis" /></meta><meta property="og:image" content="https://pubs.acs.org/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-20/acs.jmedchem.9b01313/20191018/images/large/jm9b01313_0018.jpeg" /></meta><meta property="og:description" content="In order to discover novel hypoxia-inducible factor 1 (HIF-1) inhibitors for the cancer metastasis treatment, 68 new aryl carboxamide compounds were synthesized and evaluated for their inhibitory effect by dual luciferase-reporter assay. Based on five rounds of investigation on structure–activity relationships step by step, compound 30m was discovered as the most active inhibitor (IC50 = 0.32 μM) with no obvious cytotoxicity (CC50 &gt; 50 μM). It effectively attenuated hypoxia-induced HIF-1α protein accumulation and reduced transcription of vascular epidermal growth factor in a dose-dependent manner, which was further demonstrated by its inhibitory potency on capillary-like tube formation, angiogenesis of zebrafish as well as cellular migration and invasion. Importantly, compound 30m exhibited antimetastatic potency in breast cancer lung metastasis in the mice model, indicating its promising therapeutic potential for prevention and treatment of tumor metastasis. These results definitely merit attention for further rational design of more efficient HIF-1 inhibitors in the future." /></meta><meta property="og:type" content="Article" /></meta><meta property="og:site_name" content="ACS Publications" /></meta><meta name="twitter:card" content="summary_large_image" /></meta><meta name="twitter:site" content="@ACSPublications" /></meta>
    


    <meta name="viewport" content="width=device-width,initial-scale=1,maximum-scale=10, user-scalable=0"/></meta>















    

    <meta name="dc.identifier" content="10.1021/acs.jmedchem.9b01313"/></meta>



<meta name="format-detection" content="telephone=no">













<link rel="stylesheet" type="text/css" href="/wro/kfa7~product.css">


    <link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-roboto/font-roboto.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/css/build-f32cfd249ff7cb4cf9c7.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-lato/font-lato.css"/></link>




<meta http-equiv="X-UA-Compatible" content="IE=edge">
<meta http-equiv="content-type" content="text/html; charset=UTF-8">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/achs-1625058702970.css">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/acs-1622125181777.css">
<script type="text/javascript" src="/templates/jsp/js/jquery-3.1.1.min.js"></script>
<script type="text/javascript" src="/pb-assets/javascript/eloqua-1619549134767.js"></script>
<script async="" type="text/javascript" src="https://www.googletagservices.com/tag/js/gpt.js" rel="preconnect"></script>

<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"5200035e6e4d5180","startTime":1570117212010}'></script>






    








    
        
            <script type="text/javascript">
                (function (i, s, o, g, r, a, m) {
                    i['GoogleAnalyticsObject'] = r;
                    i[r] = i[r] || function () {
                        (i[r].q = i[r].q || []).push(arguments)
                    }, i[r].l = 1 * new Date();
                    a = s.createElement(o), m = s.getElementsByTagName(o)[0];
                    a.async = 1;
                    a.src = g;
                    m.parentNode.insertBefore(a, m)
                })(window, document, 'script', '//www.google-analytics.com/analytics.js', 'ga');
                ga('create', 'UA-7663985-4'
                    
                    
                    , 'auto'
                    
                    );
                
                
                ga('send', 'pageview');
            </script>
            
        
    















    
    
            
                
                

                <link rel="canonical" href="https://pubs.acs.org/doi/10.1021/acs.jmedchem.9b01313">
            
        




























    
    

    
    
    
    
    <script src="//unpkg.com/@theidentityselector/thiss-ds"></script>

    <script type="text/javascript">

        var SeamlessAccessService = {
            spUrl: "/action/ssostart",
            returnURL: window.location.href,
            my_context: 'seamlessaccess.org',
            timeout: 5000,

            getWAYFLessUrl: function (entityId) {
                return this.spUrl + "?idp=" + encodeURIComponent(entityId)
                    + "&redirectUri=" + encodeURIComponent(this.returnURL);
            },
            retrieveEntity: function (ms) {
                var self = this;
                var persistService = new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                if(ms == undefined || ms === ''){
                    ms = this.timeout;
                }

                return new Promise(function (resolve, reject) {
                    persistService.entities(self.my_context)
                        .then(function (res) {
                            // get the results
                            var results = res.data;
                            return resolve(results);
                        }, function (err) {
                            // failed
                            reject('retrieve entity error: ' + err);
                        });
                        // Set up the timeout
                        setTimeout(function() {
                            reject('Promise timed out ' + ms + ' ms');
                        }, ms);
                });
            },
            updateEntity: function (entitydata) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                var jsonObj = {};
                try {
                    //try to parse it, if it is a json string
                    jsonObj = JSON.parse(entitydata.val());
                } catch (e) {
                    jsonObj = entitydata;
                }
                return new Promise(function (resolve, reject) {
                    persistService.update(self.my_context, jsonObj)
                        .then(function (res) {
                            // Process the results
                            var ssoInstitutions = res.data;
                            return resolve(ssoInstitutions);
                        }, function (err) {
                            // failed
                            console.log('failed to update the local storage duo to: ' + err);
                            reject(err);
                        });
                })
            },
            removeEntity: function (entityId) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                return new Promise(function (resolve) {
                    persistService.remove(self.my_context, entityId)
                        .then(function (res) {
                            return resolve(res);
                        }, function (err) {
                            // failed
                            console.log('failed to remove from local storage duo to: ' + err);
                        });
                })
            },
            getAccessibleEntityStatus: function (doi, entityId) {
                return new Promise(function (resolve) {
                    $.ajax({
                        type: 'POST',
                        url: '/action/seamlessAccess',
                        accept: {
                            text: "application/json"
                        },
                        data: {doi: doi, entityid: entityId}

                    }).done(function (status) {
                        return resolve(status);
                    });
                });
            },
            getEntitiesWithAllInfo: function (doi) {
                let self = this,
                    arrayOfPromises = [];
                return new Promise(function (resolve, reject) {
                    self.retrieveEntity().then(function (res) {
                        let allSsoInstitutions = res;
                        for (i = 0; i < allSsoInstitutions.length; i++) {
                            let ssoInstitution = allSsoInstitutions[i];
                            arrayOfPromises.push(new Promise(function (resolve) {
                                self.getAccessibleEntityStatus(doi, ssoInstitution.entity.entityID)
                                    .then(function (entityStatus) {
                                        resolve({
                                            entityID: ssoInstitution.entity.entityID,
                                            entityTitle: ssoInstitution.entity.title,
                                            entityStatusObj: entityStatus,
                                            entitySsoUrl: self.getWAYFLessUrl(ssoInstitution.entity.entityID)
                                        });
                                    }, function (err) {
                                        console.log('failed to get the entity status: ' + err);
                                    });
                            }));
                        }
                        Promise.all(arrayOfPromises)
                            .then(function (finalResponse) {
                                resolve(finalResponse);
                            });

                    }).catch(function (err) {
                        reject(err);
                    })
                });
            }
        };

        window.addEventListener('load', function () {
            document.querySelectorAll(".sso-institution").forEach(function (institution) {
                var entityId = institution.getAttribute('data-entityid');
                var entityName = institution.getAttribute('data-name');
                var entitydata = {
                    entityID: entityId,
                    title: entityName
                };
                institution.addEventListener("click", function (e) {
                    e.preventDefault();
                    var self = this;
                    SeamlessAccessService.updateEntity(entitydata).then(function (res) {
                        console.log(res);
                        window.location.href = self.href;
                    }).catch(function (err){
                        window.location.href = self.href;
                    });
                });
            });
        });

    </script>




























    






    <meta name="google-site-verification" content="uBHpu2M2kL7VihPCSRXWyBSxooDf7L_BGgfHA3cjSfY" /></meta>


<link rel="prefetch" href="https://tpc.googlesyndication.com/safeframe/1-0-29/html/container.html"></head>
<body class="pb-ui">


























<script type="text/javascript">

    if(false) {
        document.getElementById("skipNavigationLink").onclick =function skipElement () {
            var element = document.getElementById('');
            if(element == null || element == undefined) {
                element = document.getElementsByClassName('').item(0);
            }
            element.setAttribute('tabindex','0');
            element.focus();

        }

    }

</script>











    <div id="pb-page-content" data-ng-non-bindable>
        <div data-pb-dropzone="main" data-pb-dropzone-name="Main">










        <div data-widget-def="UX3HTMLWidget" data-widget-id="ed6ae788-7707-48f4-b02c-3187c75e10db" class="hide">
        



        
        

        </div>
    




        
        




        
        



        <div class="pb-ad">
            <script type="text/javascript">
	var dartInstitutionType = 'none';
	var dartMember = 'false';
</script>
        </div>
    





        
        <script type="text/javascript">
$(document).ready(function() {
	setTimeout(function() {
		// var journalTitle = 'medicinal_chemistry';
		var taxonomyKeywords = $('.article_header-taxonomy');
		var articleKeyword = $('meta[name="keywords"]');
		var articleTitle = $('meta[name="dc.Title"]');
		var articleDescription = $('meta[name="dc.Description"]');
		var abstractKeyword = $('p.articleBody_abstractText:contains("Keywords: ")');
		var searchTerms = [];

		if (taxonomyKeywords.length > 0) {
			$(taxonomyKeywords).children(".rlist--inline").children("li").each(function() {
				searchTerms.push($(this).text());
			});
		}
		else if (articleKeyword.length > 0) { 
			searchTerms = searchTerms.concat(articleKeyword.prop('content').split(', '));
		}
		else if (abstractKeyword.length > 0) {
			searchTerms = searchTerms.concat(abstractKeyword.text().split("Keywords: ")[1].split('; '));
		}
		else if (articleDescription.length > 0) {
			$(articleDescription).each(function() {
				articleDescriptionKeywords = $(this).prop('content');
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/.,/g,"");
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/\s{2,}/g," ");
				searchTerms = searchTerms.concat(articleDescriptionKeywords.split(' '));
			});
		}

		if (articleTitle.length > 0) {
			searchTerms = searchTerms.concat(articleTitle.prop('content').split(' '));
		}

		googletag.cmd.push(function() {
			var mappingLeader = googletag.sizeMapping().
			addSize([320, 400], [320, 50]).
			addSize([320, 700], [320, 50]).
			addSize([750, 200], [728, 90]). 
			addSize([980, 690], [728, 90]).
			addSize([1024, 768], [728, 90]).
			build();
			//leaderboard
			googletag.defineSlot('/8868/journal/medicinal_chemistry/article', [728, 90], 'dfp-journal-article-leaderboard').defineSizeMapping(mappingLeader).setTargeting('location', 'leaderboard1').setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//recommend
			googletag.defineSlot("/8868/journal/medicinal_chemistry/article", [1, 1], "dfp-journal-article-recommend").setTargeting("ntvPlacement", ["1100167"]).setTargeting("location", "recommend").setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//googletag.pubads().enableSingleRequest();
			googletag.pubads().collapseEmptyDivs();
			googletag.pubads().setTargeting('inst',dartInstitutionType).setTargeting('memb',dartMember);
			googletag.pubads().addEventListener("slotRenderEnded", function(event) {
				if((event.isEmpty === false) && (event.slot.getSlotElementId() != "dfp-journal-article-recommend")) {
					$("#" + event.slot.getSlotElementId()).parents(".advertisement").slideDown();
				}
			});
			googletag.enableServices();
		});
	}, 1000);
});
</script>





        
        <script src="https://common.ccdc.cam.ac.uk/ccdc-widget/1.0.0.76/Widget.min.js"></script>




        
        <header class="header header_article_inactive">



        
        <div class="header_topbar hidden-sm hidden-xs">



        
        <div class="container"><div class="row"><div class="col-lg-3 col-md-4 col-sm-5 header_topbar_left">









        <div data-widget-def="UX3HTMLWidget" data-widget-id="0be92cec-36a8-4b4d-9a08-a28c790ce306" class="header_mainmenu">
        



        
        <ul>
	<li>
		<a href="http://www.acs.org">ACS</a>
	</li>
	<li class="header_mainmenu_current">
		<a href="/">ACS Publications</a>
	</li>
	<li>
		<a href="https://cen.acs.org">C&EN</a>
	</li>
	<li>
		<a href="https://www.cas.org">CAS</a>
	</li>
</ul>

        </div>
    
</div><div class="col-lg-9 col-md-8 col-sm-7 header_topbar_right">



        
        <div class="institution"><span class="institution-info-wrapper"><span class="institution__intro">Access provided by</span><span class="institution__name">Hong Kong University of Science and Technology Library</span></span></div>




        
        <div class="user-login-bar"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" name="heartBeatReloadInterval" value="1740000" class="heartBeatReloadInterval"/></input><input type="hidden" name="logoutUrl" value="https://pubs.acs.org/action/doLogout?logoutRedirectUrl=https%3A%2F%2Fsso.acs.org%2Fidp%2Fglogout%3Fappid%3Datypon-live%26returnURL%3Dhttps%253A%252F%252Fpubs.acs.org%252F" class="logoutUrl"/></input><img src="https://sso.acs.org/idp/heartbeat?appid=atypon-lives&amp;max_auth_age=2592000" alt="Blank image" class="ssoHeartBeatImg"/></img><span class="user-login-bar__value"><a href="https://pubs.acs.org/action/ssoRequestForLoginPage" class="user-login-bar__Login">Log In</a></span><input type="hidden" name="isUserLoggedIn" value="false" class="user-login-bar_is-loggedin"/></input><input type="hidden" name="isPaired" value="false" class="pair-device-is-paired"/></input><input type="hidden" name="isStronglyAuthenticated" value="false" class="isStronglyAuthenticated"/></input></div>
</div></div></div>
</div>




        
        <div class="header_content">



        
        <div class="container"><div class="row"><div class="header_content_main">



        
        <div class="header_content_row">



        
        <div class="header_content_left pull-left">



        
        <a href="/" title="ACS Publications. Most Trusted. Most Cited. Most Read"><img id="" alt="ACS Publications. Most Trusted. Most Cited. Most Read" src="/pb-assets/ux3/pubs-logo-481x82-1523435513963.png"/></img></a>




        
        <div class="pj-badge"></div><a href="/journal/jmcmar" title="journal logo" class="header_article-logo"><img src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo"></a><div class="header_article-separator"></div>
</div><div class="header_content_center">



        
        <div class="header_contnav">
    <div class="header_contnav-row">
         <a href="#" title="Previous" class="header_contnav-pre">
                <i class="icon-angle-left"></i>
        </a>
       <div class="header_contnav-title">
            <span>
                <a href="#" title=""></a>
            </span>
        </div>
         <a href="#" title="Next" class="header_contnav-next">
                <i class="icon-angle-right"></i>
            </a>
    </div>
</div>
</div><div class="header_content_right pull-right">



        
        <div class="header_qv-link"><a href="#" title="Quick View" data-slide-target=".article_qv-xs-container" class="w-slide__btn slide-active icon-quickview">Quick View</a></div>




        
        <div class="header_article-share">



        
        <script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="527d28d6-3414-4cb2-9560-99e677e62c0d" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone1" title="ShareDropzone1"></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone2" title="ShareDropzone2"></div><div data-db-target-of="527d28d6-3414-4cb2-9560-99e677e62c0d" id="527d28d6-3414-4cb2-9560-99e677e62c0d_Pop" class="share__block dropBlock__holder fixed"><div class="pb-dropzone" data-pb-dropzone="shareBlock" title="shareBlock"></div><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>WeChat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li><li><a role="link" class="addthis_button_email"><i aria-hidden="true" class="at-icon-wrapper icon-envelope-o"></i>Email</a></li></ul></div></div>
</div>




        
        <div class="header_article-separator"></div>




        
        <div class="quick-search"><a href="#" aria-label="quick search" class="quick-search_icon icon-search"></a><div class="quick-search_content"><form action="/action/checkIsValidDoi" name="defaultQuickSearch" method="get" title="Quick Search" autocomplete="off" class="quick-search_default"><input type="search" name="AllField" placeholder="Search text, DOI, authors, etc." aria-label="Search text, DOI, authors, etc." data-auto-complete-max-words="7" data-auto-complete-max-chars="32" data-contributors-conf="3" data-topics-conf="3" data-publication-titles-conf="3" data-history-items-conf="3" value="" required="true" class="quick-search_all-field autocomplete"/></input><button type="submit" title="Search" class="icon-search"></button><div role="radiogroup" aria-labelledby="journal filter" class="quick-search_journal-filter"><label for="thisJournalRadio" tabindex="0" aria-checked="true" role="radio" class="radio--primary"><input id="thisJournalRadio" type="radio" value="jmcmar" name="SeriesKey" checked="checked" class="all-content"/></input><span>J. Med. Chem.</span></label><label for="allPubRadio" tabindex="0" aria-checked="false" role="radio" class="radio--primary"><input id="allPubRadio" type="radio" value="" name="SeriesKey" class="all-content"/></input><span>All Publications/Website</span></label></div></form><p>OR SEARCH CITATIONS</p><form action="/action/quickLink" name="citationQuickSearch" method="get" title="Quick Search" class="quick-search_citation"><input type="hidden" name="quickLink" value="true"/></input><select name="quickLinkJournal" class="quick-search_journals-select"><option value="jmcmar">Journal of Medicinal Chemistry</option><option value="achre4">Accounts of Chemical Research</option><option value="amrcda">Accounts of Materials Research</option><option value="aastgj">ACS Agricultural Science & Technology</option><option value="aabmcb">ACS Applied Bio Materials</option><option value="aaembp">ACS Applied Electronic Materials</option><option value="aaemcq">ACS Applied Energy Materials</option><option value="aamick">ACS Applied Materials & Interfaces</option><option value="aanmf6">ACS Applied Nano Materials</option><option value="aapmcd">ACS Applied Polymer Materials</option><option value="abmcb8">ACS Bio & Med Chem Au</option><option value="abseba">ACS Biomaterials Science & Engineering</option><option value="accacs">ACS Catalysis</option><option value="acscii">ACS Central Science</option><option value="acbcct">ACS Chemical Biology</option><option value="achsc5">ACS Chemical Health & Safety</option><option value="acncdm">ACS Chemical Neuroscience</option><option value="acsccc">ACS Combinatorial Science</option><option value="aesccq">ACS Earth and Space Chemistry</option><option value="aelccp">ACS Energy Letters</option><option value="aeacb3">ACS Engineering Au</option><option value="aeacc4">ACS Environmental Au</option><option value="aeecco">ACS ES&T Engineering</option><option value="aewcaa">ACS ES&T Water</option><option value="afsthl">ACS Food Science & Technology</option><option value="aidcbc">ACS Infectious Diseases</option><option value="amlccd">ACS Macro Letters</option><option value="amacgu">ACS Materials Au</option><option value="amlcef">ACS Materials Letters</option><option value="amachv">ACS Measurement Science Au</option><option value="amclct">ACS Medicinal Chemistry Letters</option><option value="ancac3">ACS Nano</option><option value="anaccx">ACS Nanoscience Au</option><option value="acsodf">ACS Omega</option><option value="aoiab5">ACS Organic & Inorganic Au</option><option value="aptsfn">ACS Pharmacology & Translational Science</option><option value="apchd5">ACS Photonics</option><option value="apcach">ACS Physical Chemistry Au</option><option value="apaccd">ACS Polymers Au</option><option value="ascefj">ACS Sensors</option><option value="ascecg">ACS Sustainable Chemistry & Engineering</option><option value="asbcd6">ACS Synthetic Biology</option><option value="ancham">Analytical Chemistry</option><option value="bichaw">Biochemistry</option><option value="bcches">Bioconjugate Chemistry</option><option value="bomaf6">Biomacromolecules</option><option value="bipret">Biotechnology Progress</option><option value="cgeabj">C&EN Global Enterprise</option><option value="cenear">Chemical & Engineering News Archive</option><option value="chlseg">Chemical Health & Safety</option><option value="chlseg0">Chemical Health & Safety</option><option value="crtoec">Chemical Research in Toxicology</option><option value="chreay">Chemical Reviews</option><option value="cmatex">Chemistry of Materials</option><option value="cgdefu">Crystal Growth & Design</option><option value="enfuem">Energy & Fuels</option><option value="esthag">Environmental Science & Technology</option><option value="estlcu">Environmental Science & Technology Letters</option><option value="iepra6.2">I&EC Product Research and Development</option><option value="iechad">Industrial & Engineering Chemistry</option><option value="iecac0">Industrial & Engineering Chemistry Analytical Edition</option><option value="iecjc0">Industrial & Engineering Chemistry Chemical & Engineering Data Series</option><option value="iecfa7">Industrial & Engineering Chemistry Fundamentals</option><option value="iepdaw">Industrial & Engineering Chemistry Process Design and Development</option><option value="iepra6">Industrial & Engineering Chemistry Product Research and Development</option><option value="iecred">Industrial & Engineering Chemistry Research</option><option value="iecnav">Industrial and Engineering Chemistry, News Edition</option><option value="inocaj">Inorganic Chemistry</option><option value="jaaucr">JACS Au</option><option value="jacsat">Journal of the American Chemical Society</option><option value="jafcau">Journal of Agricultural and Food Chemistry</option><option value="jceaax">Journal of Chemical & Engineering Data</option><option value="jci001">Journal of Chemical Documentation</option><option value="jceda8">Journal of Chemical Education</option><option value="jchsc2">Journal of Chemical Health & Safety</option><option value="jchsc20">Journal of Chemical Health & Safety</option><option value="jcics1">Journal of Chemical Information and Computer Sciences</option><option value="jcisd8">Journal of Chemical Information and Modeling</option><option value="jctcce">Journal of Chemical Theory and Computation</option><option value="jcchff">Journal of Combinatorial Chemistry</option><option value="iechad.1">Journal of Industrial & Engineering Chemistry</option><option value="jmcmar.1">Journal of Medicinal and Pharmaceutical Chemistry</option><option value="jnprdf">Journal of Natural Products</option><option value="joceah">The Journal of Organic Chemistry</option><option value="jpchax">The Journal of Physical Chemistry</option><option value="jpchax.2">The Journal of Physical Chemistry</option><option value="jpcafh">The Journal of Physical Chemistry A</option><option value="jpcbfk">The Journal of Physical Chemistry B</option><option value="jpccck">The Journal of Physical Chemistry C</option><option value="jpclcd">The Journal of Physical Chemistry Letters</option><option value="jprobs">Journal of Proteome Research</option><option value="jamsef">Journal of the American Society for Mass Spectrometry</option><option value="jamsef1">Journal of the American Society for Mass Spectrometry</option><option value="jamsef0">Journal of the American Society for Mass Spectrometry</option><option value="langd5">Langmuir</option><option value="mamobx">Macromolecules</option><option value="mpohbp">Molecular Pharmaceutics</option><option value="nalefd">Nano Letters</option><option value="neaca9">News Edition, American Chemical Society</option><option value="orlef7">Organic Letters</option><option value="oprdfk">Organic Process Research & Development</option><option value="orgnd7">Organometallics</option><option value="iepra6.1">Product R&D</option><option value="scimts">SciMeetings</option><option value="jpchax.1">The Journal of Physical and Colloid Chemistry</option></select><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkVolume" autoComplete="false" placeholder="Vol" required="required" class="quick-search_volume-input"/></input><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkPage" autoComplete="false" placeholder="Page" required="required" class="quick-search_page-input"/></input><button type="submit" title="Search" class="icon-search"></button></form></div></div>




        
        <div class="header_my-activity">



        
        <a href="#"><i class="icon-id-badge" aria-hidden=”true”></i><span>My Activity</span></a>
<div class="header_my-activity-content">
    <div class="header_my-activity-single">
        <i aria-hidden="true" aria-label="close" class="icon-close"></i>
        <div class="" data-name="recentlyViewedDropzone">



        
        <div class="show-recently"><div class="show-recently-header">Recently Viewed</div><h6 class="show-recently-empty">You have not visited any articles yet, Please visit some articles to see contents here. </h6></div>
</div>
    </div>
</div>
</div>




        
        <div class="header_publications">



        
        <a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>Publications</span></a>

</div>




        
        <div class="header_burger-menu">



        
        <a href="#?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuIcon&amp;utm_campaign=Pubs_Refere" class="header_burger-menu_button" title="menu button" aria-label="menu button"><i class="icon-navicon"></i><i
        class="icon-close"></i></a>
<div class="header_burger-menu_content">
    <ul class="hidden-lg">
        <li><a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>publications</span></a></li>
        <li class="myActivityMobile"><a href="#" class="openTabletActivity"><i class="icon-id-badge" aria-hidden=”true”></i><span>my Activity</span></a>
            <ul>
                <li><a href="javascript:void(0)" class="recentlyViewed--open">Recently Viewed</a></li>
            </ul>
        </li>
    </ul>
    <ul>
        <li><a href="#">user resources</a>
            <ul>
                <li><a href="/page/remoteaccess"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Access Options');">Access Options</a></li>
                <li><a href="https://publish.acs.org/publish/"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Authors & Reviewers');">Authors &
                        Reviewers</a></li>
                <li><a href="http://www.acs.org/content/acs/en/membership-and-networks/acs/benefits/professional/publications-benefits.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS Members');">ACS Members</a></li>
                <li><a href="https://preferences.acspubs.org/journals"
                        onclick="ga('send', 'event', 'Home_MainMenu', 'Click', 'eAlert');">eAlerts</a></li>
                <li><a href="/page/follow.html?widget=follow-pane-mobile"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'RSS & Mobile');">RSS & Mobile</a></li>
            </ul>
        </li>
		<li><a href="#">for organizations</a>
			<ul>
			    <li><a href="https://solutions.acs.org/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Products & Services');">Products & Services</a></li>
				<li><a href="https://solutions.acs.org/access-options/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Get Access');">Get Access</a></li>
				<li><a href="https://solutions.acs.org/resources/manage-my-account/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Manage My Account');">Manage My Account</a></li>
			</ul>
		</li>
        <li><a href="#">support</a>
            <ul>
                <li><a href="/page/demo/index.html">Website Demos & Tutorials</a></li>
                <li><a href="https://acs.service-now.com/acs"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Support FAQs');">Support FAQs </a></li>
                <li><a href="#"
                        onClick="SnapEngage.startLink();return false; ga('send', 'event', 'Top Nav', 'Menu', 'Live Chat with Agent');"
                        class="help help-chat">Live Chat with Agent</a></li>
                <li><a href="https://acsmediakit.org/digital/acs-pubs/?utm_source=Nav&amp;utm_medium=Pubs&amp;utm_campaign=CEN"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Advertisers');">For Advertisers</a></li>
                <li><a href="https://solutions.acs.org/help/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Librarians & Account Managers');">For
                        Librarians & Account Managers</a></li>
            </ul>
        </li>
        <li class="hidden-sm hidden-xs"><a href="#">pairing</a>
            <ul>
                <li><a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a></li>
                <li><a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Pair this device');">Pair this device</a></li>
                <li><a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
                </li>
            </ul>
        </li>
        <li class="hidden-lg hidden-md">
            <a class="header_burger-menu_my-profile-link" href="/action/showPreferences">My Profile</a>
            <a class="header_burger-menu_login-link" href="/action/ssoRequestForLoginPage">Login</a>
            <a class="header_burger-menu_logout-link" href="#">Logout</a>
            <a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a>
            <a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode">Pair this
                device</a>
            <a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
        </li>
        <li><a href="#">about us</a>
            <ul>
                <li><a href="/page/about-us.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Overview');">Overview</a></li>
                <li><a href="http://acsopenscience.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS & Open Access');">ACS & Open Access</a>
                </li>
                <li><a href="/#partners" onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Partners');">Partners</a></li>
                <li><a href="http://acsoncampus.acs.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Events');">Events</a></li>
            </ul>
        </li>
    </ul>
</div>
<div class="activity-container-tablet"><i aria-hidden="true" class="icon-close"></i></div>


<script type="text/javascript">
  (function() {
    var se = document.createElement('script'); se.type = 'text/javascript'; se.async = true;
    se.src = 'https://storage.googleapis.com/code.snapengage.com/js/921a4ec7-cecf-43a6-afa5-6cd1346520b1.js';
    var done = false;
    se.onload = se.onreadystatechange = function() {
      if (!done&&(!this.readyState||this.readyState==='loaded'||this.readyState==='complete')) {
        done = true;
        /* Place your SnapEngage JS API code below */
        /* SnapEngage.allowChatSound(true); Example JS API: Enable sounds for Visitors. */
      }
    };
    var s = document.getElementsByTagName('script')[0]; s.parentNode.insertBefore(se, s);
  })();
</script>

<style>
    #SnapABug_Button,
    #designstudio-button {
        display: none;
    }
</style>

</div>
</div>
</div>
</div></div></div>
</div>




        
        <div class="pub"><div aria-live="polite" aria-atomic="true" class="pub-modal"><div class="pub-modal_content loop-trap"><a href="#" aria-label="close" tabindex="0" class="pub-modal_close icon-close pull-right"></a><div class="pub-modal_row"><div class="pub-modal_left"><div class="pub-modal_left-content"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_types"><h6>CONTENT TYPES</h6><ul class="pub-modal_types-list"><li data-type="all" id="allID" class="pub-modal_types-active"><a href="#"><h4>All Types</h4></a></li></ul></div><div class="pub-modal_subjects hidden-sm hidden-xs"><h6>SUBJECTS</h6><ul class="pub-modal_subjects-list"></ul></div></div></div><div class="pub-modal_right"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications: All Types</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_right--inner"><div class="pub-content"></div></div></div></div></div><input type="hidden" name="pubModalData" value="{&quot;types&quot;:[{&quot;code&quot;:&quot;journals&quot;,&quot;label&quot;:&quot;Journals&quot;},{&quot;code&quot;:&quot;books&quot;,&quot;label&quot;:&quot;Books and Reference&quot;},{&quot;code&quot;:&quot;news&quot;,&quot;label&quot;:&quot;News&quot;}],&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;,&quot;label&quot;:&quot;Analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;,&quot;label&quot;:&quot;Applied&quot;},{&quot;code&quot;:&quot;cat_biological&quot;,&quot;label&quot;:&quot;Biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;,&quot;label&quot;:&quot;Materials Science &amp; Engineering&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;,&quot;label&quot;:&quot;Organic-Inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;,&quot;label&quot;:&quot;Physical&quot;}],&quot;publications&quot;:[{&quot;char&quot;:&quot;A&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achre4/2021/achre4.2021.54.issue-15/achre4.2021.54.issue-15/20210803/achre4.2021.54.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;achre4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Chemical Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achre4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amrcda/2021/amrcda.2021.2.issue-7/amrcda.2021.2.issue-7/20210723/amrcda.2021.2.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amrcda&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Materials Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amrcda&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aastgj/2021/aastgj.2021.1.issue-3/aastgj.2021.1.issue-3/20210621/aastgj.2021.1.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aastgj&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS Agricultural Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aastgj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aabmcb/2021/aabmcb.2021.4.issue-7/aabmcb.2021.4.issue-7/20210719/aabmcb.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aabmcb&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Bio Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aabmcb&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaembp/2021/aaembp.2021.3.issue-7/aaembp.2021.3.issue-7/20210727/aaembp.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaembp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Electronic Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaembp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaemcq/2021/aaemcq.2021.4.issue-7/aaemcq.2021.4.issue-7/20210726/aaemcq.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaemcq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Energy Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaemcq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aamick/2021/aamick.2021.13.issue-30/aamick.2021.13.issue-30/20210804/aamick.2021.13.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;aamick&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Materials &amp; Interfaces&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aamick&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aanmf6/2021/aanmf6.2021.4.issue-7/aanmf6.2021.4.issue-7/20210723/aanmf6.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aanmf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Nano Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aanmf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aapmcd/2021/aapmcd.2021.3.issue-7/aapmcd.2021.3.issue-7/20210709/aapmcd.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aapmcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Polymer Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aapmcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/abmcb8/largecover.png&quot;,&quot;code&quot;:&quot;abmcb8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;}],&quot;name&quot;:&quot;ACS Bio &amp; Med Chem Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abmcb8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/abseba/2021/abseba.2021.7.issue-7/abseba.2021.7.issue-7/20210712/abseba.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;abseba&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Biomaterials Science &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abseba&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/accacs/2021/accacs.2021.11.issue-14/accacs.2021.11.issue-14/20210716/accacs.2021.11.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;accacs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Catalysis&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/accacs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acscii/2021/acscii.2021.7.issue-7/acscii.2021.7.issue-7/20210728/acscii.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acscii&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Central Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acscii&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acbcct/2021/acbcct.2021.16.issue-7/acbcct.2021.16.issue-7/20210716/acbcct.2021.16.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acbcct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acbcct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achsc5/2021/achsc5.2021.28.issue-4/achsc5.2021.28.issue-4/20210726/achsc5.2021.28.issue-4.largecover.jpg&quot;,&quot;code&quot;:&quot;achsc5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Health &amp; Safety&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achsc5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acncdm/2021/acncdm.2021.12.issue-15/acncdm.2021.12.issue-15/20210804/acncdm.2021.12.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;acncdm&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Neuroscience&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acncdm&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsccc/2020/acsccc.2020.22.issue-12/acsccc.2020.22.issue-12/20201214/acsccc.2020.22.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;acsccc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Combinatorial Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsccc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aesccq/2021/aesccq.2021.5.issue-7/aesccq.2021.5.issue-7/20210715/aesccq.2021.5.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aesccq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Earth and Space Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aesccq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aelccp/2021/aelccp.2021.6.issue-7/aelccp.2021.6.issue-7/20210709/aelccp.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aelccp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Energy Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aelccp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacb3/largecover.png&quot;,&quot;code&quot;:&quot;aeacb3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Engineering Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacb3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacc4/largecover.png&quot;,&quot;code&quot;:&quot;aeacc4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Environmental Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacc4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aeecco/2021/aeecco.2021.1.issue-7/aeecco.2021.1.issue-7/20210709/aeecco.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aeecco&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS ES&amp;T Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeecco&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aewcaa/2021/aewcaa.2021.1.issue-7/aewcaa.2021.1.issue-7/20210709/aewcaa.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aewcaa&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS ES&amp;T Water&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aewcaa&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/afsthl/2021/afsthl.2021.1.issue-6/afsthl.2021.1.issue-6/20210716/afsthl.2021.1.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;afsthl&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Food Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/afsthl&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;styleguide&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;}],&quot;name&quot;:&quot;ACS Guide to Scholarly Communication&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/styleguide&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;infocus&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS In Focus&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/infocus&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aidcbc/2021/aidcbc.2021.7.issue-7/aidcbc.2021.7.issue-7/20210709/aidcbc.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aidcbc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Infectious Diseases&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aidcbc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlccd/2021/amlccd.2021.10.issue-7/amlccd.2021.10.issue-7/20210720/amlccd.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amlccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Macro Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amacgu/largecover.png&quot;,&quot;code&quot;:&quot;amacgu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Materials Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amacgu&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlcef/2021/amlcef.2021.3.issue-8/amlcef.2021.3.issue-8/20210802/amlcef.2021.3.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;amlcef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Materials Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlcef&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amachv/largecover.png&quot;,&quot;code&quot;:&quot;amachv&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;}],&quot;name&quot;:&quot;ACS Measurement Science Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amachv&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amclct/2021/amclct.2021.12.issue-7/amclct.2021.12.issue-7/20210708/amclct.2021.12.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amclct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Medicinal Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amclct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancac3/2021/ancac3.2021.15.issue-7/ancac3.2021.15.issue-7/20210727/ancac3.2021.15.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ancac3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Nano&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancac3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/anaccx/largecover.png&quot;,&quot;code&quot;:&quot;anaccx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Nanoscience Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/anaccx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsodf/2021/acsodf.2021.6.issue-30/acsodf.2021.6.issue-30/20210803/acsodf.2021.6.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;acsodf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Omega&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsodf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aoiab5/largecover.png&quot;,&quot;code&quot;:&quot;aoiab5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;}],&quot;name&quot;:&quot;ACS Organic &amp; Inorganic Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aoiab5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aptsfn/2021/aptsfn.2021.4.issue-3/aptsfn.2021.4.issue-3/20210611/aptsfn.2021.4.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aptsfn&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Pharmacology &amp; Translational Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aptsfn&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/apchd5/2021/apchd5.2021.8.issue-7/apchd5.2021.8.issue-7/20210721/apchd5.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;apchd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Photonics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apchd5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apcach/largecover.png&quot;,&quot;code&quot;:&quot;apcach&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;}],&quot;name&quot;:&quot;ACS Physical Chemistry Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apcach&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apaccd/largecover.png&quot;,&quot;code&quot;:&quot;apaccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Polymers Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apaccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/reagents/2017/acsreagents/acsreagents/20170228/acsreagents.largecover.png&quot;,&quot;code&quot;:&quot;reagents&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS Reagent Chemicals&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/reagents&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascefj/2021/ascefj.2021.6.issue-7/ascefj.2021.6.issue-7/20210723/ascefj.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ascefj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sensors&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascefj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascecg/2021/ascecg.2021.9.issue-30/ascecg.2021.9.issue-30/20210802/ascecg.2021.9.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ascecg&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sustainable Chemistry &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascecg&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/symposium/2021/bk-2021-1379/bk-2021-1379/20210430-01/bk-2021-1379.largecover.jpg&quot;,&quot;code&quot;:&quot;symposium&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;ACS Symposium Series&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/symposium&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/asbcd6/2021/asbcd6.2021.10.issue-7/asbcd6.2021.10.issue-7/20210716/asbcd6.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;asbcd6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Synthetic Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/asbcd6&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;advances&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;Advances in Chemistry&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/advances&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancham/2021/ancham.2021.93.issue-30/ancham.2021.93.issue-30/20210803/ancham.2021.93.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ancham&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Analytical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancham&quot;}]},{&quot;char&quot;:&quot;B&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bichaw/2021/bichaw.2021.60.issue-30/bichaw.2021.60.issue-30/20210803/bichaw.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;bichaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biochemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bichaw&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bcches/2021/bcches.2021.32.issue-7/bcches.2021.32.issue-7/20210721/bcches.2021.32.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bcches&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Bioconjugate Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bcches&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bomaf6/2021/bomaf6.2021.22.issue-7/bomaf6.2021.22.issue-7/20210712/bomaf6.2021.22.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bomaf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biomacromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bomaf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/bipret/largecover.jpg&quot;,&quot;code&quot;:&quot;bipret&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;Biotechnology Progress&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bipret&quot;}]},{&quot;char&quot;:&quot;C&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgeabj/2021/cgeabj.2021.99.issue-28/cgeabj.2021.99.issue-28/20210802/cgeabj.2021.99.issue-28.largecover.jpg&quot;,&quot;code&quot;:&quot;cgeabj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;C&amp;EN Global Enterprise&quot;,&quot;type&quot;:&quot;news&quot;,&quot;url&quot;:&quot;/journal/cgeabj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/crtoec/2021/crtoec.2021.34.issue-7/crtoec.2021.34.issue-7/20210719/crtoec.2021.34.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;crtoec&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Research in Toxicology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/crtoec&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/chreay/2021/chreay.2021.121.issue-14/chreay.2021.121.issue-14/20210728/chreay.2021.121.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;chreay&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;articletoc&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Reviews&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/chreay&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cmatex/2021/cmatex.2021.33.issue-14/cmatex.2021.33.issue-14/20210727/cmatex.2021.33.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;cmatex&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemistry of Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cmatex&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgdefu/2021/cgdefu.2021.21.issue-8/cgdefu.2021.21.issue-8/20210804/cgdefu.2021.21.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;cgdefu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Crystal Growth &amp; Design&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cgdefu&quot;}]},{&quot;char&quot;:&quot;E&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/enfuem/2021/enfuem.2021.35.issue-14/enfuem.2021.35.issue-14/20210715/enfuem.2021.35.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;enfuem&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Energy &amp; Fuels&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/enfuem&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/esthag/2021/esthag.2021.55.issue-15/esthag.2021.55.issue-15/20210803/esthag.2021.55.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;esthag&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/esthag&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/estlcu/2021/estlcu.2021.8.issue-7/estlcu.2021.8.issue-7/20210713/estlcu.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;estlcu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/estlcu&quot;}]},{&quot;char&quot;:&quot;I&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.2&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;I&amp;EC Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.2&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecac0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Analytical Edition&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecac0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecjc0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Chemical &amp; Engineering Data Series&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecjc0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecfa7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Fundamentals&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecfa7&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepdaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Process Design and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepdaw&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/iecred/2021/iecred.2021.60.issue-30/iecred.2021.60.issue-30/20210804/iecred.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;iecred&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecred&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/inocaj/2021/inocaj.2021.60.issue-15/inocaj.2021.60.issue-15/20210802/inocaj.2021.60.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;inocaj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Inorganic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/inocaj&quot;}]},{&quot;char&quot;:&quot;J&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jaaucr/2021/jaaucr.2021.1.issue-7/jaaucr.2021.1.issue-7/20210726/jaaucr.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jaaucr&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;JACS Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jaaucr&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jafcau/2021/jafcau.2021.69.issue-30/jafcau.2021.69.issue-30/20210804/jafcau.2021.69.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jafcau&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Agricultural and Food Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jafcau&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceaax/2021/jceaax.2021.66.issue-7/jceaax.2021.66.issue-7/20210708/jceaax.2021.66.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceaax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical &amp; Engineering Data&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceaax&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jci001&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Documentation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jci001&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceda8/2021/jceda8.2021.98.issue-7/jceda8.2021.98.issue-7/20210713/jceda8.2021.98.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceda8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;divched&quot;}],&quot;name&quot;:&quot;Journal of Chemical Education&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceda8&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jcics1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Computer Sciences&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcics1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jcisd8/2021/jcisd8.2021.61.issue-7/jcisd8.2021.61.issue-7/20210726/jcisd8.2021.61.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jcisd8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Modeling&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcisd8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jctcce/2021/jctcce.2021.17.issue-7/jctcce.2021.17.issue-7/20210713/jctcce.2021.17.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jctcce&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Theory and Computation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jctcce&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad.1&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jmcmar.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal and Pharmaceutical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar.1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-14/jmcmar.2021.64.issue-14/20210722/jmcmar.2021.64.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;jmcmar&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jnprdf/2021/jnprdf.2021.84.issue-7/jnprdf.2021.84.issue-7/20210723/jnprdf.2021.84.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jnprdf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Natural Products&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jnprdf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/joceah/2021/joceah.2021.86.issue-14/joceah.2021.86.issue-14/20210716/joceah.2021.86.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;joceah&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Organic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/joceah&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jpchax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpchax&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcafh/2021/jpcafh.2021.125.issue-29/jpcafh.2021.125.issue-29/20210729/jpcafh.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcafh&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry A&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcafh&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcbfk/2021/jpcbfk.2021.125.issue-29/jpcbfk.2021.125.issue-29/20210729/jpcbfk.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcbfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry B&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcbfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpccck/2021/jpccck.2021.125.issue-29/jpccck.2021.125.issue-29/20210729/jpccck.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpccck&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry C&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpccck&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpclcd/2021/jpclcd.2021.12.issue-29/jpclcd.2021.12.issue-29/20210729/jpclcd.2021.12.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpclcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpclcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jprobs/2021/jprobs.2021.20.issue-7/jprobs.2021.20.issue-7/20210702/jprobs.2021.20.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jprobs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Proteome Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jprobs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jacsat/2021/jacsat.2021.143.issue-30/jacsat.2021.143.issue-30/20210804/jacsat.2021.143.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jacsat&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Chemical Society&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jacsat&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jamsef/2021/jamsef.2021.32.issue-8/jamsef.2021.32.issue-8/20210804/jamsef.2021.32.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;jamsef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Society for Mass Spectrometry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jamsef&quot;}]},{&quot;char&quot;:&quot;L&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/langd5/2021/langd5.2021.37.issue-30/langd5.2021.37.issue-30/20210803/langd5.2021.37.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;langd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Langmuir&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/langd5&quot;}]},{&quot;char&quot;:&quot;M&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mamobx/2021/mamobx.2021.54.issue-14/mamobx.2021.54.issue-14/20210727/mamobx.2021.54.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;mamobx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Macromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mamobx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mpohbp/2021/mpohbp.2021.18.issue-8/mpohbp.2021.18.issue-8/20210802/mpohbp.2021.18.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;mpohbp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Molecular Pharmaceutics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mpohbp&quot;}]},{&quot;char&quot;:&quot;N&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/nalefd/2021/nalefd.2021.21.issue-14/nalefd.2021.21.issue-14/20210728/nalefd.2021.21.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;nalefd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Nano Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/nalefd&quot;}]},{&quot;char&quot;:&quot;O&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orlef7/2021/orlef7.2021.23.issue-14/orlef7.2021.23.issue-14/20210716/orlef7.2021.23.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orlef7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orlef7&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/oprdfk/2021/oprdfk.2021.25.issue-7/oprdfk.2021.25.issue-7/20210716/oprdfk.2021.25.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;oprdfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Process Research &amp; Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/oprdfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orgnd7/2021/orgnd7.2021.40.issue-14/orgnd7.2021.40.issue-14/20210726/orgnd7.2021.40.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orgnd7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organometallics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orgnd7&quot;}]},{&quot;char&quot;:&quot;P&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Product R&amp;D&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.1&quot;}]}]}"/></input></div></div>
</header>




        
        <main data-widget-id="28284a6d-730d-4a56-93ad-909787c5ac1b" id="" class="content article"><article data-figures="https://pubs.acs.org/action/ajaxShowFigures?doi=10.1021%2Facs.jmedchem.9b01313&amp;ajax=true" data-references="https://pubs.acs.org/action/ajaxShowEnhancedAbstract?doi=10.1021%2Facs.jmedchem.9b01313&amp;ajax=true" data-enable-mathjax="true"><div class="figure-viewer"><div class="figure-viewer_row"><div class="figure-viewer_col loop-trap"><div aria-live="polite" aria-atomic="true" class="figure-viewer_modal"><a href="#" title="Close" aria-label="close" tabindex="0" class="figure-viewer_close icon-close"></a><h2 class="figure-viewer_label"><span class="figure-viewer_current"></span></h2><div class="figure-viewer_image"><a href="#" title="Next" class="figure-viewer_next icon-angle-right"></a><a href="#" title="Previous" class="figure-viewer_prev icon-angle-left"></a><div class="figure-viewer_image-content"><img src="" alt="Figure 1" class="fv-img"/></img><img src="/pb-assets/ux3/loading-1525090748317.gif" alt="Loading Img" class="loading-img"/></img></div></div><div class="figure-viewer_links"><a href="#" title="Download Hi-Res Image" target="_blank" class="figure-viewer_hi-res-link"><i class="icon-file-image-o"></i><span>Download Hi-Res Image</span></a><span class="fv-separator"></span><a href="#" title="Download to MS-PowerPoint" class="figure-viewer_ms-p-link"><i class="icon-file-powerpoint-o"></i><span>Download to MS-PowerPoint</span></a><span class="cit-this-container"><a href="/action/showCitFormats?doi=10.1021/acs.jmedchem.9b01313&amp;href=/doi/10.1021/acs.jmedchem.9b01313" title="Cite This" class="figure-viewer-cite-this-link"><i class="icon-check-circle"></i><span><strong>Cite This:</strong></span></a><span class="article_header-cite-this figure-viewer-cite-this"><span class="cit-fg-title"><i>J. Med. Chem.</i></span><span class="cit-fg-year"> 2019</span><span class="cit-fg-volume">, 62</span><span class="cit-fg-issue">, 20</span><span class="cit-fg-pageRange">, 9299-9314</span></span></span></div></div></div></div></div><div class="article_fullPage"><div class="article_header"><div class="articleHeaderDropzone5" data-pb-dropzone="articleHeaderDropzone5"><div class="advertisement">
	<div class="advertisement-link">
		<a href="http://acsmediakit.org">ADVERTISEMENT</a>
	</div>
	<div id="dfp-journal-article-leaderboard">
		<script type="text/javascript">
			$(document).ready(function() {
				setTimeout(function() {
					googletag.cmd.push(function() { googletag.display("dfp-journal-article-leaderboard"); });
				}, 1400);
			});
		</script>
	</div>
</div></div><div class="container container_scaled-down"><div class="row"><div class="col-xs-12.clearfix"><div class="article_header-left pull-left"><div class="article_header-dropzone-1"><div class="articleHeaderDropzone1" data-pb-dropzone="articleHeaderDropzone1"><div class="content-navigation clearfix"><a href="/toc/jmcmar/62/20" title="Return to Issue" id="returnToIssues" class="content-navigation__btn--return"><span>RETURN TO ISSUE</span></a><a href="/doi/10.1021/acs.jmedchem.9b01264" title="Previous" id="prevID" class="content-navigation__btn--pre"><i class="icon-angle-left"></i><span>PREV</span></a><span class="content-navigation__contentType">Article</span><a href="/doi/10.1021/acs.jmedchem.9b01340" title="Next" id="nextID" class="content-navigation__btn--next"><span>NEXT</span><i class="icon-angle-right"></i></a></div></div></div><div class="headerLogo_e-alertsMobile_container"><div class="article_header-logo hidden-lg"><div class="pj-badge"></div><a href="/journal/jmcmar" title="Journal Logo"><img src="/specs/ux3/releasedAssets/images/loader.gif" data-src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo" /></img></a></div><div class="e-alertsMobile_container hidden-md hidden-lg"></div></div><h1 class="article_header-title"><span class="hlFld-Title">Discovery of Novel Aryl Carboxamide Derivatives as Hypoxia-Inducible Factor 1α Signaling Inhibitors with Potent Activities of Anticancer Metastasis</span></h1><ul class="loa"><li><span><span class="hlFld-ContribAuthor">Mingming Liu</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Mingming Liu</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">School of Pharmacy, Anhui Medical University, Hefei 230032, China</div><div class="loa-info-affiliations-info">Shanghai Key Laboratory of New Drug Design, East China University of Science and Technology, Shanghai 200237, China</div><div class="loa-info-affiliations-info">Anhui Chem-Bright Bioengineering Company Limited, Huaibei 235025, China</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Mingming++Liu">Mingming Liu</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Yuru Liang</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Yuru Liang</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">School of Pharmacy, Fudan University, Shanghai 201203, China</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Yuru++Liang">Yuru Liang</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Zhongzhen Zhu</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Zhongzhen Zhu</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">School of Pharmacy, Anhui Medical University, Hefei 230032, China</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Zhongzhen++Zhu">Zhongzhen Zhu</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Jin Wang</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Jin Wang</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">School of Pharmacy, Anhui Medical University, Hefei 230032, China</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Jin++Wang">Jin Wang</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Xingxing Cheng</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Xingxing Cheng</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">School of Pharmacy, Anhui Medical University, Hefei 230032, China</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Xingxing++Cheng">Xingxing Cheng</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Jiayi Cheng</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Jiayi Cheng</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">School of Pharmacy, Fudan University, Shanghai 201203, China</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Jiayi++Cheng">Jiayi Cheng</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Binpeng Xu</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Binpeng Xu</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Anhui Chem-Bright Bioengineering Company Limited, Huaibei 235025, China</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Binpeng++Xu">Binpeng Xu</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Rong Li</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Rong Li</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">School of Pharmacy, Anhui Medical University, Hefei 230032, China</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Rong++Li">Rong Li</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Xinhua Liu</span><strong>*</strong><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Xinhua Liu</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">School of Pharmacy, Anhui Medical University, Hefei 230032, China</div></div><span class="conrtib-corresp"><strong>*</strong>E-mail: <a href="/cdn-cgi/l/email-protection#2058484c49554858601116130e434f4d"><span class="__cf_email__" data-cfemail="ea928286839f8292aadbdcd9c4898587">[email protected]</span></a>. Phone: +86-551-65172353. Fax: +86-551-65172353 (X.L.).</span><span class="conrtib-corresp"></span><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Xinhua++Liu">Xinhua Liu</a></span></div><div class="loa-info-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0002-7984-2977" title="Orcid link">http://orcid.org/0000-0002-7984-2977</a></div></div></span></li><span class="comma-separator">, and </span><li><span><span class="hlFld-ContribAuthor">Yang Wang</span><strong>*</strong><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Yang Wang</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">School of Pharmacy, Fudan University, Shanghai 201203, China</div></div><span class="conrtib-corresp"><strong>*</strong>E-mail: <a href="/cdn-cgi/l/email-protection#80f7e1eee7f9e1eee7c0f3e8edf5aee5e4f5aee3ee"><span class="__cf_email__" data-cfemail="6f180e0108160e01082f1c07021a410a0b1a410c01">[email protected]</span></a>. Phone: +86-21-51980115 (Y.W.).</span><span class="conrtib-corresp"></span><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Yang++Wang">Yang Wang</a></span></div></div></span></li><span class="comma-separator"></span></ul><div class="article_header-meta clearfix"><div class="article_header-meta-left pull-left"><input type="hidden" name="journalCodeForjhpLink" value="jmcmar" /></input><input type="hidden" name="journalNameForjhpLink" value="Journal of Medicinal Chemistry" /></input><div class="article_header-cite-this"><a href="/action/showCitFormats?doi=10.1021%2Facs.jmedchem.9b01313&amp;href=/doi/10.1021%2Facs.jmedchem.9b01313" title="Cite This"><i class="icon-check-circle"></i><strong>Cite this: </strong></a><span class="cit-title"><i>J. Med. Chem.</i></span> <span class="cit-year-info"><span>2019</span></span><span class="cit-volume">, 62</span><span class="cit-issue">, 20</span><span class="cit-pageRange">, 9299–9314</span></div><div class="article_header-epubdate"><span class="pub-date epub-date">Publication Date</span><span class="web-text"> (Web)</span><span class="date-separator">:</span><span class="pub-date-value">September 26, 2019</span><div class="article_header-history base dropBlock"><a href="#" data-db-target-for="article_header-history" title="History" target="_self" class="" aria-expanded="false"><i class="icon-angle-down"></i><i class="icon-angle-up"></i></a><div data-db-target-of="article_header-history" class="dropBlock__holder" aria-hidden="true"><div class="articleHeaderHistoryDropzone" data-pb-dropzone="articleHeaderHistoryDropzone"><h4>Publication History</h4>




        
        <ul class="rlist article-chapter-history-list"><li><span class="item_label"><b>Received</b></span>10 August 2019</li><li><span class="item_label"><b>Published</b> online</span>26 September 2019</li><li><span class="item_label"><b>Published</b> in</span><span class="item_label-issue">issue</span> 24 October 2019</li></ul></div></div></div></div><div class="article_header-doiurl"><a href="https://doi.org/10.1021/acs.jmedchem.9b01313" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.9b01313</a></div><div class="article_header-article-copyright"><strong>Copyright © 2019 American Chemical Society</strong></div><div class="article_rightPermissionsLink"><div class="articleHeaderDropzone4" data-pb-dropzone="articleHeaderDropzone4"><div class="articleRightsPermissionsLink"><a href="/servlet/linkout?type=rightslink&amp;url=startPage%3D9299%26pageCount%3D16%26copyright%3DAmerican%2BChemical%2BSociety%26author%3DMingming%2BLiu%252C%2BYuru%2BLiang%252C%2BZhongzhen%2BZhu%252C%2Bet%2Bal%26orderBeanReset%3Dtrue%26imprint%3DAmerican%2BChemical%2BSociety%26volumeNum%3D62%26issueNum%3D20%26contentID%3Dacs.jmedchem.9b01313%26title%3DDiscovery%2Bof%2BNovel%2BAryl%2BCarboxamide%2BDerivatives%2Bas%2BHypoxia-Inducible%2BFactor%2B1%25CE%25B1%2BSignaling%2BInhibitors%2Bwith%2BPotent%2BActivities%2Bof%2BAnticancer%2BMetastasis%26numPages%3D16%26pa%3D%26issn%3D0022-2623%26publisherName%3Dacs%26publication%3Djmcmar%26rpt%3Dn%26endPage%3D9314%26publicationDate%3DOctober%2B2019">RIGHTS & PERMISSIONS</a></div></div></div><div class="article_header-access-block"><div class="article_header-open-access"></div><div class="article_header-access-icon"><img src="/products/achs/releasedAssets/images/subscribed.svg" alt="Subscribed Access" /></img></div></div></div><div class="article_header-meta-center pull-left"><div class="articleHeaderDropzone3" data-pb-dropzone="articleHeaderDropzone3"><div class="articleMetrics"><div class="articleMetrics_table"><div class="articleMetrics_row"><input type="hidden" name="articleMetricsDoi" value="10.1021/acs.jmedchem.9b01313"/></input><div class="articleMetrics_metric"><h6>Article Views</h6><div class="articleMetrics-val">3015</div></div><div class="articleMetrics_altmetric"><h6>Altmetric</h6><div class="articleMetrics-val articleMetrics_score">-</div><div class="altmetric-donut hidden"><div data-badge-details="right" data-badge-type="donut" data-hide-no-mentions="false" data-condensed="true" class="altmetric-embed"></div></div></div><div class="articleMetrics_count"><h6>Citations</h6><div class="articleMetrics-val"><a href="#citeThis" class="internalNav">4</a></div></div></div></div><div class="articleMetrics_about"><div class="base dropBlock"><a href="#" data-db-target-for="aboutArticleMetrics" class="article_aboutLink">LEARN ABOUT THESE METRICS</a><div data-db-target-of="aboutArticleMetrics" aria-live="polite" aria-atomic="true" role="alert" class="dropBlock__holder"><i aria-hidden="true" class="icon-close_thin"></i><p>Article Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to reflect usage leading up to the last few days.</p><p>Citations are the number of other articles citing this article, calculated by Crossref and updated daily.<a href="https://www.crossref.org/services/cited-by/" title="Find more information about Crossref citation counts"> Find more information about Crossref citation counts.</a></p><p>The Altmetric Attention Score is a quantitative measure of the attention that a research article has received online. Clicking on the donut icon will load a page at altmetric.com with additional details about the score and the social media presence for the given article. Find more information on<a href="https://help.altmetric.com/support/solutions/articles/6000233311-how-is-the-altmetric-attention-score-calculated" title="The Altmetric Attention Score and how the score is calculated"> the Altmetric Attention Score and how the score is calculated.</a></p></div></div></div></div></div></div><div class="article_header-meta-right"><div class="articleHeaderDropzone6" data-pb-dropzone="articleHeaderDropzone6"><div data-widget-def="UX3share" data-widget-id="787b5b92-0445-40f4-bdd2-9591d56f4a67" class="article_header-share share_label_visible">
        



        
        <script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="787b5b92-0445-40f4-bdd2-9591d56f4a67" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div>



        
        <div class="achs-addto-mendeley"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" class="doi" value="10.1021/acs.jmedchem.9b01313" /></input><span class="achs-addto-mendeley_label achs-addto-mendeley_addToLabel">Add to</span><span class="achs-addto-mendeley_label achs-addto-mendeley_viewInLabel">View In</span><a title="Add to mendeley button" class="achs-addto-mendeley_button" tabindex="0"><i class="achs-addto-mendeley_icon icon-mendeley"></i><i class="achs-addto-mendeley_close icon-close"></i></a><div data-db-target-of="5423a74c-bbd8-47b1-9f43-99423ee72e5c" class="achs-addto-mendeley_list dropBlock__holder"><ul><li><a href="#" title="Add Full Text with Reference" class="achs-addto-mendeley_disabled-button add-full-document"><i class="icon-bookmark-o"></i><span>Add Full Text with Reference</span></a></li><li><a href="#" title="Add Description" class="achs-mendeley_button add-metadata-description"><i class="icon-mendeley"></i><span>Add Description</span></a></li></ul></div><a href="#" title="View in mendeley button" class="achs-addto-mendeley_viewin-button"><i class="icon-mendeley"></i></a><div class="achs_loader"><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div></div><input type="hidden" name="meta-data" value="{&quot;title&quot;:&quot;Discovery of Novel Aryl Carboxamide Derivatives as Hypoxia-Inducible Factor 1α Signaling Inhibitors with Potent Activities of Anticancer Metastasis&quot;,&quot;type&quot;:&quot;journal&quot;,&quot;authors&quot;:[{&quot;first_name&quot;:&quot;Mingming&quot;,&quot;last_name&quot;:&quot;Liu&quot;},{&quot;first_name&quot;:&quot;Yuru&quot;,&quot;last_name&quot;:&quot;Liang&quot;},{&quot;first_name&quot;:&quot;Zhongzhen&quot;,&quot;last_name&quot;:&quot;Zhu&quot;},{&quot;first_name&quot;:&quot;Jin&quot;,&quot;last_name&quot;:&quot;Wang&quot;},{&quot;first_name&quot;:&quot;Xingxing&quot;,&quot;last_name&quot;:&quot;Cheng&quot;},{&quot;first_name&quot;:&quot;Jiayi&quot;,&quot;last_name&quot;:&quot;Cheng&quot;},{&quot;first_name&quot;:&quot;Binpeng&quot;,&quot;last_name&quot;:&quot;Xu&quot;},{&quot;first_name&quot;:&quot;Rong&quot;,&quot;last_name&quot;:&quot;Li&quot;},{&quot;first_name&quot;:&quot;Xinhua&quot;,&quot;last_name&quot;:&quot;Liu&quot;},{&quot;first_name&quot;:&quot;Yang&quot;,&quot;last_name&quot;:&quot;Wang&quot;}],&quot;source&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;year&quot;:&quot;2019&quot;,&quot;month&quot;:&quot;09&quot;,&quot;day&quot;:&quot;26&quot;,&quot;issue&quot;:&quot;20&quot;,&quot;volume&quot;:&quot;62&quot;,&quot;pages&quot;:&quot;9299-9314&quot;,&quot;identifiers&quot;:{&quot;doi&quot;:&quot;10.1021/acs.jmedchem.9b01313&quot;},&quot;abstract&quot;:&quot;In order to discover novel hypoxia-inducible factor 1 (HIF-1) inhibitors for the cancer metastasis treatment, 68 new aryl carboxamide compounds were synthesized and evaluated for their inhibitory effect by dual luciferase-reporter assay. Based on five rounds of investigation on structure–activity relationships step by step, compound 30m was discovered as the most active inhibitor (IC50 = 0.32 μM) with no obvious cytotoxicity (CC50 &gt; 50 μM). It effectively attenuated hypoxia-induced HIF-1α protein accumulation and reduced transcription of vascular epidermal growth factor in a dose-dependent manner, which was further demonstrated by its inhibitory potency on capillary-like tube formation, angiogenesis of zebrafish as well as cellular migration and invasion. Importantly, compound 30m exhibited antimetastatic potency in breast cancer lung metastasis in the mice model, indicating its promising therapeutic potential for prevention and treatment of tumor metastasis. These results definitely merit attention for furth&quot;}" class="meta-data"/></input><input type="hidden" name="mendeley-api-endpoint" value="https://api.mendeley.com/documents" class="mendeley-api-endpoint"/></input><input type="hidden" name="pub-access" value="full" class="pub-access"/></input><input type="hidden" name="library-url" value="https://www.mendeley.com/library/" class="library-url"/></input><input type="hidden" name="selected-share-option" class="selected-share-option"/></input></div>




        
        <div class="cit-download-dropdown"><span class="cit-download-dropdown_label">Export</span><a href="#" data-db-target-for="cit-download-dropdown_content" title="Download citation button" class="cit-download-dropdown_button"><span>RIS</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div data-db-target-of="cit-download-dropdown_content" class="cit-download-dropdown_content"><ul><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.9b01313&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.9b01313" title="Citation"><span>Citation</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.9b01313&amp;include=abs&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.9b01313" title="Citation and abstract"><span>Citation and abstract</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.9b01313&amp;include=ref&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.9b01313" title="Citation and references"><span>Citation and references</span></a></li><li><a href="/action/showCitFormats?doi=10.1021%2Facs.jmedchem.9b01313&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.9b01313&amp;href=/doi/10.1021/acs.jmedchem.9b01313" title="Cite This"><i class="icon-plus-square"></i><span>More Options</span></a></li></ul></div></div>
<div data-db-target-of="787b5b92-0445-40f4-bdd2-9591d56f4a67" id="787b5b92-0445-40f4-bdd2-9591d56f4a67_Pop" class="share__block dropBlock__holder fixed"><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>Wechat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li></ul></div></div>

        </div></div></div></div><div class="article_header-footer"><div class="article_header-footer-left pull-left clearfix"><div class="article_header-links pull-left"><input class="pub-doi" type="hidden" name="pub-doi" value="10.1021/acs.jmedchem.9b01313" /></input><a href="/doi/pdf/10.1021/acs.jmedchem.9b01313" title="PDF" target="_blank" class="button_primary pdf-button"><i class="icon-file-pdf-o"></i><span>PDF (5 MB)
                            </span></a><a href="/servlet/linkout?suffix=s0&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.9b01313&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fid%3Ddoi%3A10.1021%252Facs.jmedchem.9b01313%26sid%3Dliteratum%253Aachs%26pmid%3D31556611%26genre%3Darticle%26aulast%3DLiu%26date%3D2019%26atitle%3DDiscovery%2Bof%2BNovel%2BAryl%2BCarboxamide%2BDerivatives%2Bas%2BHypoxia-Inducible%2BFactor%2B1%25CE%25B1%2BSignaling%2BInhibitors%2Bwith%2BPotent%2BActivities%2Bof%2BAnticancer%2BMetastasis%26jtitle%3DJournal%2Bof%2BMedicinal%2BChemistry%26title%3DJournal%2Bof%2BMedicinal%2BChemistry%26volume%3D62%26issue%3D20%26spage%3D9299%26epage%3D9314%26issn%3D0022-2623" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a><div class="articleHeaderDropzone8" data-pb-dropzone="articleHeaderDropzone8"><div class="external-alerts-management"><input type="hidden" name="pub-type" value="article" class="pub-type"/></input><input type="hidden" name="is-enabled" value="true" class="is-enabled"/></input><input type="hidden" name="is-authenticated" value="false" class="is-authenticated"/></input><input type="hidden" name="pub-code" value="jmcmar" class="pub-code"/></input><input type="hidden" name="linkout-url" value="https://preferences.acspubs.org/journals" class="linkout-url"/></input><button data-toggle="modal" data-target="#ealertsModal" class="ealerts-toggle-btn hidden"></button><a class="button_primary_2 niHeader_getEAlerts jhHeader_sub_info"><i class="icon-send"></i><i class="icon-envelope"></i><i class="icon-check"></i><span class="ealerts-btn-text">Get e-Alerts</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div class="ux-modal-container"><div id="ealertsModal" style="display: none;" aria-live="polite" aria-atomic="true" class="modal"><div class="modal__dialog"><div class="modal__body"><iframe src="" class="ealerts-frame"></iframe></div></div></div></div><input type="hidden" id="ealertsModalSrc" value="https://preferences.acspubs.org/jmcmar?ifr=1"/></input></div></div></div><div class="article_header-suppInfo pull-left"><i class="icon-supporting-info"></i><span class="article_header-suppInfo-text">Supporting Info (2)</span><span class="article_header-suppInfo-arrow">»</span><a href="#" data-slide-target=".tab__pane-suppInfo" title="Supporting Information" class="article_header-suppInfo-link-mobile hidden-sm hidden-md hidden-lg w-slide__btn">Supporting Information
                </a><a href="#article_content-right" title="Supporting Information" data-scrollDuration="1000" class="article_header-suppInfo-link internalNav hidden-xs">Supporting Information
                </a></div></div><div class="article_header-footer-right"><div class="articleHeaderDropzone7" data-pb-dropzone="articleHeaderDropzone7"><div class="article_header-footer-right"><div class="article_header-taxonomy"><span>SUBJECTS:</span><ul class="rlist--inline loa"><li><a href="/action/doSearch?ConceptID=290896" title="Cells">Cells</a>,</li><li><a href="/action/doSearch?ConceptID=292528" title="Inhibitors">Inhibitors</a>,</li><li><a href="/action/doSearch?ConceptID=291793" title="Inhibition">Inhibition</a>,</li><li><a href="/action/doSearch?ConceptID=292258" title="Cancer">Cancer</a>,</li><li><a href="/action/doSearch?ConceptID=291241" title="Phenyls">Phenyls</a></li></ul></div></div></div></div></div></div><div class="article_header-right pull-left hidden-md hidden-sm hidden-xs"><div class="articleHeaderDropzone2" data-pb-dropzone="articleHeaderDropzone2"><div class="cover-image"><div class="cover-image__image"><a href="/toc/jmcmar/62/20" title="Go to Journal of Medicinal Chemistry "><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-20/jmcmar.2019.62.issue-20/20191024/jmcmar.2019.62.issue-20.largecover.jpg" alt="Go to Journal of Medicinal Chemistry "/></img></a></div></div>




        
        
<script>
 $(document).ready(function() {
   $('.article_header .external-alerts-management .niHeader_getEAlerts').each(function(){
	 var Tab = $(this).attr("href");
	   if(typeof Tab != undefined && Tab != false){
		 console.log("Testing Tab");
		 $(this).attr('href','#');
	   }
   });
 });
 $(document).on('click', '.article_header .external-alerts-management .niHeader_getEAlerts', function (e) {
	 //do something
	 if($(this).hasClass('registered')){
	  //send data to analytics for registered users
	      ga('send','event','Registered e-Alert','Article Page Click','jmcmar');
	  }else{
	     //send data to analytics for non-registered users
	      ga('send','event','Get e-Alert','Article Page Click','jmcmar');
	  }
  });
</script>





        
        <div class="pj-badge"></div>




        
        <div class="aJhp_link"></div>
<a href="/action/doUpdateAlertSettings?action=addJournal&amp;journalCode=jmcmar" class="button_primary_2"><i class="icon-send"></i><span>Get e-Alerts</span></a></div></div></div></div></div></div></div><div class="article_abstract"><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><h2 class="article_abstract-title" id="Abstract">Abstract</h2><div class="article_abstract-content hlFld-Abstract" id="abstractBox"><figure id="_i1" data-index="0" class="article__inlineFigure article_abstract-img"><img class="inline-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-20/acs.jmedchem.9b01313/20191018/images/medium/jm9b01313_0018.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-20/acs.jmedchem.9b01313/20191018/images/large/jm9b01313_0018.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b01313&amp;id=_i1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><p class="articleBody_abstractText">In order to discover novel hypoxia-inducible factor 1 (HIF-1) inhibitors for the cancer metastasis treatment, 68 new aryl carboxamide compounds were synthesized and evaluated for their inhibitory effect by dual luciferase-reporter assay. Based on five rounds of investigation on structure–activity relationships step by step, compound <b>30m</b> was discovered as the most active inhibitor (IC<sub>50</sub> = 0.32 μM) with no obvious cytotoxicity (CC<sub>50</sub> > 50 μM). It effectively attenuated hypoxia-induced HIF-1α protein accumulation and reduced transcription of vascular epidermal growth factor in a dose-dependent manner, which was further demonstrated by its inhibitory potency on capillary-like tube formation, angiogenesis of zebrafish as well as cellular migration and invasion. Importantly, compound <b>30m</b> exhibited antimetastatic potency in breast cancer lung metastasis in the mice model, indicating its promising therapeutic potential for prevention and treatment of tumor metastasis. These results definitely merit attention for further rational design of more efficient HIF-1 inhibitors in the future.</p></div></div></div></div></div><div class="article_content"><ul class="tab-nav-shortcut"><li><i class="icon-image"></i></li><li><i class="icon-link"></i></li><li><i class="icon-supporting-info"></i></li></ul><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><div class="article_content-table hlFld-FullText"><div class="article_content-row"><div class="article_content-left"><div id="sec1" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i2">1.  Introduction</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_83054" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_83054" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Cancer metastasis is a multiple process in which cancer cells disseminate from the primary tumor to distant secondary organs through the circulatory system. The migratory and invasive capabilities facilitate metastatic cells to invade through the basement membrane, intravasate into lumina or blood vessels, and extravasate into the parenchyma of distant tissues, thereby generating clinically detectable metastatic tumors.<a onclick="showRef(event, 'ref1 ref2'); return false;" href="javascript:void(0);" class="ref ref1 ref2">(1,2)</a> Metastasis remains the leading cause of therapeutic failure and responsible for over 90% of cancer-associated patient mortality, mainly because of the reason that most of the current chemotherapeutic agents control tumor growth rather than its metastasis.<a onclick="showRef(event, 'ref3 ref4'); return false;" href="javascript:void(0);" class="ref ref3 ref4">(3,4)</a> Recent advance in the understanding of the molecular signaling pathway that regulates metastatic spread provides potential therapeutic targets for cancer metastasis prevention and inhibition.<a onclick="showRef(event, 'ref5 ref6'); return false;" href="javascript:void(0);" class="ref ref5 ref6">(5,6)</a></div><div class="NLM_p">Hypoxia-inducible factor 1 (HIF-1), a transcription factor that responds to a hypoxic environment, is a heterodimer composed of HIF-1α and HIF-1β subunits. Under the normoxia condition, the hydroxylated HIF-1α subunit is recognized by the von Hippel–Lindau (VHL) E3-ubiquitin ligase complex and subjected to proteasomal degradation subsequently,<a onclick="showRef(event, 'ref7 ref8'); return false;" href="javascript:void(0);" class="ref ref7 ref8">(7,8)</a> whereas under hypoxic conditions, the absence of oxygen and decreasing hydroxylation stabilize HIF-1α, resulting in its nuclear translocation and dimerization with HIF-1β. The heterodimer binds to the hypoxia responsive element (HRE) located in the region of target genes promotor, and therefore activates transcription of a number of downstream target genes.<a onclick="showRef(event, 'ref9 ref10'); return false;" href="javascript:void(0);" class="ref ref9 ref10">(9,10)</a> These genes encode proteins, including vascular epidermal growth factor (VEGF), matrix metalloproteases (MMPs), snail1, twist and glucose transporter type 1 (GLUT1), and so forth,<a onclick="showRef(event, 'ref11 ref12 ref13 ref14 ref15'); return false;" href="javascript:void(0);" class="ref ref11 ref12 ref13 ref14 ref15">(11−15)</a> which promote cancer development and metastasis through enhancing cellular motility and invasiveness, inducing epithelial–mesenchymal transition (EMT) and cancer stem cell properties, promoting angiogenesis, reprogramming glucose metabolism, and resisting apoptosis.<a onclick="showRef(event, 'ref16 ref17 ref18 ref19'); return false;" href="javascript:void(0);" class="ref ref16 ref17 ref18 ref19">(16−19)</a> Recent studies have highlighted that dramatic overexpression of HIF-1 was measured in many human cancers, such as breast cancer, ovarian cancer, hepatocellular carcinoma, cervical cancer, and so on, leading to tumor metastasis and poor patient prognosis.<a onclick="showRef(event, 'ref20 ref21 ref22'); return false;" href="javascript:void(0);" class="ref ref20 ref21 ref22">(20−22)</a> Therefore, HIF-l has been considered to be a promising target for the development of novel therapeutics against cancer metastasis.<a onclick="showRef(event, 'ref23 ref24 ref25'); return false;" href="javascript:void(0);" class="ref ref23 ref24 ref25">(23−25)</a></div><div class="NLM_p">In recent years, a number of small-molecule inhibitors have been identified with the capacity to reduce the transcriptional activities of HIF-1 or to induce HIF-1α degradation (<a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a></a>), including adamantyl-based inhibitors (<b>1</b>, LW6), carborane-based inhibitors (<b>2</b>, GN26361), manassantin A (<b>3</b>) and derivatives, deguelin (<b>4</b>) and its ring-truncated derivatives (<b>5</b>, SH-1280), sulfonamide derivatives (<b>6</b>, KCN), YC-1 (<b>7</b>) and derivatives, and so forth.<a onclick="showRef(event, 'ref26 ref27 ref28 ref29 ref30 ref31 ref32 ref33'); return false;" href="javascript:void(0);" class="ref ref26 ref27 ref28 ref29 ref30 ref31 ref32 ref33">(26−33)</a> Most of these inhibitors were discovered through high throughput screening or natural products screening with a large molecular weight, complicated chemical structures, relative hydrophobicity, poor water solubility and low potency, which thereby limited their further development. Unfortunately, there is no HIF-1 inhibitor that has been approved by FDA for the cancer treatment till date. Therefore, there is still an urgent need to discover novel HIF-1 inhibitors with sufficient potency, low toxicity, good druggability, and novel chemical diversity.</div><figure id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-20/acs.jmedchem.9b01313/20191018/images/medium/jm9b01313_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-20/acs.jmedchem.9b01313/20191018/images/large/jm9b01313_0001.jpeg" id="gr1" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Structures of representative HIF-1α inhibitors.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-20/acs.jmedchem.9b01313/20191018/images/large/jm9b01313_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b01313&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Considering the advantages of fragment-based approaches in discovering novel leading compounds, an in-house fragment collection (M.W. < 300 Da) was screened using HRE luciferase reporter assay to identify hits of HIF-1 inhibitors for further optimization. From the screening, a thiazole carboxamide fragment <b>8</b> (M.W. = 246 Da, <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a></a>) was identified as a preliminary hit containing the moderate inhibitory effect with the IC<sub>50</sub> value of 55.7 μM. Biological evaluation showed that this hit inhibited the invasion and migration of breast cancer MDA-MB-231 cells without obvious cytotoxicity. These results encouraged us to conduct further structural optimization and structure–activity relationship (SAR) studies to improve the potency for intervention of cancer metastasis. Therefore, based on the chemical structure of this hit and the rational drug design, a small-molecular library of 68 novel aryl carboxamide derivatives was constructed and evaluated as HIF-1 inhibitors.</div><figure id="fig2" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-20/acs.jmedchem.9b01313/20191018/images/medium/jm9b01313_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-20/acs.jmedchem.9b01313/20191018/images/large/jm9b01313_0002.jpeg" id="gr2" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Structural optimization step by step.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-20/acs.jmedchem.9b01313/20191018/images/large/jm9b01313_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b01313&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec2" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i3">2.  Design</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_78475" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_78475" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p last">In order to carry out more extensive rational design, the modification and SAR study of hit <b>8</b> were approached in a step-by-step manner. As shown in <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a></a>, the hit was divided into three regions, namely, the methyl group (region <b>A</b>), the thiazole ring (region <b>B</b>), and the phenyl group (region <b>C</b>) by the connection of <i>N</i>-ethyl amide (<b>Linker</b>). First, region <b>C</b> was modified with several substituted phenyl and heterocyclic groups as well as the length of the <b>Linker</b> was investigated, resulting in 2-chlorophenyl and 4-pyridyl analogs with improved activities (step 1). For fragment growing, phenyl or heterocycles were introduced to replace the methyl group (region <b>A</b>). The results from SAR showed that introduction of phenyl into region <b>A</b> achieved increasing activities (step 2). Next, the thiazole ring (region <b>B</b>) was replaced with a variety of five- and six-membered aromatic rings, including pyridine-2-carbonamide which showed relatively better activity (step 3). Then, the substituent on the phenyl ring of region <b>C</b> was further optimized, and the replacement of chlorine with fluorine dramatically increased activity (step 4). Finally, the phenyl group of region <b>A</b> was replaced with a variety of heterocycles and substituted phenyl, and 2-methoxyl phenyl substituent turned out to be the best alternative with an activity of almost 170 fold stronger than that of hit <b>8</b> (step 5).</div></div><div id="sec3" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i4">3.  Chemistry</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_32571" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_32571" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">As depicted in <a class="ref internalNav" href="#sch1" aria-label="Scheme 1">Scheme 1</a>, thiazole and other aryl carboxamides (<b>8</b>, <b>10a–h</b>, <b>12a–f</b>) were prepared by acylation of various substituted amines with corresponding aryl carbonyl chlorides, which were generated by the reaction of commercial available acids (<b>9</b> and <b>11a–c</b>) with oxalyl chloride.</div><figure id="sch1" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-20/acs.jmedchem.9b01313/20191018/images/medium/jm9b01313_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-20/acs.jmedchem.9b01313/20191018/images/large/jm9b01313_0007.jpeg" id="gr7" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 1. Synthesis of <b>8</b>, <b>10a–h</b>, and <b>12a–f</b></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-20/acs.jmedchem.9b01313/20191018/images/large/jm9b01313_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b01313&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">The synthesis of five-membered heterocycles carboxamides <b>15a–f</b> and <b>18a–j</b> was described in <a class="ref internalNav" href="#sch2" aria-label="Scheme 2">Scheme 2</a>. As key intermediates, aryl thiazolyl carboxylic acid ethyl esters (<b>13a–c</b>), phenyl oxazolyl carboxylic acid ethyl esters (<b>16a–b</b>), and phenyl oxadiazolyl carboxylic acid ethyl esters (<b>16c–e</b>) were synthesized according to the literature studies,<a onclick="showRef(event, 'ref34 ref35'); return false;" href="javascript:void(0);" class="ref ref34 ref35">(34,35)</a> respectively (see the <a href="/doi/suppl/10.1021/acs.jmedchem.9b01313/suppl_file/jm9b01313_si_003.pdf" class="ext-link">Supporting Information</a>). Hydrolysis of the esters <b>13a–c</b> and <b>16a–e</b> with LiOH in ethanol produced the corresponding acids <b>14a–c</b> and <b>17a–e</b>, respectively. Finally, the targeted thiazole, oxazole, and oxadiazole carboxamides <b>15a–f</b> and <b>18a–j</b> were obtained by a similar procedure described in <a class="ref internalNav" href="#sch1" aria-label="Scheme 1">Scheme 1</a>.</div><figure id="sch2" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-20/acs.jmedchem.9b01313/20191018/images/medium/jm9b01313_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-20/acs.jmedchem.9b01313/20191018/images/large/jm9b01313_0008.jpeg" id="gr8" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 2. Synthesis of <b>15a–f</b> and <b>18a–j</b></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-20/acs.jmedchem.9b01313/20191018/images/large/jm9b01313_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b01313&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">As outlined in <a class="ref internalNav" href="#sch3" aria-label="Scheme 3">Scheme 3</a>, Suzuki coupling of phenylboronic acid (<b>21</b>) with 5-bromopicolinic acid (<b>22a</b>) or 6-bromonicotinic acid (<b>22b</b>) in the presence of Pd(PPh<sub>3</sub>)<sub>2</sub>Cl<sub>2</sub> afforded phenyl-substituted pyridine carboxylic acids <b>23a–b</b>. Pyrimidine-4-carboxamide <b>25a</b> and pyrimidine-2-carboxamide <b>25b</b> were synthesized according to the literature<a onclick="showRef(event, 'ref36'); return false;" href="javascript:void(0);" class="ref ref36">(36)</a> (see the <a href="/doi/suppl/10.1021/acs.jmedchem.9b01313/suppl_file/jm9b01313_si_003.pdf" class="ext-link">Supporting Information</a>) and were then hydrolyzed in 20% H<sub>2</sub>SO<sub>4</sub> (aq) to give the corresponding pyrimidine carboxylic acids <b>26a–b</b>, respectively. Finally, the targeted amides <b>20a–b</b>, <b>24a–d</b>, and <b>27a–b</b> were obtained by a similar procedure described in <a class="ref internalNav" href="#sch1" aria-label="Scheme 1">Scheme 1</a>.</div><figure id="sch3" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Scheme 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-20/acs.jmedchem.9b01313/20191018/images/medium/jm9b01313_0009.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-20/acs.jmedchem.9b01313/20191018/images/large/jm9b01313_0009.jpeg" id="gr9" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 3. Synthesis of <b>20a–b</b>, <b>24a–d</b>, and <b>27a–b</b></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-20/acs.jmedchem.9b01313/20191018/images/large/jm9b01313_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b01313&amp;id=sch3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">As described in <a class="ref internalNav" href="#sch4" aria-label="Scheme 4">Scheme 4</a>, the synthesis of series of 5-phenylpicolinic amides <b>28a–l</b> was similar to that of compounds <b>20a–b</b>. Meanwhile, acylation of 2-fluorophenethylamine by 5-bromopicolinic acid (<b>22a</b>), followed by Suzuki coupling reaction with various aryl boronic acids, gave target 5-aryl substituted picolinic amides <b>30a–r</b>.</div><figure id="sch4" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Scheme 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-20/acs.jmedchem.9b01313/20191018/images/medium/jm9b01313_0010.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-20/acs.jmedchem.9b01313/20191018/images/large/jm9b01313_0010.jpeg" id="gr10" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 4. Synthesis of <b>28a–l</b> and <b>30a–r</b></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-20/acs.jmedchem.9b01313/20191018/images/large/jm9b01313_0010.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b01313&amp;id=sch4"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec4" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i9">4.  Result and Discussion</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_43051" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_43051" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec4_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i10" class="anchor-spacer"></div><h3 class="article-section__title" id="_i10">4.1.  Cell-Based HRE Assay and SAR Studies</h3><div class="NLM_p">To improve the potency of hit <b>8</b> and identify more effective inhibitors of HIF-1, 68 new compounds were designed and synthesized based on SAR studies step by step. The inhibition rates (IRs) of synthesized compounds were initially determined at 10 μM by HRE luciferase reporter assay in human hepatocellular carcinoma LM3 cells under the hypoxia condition. In the assay, LM3 cells were cotransfected with a HIF-1 reporter vector which contains five copies of HRE sequences located in the region of firefly luciferase gene promotor along with pRL-SV40 plasmid encoding Renilla luciferase. After transfection, cells were treated with tested compounds and incubated under hypoxia. Under the hypoxic condition, accumulated heterodimers of HIF-1α and HIF-1β were bound to the HRE sequences and prompted the transcription of firefly luciferase. Inhibition of HIF-1 signaling by tested compounds reduced the expression of firefly luciferase leading to diminish firefly luminescence. To determine the inhibitory effect of synthesized compounds, the firefly luminescence signal was measured by using a microplate reader and normalized to the luminescence of Renilla luciferase. LW6 (<b>1</b>) was selected as the positive control.<a onclick="showRef(event, 'ref37'); return false;" href="javascript:void(0);" class="ref ref37">(37)</a></div><div class="NLM_p">First, we examined the effect of the phenethyl group (region <b>C</b> and Linker) of hit <b>8</b> on inhibitory activity. As listed in <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a></a>, replacement of phenethyl by benzyl (<b>10a</b>) or 3-phenylpropyl (<b>10b</b>) decreases the potency, indicating that the favorable length of two C atoms between N and phenyl. Introduction of a chlorine atom at the ortho-position of the phenyl ring (<b>10c</b>) significantly increased the potency, whereas meta or para substitution diminished it. Replacement of phenyl by pyridin-4-yl (<b>10h</b>) led to increasing IR from 21.2 to 31.3%. Based on these findings, 2-chlorophenethyl and 2-(pyridin-4-yl)ethyl were fixed in the following structural optimization (<a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a></a>).</div><div class="NLM_table-wrap" id="tbl1"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 1. HIF-1 Inhibition Activities of Hit <b>8</b> and Compounds <b>10a–h</b> at 10 μM</div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-20/acs.jmedchem.9b01313/20191018/images/medium/jm9b01313_0011.gif" alt="" id="GRAPHIC-d7e738-autogenerated" /></img><div class="scrollable-table-wrap"><table class="table "><colgroup><col align="left" /></col><col align="left" /></col><col align="char" char="±" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">compound</th><th class="colsep0 rowsep0" align="center">R</th><th class="colsep0 rowsep0" align="center" char="±">HRE inhibition (%) ± SD</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>8</b></td><td class="colsep0 rowsep0" align="left">phenethyl</td><td class="colsep0 rowsep0" align="char" char="±">21.2 ± 3.1</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>10a</b></td><td class="colsep0 rowsep0" align="left">benzyl</td><td class="colsep0 rowsep0" align="char" char="±">3.1 ± 2.4</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>10b</b></td><td class="colsep0 rowsep0" align="left">3-phenylpropyl</td><td class="colsep0 rowsep0" align="char" char="±">6.5 ± 0.3</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>10c</b></td><td class="colsep0 rowsep0" align="left">2-chlorophenethyl</td><td class="colsep0 rowsep0" align="char" char="±">42.7 ± 6.6</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>10d</b></td><td class="colsep0 rowsep0" align="left">3-chlorophenethyl</td><td class="colsep0 rowsep0" align="char" char="±">1.2 ± 1.1</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>10e</b></td><td class="colsep0 rowsep0" align="left">4-chlorophenethyl</td><td class="colsep0 rowsep0" align="char" char="±">0.6 ± 1.1</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>10f</b></td><td class="colsep0 rowsep0" align="left">2-(pyridin-2-yl)ethyl</td><td class="colsep0 rowsep0" align="char" char="±">5.1 ± 2.7</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>10g</b></td><td class="colsep0 rowsep0" align="left">2-(pyridin-3-yl)ethyl</td><td class="colsep0 rowsep0" align="char" char="±">2.4 ± 1.9</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>10h</b></td><td class="colsep0 rowsep0" align="left">2-(pyridin-4-yl)ethyl</td><td class="colsep0 rowsep0" align="char" char="±">31.3 ± 5.2</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>1</b> (LW6)</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="char" char="±">73.5 ± 4.7</td></tr></tbody></table></div></div><div class="NLM_p">As listed in <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a></a>, keeping 2-chlorophenethyl or 2-(pyridin-4-yl)ethyl unchanged, the thiazole ring (region <b>B</b>) was replaced by other aromatic rings, such as phenyl (<b>12a–b</b>), furan (<b>12c–d</b>), and pyridine (<b>12e–f</b>), resulting in no obvious improvement of activities. Replacing the methyl group (region <b>A</b>) with the phenyl ring led to increasing potency as shown by compounds <b>15a–b</b>, however, introduction of pyridin-3-yl (<b>15c–d</b>) or pyridin-4-yl (<b>15e–f</b>) appeared to be unfavorable. Therefore, we fixed the phenyl ring as region <b>A</b> and focused on the modification of the thiazole ring (<a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a></a>).</div><div class="NLM_table-wrap" id="tbl2"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 2. HIF-1 Inhibition Activities of Compounds <b>12a–f</b> and <b>15a–f</b> at 10 μM</div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-20/acs.jmedchem.9b01313/20191018/images/medium/jm9b01313_0012.gif" alt="" id="GRAPHIC-d7e936-autogenerated" /></img><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-20/acs.jmedchem.9b01313/20191018/images/medium/jm9b01313_0013.gif" alt="" id="gr11" /></img><div></div></div><div class="NLM_p">To explore the influence of the aromatic ring of region <b>B</b> against HIF-1 inhibitory activity, a variety of five- and six-membered aromatic rings were screened. As listed in <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">Table <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a></a>, all of these phenyl-substituted aromatic carboxamides showed moderate to potent inhibitory activities with IR values ranging from 36.9 to 77.2%, indicating the critical role of phenyl substitution of region <b>A</b>. In general, six-membered aromatic ring derivatives (<b>20a–b</b>, <b>24a–d</b>, and <b>27a–b</b>) exhibited more effective inhibition than five-membered heterocyclic ones (<b>18a–j</b>), possibly because of their appropriate ring sizes or polarities for the binding site. More interestingly, <i>N</i>-2-chlorophenethyl-substituted biphenyl carboxamide (<b>20a</b>) showed the highest potency (IR = 77.2%), which may imply that the aromatic ring in region <b>C</b> mainly exerts π–π stacking or hydrophobic interaction instead of hydrogen-bond effects, whereas the corresponding <i>N</i>-2-(pyridin-4-yl)ethyl substituent (<b>20b</b>) displayed reduced inhibitory activity (IR = 42.0%). Considering that both picolinamides (<b>24a–b</b>) possessed acceptable potency, with IR values of 68.4 and 60.7%, respectively, we next fixed the 5-phenylpicolinamide group to region <b>B</b> and further modified the substitution on the phenyl group in region <b>C</b> (<a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a></a>).</div><div class="NLM_table-wrap" id="tbl3"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 3. HIF-1 Inhibition Activities of Compounds <b>18a–j</b>, <b>20a–b</b>, <b>24a–d</b>, and <b>27a–b</b> at 10 μM</div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-20/acs.jmedchem.9b01313/20191018/images/medium/jm9b01313_0014.gif" alt="" id="GRAPHIC-d7e1010-autogenerated" /></img><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-20/acs.jmedchem.9b01313/20191018/images/medium/jm9b01313_0015.gif" alt="" id="gr12" /></img><div></div></div><div class="NLM_p">Compared with <b>24a</b>, unexpectedly, deletion of the chlorine atom of region <b>C</b> (<b>28a</b>) significantly elevated the inhibitory activity (<a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">Table <a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">4</a></a>) with IR values increasing from 68.4 to 82.2%, suggesting no obvious correlation between the electronic effects of substituent and activities. Subsequently, we examined the positional effect of the chlorine and fluorine on the phenyl ring. It turned out that most of chlorine and fluorine substitution (<b>28b–c</b> and <b>28e–f</b>) showed weaker activities than that of the unsubstituted derivative (<b>28a</b>), except the <i>ortho</i>-fluorine-substituted derivative (<b>28d</b>) with an IR value of 91.4%. In addition, pyridin-2-yl, pyridin-3-yl and para-hydroxyl, amino-, methyl-, nitro-substituted phenyl derivatives (<b>28g–l</b>) displayed unsatisfied activities.</div><div class="NLM_table-wrap" id="tbl4"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 4. HIF-1 Inhibition Activities of Compounds <b>28a–l</b> at 10 μM</div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-20/acs.jmedchem.9b01313/20191018/images/medium/jm9b01313_0016.gif" alt="" id="GRAPHIC-d7e1055-autogenerated" /></img><div class="scrollable-table-wrap"><table class="table "><colgroup><col align="left" /></col><col align="left" /></col><col align="char" char="±" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">compound</th><th class="colsep0 rowsep0" align="center">R</th><th class="colsep0 rowsep0" align="center" char="±">HRE inhibition (%) ± SD</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>28a</b></td><td class="colsep0 rowsep0" align="left">phenyl</td><td class="colsep0 rowsep0" align="char" char="±">82.2 ± 4.1</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>28b</b></td><td class="colsep0 rowsep0" align="left">3-chlorophenyl</td><td class="colsep0 rowsep0" align="char" char="±">64.6 ± 5.7</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>28c</b></td><td class="colsep0 rowsep0" align="left">4-chlorophenyl</td><td class="colsep0 rowsep0" align="char" char="±">58.2 ± 8.3</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>28d</b></td><td class="colsep0 rowsep0" align="left">2-fluorophenyl</td><td class="colsep0 rowsep0" align="char" char="±">91.4 ± 4.4</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>28e</b></td><td class="colsep0 rowsep0" align="left">3-fluorophenyl</td><td class="colsep0 rowsep0" align="char" char="±">58.7 ± 2.6</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>28f</b></td><td class="colsep0 rowsep0" align="left">4-fluorophenyl</td><td class="colsep0 rowsep0" align="char" char="±">46.1 ± 11.2</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>28g</b></td><td class="colsep0 rowsep0" align="left">pyridin-2-yl</td><td class="colsep0 rowsep0" align="char" char="±">43.7 ± 7.9</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>28h</b></td><td class="colsep0 rowsep0" align="left">pyridin-3-yl</td><td class="colsep0 rowsep0" align="char" char="±">44.5 ± 0.9</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>28i</b></td><td class="colsep0 rowsep0" align="left">4-hydroxyphenyl</td><td class="colsep0 rowsep0" align="char" char="±">36.9 ± 4.1</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>28j</b></td><td class="colsep0 rowsep0" align="left">4-aminophenyl</td><td class="colsep0 rowsep0" align="char" char="±">60.2 ± 3.7</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>28k</b></td><td class="colsep0 rowsep0" align="left">4-methylphenyl</td><td class="colsep0 rowsep0" align="char" char="±">31.8 ± 3.0</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>28l</b></td><td class="colsep0 rowsep0" align="left">4-nitrophenyl</td><td class="colsep0 rowsep0" align="char" char="±">40.2 ± 2.8</td></tr></tbody></table></div></div><div class="NLM_p">On the basis of SAR studies above, we maintained <i>N</i>-(2-fluorophenethyl)picolinamide and optimized the phenyl ring of region <b>A</b> (<a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a></a>). As listed in <a class="ref showTableEvent internalNav" data-ID="tbl5" href="#tbl5">Table <a class="ref showTableEvent internalNav" data-ID="tbl5" href="#tbl5">5</a></a>, eighteen compounds were designed, synthesized, and evaluated for HIF-1 inhibition. Among them, thiophen-3-yl-substituted compound (<b>30d</b>) maintained HIF-1 inhibitory potency similar to that of <b>28d</b>, while furanyl, pyridinyl, and pyrazolyl substitutions (<b>30a–b</b>, and <b>30e–f</b>) resulted in decreased activities more or less. With regard to substituted phenyl derivatives (<b>30g–r</b>), ortho substitutions were more favorable than meta- and para-substitutions; fluorine (<b>30g–i</b>) and methoxy (<b>30m–o</b>) substitutions displayed acceptable activities. Particularly, the 2-methoxyphenyl derivative (<b>30m</b>) was the most active inhibitor with an IR value of 97.7%.</div><div class="NLM_table-wrap" id="tbl5"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 5. HIF-1 Inhibition Activities of Compounds <b>30a–r</b> at 10 μM</div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-20/acs.jmedchem.9b01313/20191018/images/medium/jm9b01313_0017.gif" alt="" id="GRAPHIC-d7e1283-autogenerated" /></img><div class="scrollable-table-wrap"><table class="table "><colgroup><col align="left" /></col><col align="left" /></col><col align="char" char="±" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">compound</th><th class="colsep0 rowsep0" align="center">Ar</th><th class="colsep0 rowsep0" align="center" char="±">HRE inhibition (%) ± SD</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>30a</b></td><td class="colsep0 rowsep0" align="left">furan-2-yl</td><td class="colsep0 rowsep0" align="char" char="±">57.2 ± 7.7</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>30b</b></td><td class="colsep0 rowsep0" align="left">furan-3-yl</td><td class="colsep0 rowsep0" align="char" char="±">73.4 ± 6.1</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>30c</b></td><td class="colsep0 rowsep0" align="left">thiophen-2-yl</td><td class="colsep0 rowsep0" align="char" char="±">80.0 ± 2.0</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>30d</b></td><td class="colsep0 rowsep0" align="left">thiophen-3-yl</td><td class="colsep0 rowsep0" align="char" char="±">88.2 ± 3.5</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>30e</b></td><td class="colsep0 rowsep0" align="left">pyridin-4-yl</td><td class="colsep0 rowsep0" align="char" char="±">57.5 ± 3.1</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>30f</b></td><td class="colsep0 rowsep0" align="left">1<i>H</i>-pyrazol-4-yl</td><td class="colsep0 rowsep0" align="char" char="±">29.5 ± 4.1</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>30g</b></td><td class="colsep0 rowsep0" align="left">2-fluorophenyl</td><td class="colsep0 rowsep0" align="char" char="±">83.8 ± 9.4</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>30h</b></td><td class="colsep0 rowsep0" align="left">3-fluorophenyl</td><td class="colsep0 rowsep0" align="char" char="±">55.3 ± 14.2</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>30i</b></td><td class="colsep0 rowsep0" align="left">4-fluorophenyl</td><td class="colsep0 rowsep0" align="char" char="±">41.2 ± 12.4</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>30j</b></td><td class="colsep0 rowsep0" align="left">2-hydroxyphenyl</td><td class="colsep0 rowsep0" align="char" char="±">43.6 ± 5.0</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>30k</b></td><td class="colsep0 rowsep0" align="left">3-hydroxyphenyl</td><td class="colsep0 rowsep0" align="char" char="±">0.3 ± 1.5</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>30l</b></td><td class="colsep0 rowsep0" align="left">4-hydroxyphenyl</td><td class="colsep0 rowsep0" align="char" char="±">33.2 ± 4.1</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>30m</b></td><td class="colsep0 rowsep0" align="left">2-methoxyphenyl</td><td class="colsep0 rowsep0" align="char" char="±">97.7 ± 1.4</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>30n</b></td><td class="colsep0 rowsep0" align="left">3-methoxyphenyl</td><td class="colsep0 rowsep0" align="char" char="±">53.8 ± 3.8</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>30o</b></td><td class="colsep0 rowsep0" align="left">4-methoxyphenyl</td><td class="colsep0 rowsep0" align="char" char="±">45.6 ± 6.4</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>30p</b></td><td class="colsep0 rowsep0" align="left">2-cyanophenyl</td><td class="colsep0 rowsep0" align="char" char="±">62.7 ± 2.7</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>30q</b></td><td class="colsep0 rowsep0" align="left">3-cyanophenyl</td><td class="colsep0 rowsep0" align="char" char="±">44.5 ± 7.1</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>30r</b></td><td class="colsep0 rowsep0" align="left">4-cyanophenyl</td><td class="colsep0 rowsep0" align="char" char="±">13.1 ± 6.9</td></tr></tbody></table></div></div><div class="NLM_p">Finally, fifteen compounds with an IR more than 60% were selected for determination of their IC<sub>50</sub> values (<a class="ref showTableEvent internalNav" data-ID="tbl6" href="#tbl6">Table <a class="ref showTableEvent internalNav" data-ID="tbl6" href="#tbl6">6</a></a>). Among them, six compounds with IC<sub>50</sub> values below 3 μM showed better HIF-1 inhibitory activity than that of positive control <b>1</b>, and no obvious cytotoxicity was observed (CC<sub>50</sub> > 50 μM). To summarize, of these 68 newly synthesized compounds, <b>30m</b> was the most active compound with an IC<sub>50</sub> value of 0.32 μM, almost 10 fold more effective than that of <b>1</b>.<a onclick="showRef(event, 'ref37'); return false;" href="javascript:void(0);" class="ref ref37">(37)</a> In comparison to the structure of original hit <b>8</b>, the 2-methoxyphenyl group (region <b>A</b>) is essential for the activity, the replacement of thiazole by pyridine (region <b>B</b>) improves the potency, and the introduction of the fluorine atom to the phenyl ring (region <b>C</b>) is beneficial to the inhibitory effect. Thus, through five rounds of optimization, <b>30m</b> showed over 170 fold enhancement of inhibitory activity against HIF-1 compared with the hit <b>8</b> and therefore was selected for further bioactivity evaluation.</div><div class="NLM_table-wrap" id="tbl6"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 6. IC<sub>50</sub> Values of Selected Compounds against HIF-1</div></div></div><div class="scrollable-table-wrap"><table class="table "><colgroup><col align="left" /></col><col align="char" char="." /></col><col align="left" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">compound</th><th class="colsep0 rowsep0" align="center" char=".">HRE IC<sub>50</sub> (μM)</th><th class="colsep0 rowsep0" align="center">cytotoxicity CC<sub>50</sub> (μM)</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>18j</b></td><td class="colsep0 rowsep0" align="char" char=".">7.32</td><td class="colsep0 rowsep0" align="left">>50</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>20a</b></td><td class="colsep0 rowsep0" align="char" char=".">2.87</td><td class="colsep0 rowsep0" align="left">>50</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>24a</b></td><td class="colsep0 rowsep0" align="char" char=".">9.84</td><td class="colsep0 rowsep0" align="left">>50</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>24b</b></td><td class="colsep0 rowsep0" align="char" char=".">13.80</td><td class="colsep0 rowsep0" align="left">>50</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>27b</b></td><td class="colsep0 rowsep0" align="char" char=".">10.04</td><td class="colsep0 rowsep0" align="left">>50</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>28a</b></td><td class="colsep0 rowsep0" align="char" char=".">4.56</td><td class="colsep0 rowsep0" align="left">>50</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>28b</b></td><td class="colsep0 rowsep0" align="char" char=".">9.84</td><td class="colsep0 rowsep0" align="left">>50</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>28d</b></td><td class="colsep0 rowsep0" align="char" char=".">0.93</td><td class="colsep0 rowsep0" align="left">>50</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>28j</b></td><td class="colsep0 rowsep0" align="char" char=".">11.61</td><td class="colsep0 rowsep0" align="left">>50</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>30b</b></td><td class="colsep0 rowsep0" align="char" char=".">4.24</td><td class="colsep0 rowsep0" align="left">>50</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>30c</b></td><td class="colsep0 rowsep0" align="char" char=".">2.48</td><td class="colsep0 rowsep0" align="left">>50</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>30d</b></td><td class="colsep0 rowsep0" align="char" char=".">1.41</td><td class="colsep0 rowsep0" align="left">>50</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>30g</b></td><td class="colsep0 rowsep0" align="char" char=".">2.16</td><td class="colsep0 rowsep0" align="left">>50</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>30m</b></td><td class="colsep0 rowsep0" align="char" char=".">0.32</td><td class="colsep0 rowsep0" align="left">>50</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>30p</b></td><td class="colsep0 rowsep0" align="char" char=".">8.53</td><td class="colsep0 rowsep0" align="left">>50</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>1</b> (LW6)</td><td class="colsep0 rowsep0" align="char" char=".">3.08</td><td class="colsep0 rowsep0" align="left">>50</td></tr></tbody></table></div></div></div><div id="sec4_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i17" class="anchor-spacer"></div><h3 class="article-section__title" id="_i17">4.2.  Inhibition of HIF-1α Accumulation</h3><div class="NLM_p">To further confirm their inhibition of the HIF-1 pathway, representative compounds <b>30f</b>, <b>30b</b>, and <b>30m</b> with low, moderate, and high potency in HRE reporter assay, respectively, hit <b>8</b>, as well as <b>1</b> as positive control were evaluated for inhibition of HIF-1α protein accumulation under the hypoxia condition using western blot assay. As shown in <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a></a>A, the effects of the tested compounds on HIF-1α protein accumulation were consistent with their potency in HRE luciferase reporter assay. Among the selected compounds, compound <b>30m</b> showed the most activity against HIF-1α accumulation, even stronger than the positive control <b>1</b>. Accordingly, the inhibitory effects of <b>30m</b> on HIF-1α accumulation were also evaluated in other cancer cell lines including breast cancer (MDA-MB-231), ovarian cancer (SKOV3), and cervical cancer (HeLa). As expected, <b>30m</b> attenuated HIF-1α accumulation in a dose-dependent manner in all of the tested cell lines (<a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a></a>B). Our recent results from qRT-polymerase chain reaction (PCR) of HIF-1α mRNA and HIF-1α protein degradation assay indicated that <b>30m</b> probably prompted the degradation of HIF-1α protein (data not shown). Next, we plan to synthesize the biotin-based photo-cross-linking probe of <b>30m</b> and to conduct the affinity pull-down experiment in order to identify the direct target of <b>30m</b>. Taken together, our data preliminarily indicated that compound <b>30m</b> could block the HIF pathway by reduction of the HIF-1α protein level and prompted us to further evaluate the effects of this compound on angiogenesis and tumor cellular metastasis.</div><figure id="fig3" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-20/acs.jmedchem.9b01313/20191018/images/medium/jm9b01313_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-20/acs.jmedchem.9b01313/20191018/images/large/jm9b01313_0003.jpeg" id="gr3" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Effects of selected compounds on hypoxia-induced accumulation of HIF-1α. (A) Expression of HIF-1α was examined in LM3 cells treated with selected compounds, including compounds <b>30b</b>, <b>30f</b>, <b>30m</b> and <b>8</b> at the concentration of 10 μM under hypoxia. <b>1</b> (LW6) was used as positive control. (B) Effects of compound <b>30m</b> on hypoxia-induced HIF-1α accumulation were determined in various human cancer cell lines, including MDA-MB-231, SKOV3, and HeLa at indicated concentrations.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-20/acs.jmedchem.9b01313/20191018/images/large/jm9b01313_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b01313&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec4_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i18" class="anchor-spacer"></div><h3 class="article-section__title" id="_i18">4.3.  Inhibition of Compound <b>50m</b> on Angiogenesis</h3><div class="NLM_p">VEGF, the target gene directly regulated by HIF-1, promotes hypoxia-induced angiogenesis, which is essential for cancer progression and metastasis.<a onclick="showRef(event, 'ref11 ref12'); return false;" href="javascript:void(0);" class="ref ref11 ref12">(11,12)</a> Silencing HIF-1/VEGF pathway, which results in reduced ability of malignant cells to recruit vasculature and colonize at distant sites, has emerged as the promising strategy for the cancer treatment.<a onclick="showRef(event, 'ref19'); return false;" href="javascript:void(0);" class="ref ref19">(19)</a> Accordingly, we first determined effects of compound <b>30m</b> on transcription of VEGF in human umbilical vein endothelial cells (HUVECs). Results obtained from real-time assay showed that <b>30m</b> effectively reduced the mRNA levels of VEGF in a dose-dependent manner (<a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a></a>A). Next, capillary-like tube formation assay was performed to further evaluate the anti-angiogenesis activity of compound <b>30m</b> in vitro. As shown in <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a></a>B, hypoxia induced a complete network structure formed by HUVECs, whereas the treatment with <b>30m</b> significantly suppressed the tubule formation at nonantiproliferative concentrations (2 and 5 μM). Particularly, at concentration of 5 μM, <b>30m</b> completely disrupted the formation of tube structures. Furthermore, the in vivo anti-angiogenic activity of <b>30m</b> was further determined by transgenic zebrafish, in which the vascular endothelial cells were labeled with green fluorescent protein (GFP). Zebrafish embryos were selected, dechlorinated, and incubated with 0.5 or 1 μM of <b>30m</b> for 24 h, meanwhile, 0.5 μM of commercial VEGFR inhibitor apatinib served as a positive control. The affection of zebrafish subintestinal vessels (SIVs) was observed under a fluorescence microscope. <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a></a>C illustrated the obvious destruction of zebrafish SIVs by exposure to compound <b>30m</b>, indicating that <b>30m</b> effectively blocked the growth of normal angiogenesis with similar activities of the positive control apatinib (<a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a></a>D).</div><figure id="fig4" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-20/acs.jmedchem.9b01313/20191018/images/medium/jm9b01313_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-20/acs.jmedchem.9b01313/20191018/images/large/jm9b01313_0004.jpeg" id="gr4" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. Effects of compound <b>30m</b> on angiogenesis in vitro and in vivo. (A) Relative expression of VEGF mRNA was determined by real-time PCR after the treatment of HUVECs with 0.5 or 1 μM of compound <b>30m</b>. Relative expression of VEGF was normalized against GAPDH. Results represent the means ± standard deviation (SD) from three independent experiments. <sup>##</sup><i>p</i> < 0.01 vs normoxia group; *<i>p</i> < 0.05, **<i>p</i> < 0.01 vs untreated control. (B) Inhibition of hypoxia-induced capillary-like tube formation. HUVECs were seeded in the 96 well plate precoated with matrigel and incubated with 2 or 5 μM of compound <b>30m</b>. Tubule branches were photographed. A representative result from three independent experiments is shown. (C) Inhibitory effect of compound <b>30m</b> on the angiogenesis of transgenic zebrafish. Zebrafish was treated with <b>30m</b> (0.5 and 1 μM) or dimethyl sulfoxide (DMSO) (<i>n</i> = 10), and the SIVs of zebrafish were observed using confocal microscopy. Apatinib was used as a positive control. Representative images from three independent experiments were shown. White arrows indicated the destruction of SIVs. (D) Histogram showed the numbers of zebrafish SIVs per field under confocal microscopy. Results represented the means ± SD. *<i>p</i> < 0.05, **<i>p</i> < 0.01 vs untreated control.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-20/acs.jmedchem.9b01313/20191018/images/large/jm9b01313_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b01313&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec4_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i19" class="anchor-spacer"></div><h3 class="article-section__title" id="_i19">4.4.  Inhibition of Compound <b>30m</b> on Cellular Migration and Invasion</h3><div class="NLM_p">Increased evidence indicates that, through HIF-1 activation, hypoxia stimulates the expression of certain genes promoting tumor cellular invasiveness and metastasis, such as MMPs and EMT regulators.<a onclick="showRef(event, 'ref13 ref14 ref18 ref19'); return false;" href="javascript:void(0);" class="ref ref13 ref14 ref18 ref19">(13,14,18,19)</a> Therefore, we performed wound healing and transwell assays to examine the inhibitory effects of compound <b>30m</b> on migration and invasion of breast cancer MDA-MB-231 cells under the hypoxic condition. To avoid induction of apoptosis or growth arrest, cells were treated with nontoxic concentrations (2, 5, and 10 μM) of <b>30m</b> for 24 h. Results from wound healing assay showed that <b>30m</b> dose-dependently impaired the ability of cells to close a wound, indicating the inhibition of cellular migration in vitro (<a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a></a>A). In transwell assay, MDA-MB-231 cells were seeded into upper chambers with or without pre-coated matrigel stimulating base membrane for determination of cellular invasion or migration, respectively. As illustrated in <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a></a>B,C, the numbers of both migratory and invasive cells were significantly reduced by <b>30m</b> in a dose-dependent manner. Furthermore, western blot assay was used to investigate whether compound <b>30m</b> could affect the expression of HIF-1 downstream genes related to cancer metastasis. As shown in <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a></a>D, the treatment of <b>30m</b> dose-dependently induced E-cadherin expression but repressed vimentin expression in MDA-MB-231 cells, indicating the reversal of the hypoxia-mediated EMT process. In addition, western blot analysis also showed that <b>30m</b> dose-dependently down-regulated the expression of MMP-2 and MMP-9, which mediate extracellular matrix (ECM) degradation and thereby promotes cancer metastasis. Together, these results implied that compound <b>30m</b> inhibited migration and invasion of cancer cells with inhibition of the EMT process and down-regulation of MMPs.</div><figure id="fig5" data-index="9" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-20/acs.jmedchem.9b01313/20191018/images/medium/jm9b01313_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-20/acs.jmedchem.9b01313/20191018/images/large/jm9b01313_0005.jpeg" id="gr5" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. Effects of compound <b>30m</b> on cellular migration and invasion. (A) Inhibition of cellular migration by compound <b>30m</b> in wound-healing assay. After a single wound was scratched on a cellular monolayer, MDA-MB-231 cells were treated with compound <b>30m</b> (2, 5 and 10 μM) or DMSO under normoxia for 1 h and hypoxia for another 24 h. Representative images from three independent experiments are shown. (B) Inhibition of cellular migration and invasion by compound <b>30m</b> in transwell assays. MDA-MB-231 cells were seeded on chambers with or without precoated matrigel for invasion or migration assay, respectively. After incubated with compound <b>30m</b>, cells that migrated through the chambers were stained with crystal violet. Representative images from three independent experiments were shown. (C) Histogram shows the numbers of migrated and invasive cells. The experiments were repeated three times and results were indicated as means ± SD. *<i>p</i> < 0.05, **<i>p</i> < 0.01 vs untreated control. (D) Expression of E-cadherin, Vimentin, MMP-2, and MMP-9 were determined by western blotting assay. GAPDH was selected as loading control. Representative results from three independent experiments were shown.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-20/acs.jmedchem.9b01313/20191018/images/large/jm9b01313_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b01313&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec4_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i20" class="anchor-spacer"></div><h3 class="article-section__title" id="_i20">4.5.  Inhibition of Compound <b>30m</b> on Tumor Metastasis in Vivo</h3><div class="NLM_p">With great interest to discover antimetastatic agents, we evaluated the inhibitory potency of compound <b>30m</b> using the breast cancer lung metastasis mice model, which was established by intravenous injection of MDA-MB-231 cells stable expressing luciferase. Mice were treated with <b>30m</b> or vehicle intraperitoneally (i.p.) every 2 days during 3 weeks. After final administration, bioluminescent imaging techniques were used to assess the ability of malignant cells to generate lung metastases. After the mice were sacrificed, the lung metastatic nodules were examined by histology. Results obtained from quantitative analysis of the bioluminescent signal (<a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">6</a></a>A,B) and hematoxylin and eosin (H&E) staining (<a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">6</a></a>D) revealed that the treatment with compound <b>30m</b> significantly reduced lung colonization of tumor cells in a dose-dependent manner without obvious body weight loss (<a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">6</a></a>C). These results indicated the therapeutic effects and low toxicity of compound <b>30m</b> in the metastatic breast cancer mice model.</div><figure id="fig6" data-index="10" class="article__inlineFigure"><h2 class="fig-label">Figure 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-20/acs.jmedchem.9b01313/20191018/images/medium/jm9b01313_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-20/acs.jmedchem.9b01313/20191018/images/large/jm9b01313_0006.jpeg" id="gr6" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 6. Compound <b>30m</b> inhibited the formation of metastasis of human breast cancer cells in the mice model. (A) MDA-MB-231 cells stably transfected with luciferase were injected directly into the tail vein of BALB/c nude mice. Mice then received vehicle or compound <b>30m</b> (15 and 30 mg/kg) starting 24 h after injection of cells. Animals received therapy every 2 days during 20 days. Bioluminescent images were acquired 24 h after the final dose of the inhibitor. (B) Quantification of bioluminescence. Data are expressed as the mean ± SD (<i>n</i> = 4 per group) *<i>p</i> < 0.05. (C) Body weights of the mice recorded at the end of the experiment. (D) Photomicrographs of mice lung tissue sections stained with H&E illustrated the formation of breast cancer metastasis. Black arrows indicate the metastatic nodules of breast cancer.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-20/acs.jmedchem.9b01313/20191018/images/large/jm9b01313_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b01313&amp;id=fig6"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div></div><div id="sec5" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i21">5.  Conclusions</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_65825" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_65825" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p last">In the present study, in order to discover novel therapeutics for cancer metastasis, series of aryl carboxamide derivatives were synthesized and evaluated for inhibition of the HIF-1 signaling pathway by dual luciferase-reporter assay. Starting from the fragment hit 2-methyl-<i>N</i>-phenethylthiazole-4-carboxamide (<b>8</b>), systematic lead optimization was carried out, in an attempt to improve potency. In particular, replacement of methyl with 2-methoxyl substituted phenyl, conversion of the thiazole moiety to pyrimidine moiety and introduction of the F atom to the phenyl ring of <i>N</i>-phenethyl led to increasing the HIF-1 inhibitory activities. After five rounds of in-depth study on SAR step by step, compound <b>30m</b> was discovered as the most active inhibitor (IC<sub>50</sub> = 0.32 μM) without obvious cytotoxicity (CC<sub>50</sub> > 50 μM). Further biological evaluation showed that it could dose-dependently block hypoxia-induced HIF-1α protein accumulation in several human cancer cell lines. Besides, it down-regulated transcription of VEGF, a downstream gene of HIF-1, which was consistent with its inhibitory potency on capillary-like tube formation in vitro and angiogenesis of zebrafish in vivo. Moreover, compound <b>30m</b> inhibited migration and invasion of tumor cells in vitro and blocked breast cancer lung metastasis in the mice model, indicating the promising therapeutic potential of compound <b>30m</b> as an effective HIF-1 inhibitor to prevent tumor metastasis and progression. Therefore, the above results are of great importance in the development of more efficient HIF-1 inhibitors for cancer therapy.</div></div><div id="sec6" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i22">6.  Experimental Section</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_23376" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_23376" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec6_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i23" class="anchor-spacer"></div><h3 class="article-section__title" id="_i23">6.1.  Chemistry</h3><div class="NLM_p">All the commercial reagents and solvents were purchased from commercial suppliers and used without further purification. Reactions were monitored by thin-layer chromatography (TLC) and visualized under UV light at 254 and 365 nm. The chromatograms were conducted on silica gel (300–400 mesh) using CombiFlash chromatography systems (Teledyne ISCO Rf200). <sup>1</sup>H and <sup>13</sup>C NMR spectral data were recorded with a Bruker 600 MHz spectrometer in CDCl<sub>3</sub> or DMSO-<i>d</i><sub>6</sub> using tetramethylsilane (TMS) as the internal standard. High-resolution mass spectrometry (HRMS) was recorded on an Agilent Technologies LC-TOF instrument. Targeted compounds were analyzed by a Shimadzu LC20A HPLC instrument with a UV/visible detector (5 μm, 4.6 mm × 150 mm C<sub>18</sub> column). The purities of all targeted compounds were determined by monitoring at 254 nm and were confirmed to be more than 95% (<a href="/doi/suppl/10.1021/acs.jmedchem.9b01313/suppl_file/jm9b01313_si_003.pdf" class="ext-link">Table S1</a>).</div><div id="sec6_1_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i24" class="anchor-spacer"></div><h4 class="article-section__title" id="_i24">6.1.1.  General Procedure for the Synthesis of Compounds <b>8</b>, <b>10a–h</b>, <b>12a–f</b>, <b>15a–f</b>, <b>18a–j</b>, <b>20a–b</b>, <b>24a–d</b>, <b>27a–b</b>, <b>28a–l</b>, and <b>29</b> Exemplified by 2-Methyl-<i>N</i>-phenethylthiazole-4-carboxamide (<b>8</b>)</h4><div class="NLM_p last">To a solution of 2-methylthiazole-4-carboxylic acid (143 mg, 1 mmol) in dry CH<sub>2</sub>Cl<sub>2</sub> (5 mL), oxalyl chloride (0.17 mL) and <i>N</i>,<i>N</i>-dimethylformamide (DMF) (1 drop) were added at 0 °C. Then, the resulting mixture was stirred at room temperature for 1 h and concentrated in vacuo to give 2-methylthiazole-4-carbonyl chloride as the crude product. To a solution of 2-phenylethanamine (121 mg, 1 mmol) in CH<sub>2</sub>Cl<sub>2</sub> (5 mL) was added Et<sub>3</sub>N (0.16 mL) and 2-methylthiazole-4-carbonyl chloride redissolved in CH<sub>2</sub>Cl<sub>2</sub> (1 mL). The reaction mixture was stirred at room temperature for additional 6–12 h. The solution was concentrated in vacuo. The residue was purified by flash chromatography to yield compound <b>8</b> as a white solid (216 mg, 93%). <sup>1</sup>H NMR (600 MHz, CDCl<sub>3</sub>): δ 7.93 (s, 1H), 7.40 (br s, 1H), 7.33–7.30 (m, 2H), 7.25–7.22 (m, 3H), 3.69 (q, <i>J</i> = 6.0 Hz, 2H), 2.93 (t, <i>J</i> = 6.0 Hz, 2H), 2.68 (s, 3H); <sup>13</sup>C NMR (151 MHz, CDCl<sub>3</sub>): δ 165.26, 160.52, 149.12, 138.31, 128.16, 127.98, 125.84, 122.17, 40.02, 35.35, 18.46; ESI-HRMS (<i>m</i>/<i>z</i>): calcd C<sub>13</sub>H<sub>14</sub>N<sub>2</sub>OS (M + H<sup>+</sup>), 247.0900; found, 247.0899.</div></div><div id="sec6_1_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i25" class="anchor-spacer"></div><h4 class="article-section__title" id="_i25">6.1.2.  <i>N</i>-Benzyl-2-methylthiazole-4-carboxamide (<b>10a</b>)</h4><div class="NLM_p last">It is obtained as a white solid in 73% yield. <sup>1</sup>H NMR (600 MHz, CDCl<sub>3</sub>): δ 7.97 (s, 1H), 7.62 (br s, 1H), 7.36–7.32 (m, 4H), 7.29–7.26 (m, 1H), 4.63 (d, <i>J</i> = 6.0 Hz, 2H), 2.67 (s, 3H); <sup>13</sup>C NMR (151 MHz, CDCl<sub>3</sub>): δ 165.36, 160.42, 148.95, 137.57, 128.07, 127.28, 126.86, 122.48, 42.75, 18.43; ESI-HRMS (<i>m</i>/<i>z</i>): calcd C<sub>12</sub>H<sub>12</sub>N<sub>2</sub>OS (M + H<sup>+</sup>), 233.0743; found, 233.0741.</div></div><div id="sec6_1_3" class="NLM_sec NLM_sec_level_3"><div id="ac_i26" class="anchor-spacer"></div><h4 class="article-section__title" id="_i26">6.1.3.  2-Methyl-<i>N</i>-(3-phenylpropyl)thiazole-4-carboxamide (<b>10b</b>)</h4><div class="NLM_p last">It is obtained as colorless oil in 64% yield. <sup>1</sup>H NMR (600 MHz, CDCl<sub>3</sub>): δ 7.93 (s, 1H), 7.36 (br s, 1H), 7.29–7.26 (m, 2H), 7.20–7.17 (m, 3H), 3.48–3.45 (m, 2H), 2.72–2.71 (m, 2H), 2.69 (s, 3H), 1.97–1.92 (m, 2H); <sup>13</sup>C NMR (151 MHz, CDCl<sub>3</sub>): δ 165.82, 161.12, 149.82, 141.40, 128.39, 128.35, 125.91, 122.65, 38.89, 33.24, 31.25, 19.05; ESI-HRMS (<i>m</i>/<i>z</i>): calcd C<sub>14</sub>H<sub>16</sub>N<sub>2</sub>OS (M + H<sup>+</sup>), 261.1056; found, 261.1059.</div></div><div id="sec6_1_4" class="NLM_sec NLM_sec_level_3"><div id="ac_i27" class="anchor-spacer"></div><h4 class="article-section__title" id="_i27">6.1.4.  <i>N</i>-(2-Chlorophenethyl)-2-methylthiazole-4-carboxamide (<b>10c</b>)</h4><div class="NLM_p last">It is obtained as colorless oil in 84% yield. <sup>1</sup>H NMR (600 MHz, CDCl<sub>3</sub>): δ 7.94 (s, 1H), 7.42 (br s, 1H), 7.36 (dd, <i>J</i> = 7.4, 1.4 Hz, 1H), 7.28–7.26 (m, 1H), 7.20–7.17 (m, 2H), 3.70 (q, <i>J</i> = 7.4 Hz, 2H), 3.06 (t, <i>J</i> = 7.4 Hz, 2H), 2.68 (s, 3H); <sup>13</sup>C NMR (151 MHz, CDCl<sub>3</sub>): δ 165.85, 161.17, 149.70, 136.52, 134.15, 130.92, 129.57, 127.97, 126.92, 122.77, 38.97, 33.66, 19.04; ESI-HRMS (<i>m</i>/<i>z</i>): calcd C<sub>13</sub>H<sub>13</sub>ClN<sub>2</sub>OS (M + H<sup>+</sup>), 281.0510; found, 281.0512.</div></div><div id="sec6_1_5" class="NLM_sec NLM_sec_level_3"><div id="ac_i28" class="anchor-spacer"></div><h4 class="article-section__title" id="_i28">6.1.5.  <i>N</i>-(3-Chlorophenethyl)-2-methylthiazole-4-carboxamide (<b>10d</b>)</h4><div class="NLM_p last">It is obtained as a white solid in 59% yield. <sup>1</sup>H NMR (600 MHz, CDCl<sub>3</sub>): δ 7.94 (s, 1H), 7.37 (br s, 1H), 7.24–7.21 (m, 3H), 7.13–7.12 (m, 1H), 3.67 (q, <i>J</i> = 7.3 Hz, 2H), 2.90 (t, <i>J</i> = 7.3 Hz, 2H), 2.69 (s, 3H); <sup>13</sup>C NMR (151 MHz, CDCl<sub>3</sub>): δ 165.39, 160.56, 148.92, 140.32, 133.71, 129.25, 128.34, 126.37, 126.10, 122.31, 39.74, 35.03, 18.48; ESI-HRMS (<i>m</i>/<i>z</i>): calcd C<sub>13</sub>H<sub>13</sub>ClN<sub>2</sub>OS (M + H<sup>+</sup>), 281.0510; found, 281.0513.</div></div><div id="sec6_1_6" class="NLM_sec NLM_sec_level_3"><div id="ac_i29" class="anchor-spacer"></div><h4 class="article-section__title" id="_i29">6.1.6.  <i>N</i>-(4-Chlorophenethyl)-2-methylthiazole-4-carboxamide (<b>10e</b>)</h4><div class="NLM_p last">It is obtained as a white solid in 70% yield. <sup>1</sup>H NMR (600 MHz, CDCl<sub>3</sub>): δ 7.93 (s, 1H), 7.37 (br s, 1H), 7.28–7.27 (m, 2H), 7.18–7.16 (m, 2H), 3.66 (q, <i>J</i> = 7.2 Hz, 2H), 2.90 (t, <i>J</i> = 7.2 Hz, 2H), 2.68 (s, 3H); <sup>13</sup>C NMR (151 MHz, CDCl<sub>3</sub>): δ 165.38, 160.54, 148.94, 136.75, 131.66, 129.52, 128.09, 122.30, 39.85, 34.69, 18.50; ESI-HRMS (<i>m</i>/<i>z</i>): calcd C<sub>13</sub>H<sub>13</sub>ClN<sub>2</sub>OS (M + H<sup>+</sup>), 281.0510; found, 281.0510.</div></div><div id="sec6_1_7" class="NLM_sec NLM_sec_level_3"><div id="ac_i30" class="anchor-spacer"></div><h4 class="article-section__title" id="_i30">6.1.7.  2-Methyl-<i>N</i>-(2-(pyridin-2-yl)ethyl)thiazole-4-carboxamide (<b>10f</b>)</h4><div class="NLM_p last">It is obtained as colorless oil in 72% yield. <sup>1</sup>H NMR (600 MHz, CDCl<sub>3</sub>): δ 8.57 (d, <i>J</i> = 4.7 Hz, 1H), 7.92 (s, 1H), 7.86 (br s, 1H), 7.62–7.59 (m, 1H), 7.20 (d, <i>J</i> = 7.8 Hz, 1H), 7.16–7.14 (m, 1H), 3.85 (q, <i>J</i> = 6.7 Hz, 2H), 3.10 (t, <i>J</i> = 6.7 Hz, 2H), 2.68 (s, 3H); <sup>13</sup>C NMR (151 MHz, CDCl<sub>3</sub>): δ 165.77, 161.13, 159.29, 149.88, 149.35, 136.45, 123.31, 122.62, 121.47, 38.65, 37.50, 19.08; ESI-HRMS (<i>m</i>/<i>z</i>): calcd C<sub>12</sub>H<sub>13</sub>N<sub>3</sub>OS (M + H<sup>+</sup>), 248.0852; found, 248.0849.</div></div><div id="sec6_1_8" class="NLM_sec NLM_sec_level_3"><div id="ac_i31" class="anchor-spacer"></div><h4 class="article-section__title" id="_i31">6.1.8.  2-Methyl-<i>N</i>-(2-(pyridin-3-yl)ethyl)thiazole-4-carboxamide (<b>10g</b>)</h4><div class="NLM_p last">It is obtained as a white solid in 85% yield. <sup>1</sup>H NMR (600 MHz, CDCl<sub>3</sub>): δ 8.49 (d, <i>J</i> = 1.6 Hz, 1H), 8.48 (dd, <i>J</i> = 4.8, 1.6 Hz, 1H), 7.92 (s, 1H), 7.57 (dt, <i>J</i> = 7.8, 1.6 Hz, 1H), 7.41 (br s, 1H), 7.24 (dd, <i>J</i> = 7.8, 4.8 Hz, 1H), 3.69 (q, <i>J</i> = 7.0 Hz, 2H), 2.94 (t, <i>J</i> = 7.0 Hz, 2H), 2.67 (s, 3H); <sup>13</sup>C NMR (151 MHz, CDCl<sub>3</sub>): δ 165.41, 160.60, 149.56, 148.84, 147.43, 135.61, 133.70, 122.88, 122.36, 39.62, 32.52, 18.45; ESI-HRMS (<i>m</i>/<i>z</i>): calcd C<sub>12</sub>H<sub>13</sub>N<sub>3</sub>OS (M + H<sup>+</sup>), 248.0852; found, 248.0856.</div></div><div id="sec6_1_9" class="NLM_sec NLM_sec_level_3"><div id="ac_i32" class="anchor-spacer"></div><h4 class="article-section__title" id="_i32">6.1.9.  2-Methyl-<i>N</i>-(2-(pyridin-4-yl)ethyl)thiazole-4-carboxamide (<b>10h</b>)</h4><div class="NLM_p last">It is obtained as a white solid in 77% yield. <sup>1</sup>H NMR (600 MHz, CDCl<sub>3</sub>): δ 8.52 (d, <i>J</i> = 5.8 Hz, 2H), 7.93 (s, 1H), 7.38 (br s, 1H), 7.17 (d, <i>J</i> = 5.8 Hz, 2H), 3.71 (q, <i>J</i> = 7.2 Hz, 2H), 2.93 (t, <i>J</i> = 7.2 Hz, 2H), 2.67 (s, 3H); <sup>13</sup>C NMR (151 MHz, CDCl<sub>3</sub>): δ 165.45, 160.59, 149.33, 148.78, 147.27, 123.51, 122.41, 38.89, 34.63, 18.45; ESI-HRMS (<i>m</i>/<i>z</i>): calcd C<sub>12</sub>H<sub>13</sub>N<sub>3</sub>OS (M + H<sup>+</sup>), 248.0852; found, 248.0855.</div></div><div id="sec6_1_10" class="NLM_sec NLM_sec_level_3"><div id="ac_i33" class="anchor-spacer"></div><h4 class="article-section__title" id="_i33">6.1.10.  <i>N</i>-(2-Chlorophenethyl)-4-methylbenzamide (<b>12a</b>)</h4><div class="NLM_p last">It is obtained as a white solid in 80% yield. <sup>1</sup>H NMR (600 MHz, CDCl<sub>3</sub>): δ 7.62–7.60 (m, 2H), 7.38–7.37 (m, 1H), 7.27–7.26 (m, 1H), 7.22–7.17 (m, 4H), 6.17 (br s, 1H), 3.73 (q, <i>J</i> = 6.8 Hz, 2H), 3.09 (t, <i>J</i> = 6.8 Hz, 2H), 2.38 (s, 3H); <sup>13</sup>C NMR (151 MHz, CDCl<sub>3</sub>): δ 166.87, 141.20, 136.08, 133.51, 131.10, 130.50, 129.05, 128.59, 127.48, 126.42, 126.19, 39.09, 32.73, 20.79; ESI-HRMS (<i>m</i>/<i>z</i>): calcd C<sub>16</sub>H<sub>16</sub>ClNO (M + H<sup>+</sup>), 274.0993; found, 274.0993.</div></div><div id="sec6_1_11" class="NLM_sec NLM_sec_level_3"><div id="ac_i34" class="anchor-spacer"></div><h4 class="article-section__title" id="_i34">6.1.11.  4-Methyl-<i>N</i>-(2-(pyridin-4-yl)ethyl)benzamide (<b>12b</b>)</h4><div class="NLM_p last">It is obtained as a white solid in 80% yield. <sup>1</sup>H NMR (600 MHz, CDCl<sub>3</sub>): δ 8.50 (d, <i>J</i> = 5.7 Hz, 2H), 7.60 (d, <i>J</i> = 7.8 Hz, 2H), 7.20 (d, <i>J</i> = 7.8 Hz, 2H), 7.15 (d, <i>J</i> = 5.7 Hz, 2H), 6.28 (br s, 1H), 3.71 (q, <i>J</i> = 7.0 Hz, 2H), 2.93 (t, <i>J</i> = 7.0 Hz, 2H), 2.38 (s, 3H); <sup>13</sup>C NMR (151 MHz, CDCl<sub>3</sub>): δ 167.00, 149.26, 147.58, 141.43, 130.83, 128.63, 126.24, 123.62, 39.65, 34.51, 20.82; ESI-HRMS (<i>m</i>/<i>z</i>): calcd C<sub>15</sub>H<sub>16</sub>N<sub>2</sub>O (M + H<sup>+</sup>), 241.1335; found, 241.1337.</div></div><div id="sec6_1_12" class="NLM_sec NLM_sec_level_3"><div id="ac_i35" class="anchor-spacer"></div><h4 class="article-section__title" id="_i35">6.1.12.  <i>N</i>-(2-Chlorophenethyl)-5-methylfuran-2-carboxamide (<b>12c</b>)</h4><div class="NLM_p last">It is obtained as colorless oil in 67% yield. <sup>1</sup>H NMR (600 MHz, CDCl<sub>3</sub>): δ 7.37 (dd, <i>J</i> = 7.5, 1.5 Hz, 1H), 7.28–7.26 (m, 1H), 7.22–7.17 (m, 2H), 6.99 (d, <i>J</i> = 3.3 Hz, 1H), 6.37 (br s, 1H), 6.08 (d, <i>J</i> = 3.3 Hz, 1H), 3.68 (td, <i>J</i> = 7.0 Hz, 2H), 3.05 (t, <i>J</i> = 7.0 Hz, 2H), 2.32 (s, 3H); <sup>13</sup>C NMR (151 MHz, CDCl<sub>3</sub>): δ 158.59, 154.32, 146.38, 136.51, 134.13, 131.00, 129.59, 128.02, 126.96, 115.28, 108.43, 38.77, 33.62, 13.74; ESI-HRMS (<i>m</i>/<i>z</i>): calcd C<sub>14</sub>H<sub>14</sub>ClNO<sub>2</sub> (M + H<sup>+</sup>), 264.0786; found, 264.0789.</div></div><div id="sec6_1_13" class="NLM_sec NLM_sec_level_3"><div id="ac_i36" class="anchor-spacer"></div><h4 class="article-section__title" id="_i36">6.1.13.  5-Methyl-<i>N</i>-(2-(pyridin-4-yl)ethyl)furan-2-carboxamide (<b>12d</b>)</h4><div class="NLM_p last">It is obtained as a white solid in 70% yield. <sup>1</sup>H NMR (600 MHz, CDCl<sub>3</sub>): δ 8.51 (d, <i>J</i> = 5.8, 2H), 7.15 (d, <i>J</i> = 5.8 Hz, 2H), 6.99 (d, <i>J</i> = 3.3 Hz, 1H), 6.43 (br s, 1H), 6.07 (d, <i>J</i> = 3.3, 1H), 3.68 (q, <i>J</i> = 7.0 Hz, 2H), 2.91 (t, <i>J</i> = 7.0 Hz, 2H), 2.29 (s, 3H); <sup>13</sup>C NMR (151 MHz, CDCl<sub>3</sub>): δ 158.00, 153.94, 149.31, 147.32, 145.50, 123.56, 114.99, 107.95, 38.68, 34.67, 13.18; ESI-HRMS (<i>m</i>/<i>z</i>): calcd C<sub>13</sub>H<sub>14</sub>N<sub>2</sub>O<sub>2</sub> (M + H<sup>+</sup>), 231.1128; found, 231.1128.</div></div><div id="sec6_1_14" class="NLM_sec NLM_sec_level_3"><div id="ac_i37" class="anchor-spacer"></div><h4 class="article-section__title" id="_i37">6.1.14.  <i>N</i>-(2-Chlorophenethyl)-6-methylpicolinamide (<b>12e</b>)</h4><div class="NLM_p last">It is obtained as a colorless oil in 61% yield. <sup>1</sup>H NMR (600 MHz, CDCl<sub>3</sub>): δ 8.23 (br s, 1H), 7.99 (d, <i>J</i> = 7.7 Hz, 1H), 7.71 (t, <i>J</i> = 7.7 Hz, 1H), 7.37 (dd, <i>J</i> = 7.5, 1.5 Hz, 1H), 7.29 (d, <i>J</i> = 7.5 Hz, 1H), 7.27–7.25 (m, 1H), 7.22–7.16 (m, 2H), 3.74 (q, <i>J</i> = 7.1 Hz, 2H), 3.09 (t, <i>J</i> = 7.1 Hz, 2H), 2.54 (s, 3H); <sup>13</sup>C NMR (151 MHz, CDCl<sub>3</sub>): δ 164.56, 157.05, 149.21, 137.38, 136.66, 134.18, 130.99, 129.57, 127.95, 126.89, 125.74, 119.14, 39.05, 33.63, 24.17; ESI-HRMS (<i>m</i>/<i>z</i>): calcd C<sub>15</sub>H<sub>15</sub>ClN<sub>2</sub>O (M + H<sup>+</sup>), 275.0946; found, 275.0949.</div></div><div id="sec6_1_15" class="NLM_sec NLM_sec_level_3"><div id="ac_i38" class="anchor-spacer"></div><h4 class="article-section__title" id="_i38">6.1.15.  6-Methyl-<i>N</i>-(2-(pyridin-4-yl)ethyl)picolinamide (<b>12f</b>)</h4><div class="NLM_p last">It is obtained as colorless oil in 73% yield. <sup>1</sup>H NMR (600 MHz, CDCl<sub>3</sub>): δ 8.53 (d, <i>J</i> = 5.9 Hz, 2H), 8.25–8.15 (m, 1H), 7.98 (d, <i>J</i> = 7.7 Hz, 1H), 7.72 (t, <i>J</i> = 7.7 Hz, 1H), 7.27 (d, <i>J</i> = 7.7 Hz, 1H), 7.19 (d, <i>J</i> = 5.9 Hz, 2H), 3.74 (q, <i>J</i> = 7.0 Hz, 2H), 2.96 (t, <i>J</i> = 7.0 Hz, 2H), 2.53 (s, 3H); <sup>13</sup>C NMR (151 MHz, CDCl<sub>3</sub>): δ 164.59, 157.13, 149.93, 148.97, 147.96, 137.46, 125.91, 124.13, 119.19, 39.58, 35.30, 24.18; ESI-HRMS (<i>m</i>/<i>z</i>): calcd C<sub>14</sub>H<sub>15</sub>N<sub>3</sub>O (M + H<sup>+</sup>), 242.1288; found, 242.1289.</div></div><div id="sec6_1_16" class="NLM_sec NLM_sec_level_3"><div id="ac_i39" class="anchor-spacer"></div><h4 class="article-section__title" id="_i39">6.1.16.  General Procedure for the Synthesis of Compounds <b>14a–c</b> and <b>17a–e</b> Exemplified by 2-Phenylthiazole-4-carboxylic Acid (<b>14a</b>)</h4><div class="NLM_p last">Aqueous solution (2 N LiOH) was added to a solution of carboxylic ester <b>13a</b> (1 equiv) in ethanol at ambient temperature. The reaction mixture was stirred for 1 h, and ethanol was then removed by evaporation in vacuo. The resulting mixture was adjusted to pH = 5–6 with 1 N HCl. The precipitated white solid was collected by filtration and dried to give the carboxylic acid <b>14a</b> as a white solid (68% yield), which was used in the next step without further purification.</div></div><div id="sec6_1_17" class="NLM_sec NLM_sec_level_3"><div id="ac_i40" class="anchor-spacer"></div><h4 class="article-section__title" id="_i40">6.1.17.  <i>N</i>-(2-Chlorophenethyl)-2-phenylthiazole-4-carboxamide (<b>15a</b>)</h4><div class="NLM_p last">It is obtained as a white solid in 48% yield from <b>9a</b>. <sup>1</sup>H NMR (600 MHz, CDCl<sub>3</sub>): δ 8.09 (s, 1H), 7.94–7.92 (m, 2H), 7.59 (br s, 1H), 7.47–7.46 (m, 3H), 7.39 (dd, <i>J</i> = 7.4, 1.7 Hz, 1H), 7.31 (dd, <i>J</i> = 7.4, 1.7 Hz, 1H), 7.24–7.19 (m, 2H), 3.76 (q, <i>J</i> = 7.0 Hz, 2H), 3.12 (t, <i>J</i> = 7.0 Hz, 2H); <sup>13</sup>C NMR (151 MHz, CDCl<sub>3</sub>): δ 167.46, 160.57, 150.19, 135.94, 133.59, 132.25, 130.45, 129.99, 129.04, 128.44, 127.46, 126.37, 125.99, 122.14, 38.47, 32.99; ESI-HRMS (<i>m</i>/<i>z</i>): calcd C<sub>18</sub>H<sub>15</sub>ClN<sub>2</sub>OS (M + H<sup>+</sup>), 349.0714; found, 349.0702.</div></div><div id="sec6_1_18" class="NLM_sec NLM_sec_level_3"><div id="ac_i41" class="anchor-spacer"></div><h4 class="article-section__title" id="_i41">6.1.18.  2-Phenyl-<i>N</i>-(2-(pyridin-4-yl)ethyl)thiazole-4-carboxamide (<b>15b</b>)</h4><div class="NLM_p last">It is obtained as a white solid in 49% yield from <b>9a</b>. <sup>1</sup>H NMR (600 MHz, CDCl<sub>3</sub>): δ 8.56 (d, <i>J</i> = 5.8 Hz, 2H), 8.09 (s, 1H), 7.92–7.90 (m, 2H), 7.56 (br s, 1H), 7.47–7.46 (m, 3H), 7.23 (d, <i>J</i> = 5.8 Hz, 2H), 3.77 (q, <i>J</i> = 7.2 Hz, 2H), 2.99 (t, <i>J</i> = 7.2 Hz, 2H); <sup>13</sup>C NMR (151 MHz, CDCl<sub>3</sub>): δ 167.65, 160.57, 149.91, 149.39, 147.25, 132.13, 130.09, 128.47, 125.96, 123.56, 122.38, 38.99, 34.72; ESI-HRMS (<i>m</i>/<i>z</i>): calcd C<sub>17</sub>H<sub>15</sub>N<sub>3</sub>OS (M + H<sup>+</sup>), 332.0828; found, 332.0831.</div></div><div id="sec6_1_19" class="NLM_sec NLM_sec_level_3"><div id="ac_i42" class="anchor-spacer"></div><h4 class="article-section__title" id="_i42">6.1.19.  <i>N</i>-(2-Chlorophenethyl)-2-(pyridin-3-yl)thiazole-4-carboxamide (<b>15c</b>)</h4><div class="NLM_p last">It is obtained as a white solid in 53% yield from <b>9b</b>. <sup>1</sup>H NMR (600 MHz, CDCl<sub>3</sub>): δ 9.16 (s, 1H), 8.70 (d, <i>J</i> = 5.4 Hz, 1H), 8.19 (d, <i>J</i> = 7.8 Hz, 1H), 8.15 (s, 1H), 7.42–7.38 (m, 2H), 7.30 (d, <i>J</i> = 7.8 Hz, 1H), 7.24–7.19 (m, 2H), 3.77 (t, <i>J</i> = 7.0 Hz, 2H), 3.12 (t, <i>J</i> = 7.0 Hz, 2H); <sup>13</sup>C NMR (151 MHz, CDCl<sub>3</sub>): δ 164.08, 160.22, 150.72, 150.65, 147.08, 135.84, 133.59, 133.11, 130.43, 129.08, 128.26, 127.55, 126.39, 123.16, 122.88, 38.54, 32.90; ESI-HRMS (<i>m</i>/<i>z</i>): calcd C<sub>17</sub>H<sub>14</sub>ClN<sub>3</sub>OS (M + H<sup>+</sup>), 344.0619; found, 344.0618.</div></div><div id="sec6_1_20" class="NLM_sec NLM_sec_level_3"><div id="ac_i43" class="anchor-spacer"></div><h4 class="article-section__title" id="_i43">6.1.20.  2-(Pyridin-3-yl)-<i>N</i>-(2-(pyridin-4-yl)ethyl)thiazole-4-carboxamide (<b>15d</b>)</h4><div class="NLM_p last">It is obtained as a white solid in 51% yield from <b>9b</b>. <sup>1</sup>H NMR (600 MHz, CDCl<sub>3</sub>): δ 9.13 (d, <i>J</i> = 1.5 Hz, 1H), 8.68 (dd, <i>J</i> = 4.8, 1.5 Hz, 1H), 8.54 (d, <i>J</i> = 6.0 Hz, 2H), 8.20–8.18 (m, 1H), 8.19 (s, 1H), 7.53 (br s, 1H), 7.40 (dd, <i>J</i> = 8.0, 4.8 Hz, 1H), 7.19 (d, <i>J</i> = 6.0 Hz, 2H), 3.76 (q, <i>J</i> = 7.2 Hz, 2H), 2.98 (t, <i>J</i> = 7.2 Hz, 2H); <sup>13</sup>C NMR (151 MHz, CDCl<sub>3</sub>): δ 164.27, 160.24, 150.81, 150.39, 149.40, 147.15, 147.06, 133.08, 128.16, 123.53, 123.19, 123.13, 39.04, 34.65; ESI-HRMS (<i>m</i>/<i>z</i>): calcd C<sub>16</sub>H<sub>14</sub>N<sub>4</sub>OS (M + H<sup>+</sup>), 311.0961; found, 311.0966.</div></div><div id="sec6_1_21" class="NLM_sec NLM_sec_level_3"><div id="ac_i44" class="anchor-spacer"></div><h4 class="article-section__title" id="_i44">6.1.21.  <i>N</i>-(2-Chlorophenethyl)-2-(pyridin-4-yl)thiazole-4-carboxamide (<b>15e</b>)</h4><div class="NLM_p last">It is obtained as a white solid in 57% yield. <sup>1</sup>H NMR (600 MHz, CDCl<sub>3</sub>): δ 8.74 (dd, <i>J</i> = 4.6, 1.5 Hz, 2H), 8.21 (s, 1H), 7.78 (dd, <i>J</i> = 4.6, 1.5 Hz, 2H), 7.39 (dd, <i>J</i> = 7.3, 1.7 Hz, 1H), 7.30 (dd, <i>J</i> = 7.1, 1.9 Hz, 1H), 7.24–7.19 (m, 2H), 3.76 (t, <i>J</i> = 7.2 Hz, 2H), 3.12 (t, <i>J</i> = 7.2 Hz, 2H); <sup>13</sup>C NMR (151 MHz, CDCl<sub>3</sub>): δ 164.54, 160.02, 150.90, 150.19, 138.89, 135.82, 133.59, 130.43, 129.08, 127.55, 126.40, 123.80, 119.68, 38.46, 32.88; ESI-HRMS (<i>m</i>/<i>z</i>): calcd C<sub>17</sub>H<sub>14</sub>ClN<sub>3</sub>OS (M + H<sup>+</sup>), 344.0619; found, 344.0619.</div></div><div id="sec6_1_22" class="NLM_sec NLM_sec_level_3"><div id="ac_i45" class="anchor-spacer"></div><h4 class="article-section__title" id="_i45">6.1.22.  2-(Pyridin-4-yl)-<i>N</i>-(2-(pyridin-4-yl)ethyl)thiazole-4-carboxamide (<b>15f</b>)</h4><div class="NLM_p last">It is obtained as a white solid in 56% yield from <b>9c</b>. <sup>1</sup>H NMR (600 MHz, CDCl<sub>3</sub>): δ 8.73 (d, <i>J</i> = 6.0 Hz, 2H), 8.54 (d, <i>J</i> = 5.8 Hz, 2H), 8.21 (s, 1H), 7.75 (d, <i>J</i> = 6.0 Hz, 2H), 7.49 (br s, 1H), 7.19 (d, <i>J</i> = 5.8 Hz, 2H), 3.77 (q, <i>J</i> = 7.2 Hz, 2H), 2.98 (t, <i>J</i> = 7.2 Hz, 2H); <sup>13</sup>C NMR (151 MHz, CDCl<sub>3</sub>): δ 164.74, 160.09, 150.65, 150.23, 149.41, 147.11, 138.76, 124.03, 123.54, 119.64, 39.05, 34.65; ESI-HRMS (<i>m</i>/<i>z</i>): calcd C<sub>16</sub>H<sub>14</sub>N<sub>4</sub>OS (M + H<sup>+</sup>), 311.0961; found, 311.0965.</div></div><div id="sec6_1_23" class="NLM_sec NLM_sec_level_3"><div id="ac_i46" class="anchor-spacer"></div><h4 class="article-section__title" id="_i46">6.1.23.  <i>N</i>-(2-Chlorophenethyl)-2-phenyloxazole-4-carboxamide (<b>18a</b>)</h4><div class="NLM_p last">It is obtained as a white solid in 48% yield from <b>16a</b>. <sup>1</sup>H NMR (600 MHz, CDCl<sub>3</sub>): δ 8.23 (s, 1H), 8.03–8.02 (m, 2H), 7.50–7.47 (m, 3H), 7.39 (dd, <i>J</i> = 7.5, 1.5 Hz, 1H), 7.30 (dd, <i>J</i> = 7.3, 1.7 Hz, 1H), 7.24–7.18 (m, 2H), 7.16 (br s, 1H), 3.73 (q, <i>J</i> = 7.2 Hz, 2H), 3.10 (t, <i>J</i> = 7.2 Hz, 2H); <sup>13</sup>C NMR (151 MHz, CDCl<sub>3</sub>): δ 161.37, 160.74, 140.69, 137.26, 136.41, 134.17, 131.00, 130.98, 129.62, 128.87, 128.07, 126.97, 126.63, 126.59, 38.77, 33.58; ESI-HRMS (<i>m</i>/<i>z</i>): calcd C<sub>18</sub>H<sub>15</sub>ClN<sub>2</sub>O<sub>2</sub> (M + H<sup>+</sup>), 349.0714; found, 349.0702.</div></div><div id="sec6_1_24" class="NLM_sec NLM_sec_level_3"><div id="ac_i47" class="anchor-spacer"></div><h4 class="article-section__title" id="_i47">6.1.24.  2-Phenyl-<i>N</i>-(2-(pyridin-4-yl)ethyl)oxazole-4-carboxamide (<b>18b</b>)</h4><div class="NLM_p last">It is obtained as a white solid in 50% yield from <b>16a</b>. <sup>1</sup>H NMR (600 MHz, CDCl<sub>3</sub>): δ 8.56 (d, <i>J</i> = 5.9 Hz, 2H), 8.24 (s, 1H), 8.03–7.99 (m, 2H), 7.50–7.46 (m, 3H), 7.22 (d, <i>J</i> = 5.9 Hz, 2H), 7.13 (br s, 1H), 3.74 (q, <i>J</i> = 7.2 Hz, 2H), 2.97 (t, <i>J</i> = 7.2 Hz, 2H); <sup>13</sup>C NMR (151 MHz, CDCl<sub>3</sub>): δ 160.88, 160.14, 149.38, 147.15, 140.17, 136.43, 130.51, 128.30, 125.99, 125.91, 123.53, 38.65, 34.65; ESI-HRMS (<i>m</i>/<i>z</i>): calcd C<sub>17</sub>H<sub>15</sub>N<sub>3</sub>O<sub>2</sub> (M + H<sup>+</sup>), 294.1237; found, 294.1237.</div></div><div id="sec6_1_25" class="NLM_sec NLM_sec_level_3"><div id="ac_i48" class="anchor-spacer"></div><h4 class="article-section__title" id="_i48">6.1.25.  <i>N</i>-(2-Chlorophenethyl)-5-phenyloxazole-2-carboxamide (<b>18c</b>)</h4><div class="NLM_p last">It is obtained as a white solid in 46% yield from <b>16b</b>. <sup>1</sup>H NMR (600 MHz, CDCl<sub>3</sub>): δ 7.76–7.74 (m, 2H), 7.46–7.43 (m, 2H), 7.40–7.37 (m, 3H), 7.28–7.27 (m, 1H), 7.23–7.18 (m, 2H), 7.14 (br s, 1H), 3.75 (q, <i>J</i> = 6.8 Hz, 2H), 3.09 (t, <i>J</i> = 7.1 Hz, 2H); <sup>13</sup>C NMR (151 MHz, CDCl<sub>3</sub>): δ 155.27, 154.21, 153.95, 136.09, 134.13, 130.95, 129.68, 129.48, 128.97, 128.21, 127.04, 126.88, 124.93, 122.54, 39.26, 33.34; ESI-HRMS (<i>m</i>/<i>z</i>): calcd C<sub>18</sub>H<sub>15</sub>ClN<sub>2</sub>O<sub>2</sub> (M + H<sup>+</sup>), 349.0714; found, 349.0716.</div></div><div id="sec6_1_26" class="NLM_sec NLM_sec_level_3"><div id="ac_i49" class="anchor-spacer"></div><h4 class="article-section__title" id="_i49">6.1.26.  5-Phenyl-<i>N</i>-(2-(pyridin-4-yl)ethyl)oxazole-2-carboxamide (<b>18d</b>)</h4><div class="NLM_p last">It is obtained as a white solid in 53% yield from <b>16b</b>. <sup>1</sup>H NMR (600 MHz, CDCl<sub>3</sub>): δ 8.56 (d, <i>J</i> = 4.6 Hz, 2H), 7.76–7.74 (m, 2H), 7.46–7.44 (m, 2H), 7.41–7.39 (m, 1H), 7.38 (s, 1H), 7.23 (d, <i>J</i> = 4.6 Hz, 2H), 7.12 (br s, 1H), 3.77 (q, <i>J</i> = 7.0 Hz, 2H), 2.98 (t, <i>J</i> = 7.0 Hz, 2H); <sup>13</sup>C NMR (151 MHz, CDCl<sub>3</sub>): δ 154.67, 153.58, 153.37, 149.48, 146.75, 128.99, 128.41, 126.19, 124.37, 123.45, 121.95, 39.12, 34.39; ESI-HRMS (<i>m</i>/<i>z</i>): calcd C<sub>17</sub>H<sub>15</sub>N<sub>3</sub>O<sub>2</sub> (M + H<sup>+</sup>), 294.1237; found, 294.1237.</div></div><div id="sec6_1_27" class="NLM_sec NLM_sec_level_3"><div id="ac_i50" class="anchor-spacer"></div><h4 class="article-section__title" id="_i50">6.1.27.  <i>N</i>-(2-Chlorophenethyl)-5-phenyl-1,2,4-oxadiazole-3-carboxamide (<b>18e</b>)</h4><div class="NLM_p last">It is obtained as a white solid in 56% yield from <b>16c</b>. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ 8.57 (d, <i>J</i> = 6.0 Hz, 2H), 8.17–8.15 (m, 2H), 7.67–7.63 (m, 1H), 7.58–7.54 (m, 2H), 7.21 (d, <i>J</i> = 6.0 Hz, 2H), 7.12 (br s, 1H), 3.81 (q, <i>J</i> = 7.0 Hz, 2H), 3.00 (t, <i>J</i> = 7.0 Hz, 2H); <sup>13</sup>C NMR (151 MHz, CDCl<sub>3</sub>): δ 176.20, 163.28, 155.86, 135.36, 133.54, 132.84, 130.40, 129.13, 128.64, 127.73, 127.70, 126.51, 122.75, 38.78, 32.56; ESI-HRMS (<i>m</i>/<i>z</i>): calcd C<sub>17</sub>H<sub>14</sub>ClN<sub>3</sub>O<sub>2</sub> (M + H<sup>+</sup>), 350.0667; found, 350.0655.</div></div><div id="sec6_1_28" class="NLM_sec NLM_sec_level_3"><div id="ac_i51" class="anchor-spacer"></div><h4 class="article-section__title" id="_i51">6.1.28.  5-Phenyl-<i>N</i>-(2-(pyridin-4-yl)ethyl)-1,2,4-oxadiazole-3-carboxamide (<b>18f</b>)</h4><div class="NLM_p last">It is obtained as a white solid in 63% yield from <b>16c</b>. <sup>1</sup>H NMR (600 MHz, DMSO-<i>d</i><sub>6</sub>): δ 9.15 (t, <i>J</i> = 7.2 Hz, 1H), 8.44 (d, <i>J</i> = 5.9 Hz, 2H), 8.12 (d, <i>J</i> = 7.0 Hz, 2H), 7.72 (t, <i>J</i> = 7.0 Hz, 1H), 7.64 (t, <i>J</i> = 7.0 Hz, 2H), 7.25 (d, <i>J</i> = 5.9 Hz, 2H), 3.55 (q, <i>J</i> = 7.2 Hz, 2H), 2.88 (t, <i>J</i> = 7.2 Hz, 2H); <sup>13</sup>C NMR (151 MHz, DMSO-<i>d</i><sub>6</sub>): δ 176.41, 164.62, 156.57, 149.99, 148.45, 134.20, 130.13, 128.52, 124.71, 123.42, 40.49, 34.21; ESI-HRMS (<i>m</i>/<i>z</i>): calcd C<sub>16</sub>H<sub>14</sub>N<sub>4</sub>O<sub>2</sub> (M + H<sup>+</sup>), 317.1009; found, 317.1006.</div></div><div id="sec6_1_29" class="NLM_sec NLM_sec_level_3"><div id="ac_i52" class="anchor-spacer"></div><h4 class="article-section__title" id="_i52">6.1.29.  <i>N</i>-(2-Chlorophenethyl)-3-phenyl-1,2,4-oxadiazole-5-carboxamide (<b>18g</b>)</h4><div class="NLM_p last">It is obtained as a white solid in 62% yield from <b>16d</b>. <sup>1</sup>H NMR (600 MHz, CDCl<sub>3</sub>): δ 8.09–8.08 (m, 2H), 7.56–7.54 (m, 1H), 7.52–7.49 (m, 2H), 7.41–7.39 (m, 1H), 7.29–7.26 (m, 1H), 7.25–7.22 (m, 3H), 3.80 (q, <i>J</i> = 7.1 Hz, 2H), 3.13 (t, <i>J</i> = 7.1 Hz, 2H); <sup>13</sup>C NMR (151 MHz, CDCl<sub>3</sub>): δ 168.68, 168.56, 153.11, 135.66, 134.13, 131.74, 130.95, 129.80, 128.97, 128.44, 127.53, 127.18, 125.78, 39.71, 33.07; ESI-HRMS (<i>m</i>/<i>z</i>): calcd C<sub>17</sub>H<sub>14</sub>ClN<sub>3</sub>O<sub>2</sub> (M + H<sup>+</sup>), 350.0667; found, 350.0664.</div></div><div id="sec6_1_30" class="NLM_sec NLM_sec_level_3"><div id="ac_i53" class="anchor-spacer"></div><h4 class="article-section__title" id="_i53">6.1.30.  3-Phenyl-<i>N</i>-(2-(pyridin-4-yl)ethyl)-1,2,4-oxadiazole-5-carboxamide (<b>18h</b>)</h4><div class="NLM_p last">It is obtained as a white solid in 52% yield from <b>16d</b>. <sup>1</sup>H NMR (600 MHz, CDCl<sub>3</sub>): δ 8.55 (dd, <i>J</i> = 4.5, 1.4 Hz, 2H), 8.06–8.05 (m, 2H), 7.55–7.52 (m, 1H), 7.50–7.48 (m, 2H), 7.44 (br s, 1H), 7.19 (dd, <i>J</i> = 4.5, 1.4 Hz, 2H), 3.80 (q, <i>J</i> = 7.0 Hz, 2H), 3.00 (t, <i>J</i> = 7.0 Hz, 2H); <sup>13</sup>C NMR (151 MHz, CDCl<sub>3</sub>): δ 168.71, 168.44, 153.24, 150.04, 147.07, 131.80, 128.97, 127.48, 125.64, 124.04, 40.18, 34.67; ESI-HRMS (<i>m</i>/<i>z</i>): calcd C<sub>16</sub>H<sub>14</sub>N<sub>4</sub>O<sub>2</sub> (M + H<sup>+</sup>), 317.1009; found, 317.1006.</div></div><div id="sec6_1_31" class="NLM_sec NLM_sec_level_3"><div id="ac_i54" class="anchor-spacer"></div><h4 class="article-section__title" id="_i54">6.1.31.  <i>N</i>-(2-Chlorophenethyl)-5-phenyl-1,3,4-oxadiazole-2-carboxamide (<b>18i</b>)</h4><div class="NLM_p last">It is obtained as a white solid in 51% yield from <b>16e</b>. <sup>1</sup>H NMR (600 MHz, CDCl<sub>3</sub>): δ 8.15 (d, <i>J</i> = 8.3 Hz, 2H), 7.59 (t, <i>J</i> = 8.3 Hz, 1H), 7.53 (t, <i>J</i> = 8.3 Hz, 2H), 7.38–7.37 (m, 1H), 7.34 (br s, 1H), 7.27–7.26 (m, 1H), 7.23–7.19 (m, 2H), 3.80 (q, <i>J</i> = 7.0 Hz, 2H), 3.12 (t, <i>J</i> = 7.0 Hz, 2H); <sup>13</sup>C NMR (151 MHz, DMSO-<i>d</i><sub>6</sub>): δ 165.41, 158.90, 153.48, 136.83, 133.65, 133.12, 131.59, 130.01, 129.76, 128.83, 127.80, 127.51, 123.26, 39.33, 32.88; ESI-HRMS (<i>m</i>/<i>z</i>): calcd C<sub>17</sub>H<sub>14</sub>ClN<sub>3</sub>O<sub>2</sub> (M + H<sup>+</sup>), 328.0847; found, 328.0846.</div></div><div id="sec6_1_32" class="NLM_sec NLM_sec_level_3"><div id="ac_i55" class="anchor-spacer"></div><h4 class="article-section__title" id="_i55">6.1.32.  5-Phenyl-<i>N</i>-(2-(pyridin-4-yl)ethyl)-1,3,4-oxadiazole-2-carboxamide (<b>18j</b>)</h4><div class="NLM_p last">It is obtained as a white solid in 49% yield from <b>16e</b>. <sup>1</sup>H NMR (600 MHz, CDCl<sub>3</sub>): δ 8.56 (dd, <i>J</i> = 4.5, 1.4 Hz, 2H), 8.16–8.14 (m, 2H), 7.61–7.59 (m, 1H), 7.56–7.53 (m, 2H), 7.28 (br t, 1H), 7.21 (dd, <i>J</i> = 4.5, 1.4 Hz, 2H), 3.81 (q, <i>J</i> = 7.0 Hz, 2H), 2.99 (t, <i>J</i> = 7.0 Hz, 2H); <sup>13</sup>C NMR (151 MHz, CDCl<sub>3</sub>): δ 166.60, 158.28, 153.41, 150.10, 147.03, 132.69, 129.20, 127.49, 124.00, 122.79, 40.01, 34.84; ESI-HRMS (<i>m</i>/<i>z</i>): calcd C<sub>16</sub>H<sub>14</sub>N<sub>4</sub>O<sub>2</sub> (M + H<sup>+</sup>), 317.1009; found, 317.1014.</div></div><div id="sec6_1_33" class="NLM_sec NLM_sec_level_3"><div id="ac_i56" class="anchor-spacer"></div><h4 class="article-section__title" id="_i56">6.1.33.  <i>N</i>-(2-Chlorophenethyl)biphenyl-4-carboxamide (<b>20a</b>)</h4><div class="NLM_p last">It is obtained as a white solid in 74% yield <sup>1</sup>H NMR (600 MHz, CDCl<sub>3</sub>): δ 7.79 (d, <i>J</i> = 8.4 Hz, 2H), 7.64 (d, <i>J</i> = 8.4 Hz, 2H), 7.61–7.59 (m, 2H), 7.47–7.44 (m, 2H), 7.40–7.37 (m, 2H), 7.29 (dd, <i>J</i> = 7.3, 1.9 Hz, 1H), 7.24–7.18 (m, 2H), 6.29 (br s, 1H), 3.77 (q, <i>J</i> = 6.8 Hz, 2H), 3.12 (t, <i>J</i> = 6.8 Hz, 2H); <sup>13</sup>C NMR (151 MHz, CDCl<sub>3</sub>): δ 166.64, 143.62, 139.39, 136.05, 133.52, 132.60, 130.51, 129.08, 128.28, 127.53, 127.35, 126.75, 126.60, 126.56, 126.47, 39.20, 32.72; ESI-HRMS (<i>m</i>/<i>z</i>): calcd C<sub>21</sub>H<sub>18</sub>ClNO (M + H<sup>+</sup>), 336.1150; found, 336.1151.</div></div><div id="sec6_1_34" class="NLM_sec NLM_sec_level_3"><div id="ac_i57" class="anchor-spacer"></div><h4 class="article-section__title" id="_i57">6.1.34.  <i>N</i>-(2-(Pyridin-4-yl)ethyl)biphenyl-4-carboxamide (<b>20b</b>)</h4><div class="NLM_p last">It is obtained as a white solid in 74% yield <sup>1</sup>H NMR (600 MHz, CDCl<sub>3</sub>): δ 8.53 (d, <i>J</i> = 4.6 Hz, 2H), 7.78 (d, <i>J</i> = 8.3 Hz, 2H), 7.64 (d, <i>J</i> = 8.3 Hz, 2H), 7.60 (d, <i>J</i> = 7.2 Hz, 2H), 7.47–7.44 (m, 2H), 7.39–7.37 (m, 1H), 7.17 (d, <i>J</i> = 4.6 Hz, 2H), 6.34 (br s, 1H), 3.76 (q, <i>J</i> = 7.0 Hz, 2H), 2.97 (t, <i>J</i> = 7.0 Hz, 2H); <sup>13</sup>C NMR (151 MHz, CDCl<sub>3</sub>): δ 166.71, 149.39, 147.43, 143.86, 139.29, 132.31, 128.31, 127.43, 126.73, 126.67, 126.56, 123.59, 39.69, 34.53; ESI-HRMS (<i>m</i>/<i>z</i>): calcd C<sub>20</sub>H<sub>18</sub>N<sub>2</sub>O (M + H<sup>+</sup>), 303.1492; found, 303.1487.</div></div><div id="sec6_1_35" class="NLM_sec NLM_sec_level_3"><div id="ac_i58" class="anchor-spacer"></div><h4 class="article-section__title" id="_i58">6.1.35.  Synthesis of 5-Phenylpicolinic Acid (<b>23a</b>) and 6-Phenylnicotinic Acid (<b>23b</b>)</h4><div class="NLM_p last">A mixture of 5-bromo-pyridine-2-carboxylic acid (<b>22a</b>) or 6-bromonicotinic acid (<b>22b</b>) (1.98 g, 9.9 mmol), phenylboronic acid <b>21</b> (1.6 g, 13.2 mmol), K<sub>2</sub>CO<sub>3</sub> (2.46 g, 17.82 mmol) and Pd(PPh<sub>3</sub>)<sub>2</sub>Cl<sub>2</sub> (0.69 g, 1.2 mmol) in dioxane–water (v/v = 3:1, 40 mL) was stirred at 110 °C under a N<sub>2</sub> atmosphere for 12 h. The reaction mixture was cooled to room temperature, adjusted to pH = 9–10 with saturated aqueous solution of NaHCO<sub>3</sub>, and filtered. The filtrate was washed with Et<sub>2</sub>O. The aqueous layer was adjusted to pH = 4–5 with 1 N HCl and extracted with ethyl acetate. The combined organic layer was dried over Na<sub>2</sub>SO<sub>4</sub> and concentrated to give the crude product <b>23a</b> as a white solid (61% yield) or <b>23b</b> as a white solid (69% yield), which was used for the next step without purification.</div></div><div id="sec6_1_36" class="NLM_sec NLM_sec_level_3"><div id="ac_i59" class="anchor-spacer"></div><h4 class="article-section__title" id="_i59">6.1.36.  <i>N</i>-(2-Chlorophenethyl)-5-phenylpicolinamide (<b>24a</b>)</h4><div class="NLM_p last">It is obtained as a white solid in 77% yield. <sup>1</sup>H NMR (600 MHz, CDCl<sub>3</sub>): δ 8.75 (d, <i>J</i> = 1.9 Hz, 1H), 8.28 (d, <i>J</i> = 8.1 Hz, 1H), 8.22 (br s, 1H), 8.05 (dd, <i>J</i> = 8.1, 1.9 Hz, 1H), 7.62 (d, <i>J</i> = 7.3 Hz, 2H), 7.51 (t, <i>J</i> = 7.3 Hz, 2H), 7.45 (t, <i>J</i> = 7.3 Hz, 1H), 7.38 (dd, <i>J</i> = 7.5, 1.6 Hz, 1H), 7.30 (dd, <i>J</i> = 7.2, 1.8 Hz, 1H), 7.22–7.17 (m, 2H), 3.78 (q, <i>J</i> = 7.1 Hz, 2H), 3.12 (t, <i>J</i> = 7.1 Hz, 2H); <sup>13</sup>C NMR (151 MHz, CDCl<sub>3</sub>): δ 160.38, 144.61, 142.64, 135.09, 133.06, 132.65, 131.53, 130.25, 127.01, 125.67, 125.24, 124.70, 124.05, 123.28, 122.99, 118.23, 35.18, 29.72; ESI-HRMS (<i>m</i>/<i>z</i>): calcd C<sub>20</sub>H<sub>17</sub>ClN<sub>2</sub>O (M + H<sup>+</sup>), 341.1260; found, 341.1263.</div></div><div id="sec6_1_37" class="NLM_sec NLM_sec_level_3"><div id="ac_i60" class="anchor-spacer"></div><h4 class="article-section__title" id="_i60">6.1.37.  5-Phenyl-<i>N</i>-(2-(pyridin-4-yl)ethyl)picolinamide (<b>24b</b>)</h4><div class="NLM_p last">It is obtained as a white solid in 73% yield. <sup>1</sup>H NMR (600 MHz, CDCl<sub>3</sub>): δ 8.73 (d, <i>J</i> = 2.0 Hz, 1H), 8.54 (d, <i>J</i> = 5.8 Hz, 2H), 8.24 (d, <i>J</i> = 8.1 Hz, 1H), 8.13 (br s, 1H), 8.02 (dd, <i>J</i> = 8.1, 2.0 Hz, 1H), 7.60 (d, <i>J</i> = 7.3 Hz, 2H), 7.50 (t, <i>J</i> = 7.3 Hz, 2H), 7.44 (t, <i>J</i> = 7.3 Hz, 2H), 7.19 (d, <i>J</i> = 5.8 Hz, 2H), 3.78 (q, <i>J</i> = 7.1 Hz, 2H), 2.97 (t, <i>J</i> = 7.1 Hz, 2H); <sup>13</sup>C NMR (151 MHz, CDCl<sub>3</sub>): δ 163.74, 149.36, 147.66, 147.33, 146.04, 138.61, 136.31, 134.95, 128.62, 128.11, 126.63, 123.54, 121.61, 39.03, 34.67; ESI-HRMS (<i>m</i>/<i>z</i>): calcd C<sub>19</sub>H<sub>17</sub>N<sub>3</sub>O (M + H<sup>+</sup>), 304.1444; found, 304.1448.</div></div><div id="sec6_1_38" class="NLM_sec NLM_sec_level_3"><div id="ac_i61" class="anchor-spacer"></div><h4 class="article-section__title" id="_i61">6.1.38.  <i>N</i>-(2-Chlorophenethyl)-6-phenylnicotinamide (<b>24c</b>)</h4><div class="NLM_p last">It is obtained as a white solid in 72% yield. <sup>1</sup>H NMR (600 MHz, CDCl<sub>3</sub>): δ 8.95 (s, 1H), 8.14 (d, <i>J</i> = 8.3 Hz, 1H), 8.02 (d, <i>J</i> = 7.6 Hz, 2H), 7.81 (d, <i>J</i> = 8.3 Hz, 1H), 7.50 (t, <i>J</i> = 7.6 Hz, 2H), 7.47–7.46 (m, 1H), 7.40 (d, <i>J</i> = 7.7 Hz, 1H), 7.29 (d, <i>J</i> = 7.3 Hz, 1H), 7.25–7.19 (m, 2H), 6.24 (br s, 1H), 3.80 (q, <i>J</i> = 6.8 Hz, 2H), 3.13 (t, <i>J</i> = 6.8 Hz, 2H); <sup>13</sup>C NMR (151 MHz, CDCl<sub>3</sub>): δ 165.10, 159.31, 147.04, 137.65, 135.79, 135.42, 135.02, 133.50, 132.99, 130.50, 129.17, 128.29, 127.70, 127.36, 126.58, 119.60, 39.32, 32.57; ESI-HRMS (<i>m</i>/<i>z</i>): calcd C<sub>20</sub>H<sub>17</sub>ClN<sub>2</sub>O (M + H<sup>+</sup>), 337.1102; found, 337.1102.</div></div><div id="sec6_1_39" class="NLM_sec NLM_sec_level_3"><div id="ac_i62" class="anchor-spacer"></div><h4 class="article-section__title" id="_i62">6.1.39.  6-Phenyl-<i>N</i>-(2-(pyridin-4-yl)ethyl)nicotinamide (<b>24d</b>)</h4><div class="NLM_p last">It is obtained as a white solid in 73% yield. <sup>1</sup>H NMR (600 MHz, CDCl<sub>3</sub>): δ 8.97 (d, <i>J</i> = 2.0 Hz, 1H), 8.56 (d, <i>J</i> = 5.9 Hz, 2H), 8.15 (dd, <i>J</i> = 8.3, 2.0 Hz, 1H), 8.05–8.04 (m, 2H), 7.83 (d, <i>J</i> = 8.3 Hz, 1H), 7.53–7.48 (m, 3H), 7.21 (d, <i>J</i> = 5.9 Hz, 2H), 6.33 (br s, 1H), 3.81 (q, <i>J</i> = 7.0 Hz, 2H), 3.01 (t, <i>J</i> = 7.0 Hz, 2H); <sup>13</sup>C NMR (151 MHz, CDCl<sub>3</sub>): δ 165.74, 160.00, 149.95, 147.87, 147.71, 138.20, 135.91, 129.79, 128.86, 128.09, 127.15, 124.14, 120.07, 40.34, 35.06; ESI-HRMS (<i>m</i>/<i>z</i>): calcd C<sub>19</sub>H<sub>17</sub>N<sub>3</sub>O (M + H<sup>+</sup>), 304.1444; found, 304.1445.</div></div><div id="sec6_1_40" class="NLM_sec NLM_sec_level_3"><div id="ac_i63" class="anchor-spacer"></div><h4 class="article-section__title" id="_i63">6.1.40.  Synthesis of 6-Phenylpyrimidine-4-carboxylic Acid (<b>26a</b>) and 4-Phenylpyrimidine-2-carboxylic Acid (<b>26b</b>)<a onclick="showRef(event, 'ref36'); return false;" href="javascript:void(0);" class="ref ref36">(36)</a></h4><div class="NLM_p last">The mixture of <b>25a</b> or <b>25b</b> (5 g, 0.025 mol) and 20% aqueous solution of H<sub>2</sub>SO<sub>4</sub> (100 mL) was refluxed at 100 °C for 5–10 h. After TLC showed the completion of the reaction, the reaction mixture was poured into stirring ice water. The precipitate was filtered and dried to obtain crude product <b>26a</b> as a white solid (34% yield) or <b>26b</b> as a white solid (39% yield), which were used for the next step without purification.</div></div><div id="sec6_1_41" class="NLM_sec NLM_sec_level_3"><div id="ac_i64" class="anchor-spacer"></div><h4 class="article-section__title" id="_i64">6.1.41.  <i>N</i>-(2-Chlorophenethyl)-6-phenylpyrimidine-4-carboxamide (<b>27a</b>)</h4><div class="NLM_p last">It is obtained as a white solid in 71% yield. <sup>1</sup>H NMR (600 MHz, CDCl<sub>3</sub>): δ 9.20 (d, <i>J</i> = 1.0 Hz, 1H), 8.54 (d, <i>J</i> = 1.0 Hz, 1H), 8.20–8.18 (m, 2H), 8.15 (br s, 1H), 7.54–7.52 (m, 3H), 7.38 (dd, <i>J</i> = 7.2, 1.6 Hz, 1H), 7.28–7.27 (m, 1H), 7.23–7.18 (m, 2H), 3.79 (q, <i>J</i> = 7.0 Hz, 2H), 3.12 (t, <i>J</i> = 7.0 Hz, 2H); <sup>13</sup>C NMR (151 MHz, CDCl<sub>3</sub>): δ 165.77, 162.48, 157.27, 155.99, 149.43, 146.95, 135.36, 131.04, 128.52, 126.80, 123.46, 113.33, 39.12, 34.45; ESI-HRMS (<i>m</i>/<i>z</i>): calcd C<sub>18</sub>H<sub>16</sub>N<sub>4</sub>O (M + H<sup>+</sup>), 305.1397; found, 305.1401.</div></div><div id="sec6_1_42" class="NLM_sec NLM_sec_level_3"><div id="ac_i65" class="anchor-spacer"></div><h4 class="article-section__title" id="_i65">6.1.42.  4-Phenyl-<i>N</i>-(2-(pyridin-4-yl)ethyl)pyrimidine-2-carboxamide (<b>27b</b>)</h4><div class="NLM_p last">It is obtained as a white solid in 73% yield. <sup>1</sup>H NMR (600 MHz, CDCl<sub>3</sub>): δ 9.20 (s, 1H), 8.54 (d, <i>J</i> = 4.6 Hz, 2H), 8.52 (s, 1H), 8.19–8.18 (m, 2H), 8.13 (br s, 1H), 7.54–7.53 (m, 3H), 7.18 (d, <i>J</i> = 4.6 Hz, 2H), 3.79 (q, <i>J</i> = 7.2 Hz, 2H), 2.97 (t, <i>J</i> = 7.2 Hz, 2H); <sup>13</sup>C NMR (151 MHz, CDCl<sub>3</sub>): δ 165.67, 162.45, 157.25, 156.27, 135.64, 135.46, 133.59, 130.98, 130.33, 129.11, 128.51, 127.58, 126.80, 126.42, 113.35, 38.66, 32.83; ESI-HRMS (<i>m</i>/<i>z</i>): calcd C<sub>19</sub>H<sub>16</sub>ClN<sub>3</sub>O (M + H<sup>+</sup>), 360.0874; found, 360.0874.</div></div><div id="sec6_1_43" class="NLM_sec NLM_sec_level_3"><div id="ac_i66" class="anchor-spacer"></div><h4 class="article-section__title" id="_i66">6.1.43.  <i>N</i>-Phenethyl-5-phenylpicolinamide (<b>28a</b>)</h4><div class="NLM_p last">It is obtained as a white solid in 71% yield. <sup>1</sup>H NMR (600 MHz, DMSO-<i>d</i><sub>6</sub>): δ 8.91 (d, <i>J</i> = 2.0 Hz, 1H), 8.81 (br s, 1H), 8.25 (dd, <i>J</i> = 8.1, 2.0 Hz, 1H), 8.08 (d, <i>J</i> = 8.1 Hz, 1H), 7.78 (d, <i>J</i> = 7.6 Hz, 2H), 7.52 (t, <i>J</i> = 7.6 Hz, 2H), 7.45 (t, <i>J</i> = 7.6 Hz, 1H), 7.29–7.27 (m, 2H), 7.24–7.23 (m, 2H), 7.20–7.17 (m, 1H), 3.56 (q, <i>J</i> = 7.1 Hz, 2H), 2.87 (t, <i>J</i> = 7.1 Hz, 2H); <sup>13</sup>C NMR (151 MHz, DMSO-<i>d</i><sub>6</sub>): δ 163.95, 149.27, 146.88, 139.83, 138.31, 136.66, 135.97, 129.66, 129.16, 129.04, 128.80, 127.59, 126.55, 122.38, 40.80, 35.59; ESI-HRMS (<i>m</i>/<i>z</i>): calcd C<sub>20</sub>H<sub>18</sub>N<sub>2</sub>O (M + H<sup>+</sup>), 303.1492; found, 303.1496.</div></div><div id="sec6_1_44" class="NLM_sec NLM_sec_level_3"><div id="ac_i67" class="anchor-spacer"></div><h4 class="article-section__title" id="_i67">6.1.44.  <i>N</i>-(3-Chlorophenethyl)-5-phenylpicolinamide (<b>28b</b>)</h4><div class="NLM_p last">It is obtained as a white solid in 74% yield. <sup>1</sup>H NMR (600 MHz, CDCl<sub>3</sub>): δ 8.74 (d, <i>J</i> = 2.2 Hz, 1H), 8.25 (d, <i>J</i> = 8.1 Hz, 1H), 8.15 (br t, 1H), 8.02 (dd, <i>J</i> = 8.1, 2.2 Hz, 1H), 7.61–7.60 (m, 2H), 7.50 (t, <i>J</i> = 7.5 Hz, 2H), 7.45–7.43 (m, 1H), 7.26–7.21 (m, 3H), 7.15 (d, <i>J</i> = 7.2 Hz, 1H), 3.74 (q, <i>J</i> = 7.2 Hz, 2H), 2.94 (t, <i>J</i> = 7.2 Hz, 2H); <sup>13</sup>C NMR (151 MHz, CDCl<sub>3</sub>): δ 164.28, 148.44, 146.60, 140.98, 139.10, 136.96, 135.51, 134.35, 129.84, 129.19, 128.94, 128.67, 127.22, 126.96, 126.70, 122.20, 40.49, 35.65; ESI-HRMS (<i>m</i>/<i>z</i>): calcd C<sub>20</sub>H<sub>17</sub>ClN<sub>2</sub>O (M + H<sup>+</sup>), 337.1102; found, 337.1108.</div></div><div id="sec6_1_45" class="NLM_sec NLM_sec_level_3"><div id="ac_i68" class="anchor-spacer"></div><h4 class="article-section__title" id="_i68">6.1.45.  <i>N</i>-(4-Chlorophenethyl)-5-phenylpicolinamide (<b>28c</b>)</h4><div class="NLM_p last">It is obtained as a white solid in 75% yield. <sup>1</sup>H NMR (600 MHz, CDCl<sub>3</sub>): δ 8.73 (d, <i>J</i> = 1.8 Hz, 1H), 8.25 (d, <i>J</i> = 8.1 Hz, 1H), 8.13 (br s, 1H), 8.01 (dd, <i>J</i> = 8.1 Hz, 1.8 Hz, 1H), 7.60 (d, <i>J</i> = 7.6 Hz, 2H), 7.50 (t, <i>J</i> = 7.6 Hz, 2H), 7.44 (t, <i>J</i> = 7.6 Hz, 1H), 7.28 (d, <i>J</i> = 8.3 Hz, 2H), 7.19 (d, <i>J</i> = 8.3 Hz, 2H), 3.73 (q, <i>J</i> = 7.2 Hz, 2H), 2.93 (t, <i>J</i> = 7.2 Hz, 2H); <sup>13</sup>C NMR (151 MHz, CDCl<sub>3</sub>): δ 164.22, 148.48, 146.59, 139.06, 137.42, 136.95, 135.49, 132.28, 130.12, 129.20, 128.71, 128.67, 127.22, 122.19, 40.57, 35.32; ESI-HRMS (<i>m</i>/<i>z</i>): calcd C<sub>20</sub>H<sub>17</sub>ClN<sub>2</sub>O (M + H<sup>+</sup>), 337.1102; found, 337.1102.</div></div><div id="sec6_1_46" class="NLM_sec NLM_sec_level_3"><div id="ac_i69" class="anchor-spacer"></div><h4 class="article-section__title" id="_i69">6.1.46.  <i>N</i>-(2-Fluorophenethyl)-5-phenylpicolinamide (<b>28d</b>)</h4><div class="NLM_p last">It is obtained as a white solid in 71% yield. <sup>1</sup>H NMR (600 MHz, CDCl<sub>3</sub>): δ 8.73 (d, <i>J</i> = 1.5 Hz, 1H), 8.24 (d, <i>J</i> = 8.0 Hz, 1H), 8.16 (br s, 1H), 8.00 (dd, <i>J</i> = 8.0, 1.5 Hz, 1H), 7.59 (d, <i>J</i> = 7.6 Hz, 2H), 7.49 (t, <i>J</i> = 7.6 Hz, 2H), 7.43 (t, <i>J</i> = 7.6 Hz, 1H), 7.25–7.22 (m, 1H), 7.21–7.19 (m, 1H), 7.08–7.06 (m, 1H), 7.05–7.02 (m, 1H), 3.75 (q, <i>J</i> = 7.1 Hz, 2H), 3.00 (t, <i>J</i> = 7.1 Hz, 2H); <sup>13</sup>C NMR (151 MHz, DMSO-<i>d</i><sub>6</sub>): δ 164.08, 161.23, 149.25, 146.93, 138.34, 136.69, 136.02, 131.63, 129.72, 129.22, 128.77, 127.65, 126.49, 124.84, 122.45, 115.60, 40.49, 28.98; ESI-HRMS (<i>m</i>/<i>z</i>): calcd C<sub>20</sub>H<sub>17</sub>FN<sub>2</sub>O (M + H<sup>+</sup>), 321.1398; found, 321.1399.</div></div><div id="sec6_1_47" class="NLM_sec NLM_sec_level_3"><div id="ac_i70" class="anchor-spacer"></div><h4 class="article-section__title" id="_i70">6.1.47.  <i>N</i>-(3-Fluorophenethyl)-5-phenylpicolinamide (<b>28e</b>)</h4><div class="NLM_p last">It is obtained as a white solid in 74% yield. <sup>1</sup>H NMR (600 MHz, CDCl<sub>3</sub>): δ 8.76 (d, <i>J</i> = 1.8 Hz, 1H), 8.28 (d, <i>J</i> = 8.1, 1H), 8.17 (br t, 1H), 8.05 (dd, <i>J</i> = 8.1, 1.8 Hz, 1H), 7.63 (d, <i>J</i> = 7.3 Hz, 2H), 7.53 (t, <i>J</i> = 7.3 Hz, 2H), 7.48–7.47 (m, 1H), 7.32–7.29 (m, 1H), 7.07 (d, <i>J</i> = 7.6 Hz, 1H), 7.01–6.99 (m, 1H), 6.97–6.95 (m, 1H), 3.78 (q, <i>J</i> = 7.2 Hz, 2H), 2.99 (t, <i>J</i> = 7.2 Hz, 2H); <sup>13</sup>C NMR (151 MHz, CDCl<sub>3</sub>): δ 163.67, 162.10, 147.81, 146.02, 140.89, 138.50, 136.35, 134.95, 129.45, 128.62, 128.09, 126.64, 123.85, 121.62, 115.07, 112.81, 39.89, 35.10; ESI-HRMS (<i>m</i>/<i>z</i>): calcd C<sub>20</sub>H<sub>17</sub>FN<sub>2</sub>O (M + H<sup>+</sup>), 321.1398; found, 321.1399.</div></div><div id="sec6_1_48" class="NLM_sec NLM_sec_level_3"><div id="ac_i71" class="anchor-spacer"></div><h4 class="article-section__title" id="_i71">6.1.48.  <i>N</i>-(4-Fluorophenethyl)-5-phenylpicolinamide (<b>28f</b>)</h4><div class="NLM_p last">It is obtained as a white solid in 78% yield. <sup>1</sup>H NMR (600 MHz, CDCl<sub>3</sub>): δ 8.74 (d, <i>J</i> = 2.3 Hz, 1H), 8.25 (d, <i>J</i> = 8.1 Hz, 1H), 8.11 (br s, 1H), 8.02 (dd, <i>J</i> = 8.1, 2.3 Hz, 1H), 7.62–7.60 (m, 2H), 7.52–7.49 (m, 2H), 7.46–7.43 (m, 1H), 7.23–7.21 (m, 2H), 7.02–6.99 (m, 2H), 3.73 (q, <i>J</i> = 7.2 Hz, 2H), 2.94 (t, <i>J</i> = 7.2 Hz, 2H); <sup>13</sup>C NMR (151 MHz, CDCl<sub>3</sub>): δ 163.62, 160.77, 147.91, 146.01, 138.46, 136.38, 134.90, 134.00, 129.58, 128.60, 128.07, 126.63, 121.58, 114.78, 40.18, 34.56; ESI-HRMS (<i>m</i>/<i>z</i>): calcd C<sub>20</sub>H<sub>17</sub>FN<sub>2</sub>O (M + H<sup>+</sup>), 321.1398; found, 321.14.</div></div><div id="sec6_1_49" class="NLM_sec NLM_sec_level_3"><div id="ac_i72" class="anchor-spacer"></div><h4 class="article-section__title" id="_i72">6.1.49.  5-Phenyl-<i>N</i>-(2-(pyridin-2-yl)ethyl)picolinamide (<b>28g</b>)</h4><div class="NLM_p last">It is obtained as a white solid in 74% yield. <sup>1</sup>H NMR (600 MHz, CDCl<sub>3</sub>): δ 8.74 (d, <i>J</i> = 2.0 Hz, 1H), 8.59 (d, <i>J</i> = 4.7 Hz, 1H), 8.51 (br t, 1H), 8.24 (d, <i>J</i> = 8.1 Hz, 1H), 7.99 (dd, <i>J</i> = 8.1, 2.0 Hz, 1H), 7.62–7.58 (m, 3H), 7.48 (t, <i>J</i> = 7.6 Hz, 2H), 7.42 (t, <i>J</i> = 7.6 Hz, 1H), 7.21 (d, <i>J</i> = 7.6 Hz, 1H), 7.16–7.13 (m, 1H), 3.91 (q, <i>J</i> = 6.5 Hz, 2H), 3.14 (t, <i>J</i> = 6.5 Hz, 2H); <sup>13</sup>C NMR (151 MHz, CDCl<sub>3</sub>): δ 164.28, 159.28, 149.34, 148.76, 146.66, 138.86, 137.07, 136.53, 135.36, 129.16, 128.58, 127.20, 123.37, 122.14, 121.52, 38.84, 37.57; ESI-HRMS (<i>m</i>/<i>z</i>): calcd C<sub>19</sub>H<sub>17</sub>N<sub>3</sub>O (M + H<sup>+</sup>), 304.1444; found, 304.1448.</div></div><div id="sec6_1_50" class="NLM_sec NLM_sec_level_3"><div id="ac_i73" class="anchor-spacer"></div><h4 class="article-section__title" id="_i73">6.1.50.  5-Phenyl-<i>N</i>-(2-(pyridin-3-yl)ethyl)picolinamide (<b>28h</b>)</h4><div class="NLM_p last">It is obtained as a white solid in 67% yield. <sup>1</sup>H NMR (600 MHz, CDCl<sub>3</sub>): δ 8.73 (dd, <i>J</i> = 2.3, 0.8 Hz, 1H), 8.53 (d, <i>J</i> = 1.8 Hz, 1H), 8.50 (dd, <i>J</i> = 4.8, 1.8 Hz, 1H), 8.24 (dd, <i>J</i> = 8.1, 0.8 Hz, 1H), 8.15 (br s, 1H), 8.02 (dd, <i>J</i> = 8.1, 2.3 Hz, 1H), 7.61–7.60 (m, 3H), 7.51–7.49 (m, 2H), 7.46–7.43 (m, 1H), 7.25–7.24 (m, 1H), 3.77 (q, <i>J</i> = 7.0 Hz, 2H), 2.98 (t, <i>J</i> = 7.0 Hz, 2H); <sup>13</sup>C NMR (151 MHz, CDCl<sub>3</sub>): δ 164.32, 150.19, 148.37, 148.04, 146.62, 139.14, 136.94, 136.17, 135.49, 134.35, 129.18, 128.66, 127.21, 123.45, 122.16, 40.35, 33.15; ESI-HRMS (<i>m</i>/<i>z</i>): calcd C<sub>19</sub>H<sub>17</sub>N<sub>3</sub>O (M + H<sup>+</sup>), 304.1444; found, 304.1449.</div></div><div id="sec6_1_51" class="NLM_sec NLM_sec_level_3"><div id="ac_i74" class="anchor-spacer"></div><h4 class="article-section__title" id="_i74">6.1.51.  <i>N</i>-(4-Hydroxyphenethyl)-5-phenylpicolinamide (<b>28i</b>)</h4><div class="NLM_p last">It is obtained as a white solid in 74% yield. <sup>1</sup>H NMR (600 MHz, CDCl<sub>3</sub>): δ 8.75 (d, <i>J</i> = 1.7 Hz, 1H), 8.28 (d, <i>J</i> = 8.1 Hz, 1H), 8.21 (br s, 1H), 8.05 (dd, <i>J</i> = 8.1, 1.7 Hz, 1H), 7.62–7.60 (m, 2H), 7.51 (t, <i>J</i> = 7.5 Hz, 2H), 7.45 (t, <i>J</i> = 7.5 Hz, 1H), 7.13 (d, <i>J</i> = 8.4 Hz, 2H), 6.80 (d, <i>J</i> = 8.4 Hz, 2H), 3.72 (q, <i>J</i> = 7.0 Hz, 2H), 2.90 (t, <i>J</i> = 7.0 Hz, 2H); <sup>1</sup>C NMR (151 MHz, DMSO-<i>d</i><sub>6</sub>): δ 163.28, 155.47, 148.67, 146.29, 137.68, 136.06, 135.39, 131.35, 129.31, 129.08, 128.57, 127.00, 121.78, 114.99, 40.53, 34.19; ESI-HRMS (<i>m</i>/<i>z</i>): calcd C<sub>20</sub>H<sub>18</sub>N<sub>2</sub>O<sub>2</sub> (M + H<sup>+</sup>), 337.1102; found, 337.1102.</div></div><div id="sec6_1_52" class="NLM_sec NLM_sec_level_3"><div id="ac_i75" class="anchor-spacer"></div><h4 class="article-section__title" id="_i75">6.1.52.  <i>N</i>-(4-Aminophenethyl)-5-phenylpicolinamide (<b>28j</b>)</h4><div class="NLM_p last">It is obtained as a white solid in 72% yield. <sup>1</sup>H NMR (600 MHz, CDCl<sub>3</sub>): δ 8.74 (d, <i>J</i> = 2.1 Hz, 1H), 8.26 (d, <i>J</i> = 8.0 Hz, 1H), 8.12 (br s, 1H), 8.01 (dd, <i>J</i> = 8.0, 2.1 Hz, 1H), 7.60 (d, <i>J</i> = 7.7 Hz, 2H), 7.50 (t, <i>J</i> = 7.7 Hz, 2H), 7.44 (t, <i>J</i> = 7.7 Hz, 1H), 7.06 (d, <i>J</i> = 8.2 Hz, 2H), 6.66 (d, <i>J</i> = 8.2 Hz, 2H), 3.70 (q, <i>J</i> = 7.2 Hz, 2H), 3.63 (br s, 2H), 2.85 (t, <i>J</i> = 7.2 Hz, 2H); <sup>13</sup>C NMR (151 MHz, CDCl<sub>3</sub>): δ 164.14, 148.74, 146.57, 144.78, 138.90, 137.06, 135.42, 129.58, 129.17, 128.89, 128.59, 127.21, 122.14, 115.42, 41.03, 35.08; ESI-HRMS (<i>m</i>/<i>z</i>): calcd C<sub>20</sub>H<sub>19</sub>N<sub>3</sub>O (M + H<sup>+</sup>), 318.1601; found, 318.1603.</div></div><div id="sec6_1_53" class="NLM_sec NLM_sec_level_3"><div id="ac_i76" class="anchor-spacer"></div><h4 class="article-section__title" id="_i76">6.1.53.  <i>N</i>-(4-Methylphenethyl)-5-phenylpicolinamide (<b>28k</b>)</h4><div class="NLM_p last">It is obtained as a white solid in 70% yield. <sup>1</sup>H NMR (600 MHz, CDCl<sub>3</sub>): δ 8.75 (d, <i>J</i> = 2.1 Hz, 1H), 8.27 (d, <i>J</i> = 8.1 Hz, 1H), 8.16 (br s, 1H), 8.02 (dd, <i>J</i> = 8.1, 2.1 Hz, 1H), 7.61 (d, <i>J</i> = 7.3 Hz, 2H), 7.51 (t, <i>J</i> = 7.3 Hz, 2H), 7.45 (t, <i>J</i> = 7.3 Hz, 1H), 7.18–7.14 (m, 4H), 3.75 (q, <i>J</i> = 7.2 Hz, 2H), 2.94 (t, <i>J</i> = 7.2 Hz, 2H), 2.34 (s, 3H); <sup>13</sup>C NMR (151 MHz, CDCl<sub>3</sub>): δ 164.21, 148.63, 146.58, 138.97, 137.01, 135.94, 135.84, 135.62, 135.47, 129.29, 129.19, 128.65, 127.22, 122.19, 40.89, 35.52, 21.02; ESI-HRMS (<i>m</i>/<i>z</i>): calcd C<sub>21</sub>H<sub>20</sub>N<sub>2</sub>O (M + H<sup>+</sup>), 317.1648; found, 317.1648.</div></div><div id="sec6_1_54" class="NLM_sec NLM_sec_level_3"><div id="ac_i77" class="anchor-spacer"></div><h4 class="article-section__title" id="_i77">6.1.54.  <i>N</i>-(4-Nitrophenethyl)-5-phenylpicolinamide (<b>28l</b>)</h4><div class="NLM_p last">It is obtained as a white solid in 70% yield. <sup>1</sup>H NMR (600 MHz, CDCl<sub>3</sub>): δ 8.72 (d, <i>J</i> = 1.6 Hz, 1H), 8.23 (d, <i>J</i> = 8.0 Hz, 1H), 8.17–8.15 (m, 3H), 8.02 (dd, <i>J</i> = 8.0, 1.6 Hz, 1H), 7.59 (d, <i>J</i> = 7.3 Hz, 2H), 7.49 (t, <i>J</i> = 7.3 Hz, 2H), 7.46–7.41 (m, 3H), 3.79 (q, <i>J</i> = 7.1 Hz, 2H), 3.08 (t, <i>J</i> = 7.1 Hz, 2H); <sup>13</sup>C NMR (151 MHz, CDCl<sub>3</sub>): δ 164.39, 148.22, 146.85, 146.75, 146.64, 139.24, 136.84, 135.53, 129.63, 129.21, 128.73, 127.20, 123.80, 122.21, 40.14, 35.85; ESI-HRMS (<i>m</i>/<i>z</i>): calcd C<sub>20</sub>H<sub>17</sub>N<sub>3</sub>O<sub>3</sub> (M + H<sup>+</sup>), 348.1343; found, 348.1339.</div></div><div id="sec6_1_55" class="NLM_sec NLM_sec_level_3"><div id="ac_i78" class="anchor-spacer"></div><h4 class="article-section__title" id="_i78">6.1.55.  5-Bromo-<i>N</i>-(2-fluorophenethyl)picolinamide (<b>29</b>)</h4><div class="NLM_p last">It is obtained as a white solid (246 mg, 76%) <sup>1</sup>H NMR (600 MHz, CDCl<sub>3</sub>): δ 8.57 (d, <i>J</i> = 2.2 Hz, 1H), 8.10 (d, <i>J</i> = 8.3 Hz, 1H), 8.00 (br s, 1H), 7.96 (dd, <i>J</i> = 8.3, 2.2 Hz, 1H), 7.24–7.20 (m, 2H), 7.09–7.02 (m, 2H), 3.72 (q, <i>J</i> = 7.1 Hz, 2H), 2.99 (t, <i>J</i> = 7.1 Hz, 2H); ESI-HRMS (<i>m</i>/<i>z</i>): calcd C<sub>14</sub>H<sub>12</sub>BrFN<sub>2</sub>O (M + H<sup>+</sup>), 323.1090; found, 323.1093.</div></div><div id="sec6_1_56" class="NLM_sec NLM_sec_level_3"><div id="ac_i79" class="anchor-spacer"></div><h4 class="article-section__title" id="_i79">6.1.56.  General Procedure for the Synthesis of <b>30a–r</b> Exemplified by <i>N</i>-(2-Fluorophenethyl)-5-(furan-2-yl)picolinamide (<b>30a</b>)</h4><div class="NLM_p last">A mixture of compound <b>49</b> (161 mg, 0.5 mmol), furan-2-yl boronic acid (75 mg, 0.66 mmol), K<sub>2</sub>CO<sub>3</sub> (124 mg, 0.9 mmol), and Pd(PPh<sub>3</sub>)<sub>2</sub>Cl<sub>2</sub> (35 mg, 0.05 mmol) in dioxane–water (v/v = 3:1, 20 mL) was stirred at 110 °C under a N<sub>2</sub> atmosphere for 12 h. The reaction mixture was cooled to room temperature and extracted with ethyl acetate. The combined organic layer was dried over anhydrous Na<sub>2</sub>SO<sub>4</sub>. After removal of the solvent in vacuo, the residue was purified by flash chromatography to yield compound <b>30a</b> as a white solid (68% yield). <sup>1</sup>H NMR (600 MHz, CDCl<sub>3</sub>): δ 8.84 (d, <i>J</i> = 2.2 Hz, 1H), 8.08 (dd, <i>J</i> = 8.3, 2.2 Hz, 1H), 7.73 (d, <i>J</i> = 8.3 Hz, 1H), 7.57 (d, <i>J</i> = 1.7 Hz, 1H), 7.25–7.22 (m, 2H), 7.14 (d, <i>J</i> = 3.4 Hz, 1H), 7.11–7.10 (m, 1H), 7.09–7.06 (m, 1H), 6.56 (dd, <i>J</i> = 3.4, 1.7 Hz, 1H), 6.26 (br s, 1H), 3.74 (q, <i>J</i> = 6.6 Hz, 2H), 3.01 (t, <i>J</i> = 6.6 Hz, 2H); <sup>13</sup>C NMR (151 MHz, CDCl<sub>3</sub>): δ 164.79, 160.50, 152.20, 150.78, 147.11, 143.65, 135.26, 130.60, 128.00, 127.26, 125.00, 123.82, 117.50, 114.89, 111.81, 109.89, 39.61, 28.50; ESI-HRMS (<i>m</i>/<i>z</i>): calcd C<sub>18</sub>H<sub>15</sub>FN<sub>2</sub>O<sub>2</sub> (M + H<sup>+</sup>), 311.1190; found, 311.1190.</div></div><div id="sec6_1_57" class="NLM_sec NLM_sec_level_3"><div id="ac_i80" class="anchor-spacer"></div><h4 class="article-section__title" id="_i80">6.1.57.  <i>N</i>-(2-Fluorophenethyl)-5-(furan-3-yl)picolinamide (<b>30b</b>)</h4><div class="NLM_p last">It is obtained as a white solid in 65% yield. <sup>1</sup>H NMR (600 MHz, DMSO-<i>d</i><sub>6</sub>): δ 8.91 (d, <i>J</i> = 2.1 Hz, 1H), 8.85 (t, <i>J</i> = 6.8 Hz, 1H), 8.45 (s, 1H), 8.20 (dd, <i>J</i> = 8.1, 2.1 Hz, 1H), 8.02 (d, <i>J</i> = 8.1 Hz, 1H), 7.85 (t, <i>J</i> = 1.7 Hz, 1H), 7.32 (td, <i>J</i> = 7.6, 1.7 Hz, 1H), 7.28–7.25 (m, 1H), 7.15–7.13 (m, 3H), 3.56 (q, <i>J</i> = 6.8 Hz, 2H), 2.92 (t, <i>J</i> = 6.8 Hz, 2H); <sup>13</sup>C NMR (151 MHz, DMSO-<i>d</i><sub>6</sub>): δ 163.45, 160.44, 148.03, 145.23, 144.76, 140.94, 133.72, 130.97, 130.24, 128.12, 125.83, 124.19, 122.08, 121.80, 114.96, 108.35, 39.87, 28.34; ESI-HRMS (<i>m</i>/<i>z</i>): calcd C<sub>18</sub>H<sub>15</sub>FN<sub>2</sub>O<sub>2</sub> (M + H<sup>+</sup>), 311.1190; found, 311.1191.</div></div><div id="sec6_1_58" class="NLM_sec NLM_sec_level_3"><div id="ac_i81" class="anchor-spacer"></div><h4 class="article-section__title" id="_i81">6.1.58.  <i>N</i>-(2-Fluorophenethyl)-5-(thiophen-2-yl)picolinamide (<b>30c</b>)</h4><div class="NLM_p last">It is obtained as a white solid in 67% yield. <sup>1</sup>H NMR (600 MHz, CDCl<sub>3</sub>): δ 8.77 (d, <i>J</i> = 2.3 Hz, 1H), 8.19 (d, <i>J</i> = 8.1 Hz, 1H), 8.09 (br s, 1H), 8.00 (dd, <i>J</i> = 8.1, 2.3 Hz, 1H), 7.44 (dd, <i>J</i> = 3.6, 1.0 Hz, 1H), 7.42 (dd, <i>J</i> = 5.1, 1.0 Hz, 1H), 7.25–7.21 (m, 2H), 7.15 (dd, <i>J</i> = 5.1, 3.6 Hz, 1H), 7.08 (t, <i>J</i> = 7.4, 1H), 7.07–7.02 (m, 1H), 3.75 (q, <i>J</i> = 7.0 Hz, 2H), 3.01 (t, <i>J</i> = 7.0 Hz, 2H); <sup>13</sup>C NMR (151 MHz, CDCl<sub>3</sub>): δ 164.07, 161.32, 148.40, 145.12, 139.59, 133.79, 132.68, 131.06, 128.46, 128.26, 126.92, 125.84, 125.05, 124.14, 122.29, 115.34, 39.53, 29.34; ESI-HRMS (<i>m</i>/<i>z</i>): calcd C<sub>18</sub>H<sub>15</sub>FN<sub>2</sub>OS (M + H<sup>+</sup>), 327.0962; found, 327.0962.</div></div><div id="sec6_1_59" class="NLM_sec NLM_sec_level_3"><div id="ac_i82" class="anchor-spacer"></div><h4 class="article-section__title" id="_i82">6.1.59.  <i>N</i>-(2-Fluorophenethyl)-5-(thiophen-3-yl)picolinamide (<b>30d</b>)</h4><div class="NLM_p last">It is obtained as a white solid in 61% yield. <sup>1</sup>H NMR (600 MHz, DMSO-<i>d</i><sub>6</sub>): δ 8.98 (d, <i>J</i> = 1.6 Hz, 1H), 8.84 (t, <i>J</i> = 6.0 Hz, 1H), 8.28 (dd, <i>J</i> = 8.1, 2.2 Hz, 1H), 8.17–8.16 (m, 1H), 8.01 (d, <i>J</i> = 8.1 Hz, 1H), 7.72 (dd, <i>J</i> = 5.0, 2.9 Hz, 1H), 7.70 (dd, <i>J</i> = 5.0, 1.6 Hz, 1H), 7.32–7.28 (m, 1H), 7.26–7.21 (m, 1H), 7.15–7.08 (m, 2H), 3.54 (q, <i>J</i> = 7.1 Hz, 2H), 2.90 (t, <i>J</i> = 7.1 Hz, 2H); <sup>13</sup>C NMR (151 MHz, CDCl<sub>3</sub>): δ 163.64, 160.41, 147.59, 145.31, 137.42, 133.91, 133.19, 131.48, 130.51, 127.90, 127.69, 126.73, 125.21, 123.58, 121.77, 114.76, 38.92, 28.76; ESI-HRMS (<i>m</i>/<i>z</i>): calcd C<sub>18</sub>H<sub>15</sub>FN<sub>2</sub>OS (M + H<sup>+</sup>), 327.0962; found, 327.0963.</div></div><div id="sec6_1_60" class="NLM_sec NLM_sec_level_3"><div id="ac_i83" class="anchor-spacer"></div><h4 class="article-section__title" id="_i83">6.1.60.  <i>N</i>-(2-Fluorophenethyl)-3,4′-bipyridine-6-carboxamide (<b>30e</b>)</h4><div class="NLM_p last">It is obtained as a white solid in 67% yield. <sup>1</sup>H NMR (600 MHz, CDCl<sub>3</sub>): δ 8.78 (d, <i>J</i> = 1.8 Hz, 1H), 8.74 (d, <i>J</i> = 5.9 Hz, 2H), 8.30 (d, <i>J</i> = 8.1 Hz, 1H), 8.16 (br s, 1H), 8.07 (dd, <i>J</i> = 8.1, 2.2 Hz, 1H), 7.52 (dd, <i>J</i> = 4.6, 1.8 Hz, 2H), 7.26–7.23 (m, 1H), 7.23–7.19 (m, 1H), 7.08 (t, <i>J</i> = 7.2 Hz, 1H), 7.06–7.02 (m, 1H), 3.76 (q, <i>J</i> = 7.0 Hz, 2H), 3.01 (t, <i>J</i> = 7.0 Hz, 2H). <sup>13</sup>C NMR (151 MHz, CDCl<sub>3</sub>): δ 163.78, 162.12, 150.67, 150.12, 146.47, 144.36, 136.11, 135.64, 132.10, 131.04, 128.30, 124.18, 122.39, 121.55, 115.30, 39.60, 29.32; ESI-HRMS (<i>m</i>/<i>z</i>): calcd C<sub>19</sub>H<sub>16</sub>FN<sub>3</sub>O (M + H<sup>+</sup>), 322.1350; found, 322.1354.</div></div><div id="sec6_1_61" class="NLM_sec NLM_sec_level_3"><div id="ac_i84" class="anchor-spacer"></div><h4 class="article-section__title" id="_i84">6.1.61.  <i>N</i>-(2-Fluorophenethyl)-5-(1<i>H</i>-pyrazol-4-yl)picolinamide (<b>30f</b>)</h4><div class="NLM_p last">It is obtained as a white solid in 66% yield. <sup>1</sup>H NMR (600 MHz, CDCl<sub>3</sub>): δ 8.69 (d, <i>J</i> = 1.8 Hz, 1H), 8.20 (d, <i>J</i> = 8.1 Hz, 1H), 8.12 (br s, 1H), 7.96 (s, 2H), 7.92 (dd, <i>J</i> = 8.1, 1.8 Hz, 1H), 7.25–7.21 (m, 2H), 7.09–7.03 (m, 2H), 3.75 (q, <i>J</i> = 7.1 Hz, 2H), 3.01 (t, <i>J</i> = 7.1 Hz, 2H); <sup>13</sup>C NMR (151 MHz, DMSO-<i>d</i><sub>6</sub>): δ 163.58, 160.38, 147.02, 144.76, 136.63, 132.92, 131.26, 130.99, 128.09, 126.61, 125.87, 124.19, 121.81, 117.07, 114.96, 38.83, 28.36; ESI-HRMS (<i>m</i>/<i>z</i>): calcd C<sub>17</sub>H<sub>15</sub>FN<sub>4</sub>O (M + H<sup>+</sup>), 311.1303; found, 311.1300.</div></div><div id="sec6_1_62" class="NLM_sec NLM_sec_level_3"><div id="ac_i85" class="anchor-spacer"></div><h4 class="article-section__title" id="_i85">6.1.62.  <i>N</i>-(2-Fluorophenethyl)-5-(2-fluorophenyl)picolinamide (<b>30g</b>)</h4><div class="NLM_p last">It is obtained as a white solid in 69% yield. <sup>1</sup>H NMR (600 MHz, CDCl<sub>3</sub>): δ 8.73 (s, 1H), 8.29 (d, <i>J</i> = 8.1 Hz, 1H), 8.19 (br t, 1H), 8.04 (dt, <i>J</i> = 8.1, 1.8 Hz 1H), 7.48 (td, <i>J</i> = 7.6, 1.8 Hz, 1H), 7.45–7.42 (m, 1H), 7.30–7.29 (m, 2H), 7.25–7.23 (m, 2H), 7.12–7.07 (m, 2H), 3.78 (q, <i>J</i> = 7.0 Hz, 2H), 3.04 (t, <i>J</i> = 7.0 Hz, 2H); <sup>13</sup>C NMR (151 MHz, CDCl<sub>3</sub>): δ 163.55, 160.61, 159.04, 148.15, 147.41, 136.82, 133.48, 130.49, 129.92, 129.84, 127.68, 125.23, 124.29, 124.20, 123.56, 121.28, 115.82, 114.76, 38.93, 28.76; ESI-HRMS (<i>m</i>/<i>z</i>): calcd C<sub>20</sub>H<sub>16</sub>F<sub>2</sub>N<sub>2</sub>O (M + H<sup>+</sup>), 339.1303; found, 339.1309.</div></div><div id="sec6_1_63" class="NLM_sec NLM_sec_level_3"><div id="ac_i86" class="anchor-spacer"></div><h4 class="article-section__title" id="_i86">6.1.63.  <i>N</i>-(2-Fluorophenethyl)-5-(3-fluorophenyl)picolinamide (<b>30h</b>)</h4><div class="NLM_p last">It is obtained as a white solid in 65% yield. <sup>1</sup>H NMR (600 MHz, CDCl<sub>3</sub>): δ 8.72 (d, <i>J</i> = 2.2 Hz, 1H), 8.26 (d, <i>J</i> = 8.1 Hz, 1H), 8.17 (br s, 1H), 8.00 (dd, <i>J</i> = 8.1, 2.2 Hz, 1H), 7.49–7.45 (m, 1H), 7.39 (d, <i>J</i> = 7.7 Hz, 1H), 7.30 (dd, <i>J</i> = 8.0, 1.6 Hz, 1H), 7.26–7.21 (m, 2H), 7.14–7.10 (m, 1H), 7.08–7.04 (m, 2H), 3.76 (q, <i>J</i> = 7.1 Hz, 2H), 3.02 (t, <i>J</i> = 7.1 Hz, 2H); <sup>13</sup>C NMR (151 MHz, CDCl<sub>3</sub>): δ 163.67, 162.81, 160.73, 148.26, 145.98, 138.53, 137.25, 135.02, 130.51, 130.24, 127.76, 125.12, 123.61, 122.34, 121.67, 115.00, 114.79, 113.61, 39.03, 28.71; ESI-HRMS (<i>m</i>/<i>z</i>): calcd C<sub>20</sub>H<sub>16</sub>F<sub>2</sub>N<sub>2</sub>O (M + H<sup>+</sup>), 339.1303; found, 339.1306.</div></div><div id="sec6_1_64" class="NLM_sec NLM_sec_level_3"><div id="ac_i87" class="anchor-spacer"></div><h4 class="article-section__title" id="_i87">6.1.64.  <i>N</i>-(2-Fluorophenethyl)-5-(4-fluorophenyl)picolinamide (<b>30i</b>)</h4><div class="NLM_p last">It is obtained as a white solid in 69% yield. <sup>1</sup>H NMR (600 MHz, CDCl<sub>3</sub>): δ 8.70 (d, <i>J</i> = 2.2 Hz, 1H), 8.25 (d, <i>J</i> = 8.1 Hz, 1H), 8.14 (br s, 1H), 7.97 (dd, <i>J</i> = 8.1, 2.2 Hz, 1H), 7.59–7.56 (m, 2H), 7.25–7.23 (m, 1H), 7.21–7.18 (m, 3H), 7.09–7.03 (m, 2H), 3.76 (q, <i>J</i> = 7.0 Hz, 2H), 3.02 (t, <i>J</i> = 7.0 Hz, 2H); <sup>13</sup>C NMR (151 MHz, CDCl<sub>3</sub>): δ 163.58, 162.44, 160.39, 147.98, 145.81, 137.44, 134.73, 132.55, 130.49, 128.36, 127.69, 125.22, 123.56, 121.60, 115.65, 114.76, 38.94, 28.75; ESI-HRMS (<i>m</i>/<i>z</i>): calcd C<sub>20</sub>H<sub>16</sub>F<sub>2</sub>N<sub>2</sub>O (M + H<sup>+</sup>), 339.1303; found, 339.1304.</div></div><div id="sec6_1_65" class="NLM_sec NLM_sec_level_3"><div id="ac_i88" class="anchor-spacer"></div><h4 class="article-section__title" id="_i88">6.1.65.  <i>N</i>-(2-Fluorophenethyl)-5-(2-hydroxyphenyl)picolinamide (<b>30j</b>)</h4><div class="NLM_p last">It is obtained as a white solid in 70% yield. <sup>1</sup>H NMR (600 MHz, DMSO-<i>d</i><sub>6</sub>): δ 9.82 (s, 1H), 8.83 (t, <i>J</i> = 7.0 Hz, 1H), 8.80 (d, <i>J</i> = 2.0 Hz, 1H), 8.14 (dd, <i>J</i> = 8.1, 2.0 Hz, 1H), 8.05 (d, <i>J</i> = 8.1 Hz, 1H), 7.38 (d, <i>J</i> = 7.6 Hz, 1H), 7.33 (t, <i>J</i> = 7.6 Hz, 1H), 7.27–7.25 (m, 2H), 7.16–7.12 (m, 2H), 7.01 (d, <i>J</i> = 8.1 Hz, 1H), 6.95 (t, <i>J</i> = 7.6 Hz, 1H), 3.59 (q, <i>J</i> = 7.0 Hz, 2H), 2.94 (t, <i>J</i> = 7.0 Hz, 2H) <sup>13</sup>C NMR (151 MHz, DMSO-<i>d</i><sub>6</sub>): δ 163.64, 160.26, 154.50, 148.10, 147.74, 137.40, 136.51, 130.96, 130.16, 129.73, 128.09, 125.83, 124.16, 123.42, 121.07, 119.60, 116.09, 114.93, 38.85, 28.36; ESI-HRMS (<i>m</i>/<i>z</i>): calcd C<sub>20</sub>H<sub>17</sub>FN<sub>2</sub>O<sub>2</sub> (M + H<sup>+</sup>), 337.1347; found, 337.1348.</div></div><div id="sec6_1_66" class="NLM_sec NLM_sec_level_3"><div id="ac_i89" class="anchor-spacer"></div><h4 class="article-section__title" id="_i89">6.1.66.  <i>N</i>-(2-Fluorophenethyl)-5-(3-hydroxyphenyl)picolinamide (<b>30k</b>)</h4><div class="NLM_p last">It is obtained as a white solid in 66% yield. <sup>1</sup>H NMR (600 MHz, DMSO-<i>d</i><sub>6</sub>): δ 9.72 (s, 1H), 8.93 (t, <i>J</i> = 7.0 Hz, 1H), 8.86 (d, <i>J</i> = 2.0 Hz, 1H), 8.19 (dd, <i>J</i> = 8.1, 2.0 Hz, 1H), 8.07 (d, <i>J</i> = 8.1 Hz, 1H), 7.63–7.61 (m, 1H), 7.34 (t, <i>J</i> = 7.8 Hz, 2H), 7.33–7.32 (m, 1H), 7.20–7.19 (m, 1H), 7.15–7.11 (m, 2H), 6.89–6.87 (m, 1H), 3.58 (q, <i>J</i> = 7.0 Hz, 2H), 2.93 (t, <i>J</i> = 7.0 Hz, 2H); <sup>13</sup>C NMR (151 MHz, DMSO-<i>d</i><sub>6</sub>): δ 163.50, 160.50, 157.90, 148.67, 146.14, 137.88, 137.43, 135.24, 130.95, 130.13, 128.51, 128.05, 124.17, 121.79, 117.69, 115.59, 114.93, 113.70, 38.88, 28.34; ESI-HRMS (<i>m</i>/<i>z</i>): calcd C<sub>20</sub>H<sub>17</sub>FN<sub>2</sub>O<sub>2</sub> (M + H<sup>+</sup>), 337.1347; found, 337.1350.</div></div><div id="sec6_1_67" class="NLM_sec NLM_sec_level_3"><div id="ac_i90" class="anchor-spacer"></div><h4 class="article-section__title" id="_i90">6.1.67.  <i>N</i>-(2-Fluorophenethyl)-5-(4-hydroxyphenyl)picolinamide (<b>30l</b>)</h4><div class="NLM_p last">It is obtained as a white solid in 65% yield. <sup>1</sup>H NMR (600 MHz, DMSO-<i>d</i><sub>6</sub>): δ 9.73 (s, 1H), 8.85 (d, <i>J</i> = 2.0 Hz, 1H), 8.79 (t, <i>J</i> = 7.0 Hz, 1H), 8.16 (dd, <i>J</i> = 8.2, 2.0 Hz, 1H), 8.03 (d, <i>J</i> = 8.2 Hz, 1H), 7.64 (d, <i>J</i> = 8.6 Hz, 2H), 7.34–7.31 (m, 1H), 7.27–7.26 (m, 1H), 7.16–7.11 (m, 2H), 6.92 (d, <i>J</i> = 8.6 Hz, 2H), 3.58 (q, <i>J</i> = 7.0 Hz, 2H), 2.93 (t, <i>J</i> = 7.0 Hz, 2H); <sup>13</sup>C NMR (151 MHz, DMSO-<i>d</i><sub>6</sub>): δ 163.60, 160.53, 158.14, 147.67, 145.51, 137.73, 134.18, 130.95, 128.17, 128.09, 126.61, 125.89, 124.16, 121.71, 115.94, 114.93, 38.85, 28.36; ESI-HRMS (<i>m</i>/<i>z</i>): calcd C<sub>20</sub>H<sub>17</sub>FN<sub>2</sub>O<sub>2</sub> (M + H<sup>+</sup>), 337.1347; found, 337.1345.</div></div><div id="sec6_1_68" class="NLM_sec NLM_sec_level_3"><div id="ac_i91" class="anchor-spacer"></div><h4 class="article-section__title" id="_i91">6.1.68.  <i>N</i>-(2-Fluorophenethyl)-5-(2-methoxyphenyl)picolinamide (<b>30m</b>)</h4><div class="NLM_p last">It is obtained as a white solid in 70% yield. <sup>1</sup>H NMR (600 MHz, CDCl<sub>3</sub>): δ 8.68 (d, <i>J</i> = 2.1 Hz, 1H), 8.22 (d, <i>J</i> = 8.1 Hz, 1H), 8.18 (br s, 1H), 8.00 (dd, <i>J</i> = 8.1, 2.1 Hz, 1H), 7.41–7.38 (m, 1H), 7.33 (dd, <i>J</i> = 7.5, 1.5 Hz, 1H), 7.26–7.25 (m, 1H), 7.22–7.21 (m, 1H), 7.09–7.06 (m, 2H), 7.04–7.01 (m, 2H), 3.83 (s, 3H), 3.75 (q, <i>J</i> = 7.0 Hz, 2H), 3.01 (t, <i>J</i> = 7.0 Hz, 2H); <sup>13</sup>C NMR (151 MHz, CDCl<sub>3</sub>): δ 164.45, 162.13, 156.60, 148.60, 147.97, 137.87, 136.81, 131.06, 130.58, 130.02, 128.18, 126.32, 125.96, 124.11, 121.48, 121.13, 115.40, 111.39, 55.52, 39.49, 29.39; ESI-HRMS (<i>m</i>/<i>z</i>): calcd C<sub>21</sub>H<sub>19</sub>FN<sub>2</sub>O<sub>2</sub> (M + H<sup>+</sup>), 351.1503; found, 351.1508.</div></div><div id="sec6_1_69" class="NLM_sec NLM_sec_level_3"><div id="ac_i92" class="anchor-spacer"></div><h4 class="article-section__title" id="_i92">6.1.69.  <i>N</i>-(2-Fluorophenethyl)-5-(3-methoxyphenyl)picolinamide (<b>30n</b>)</h4><div class="NLM_p last">It is obtained as a white solid in 65% yield. <sup>1</sup>H NMR (600 MHz, CDCl<sub>3</sub>): δ 8.72 (s, 1H), 8.23 (d, <i>J</i> = 8.1 Hz, 1H), 8.16 (br s, 1H), 7.99 (d, <i>J</i> = 8.1 Hz, 1H), 7.41–7.38 (m, 1H), 7.26–7.24 (m, 1H), 7.22–7.20 (m, 1H), 7.19–7.16 (m, 1H), 7.11 (d, <i>J</i> = 1.8 Hz, 1H), 7.07 (t, <i>J</i> = 7.5 Hz, 1H), 7.05–7.02 (m, 1H), 6.97 (d, <i>J</i> = 7.5 Hz, 1H), 3.86 (d, <i>J</i> = 1.8 Hz, 3H), 3.75 (q, <i>J</i> = 7.2 Hz, 2H), 3.00 (t, <i>J</i> = 7.2 Hz, 2H); <sup>13</sup>C NMR (151 MHz, DMSO-<i>d</i><sub>6</sub>): δ 164.06, 161.22, 160.35, 149.33, 147.03, 138.17, 136.13, 131.62, 130.81, 128.76, 126.48, 124.82, 122.36, 119.87, 115.66, 115.52, 114.82, 113.08, 55.73, 39.51, 28.97. ESI-HRMS (<i>m</i>/<i>z</i>): calcd C<sub>21</sub>H<sub>19</sub>FN<sub>2</sub>O<sub>2</sub> (M + H<sup>+</sup>), 351.1503; found, 351.1508.</div></div><div id="sec6_1_70" class="NLM_sec NLM_sec_level_3"><div id="ac_i93" class="anchor-spacer"></div><h4 class="article-section__title" id="_i93">6.1.70.  <i>N</i>-(2-Fluorophenethyl)-5-(4-methoxyphenyl)picolinamide (<b>30o</b>)</h4><div class="NLM_p last">It is obtained as a white solid in 62% yield. <sup>1</sup>H NMR (600 MHz, CDCl<sub>3</sub>): δ 8.73 (dd, <i>J</i> = 2.2, 0.6 Hz, 1H), 8.24 (dd, <i>J</i> = 8.1, 0.6 Hz, 1H), 8.17 (br s, 1H), 7.99 (dd, <i>J</i> = 8.1, 2.2 Hz, 1H), 7.58–7.57 (m, 2H), 7.30–7.28 (m, 1H), 7.26–7.22 (m, 1H), 7.11–7.07 (m, 2H), 7.06–7.04 (m, 2H), 3.89 (s, 3H), 3.78 (q, <i>J</i> = 7.0 Hz, 2H), 3.04 (t, <i>J</i> = 7.2 Hz, 2H); <sup>13</sup>C NMR (151 MHz, CDCl<sub>3</sub>): δ 163.79, 160.74, 159.61, 147.32, 145.56, 138.02, 134.20, 130.50, 128.74, 127.75, 127.66, 125.27, 123.55, 121.55, 114.75, 114.09, 54.79, 38.91, 28.77; ESI-HRMS (<i>m</i>/<i>z</i>): calcd C<sub>21</sub>H<sub>19</sub>FN<sub>2</sub>O<sub>2</sub> (M + H<sup>+</sup>), 351.1503; found, 351.1505.</div></div><div id="sec6_1_71" class="NLM_sec NLM_sec_level_3"><div id="ac_i94" class="anchor-spacer"></div><h4 class="article-section__title" id="_i94">6.1.71.  5-(2-Cyanophenyl)-<i>N</i>-(2-fluorophenethyl)picolinamide (<b>30p</b>)</h4><div class="NLM_p last">It is obtained as a white solid in 64% yield. <sup>1</sup>H NMR (600 MHz, CDCl<sub>3</sub>): δ 8.59 (d, <i>J</i> = 2.2 Hz, 1H), 8.22 (d, <i>J</i> = 8.0 Hz, 1H), 8.16 (t, <i>J</i> = 7.0 Hz, 1H), 7.92 (dd, <i>J</i> = 8.0, 2.2 Hz, 1H), 7.70 (d, <i>J</i> = 7.6 Hz, 1H), 7.56 (td, <i>J</i> = 7.5, 1.2 Hz, 1H), 7.50 (td, <i>J</i> = 7.6, 1.0 Hz, 1H), 7.39 (d, <i>J</i> = 7.5 Hz, 1H), 7.26–7.25 (m, 1H), 7.22–7.20 (m, 1H), 7.09–7.07 (m, 1H), 7.06–7.02 (m, 1H), 3.74 (q, <i>J</i> = 7.0 Hz, 2H), 3.00 (t, <i>J</i> = 7.0 Hz, 2H); <sup>13</sup>C NMR (151 MHz, CDCl<sub>3</sub>): δ 170.06, 163.52, 160.45, 148.31, 147.05, 137.78, 136.63, 135.16, 134.47, 130.48, 130.27, 129.98, 128.11, 127.87, 127.70, 125.18, 123.60, 121.25, 114.77, 38.93, 28.75; ESI-HRMS (<i>m</i>/<i>z</i>): calcd C<sub>21</sub>H<sub>16</sub>FN<sub>3</sub>O (M + H<sup>+</sup>), 346.1350; found, 346.1350.</div></div><div id="sec6_1_72" class="NLM_sec NLM_sec_level_3"><div id="ac_i95" class="anchor-spacer"></div><h4 class="article-section__title" id="_i95">6.1.72.  5-(3-Cyanophenyl)-<i>N</i>-(2-fluorophenethyl)picolinamide (<b>30q</b>)</h4><div class="NLM_p last">It is obtained as a white solid in 69% yield. <sup>1</sup>H NMR (600 MHz, CDCl<sub>3</sub>): δ 8.75 (d, <i>J</i> = 2.0 Hz, 1H), 8.32 (d, <i>J</i> = 8.1 Hz, 1H), 8.17 (br s, 1H), 8.04 (dd, <i>J</i> = 8.1, 2.0 Hz, 1H), 7.91 (s, 1H), 7.86 (d, <i>J</i> = 7.8 Hz, 1H), 7.76 (d, <i>J</i> = 7.8 Hz, 1H), 7.66 (t, <i>J</i> = 7.8 Hz, 1H), 7.27–7.25 (m, 1H), 7.24–7.23 (m, 1H), 7.12–7.11 (m, 1H), 7.10–7.06 (m, 1H), 3.79 (q, <i>J</i> = 7.0 Hz, 2H), 3.04 (t, <i>J</i> = 7.0 Hz, 2H); <sup>13</sup>C NMR (151 MHz, CDCl<sub>3</sub>): δ 163.25, 160.31, 148.96, 145.86, 137.79, 136.15, 135.08, 131.41, 130.93, 130.49, 130.14, 129.52, 127.75, 125.14, 123.58, 121.80, 117.65, 114.79, 112.99, 39.00, 28.73; ESI-HRMS (<i>m</i>/<i>z</i>): calcd C<sub>21</sub>H<sub>16</sub>FN<sub>3</sub>O (M + H<sup>+</sup>), 346.1350; found, 346.1350.</div></div><div id="sec6_1_73" class="NLM_sec NLM_sec_level_3"><div id="ac_i96" class="anchor-spacer"></div><h4 class="article-section__title" id="_i96">6.1.73.  5-(4-Cyanophenyl)-<i>N</i>-(2-fluorophenethyl)picolinamide (<b>30r</b>)</h4><div class="NLM_p last">It is obtained as a white solid in 61% yield. <sup>1</sup>H NMR (600 MHz, CDCl<sub>3</sub>): δ 8.75 (d, <i>J</i> = 1.5 Hz, 1H), 8.30 (d, <i>J</i> = 8.1 Hz, 1H), 8.15 (br s, 1H), 8.04 (dd, <i>J</i> = 8.1, 1.5 Hz, 1H), 7.80 (d, <i>J</i> = 8.1 Hz, 2H), 7.72 (d, <i>J</i> = 8.1 Hz, 2H), 7.24–7.21 (m, 2H), 7.09 (t, <i>J</i> = 7.4 Hz, 1H), 7.05 (t, <i>J</i> = 8.0 Hz, 1H), 3.76 (q, <i>J</i> = 7.0 Hz, 2H), 3.02 (t, <i>J</i> = 7.0 Hz, 2H); <sup>13</sup>C NMR (151 MHz, CDCl<sub>3</sub>): δ 163.23, 160.51, 149.09, 145.99, 140.88, 136.44, 135.19, 132.37, 130.48, 127.76, 127.31, 125.13, 123.60, 121.78, 117.77, 114.79, 111.88, 39.00, 28.72; ESI-HRMS (<i>m</i>/<i>z</i>): calcd C<sub>21</sub>H<sub>16</sub>FN<sub>3</sub>O (M + H<sup>+</sup>), 346.1350; found, 346.1352.</div></div></div><div id="sec6_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i97" class="anchor-spacer"></div><h3 class="article-section__title" id="_i97">6.2.  MTT Cell Viability Assay</h3><div class="NLM_p last">The cytotoxicity of synthesized compounds was measured by MTT assay. Briefly, LM3 cells were cultured in Dulbecco’s modified Eagle’s medium or RPMI-1640 medium supplemented with 10% fetal bovine serum (FBS), 100 U/mL penicillin and 100 μg/mL streptomycin in a humidified incubator at 37 °C in an atmosphere of 5% CO<sub>2</sub>. 5 × 10<sup>3</sup> cells per well were seeded into 96 well plates and treated with tested compounds or DMSO (diluent) for 48 h. Then, the medium with compounds or DMSO was replaced with 180 μL of fresh medium along with 20 μL of MTT solution [5 mg/mL in phosphate buffer saline (PBS)] per well and incubated at 37 °C for 4 h. Next, the MTT-containing medium was replaced with 150 μL of DMSO. After newly formed formazan crystals was dissolved, absorbance of each well was determined by a microplate reader (SpectraMax M4, Molecular Devices) at a 570 nm wavelength. Assays were performed in triplicates. Growth IRs were calculated with the following equation<span class="NLM_disp-formula" id="ueq1"><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-20/acs.jmedchem.9b01313/20191018/images/medium/jm9b01313_m001.gif" alt="" id="_i98" /></img></span></div></div><div id="sec6_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i99" class="anchor-spacer"></div><h3 class="article-section__title" id="_i99">6.3.  Dual Luciferase-Reporter Assay</h3><div class="NLM_p last">LM3 cells were seeded into a 24 well plate and cotransfected with the luciferase reporter plasmid (pGL3-HRE-Luc) containing five copies of HREs and pRL-SV40 plasmid encoding Renilla luciferase using the Lipofectamine 2000 transfection reagent (Invitrogen) according to the manufacturer’s instructions, followed by incubation under normoxia (21% O<sub>2</sub>) for 6 h. Subsequently, the medium of each well was replaced with fresh medium containing DMSO or tested compounds, and the plates were incubated under normoxia for 1 h as well as hypoxia (1% O<sub>2</sub>) for another 24 h. The cells were washed with PBS buffer, lysed, and subjected to determine luciferase activity using the dual-luciferase reporter assay kit (Promega) according to the manufacturer’s instructions. Luminescence was measured using a microplate reader (SpectraMax M4, Molecular Devices). The firefly luminescence signals were normalized to the activities of Renilla luciferase. Results were obtained from three independent determinations and presented as mean ± SD.</div></div><div id="sec6_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i100" class="anchor-spacer"></div><h3 class="article-section__title" id="_i100">6.4.  Western Blotting Assay</h3><div class="NLM_p last">Western blots were conducted as described previously. Briefly, cells were seeded in 60 mm dishes and cultured under the normoxia condition. After 70–80% confluence, cells were treated with indicated concentrations of tested compounds or DMSO (diluent) under normoxia for 1 h and hypoxia for another 24 h. Subsequently, cells were harvested and lysed with radio-immunoprecipitation assay lysis buffer. Cell extracts were separated by SDA-PAGE electrophoresis and transferred onto polyvinylidene fluoride (PVDF) membranes (Millipore). The membranes were then blocked with 10% non-fat milk in TBST [Tris-buffered saline (TBS) containing 0.1% TWEEN-20] and reacted with primary antibodies (Proteintech), followed by incubation with secondary antibodies conjugated with horseradish peroxidase (HRP, purchased from Cell Signaling Technology). The protein bands were developed by the chemiluminescent reagents (Millipore).</div></div><div id="sec6_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i101" class="anchor-spacer"></div><h3 class="article-section__title" id="_i101">6.5.  Real-Time PCR Assay</h3><div class="NLM_p last">HUVECs were treated with <b>30m</b> or DMSO (diluent) under normoxia for 1 h and hypoxia for another 24 h. Total RNA was extracted using the TRIzol reagent (Invitrogen) and reverse transcription was performed using the primescript RT reagent kit (Takara) to obtain cDNA, which was subsequently amplified by real-time PCR using SYBR Premix Ex Taq II (Takara). The gene expression was calculated by the 2<sup>–ΔΔCt</sup> method and normalized by glyceraldehyde 3-phosphate dehydrogenase (GAPDH) as an internal control. Results were obtained from three independent determinations and presented as mean ± SD.</div></div><div id="sec6_6" class="NLM_sec NLM_sec_level_2"><div id="ac_i102" class="anchor-spacer"></div><h3 class="article-section__title" id="_i102">6.6.  Capillary-Like Tube Formation Assay</h3><div class="NLM_p last">Capillary-like tube formation assay was performed according to the procedure reported previously.<a onclick="showRef(event, 'ref38'); return false;" href="javascript:void(0);" class="ref ref38">(38)</a> Briefly, 96 well plates were coated with matrigel (Corning) and incubated at 37 °C for gelation. HUVECs (3 × 10<sup>4</sup> per well) mixed with the tested compound or DMSO (diluent) were seeded to the top of gel and incubated under hypoxia for 12 h. The capillary-like tube was observed and imaged with an inverted microscope containing charge-coupled device (CCD) camera (Olympus).</div></div><div id="sec6_7" class="NLM_sec NLM_sec_level_2"><div id="ac_i103" class="anchor-spacer"></div><h3 class="article-section__title" id="_i103">6.7.  Zebrafish Angiogenesis Assay</h3><div class="NLM_p last">The zebrafish angiogenesis studies and procedures were approved by the Animal Ethics Committee of School of Pharmacy, Fudan University. The transgenic zebrafish (fil1/EGFP) embryos at 48 hpf were incubated in 6 well plates (<i>n</i> = 10 per well) with 2 mL of aquaculture water <b>30m</b> (0.5 and 1 μM) or DMSO for 24 h. Apatinib (0.5 μM) was used as the positive control. The effects of tested compounds on SIVs of zebrafish were observed with confocal microscopy. The numbers of SIVs were counted under confocal microscopy. Results were obtained from three independent determinations and presented as mean ± SD.</div></div><div id="sec6_8" class="NLM_sec NLM_sec_level_2"><div id="ac_i104" class="anchor-spacer"></div><h3 class="article-section__title" id="_i104">6.8.  Wound Healing Assay</h3><div class="NLM_p last">Cells were seeded in 6 well and cultured under normoxia until about 90% confluence. A single scratch wound was created on the cellular monolayer using a sterile micropipette tip. Subsequently, cells were incubated with compound <b>30m</b> at indicated concentrations or DMSO (diluent) under normoxia for 1 h and hypoxia for another 24 h. Migrating cells were observed and imaged with an inverted microscope containing a CCD camera (Olympus).</div></div><div id="sec6_9" class="NLM_sec NLM_sec_level_2"><div id="ac_i105" class="anchor-spacer"></div><h3 class="article-section__title" id="_i105">6.9.  Transwell Assay</h3><div class="NLM_p last">2 × 10<sup>5</sup> cells suspending in 0.3 mL of serum-free medium per well were seeded into the upper chamber (Corning). For invasion assay, the chamber was precoated with matrigel to simulate the basement membrane. The chamber was then placed into 24 well plates, and in the lower wells was added complete medium containing 10% FBS and indicated concentrations of compound <b>30m</b> or DMSO (diluent). The plate was incubated under normoxia for 1 h and hypoxia for another 24 h. Cells migrated across the chamber were fixed with methanol, stained with crystal violet, and subsequently counted from 5 different areas per well under an inverted microscope. Results were obtained from three independent determinations and presented as mean ± SD.</div></div><div id="sec6_10" class="NLM_sec NLM_sec_level_2"><div id="ac_i106" class="anchor-spacer"></div><h3 class="article-section__title" id="_i106">6.10.  In Vivo Antimetastatic Assay</h3><div class="NLM_p last">All animal studies and procedures were approved by the Animal Ethics Committee of School of Pharmacy, Fudan University. Female BALB/c nude mice at 4–5 weeks of age were purchased from Shanghai Slac Laboratory Animal Co. Ltd. (Shanghai, China) and housed in individual ventilated cages (IVCs) under specific pathogen-free environment in the animal holding unit of Fudan University (Shanghai, China). MDA-MB-231 cells (2 × 10<sup>5</sup> per mouse) stably expressing luciferase were injected intravenously via the tail vein of nude mice. Twenty four hours after injection, mice were randomized into groups (<i>n</i> = 4) and treated i.p. with 15 and 30 mg/kg compound <b>30m</b> (dissolved in PBS containing 5% ethanol and 5% cremophor EL, 0.2 mL per mouse) or vehicle control (0.2 mL diluent) once every 2 days during 20 days. Metastatic tumors were detected and quantified using bioluminescent imaging according to the literature studies. After imagination, the mice were weighed and sacrificed, and their lung tissues were collected, fixed with 4% paraformaldehyde, and embedded in paraffin. Histochemistry analysis was performed to determine the metastatic nodules by H&E staining.</div></div></div><div class="NLM_back"><div class="article_supporting-info" id="notes1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i107"><a href="/doi/suppl/10.1021/acs.jmedchem.9b01313" class="ext-link">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_21726" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_21726" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">The Supporting Information is available free of charge on the <a href="/" class="ext-link">ACS Publications website</a> at DOI: <a href="/doi/abs/10.1021/acs.jmedchem.9b01313" class="ext-link">10.1021/acs.jmedchem.9b01313</a>.<ul class="NLM_list-list_type-label" id="silist"><li><p class="inline">Molecular formula strings and some data (<a href="/doi/suppl/10.1021/acs.jmedchem.9b01313/suppl_file/jm9b01313_si_002.csv" class="ext-link">CSV</a>)</p></li><li><p class="inline">Synthesis of intermediates <b>13a–c</b>, <b>16a–e</b>, <b>25a–b</b>; <sup>1</sup>H NMR, <sup>13</sup>C NMR spectra and the purity table of target compounds; and element analysis of representative compounds (<a href="/doi/suppl/10.1021/acs.jmedchem.9b01313/suppl_file/jm9b01313_si_003.pdf" class="ext-link">PDF</a>)</p></li></ul></p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.9b01313/suppl_file/jm9b01313_si_002.csv">jm9b01313_si_002.csv (4.38 kb)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.9b01313/suppl_file/jm9b01313_si_003.pdf">jm9b01313_si_003.pdf (10.87 MB)</a></li></ul></div></div></div><div class="testing" data-doi="10.1021/acs.jmedchem.9b01313" data-url="https://widgets.figshare.com/static/figshare.js" id="figshare-widget"></div><div class="TermsAndConditionsDropzone3" data-pb-dropzone="TermsAndConditionsDropzone3"><div data-widget-def="UX3HTMLWidget" data-widget-id="85b54935-30e9-4058-a6d2-0b40fb754a85" class="mb-4">
        



        
            <h2 class="">
                Terms & Conditions
            </h2>
        
        <p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system: <a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div><div class="authorInformationSection"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="authorInformationSection">Author Information</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_66415" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_66415" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><ul><li><span class="author-information-subsection-header">Corresponding Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Xinhua Liu</span> - <span class="hlFld-Affiliation affiliation">School
of Pharmacy, Anhui Medical University, Hefei 230032, China</span>; 
    <span class="author-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0002-7984-2977" title="Orcid link">http://orcid.org/0000-0002-7984-2977</a>; 
    </span><span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#e79f8f8b8e928f9fa7d6d1d4c984888a"><span class="__cf_email__" data-cfemail="f189999d98849989b1c0c7c2df929e9c">[email protected]</span></a></span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Yang Wang</span> - <span class="hlFld-Affiliation affiliation">School
of Pharmacy, Fudan University, Shanghai 201203, China</span>; 
    <span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#07706669607e66696047746f6a7229626372296469"><span class="__cf_email__" data-cfemail="3d4a5c535a445c535a7d4e55504813585948135e53">[email protected]</span></a></span></div></li></ul></li><li><span class="author-information-subsection-header">Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Mingming Liu</span> - <span class="hlFld-Affiliation affiliation">School
of Pharmacy, Anhui Medical University, Hefei 230032, China</span>; 
    <span class="hlFld-Affiliation affiliation">Shanghai
Key Laboratory of New Drug Design, East
China University of Science and Technology, Shanghai 200237, China</span>; 
    <span class="hlFld-Affiliation affiliation">Anhui
Chem-Bright Bioengineering Company Limited, Huaibei 235025, China</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Yuru Liang</span> - <span class="hlFld-Affiliation affiliation">School
of Pharmacy, Fudan University, Shanghai 201203, China</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Zhongzhen Zhu</span> - <span class="hlFld-Affiliation affiliation">School
of Pharmacy, Anhui Medical University, Hefei 230032, China</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Jin Wang</span> - <span class="hlFld-Affiliation affiliation">School
of Pharmacy, Anhui Medical University, Hefei 230032, China</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Xingxing Cheng</span> - <span class="hlFld-Affiliation affiliation">School
of Pharmacy, Anhui Medical University, Hefei 230032, China</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Jiayi Cheng</span> - <span class="hlFld-Affiliation affiliation">School
of Pharmacy, Fudan University, Shanghai 201203, China</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Binpeng Xu</span> - <span class="hlFld-Affiliation affiliation">Anhui
Chem-Bright Bioengineering Company Limited, Huaibei 235025, China</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Rong Li</span> - <span class="hlFld-Affiliation affiliation">School
of Pharmacy, Anhui Medical University, Hefei 230032, China</span></div></li></ul></li><li><span class="author-information-subsection-header">Author Contributions</span><p>M.L., Y.L., and Z.Z. are co-first authors and contributed equally to this work.</p></li><li></li><li><span class="author-information-subsection-header">Notes</span><div class="authorInformation_notesSection">The authors declare no competing financial interest.<br /></br></div></li></ul></div><div class="ack" id="ack1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i109">Acknowledgments</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_84264" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_84264" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">This study was supported by grants from the Natural Science Foundation of China (21572003 to X.L.; 21472025 and 21877015 to Y.W.; 81972040 to R.L.), by the Opening Project of Shanghai Key Laboratory of New Drug Design (SKLNDD-KF-201704), by the Natural Science Research Program of Anhui Educational Committee (KJ2019A0232), and by the Scientific Research Grants of Anhui Medical University (XJ201627).</p></div><table summary="" class="NLM_def-list" id="dl1"><tr><td colspan="2" class="NLM_title">Abbreviations</td></tr><tr><td class="NLM_term">HIF</td><td class="NLM_def"><p class="first last">hypoxia-inducible factor</p></td></tr><tr><td class="NLM_term">SAR</td><td class="NLM_def"><p class="first last">structure activity relationship</p></td></tr><tr><td class="NLM_term">VEGF</td><td class="NLM_def"><p class="first last">vascular epidermal growth factor</p></td></tr><tr><td class="NLM_term">VHL</td><td class="NLM_def"><p class="first last">von Hippel–Lindau</p></td></tr><tr><td class="NLM_term">HRE</td><td class="NLM_def"><p class="first last">hypoxia responsive element</p></td></tr><tr><td class="NLM_term">MMP</td><td class="NLM_def"><p class="first last">matrix metalloproteases</p></td></tr><tr><td class="NLM_term">EMT</td><td class="NLM_def"><p class="first last">epithelial–mesenchymal transition</p></td></tr><tr><td class="NLM_term">DMF</td><td class="NLM_def"><p class="first last"><i>N</i>,<i>N</i>-dimethylformamide</p></td></tr><tr><td class="NLM_term">DIPEA</td><td class="NLM_def"><p class="first last"><i>N</i>,<i>N</i>-diisopropylethylamine</p></td></tr><tr><td class="NLM_term">IRs</td><td class="NLM_def"><p class="first last">inhibition rates</p></td></tr><tr><td class="NLM_term">HUVECs</td><td class="NLM_def"><p class="first last">human umbilical vein endothelial cells</p></td></tr><tr><td class="NLM_term">GFP</td><td class="NLM_def"><p class="first last">green fluorescent protein</p></td></tr><tr><td class="NLM_term">GLUT1</td><td class="NLM_def"><p class="first last">glucose transporter type 1</p></td></tr><tr><td class="NLM_term">SIVs</td><td class="NLM_def"><p class="first last">subintestinal vessels</p></td></tr><tr><td class="NLM_term">ECM</td><td class="NLM_def"><p class="first last">extracellular matrix</p></td></tr><tr><td class="NLM_term">H&E staining</td><td class="NLM_def"><p class="first last">hematoxylin and eosin staining</p></td></tr><tr><td class="NLM_term">SD</td><td class="NLM_def"><p class="first last">standard deviation</p></td></tr><tr><td class="NLM_term">TLC</td><td class="NLM_def"><p class="first last">thin-layer chromatography</p></td></tr><tr><td class="NLM_term">TMS</td><td class="NLM_def"><p class="first last">tetramethylsilane</p></td></tr><tr><td class="NLM_term">HRMS</td><td class="NLM_def"><p class="first last">high-resolution mass spectrometry</p></td></tr><tr><td class="NLM_term">NMR</td><td class="NLM_def"><p class="first last">nuclear magnetic resonance</p></td></tr><tr><td class="NLM_term">ESI</td><td class="NLM_def"><p class="first last">electrospray ionization</p></td></tr><tr><td class="NLM_term">FBS</td><td class="NLM_def"><p class="first last">fetal bovine serum</p></td></tr><tr><td class="NLM_term">PBS</td><td class="NLM_def"><p class="first last">phosphate buffer saline</p></td></tr><tr><td class="NLM_term">TBS</td><td class="NLM_def"><p class="first last">tris-buffered saline</p></td></tr><tr><td class="NLM_term">PVDF</td><td class="NLM_def"><p class="first last">polyvinylidene fluoride</p></td></tr><tr><td class="NLM_term">HRP</td><td class="NLM_def"><p class="first last">horseradish peroxidase</p></td></tr><tr><td class="NLM_term">IVC</td><td class="NLM_def"><p class="first last">individual ventilated cages</p></td></tr></table><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i111">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_84173" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_84173" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="references-count">
            This article references 38 other publications.
        </p><ol id="references" class="useLabel"><li id="ref1"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref1'); return false;" data-citation="" class="refNumLink">1</a></strong><div class="NLM_citation" id="cit1"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lambert, A. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pattabiraman, D. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Weinberg, R. A.</span></span> <span> </span><span class="NLM_article-title">Emerging Biological Principles of Metastasis</span>. <i>Cell</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>168</i></span>,  <span class="NLM_fpage">670</span>– <span class="NLM_lpage">691</span>, <span class="refDoi"> DOI: 10.1016/j.cell.2016.11.037</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01313&amp;key=10.1016%2Fj.cell.2016.11.037" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01313&amp;key=28187288" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01313&amp;key=1%3ACAS%3A528%3ADC%252BC2sXis1ygt7k%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=168&publication_year=2017&pages=670-691&author=A.+W.+Lambertauthor=D.+R.+Pattabiramanauthor=R.+A.+Weinberg&title=Emerging+Biological+Principles+of+Metastasis&doi=10.1016%2Fj.cell.2016.11.037"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit1R"><div class="casContent"><span class="casTitleNuber">1</span><div class="casTitle"><span class="NLM_cas:atitle">Emerging biological principles of metastasis</span></div><div class="casAuthors">Lambert, Arthur W.; Pattabiraman, Diwakar R.; Weinberg, Robert A.</div><div class="citationInfo"><span class="NLM_cas:title">Cell (Cambridge, MA, United States)</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">168</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">670-691</span>CODEN:
                <span class="NLM_cas:coden">CELLB5</span>;
        ISSN:<span class="NLM_cas:issn">0092-8674</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">A review.  Metastases account for the great majority of cancer-assocd. deaths, yet this complex process remains the least understood aspect of cancer biol.  As the body of research concerning metastasis continues to grow at a rapid rate, the biol. programs that underlie the dissemination and metastatic outgrowth of cancer cells are beginning to come into view.  In this review we summarize the cellular and mol. mechanisms involved in metastasis, with a focus on carcinomas where the most is known, and we highlight the general principles of metastasis that have begun to emerge.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo-uzuiS1fMU7Vg90H21EOLACvtfcHk0lirdykM-xYRgw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXis1ygt7k%253D&md5=d5ce0f203ea2c68a2cdd40e1315a7797</span></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.1016%2Fj.cell.2016.11.037&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.cell.2016.11.037%26sid%3Dliteratum%253Aachs%26aulast%3DLambert%26aufirst%3DA.%2BW.%26aulast%3DPattabiraman%26aufirst%3DD.%2BR.%26aulast%3DWeinberg%26aufirst%3DR.%2BA.%26atitle%3DEmerging%2520Biological%2520Principles%2520of%2520Metastasis%26jtitle%3DCell%26date%3D2017%26volume%3D168%26spage%3D670%26epage%3D691%26doi%3D10.1016%2Fj.cell.2016.11.037" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref2"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref2'); return false;" data-citation="" class="refNumLink">2</a></strong><div class="NLM_citation" id="cit2"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Valastyan, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Weinberg, R. A.</span></span> <span> </span><span class="NLM_article-title">Tumor metastasis: molecular insights and evolving paradigms</span>. <i>Cell</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>147</i></span>,  <span class="NLM_fpage">275</span>– <span class="NLM_lpage">292</span>, <span class="refDoi"> DOI: 10.1016/j.cell.2011.09.024</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01313&amp;key=10.1016%2Fj.cell.2011.09.024" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01313&amp;key=22000009" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01313&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhtlaksb3N" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=147&publication_year=2011&pages=275-292&author=S.+Valastyanauthor=R.+A.+Weinberg&title=Tumor+metastasis%3A+molecular+insights+and+evolving+paradigms&doi=10.1016%2Fj.cell.2011.09.024"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit2R"><div class="casContent"><span class="casTitleNuber">2</span><div class="casTitle"><span class="NLM_cas:atitle">Tumor Metastasis: Molecular Insights and Evolving Paradigms</span></div><div class="casAuthors">Valastyan, Scott; Weinberg, Robert A.</div><div class="citationInfo"><span class="NLM_cas:title">Cell (Cambridge, MA, United States)</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">147</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">275-292</span>CODEN:
                <span class="NLM_cas:coden">CELLB5</span>;
        ISSN:<span class="NLM_cas:issn">0092-8674</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">A review.  Metastases represent the end products of a multistep cell-biol. process termed the invasion-metastasis cascade, which involves dissemination of cancer cells to anatomically distant organ sites and their subsequent adaptation to foreign tissue microenvironments.  Each of these events is driven by the acquisition of genetic and/or epigenetic alterations within tumor cells and the co-option of nonneoplastic stromal cells, which together endow incipient metastatic cells with traits needed to generate macroscopic metastases.  Recent advances provide provocative insights into these cell-biol. and mol. changes, which have implications regarding the steps of the invasion-metastasis cascade that appear amenable to therapeutic targeting.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpVqOPVKwPqtbVg90H21EOLACvtfcHk0lhOkOIQ9JFR1w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhtlaksb3N&md5=fa62d15c6b61bf90cfcdc1d51bbe98b9</span></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.1016%2Fj.cell.2011.09.024&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.cell.2011.09.024%26sid%3Dliteratum%253Aachs%26aulast%3DValastyan%26aufirst%3DS.%26aulast%3DWeinberg%26aufirst%3DR.%2BA.%26atitle%3DTumor%2520metastasis%253A%2520molecular%2520insights%2520and%2520evolving%2520paradigms%26jtitle%3DCell%26date%3D2011%26volume%3D147%26spage%3D275%26epage%3D292%26doi%3D10.1016%2Fj.cell.2011.09.024" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref3"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref3'); return false;" data-citation="" class="refNumLink">3</a></strong><div class="NLM_citation" id="cit3"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wan, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pantel, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kang, Y.</span></span> <span> </span><span class="NLM_article-title">Tumor metastasis: moving new biological insights into the clinic</span>. <i>Nat. Med.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>19</i></span>,  <span class="NLM_fpage">1450</span>– <span class="NLM_lpage">1464</span>, <span class="refDoi"> DOI: 10.1038/nm.3391</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01313&amp;key=10.1038%2Fnm.3391" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01313&amp;key=24202397" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01313&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhslCnt7zK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2013&pages=1450-1464&author=L.+Wanauthor=K.+Pantelauthor=Y.+Kang&title=Tumor+metastasis%3A+moving+new+biological+insights+into+the+clinic&doi=10.1038%2Fnm.3391"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit3R"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">Tumor metastasis: moving new biological insights into the clinic</span></div><div class="casAuthors">Wan, Liling; Pantel, Klaus; Kang, Yibin</div><div class="citationInfo"><span class="NLM_cas:title">Nature Medicine (New York, NY, United States)</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">19</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">1450-1464</span>CODEN:
                <span class="NLM_cas:coden">NAMEFI</span>;
        ISSN:<span class="NLM_cas:issn">1078-8956</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  As the culprit behind most cancer-related deaths, metastasis is the ultimate challenge in our effort to fight cancer as a life-threatening disease.  The explosive growth of metastasis research in the past decade has yielded an unprecedented wealth of information about the tumor-intrinsic and tumor-extrinsic mechanisms that dictate metastatic behaviors, the mol. and cellular basis underlying the distinct courses of metastatic progression in different cancers and what renders metastatic cancer refractory to available therapies.  However, integration of such new knowledge into an improved, metastasis-oriented oncol. drug development strategy is needed to thwart the development of metastatic disease at every stage of progression.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrthBY_OR1IkrVg90H21EOLACvtfcHk0lhOkOIQ9JFR1w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhslCnt7zK&md5=4f499d29cd42a0073c98167d9573aa71</span></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1038%2Fnm.3391&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnm.3391%26sid%3Dliteratum%253Aachs%26aulast%3DWan%26aufirst%3DL.%26aulast%3DPantel%26aufirst%3DK.%26aulast%3DKang%26aufirst%3DY.%26atitle%3DTumor%2520metastasis%253A%2520moving%2520new%2520biological%2520insights%2520into%2520the%2520clinic%26jtitle%3DNat.%2520Med.%26date%3D2013%26volume%3D19%26spage%3D1450%26epage%3D1464%26doi%3D10.1038%2Fnm.3391" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref4"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref4'); return false;" data-citation="" class="refNumLink">4</a></strong><div class="NLM_citation" id="cit4"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Guan, X.</span></span> <span> </span><span class="NLM_article-title">Cancer metastases: challenges and opportunities</span>. <i>Acta Pharm. Sin. B</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>5</i></span>,  <span class="NLM_fpage">402</span>– <span class="NLM_lpage">418</span>, <span class="refDoi"> DOI: 10.1016/j.apsb.2015.07.005</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01313&amp;key=10.1016%2Fj.apsb.2015.07.005" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01313&amp;key=26579471" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01313&amp;key=1%3ACAS%3A280%3ADC%252BC28rgtlOqsA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2015&pages=402-418&author=X.+Guan&title=Cancer+metastases%3A+challenges+and+opportunities&doi=10.1016%2Fj.apsb.2015.07.005"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit4R"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">Cancer metastases: challenges and opportunities</span></div><div class="casAuthors">Guan Xiangming</div><div class="citationInfo"><span class="NLM_cas:title">Acta pharmaceutica Sinica. B</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">402-18</span>
        ISSN:<span class="NLM_cas:issn">2211-3835</span>.
    </div><div class="casAbstract">Cancer metastasis is the major cause of cancer morbidity and mortality, and accounts for about 90% of cancer deaths.  Although cancer survival rate has been significantly improved over the years, the improvement is primarily due to early diagnosis and cancer growth inhibition.  Limited progress has been made in the treatment of cancer metastasis due to various factors.  Current treatments for cancer metastasis are mainly chemotherapy and radiotherapy, though the new generation anti-cancer drugs (predominantly neutralizing antibodies for growth factors and small molecule kinase inhibitors) do have the effects on cancer metastasis in addition to their effects on cancer growth.  Cancer metastasis begins with detachment of metastatic cells from the primary tumor, travel of the cells to different sites through blood/lymphatic vessels, settlement and growth of the cells at a distal site.  During the process, metastatic cells go through detachment, migration, invasion and adhesion.  These four essential, metastatic steps are inter-related and affected by multi-biochemical events and parameters.  Additionally, it is known that tumor microenvironment (such as extracellular matrix structure, growth factors, chemokines, matrix metalloproteinases) plays a significant role in cancer metastasis.  The biochemical events and parameters involved in the metastatic process and tumor microenvironment have been targeted or can be potential targets for metastasis prevention and inhibition.  This review provides an overview of these metastasis essential steps, related biochemical factors, and targets for intervention.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQ-qtzzXrDFl7xanA7vODO6fW6udTcc2eY0tnnVPkkibLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC28rgtlOqsA%253D%253D&md5=6c05f3977aa66da117e7373a7b77d387</span></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1016%2Fj.apsb.2015.07.005&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.apsb.2015.07.005%26sid%3Dliteratum%253Aachs%26aulast%3DGuan%26aufirst%3DX.%26atitle%3DCancer%2520metastases%253A%2520challenges%2520and%2520opportunities%26jtitle%3DActa%2520Pharm.%2520Sin.%2520B%26date%3D2015%26volume%3D5%26spage%3D402%26epage%3D418%26doi%3D10.1016%2Fj.apsb.2015.07.005" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref5"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref5'); return false;" data-citation="" class="refNumLink">5</a></strong><div class="NLM_citation" id="cit5"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wells, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Grahovac, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wheeler, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ma, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lauffenburger, D.</span></span> <span> </span><span class="NLM_article-title">Targeting tumor cell motility as a strategy against invasion and metastasis</span>. <i>Trends Pharmacol. Sci.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>34</i></span>,  <span class="NLM_fpage">283</span>– <span class="NLM_lpage">289</span>, <span class="refDoi"> DOI: 10.1016/j.tips.2013.03.001</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01313&amp;key=10.1016%2Fj.tips.2013.03.001" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01313&amp;key=23571046" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01313&amp;key=1%3ACAS%3A528%3ADC%252BC3sXlsFaqtLs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=34&publication_year=2013&pages=283-289&author=A.+Wellsauthor=J.+Grahovacauthor=S.+Wheelerauthor=B.+Maauthor=D.+Lauffenburger&title=Targeting+tumor+cell+motility+as+a+strategy+against+invasion+and+metastasis&doi=10.1016%2Fj.tips.2013.03.001"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit5R"><div class="casContent"><span class="casTitleNuber">5</span><div class="casTitle"><span class="NLM_cas:atitle">Targeting tumor cell motility as a strategy against invasion and metastasis</span></div><div class="casAuthors">Wells, Alan; Grahovac, Jelena; Wheeler, Sarah; Ma, Bo; Lauffenburger, Douglas</div><div class="citationInfo"><span class="NLM_cas:title">Trends in Pharmacological Sciences</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">34</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">283-289</span>CODEN:
                <span class="NLM_cas:coden">TPHSDY</span>;
        ISSN:<span class="NLM_cas:issn">0165-6147</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">A review.  Advances in diagnosis and treatment have rendered most solid tumors largely curable if they are diagnosed and treated before dissemination.  However, once they spread beyond the initial primary location, these cancers are usually highly morbid, if not fatal.  Thus, current efforts focus on both limiting initial dissemination and preventing secondary spread.  There are two modes of tumor dissemination - invasion and metastasis - each leading to unique therapeutic challenges and likely to be driven by distinct mechanisms.  However, these two forms of dissemination utilize some common strategies to accomplish movement from the primary tumor, establishment in an ectopic site, and survival therein.  The adaptive behaviors of motile cancer cells provide an opening for therapeutic approaches if we understand the mol., cellular, and tissue biol. that underlie them.  Herein, we review the signaling cascades and organ reactions that lead to dissemination, as these are non-genetic in nature, focusing on cell migration as the key to tumor progression.  In this context, the cellular phenotype will also be discussed because the modes of migration are dictated by quant. and phys. aspects of the cell motility machinery.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrcnAq4y4QiJLVg90H21EOLACvtfcHk0lhsPNTKZ4ufZA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXlsFaqtLs%253D&md5=a1434ebf9aa11f61f789ff8e9a3b52ef</span></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1016%2Fj.tips.2013.03.001&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.tips.2013.03.001%26sid%3Dliteratum%253Aachs%26aulast%3DWells%26aufirst%3DA.%26aulast%3DGrahovac%26aufirst%3DJ.%26aulast%3DWheeler%26aufirst%3DS.%26aulast%3DMa%26aufirst%3DB.%26aulast%3DLauffenburger%26aufirst%3DD.%26atitle%3DTargeting%2520tumor%2520cell%2520motility%2520as%2520a%2520strategy%2520against%2520invasion%2520and%2520metastasis%26jtitle%3DTrends%2520Pharmacol.%2520Sci.%26date%3D2013%26volume%3D34%26spage%3D283%26epage%3D289%26doi%3D10.1016%2Fj.tips.2013.03.001" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref6"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref6'); return false;" data-citation="" class="refNumLink">6</a></strong><div class="NLM_citation" id="cit6"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sun, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ma, L.</span></span> <span> </span><span class="NLM_article-title">The emerging molecular machinery and therapeutic targets of metastasis</span>. <i>Trends Pharmacol. Sci.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>36</i></span>,  <span class="NLM_fpage">349</span>– <span class="NLM_lpage">359</span>, <span class="refDoi"> DOI: 10.1016/j.tips.2015.04.001</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01313&amp;key=10.1016%2Fj.tips.2015.04.001" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01313&amp;key=25939811" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01313&amp;key=1%3ACAS%3A528%3ADC%252BC2MXmvFaksLk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=36&publication_year=2015&pages=349-359&author=Y.+Sunauthor=L.+Ma&title=The+emerging+molecular+machinery+and+therapeutic+targets+of+metastasis&doi=10.1016%2Fj.tips.2015.04.001"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">The emerging molecular machinery and therapeutic targets of metastasis</span></div><div class="casAuthors">Sun, Yutong; Ma, Li</div><div class="citationInfo"><span class="NLM_cas:title">Trends in Pharmacological Sciences</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">36</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">349-359</span>CODEN:
                <span class="NLM_cas:coden">TPHSDY</span>;
        ISSN:<span class="NLM_cas:issn">0165-6147</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">Metastasis is a 100-yr-old research topic.  Technol. advances during the past few decades have led to significant progress in our understanding of metastatic disease.  However, metastasis remains the leading cause of cancer-related mortalities.  The lack of appropriate clin. trials for metastasis preventive drugs and incomplete understanding of the mol. machinery are major obstacles in metastasis prevention and treatment.  Numerous processes, factors, and signaling pathways are involved in regulating metastasis.  Here we discuss recent progress in metastasis research, including epithelial-mesenchymal plasticity, cancer stem cells, emerging mol. determinants and therapeutic targets, and the link between metastasis and therapy resistance.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrWbKMG8jaR0bVg90H21EOLACvtfcHk0lhsPNTKZ4ufZA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXmvFaksLk%253D&md5=377ab410c450229134b7ec06755bb5ca</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1016%2Fj.tips.2015.04.001&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.tips.2015.04.001%26sid%3Dliteratum%253Aachs%26aulast%3DSun%26aufirst%3DY.%26aulast%3DMa%26aufirst%3DL.%26atitle%3DThe%2520emerging%2520molecular%2520machinery%2520and%2520therapeutic%2520targets%2520of%2520metastasis%26jtitle%3DTrends%2520Pharmacol.%2520Sci.%26date%3D2015%26volume%3D36%26spage%3D349%26epage%3D359%26doi%3D10.1016%2Fj.tips.2015.04.001" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref7"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref7'); return false;" data-citation="" class="refNumLink">7</a></strong><div class="NLM_citation" id="cit7"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bruick, R. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McKnight, S. L.</span></span> <span> </span><span class="NLM_article-title">A conserved family of prolyl-4-hydroxylases that modify HIF</span>. <i>Science</i> <span class="NLM_year" style="font-weight: bold;">2001</span>,  <span class="NLM_volume"><i>294</i></span>,  <span class="NLM_fpage">1337</span>– <span class="NLM_lpage">1340</span>, <span class="refDoi"> DOI: 10.1126/science.1066373</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01313&amp;key=10.1126%2Fscience.1066373" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01313&amp;key=11598268" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01313&amp;key=1%3ACAS%3A528%3ADC%252BD3MXotlKmtbo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=294&publication_year=2001&pages=1337-1340&author=R.+K.+Bruickauthor=S.+L.+McKnight&title=A+conserved+family+of+prolyl-4-hydroxylases+that+modify+HIF&doi=10.1126%2Fscience.1066373"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit7R"><div class="casContent"><span class="casTitleNuber">7</span><div class="casTitle"><span class="NLM_cas:atitle">A conserved family of prolyl-4-hydroxylases that modify HIF</span></div><div class="casAuthors">Bruick, Richard K.; McKnight, Steven L.</div><div class="citationInfo"><span class="NLM_cas:title">Science (Washington, DC, United States)</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">294</span>
        (<span class="NLM_cas:issue">5545</span>),
    <span class="NLM_cas:pages">1337-1340</span>CODEN:
                <span class="NLM_cas:coden">SCIEAS</span>;
        ISSN:<span class="NLM_cas:issn">0036-8075</span>.
    
            (<span class="NLM_cas:orgname">American Association for the Advancement of Science</span>)
        </div><div class="casAbstract">Mammalian cells respond to changes in oxygen availability through a conserved pathway that is regulated by the hypoxia-inducible factor (HIF).  The alpha subunit of HIF is targeted for degrdn. under normoxic conditions by a ubiquitin-ligase complex that recognizes a hydroxylated proline residue in HIF.  The authors identified a conserved family of HIF prolyl hydroxylase (HPH) enzymes that appear to be responsible for this posttranslational modification.  In cultured mammalian cells, inappropriate accumulation of HIF caused by forced expression of the HIF-1α subunit under normoxic conditions was attenuated by coexpression of HPH.  Suppression of HPH in cultured Drosophila melanogaster cells by RNA interference resulted in elevated expression of a hypoxia-inducible gene (LDH, encoding lactate dehydrogenase) under normoxic conditions.  These findings indicate that HPH is an essential component of the pathway through which cells sense oxygen.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpH62syyo7QG7Vg90H21EOLACvtfcHk0lj6QqlPH1R3vw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXotlKmtbo%253D&md5=e17b5094d300fc6e292cd063d5633502</span></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1126%2Fscience.1066373&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscience.1066373%26sid%3Dliteratum%253Aachs%26aulast%3DBruick%26aufirst%3DR.%2BK.%26aulast%3DMcKnight%26aufirst%3DS.%2BL.%26atitle%3DA%2520conserved%2520family%2520of%2520prolyl-4-hydroxylases%2520that%2520modify%2520HIF%26jtitle%3DScience%26date%3D2001%26volume%3D294%26spage%3D1337%26epage%3D1340%26doi%3D10.1126%2Fscience.1066373" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref8"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref8'); return false;" data-citation="" class="refNumLink">8</a></strong><div class="NLM_citation" id="cit8"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kamura, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sato, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Iwai, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Czyzyk-Krzeska, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Conaway, R. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Conaway, J. W.</span></span> <span> </span><span class="NLM_article-title">Activation of HIF1alpha ubiquitination by a reconstituted von Hippel-Lindau (VHL) tumor suppressor complex</span>. <i>Proc. Natl. Acad. Sci. U.S.A.</i> <span class="NLM_year" style="font-weight: bold;">2000</span>,  <span class="NLM_volume"><i>97</i></span>,  <span class="NLM_fpage">10430</span>– <span class="NLM_lpage">10435</span>, <span class="refDoi"> DOI: 10.1073/pnas.190332597</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01313&amp;key=10.1073%2Fpnas.190332597" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01313&amp;key=10973499" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01313&amp;key=1%3ACAS%3A528%3ADC%252BD3cXms1Crsb4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=97&publication_year=2000&pages=10430-10435&author=T.+Kamuraauthor=S.+Satoauthor=K.+Iwaiauthor=M.+Czyzyk-Krzeskaauthor=R.+C.+Conawayauthor=J.+W.+Conaway&title=Activation+of+HIF1alpha+ubiquitination+by+a+reconstituted+von+Hippel-Lindau+%28VHL%29+tumor+suppressor+complex&doi=10.1073%2Fpnas.190332597"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit8R"><div class="casContent"><span class="casTitleNuber">8</span><div class="casTitle"><span class="NLM_cas:atitle">Activation of HIF1α ubiquitination by a reconstituted von Hippel-Lindau (VHL) tumor suppressor complex</span></div><div class="casAuthors">Kamura, Takumi; Sato, Shigeo; Iwai, Kazuhiro; Czyzyk-Krzeska, Maria; Conaway, Ronald C.; Conaway, Joan Weliky</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">97</span>
        (<span class="NLM_cas:issue">19</span>),
    <span class="NLM_cas:pages">10430-10435</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">Mutations in the VHL tumor suppressor gene result in constitutive expression of many hypoxia-inducible genes, at least in part because of increases in the cellular level of hypoxia-inducible transcription factor HIF1α, which in normal cells is rapidly ubiquitinated and degraded by the proteasome under normoxic conditions.  The recent observation that the VHL protein is a subunit of an Skp1-Cul1/Cdc53-F-box (SCF)-like E3 ubiquitin ligase raised the possibility that VHL may be directly responsible for regulating cellular levels of HIF1α by targeting it for ubiquitination and proteolysis.  In this report, we test this hypothesis directly.  We report development of methods for prodn. of the purified recombinant VHL complex and present direct biochem. evidence that it can function with an E1 ubiquitin-activating enzyme and E2 ubiquitin-conjugating enzyme to activate HIF1α ubiquitination in vitro.  Our findings provide new insight into the function of the VHL tumor suppressor protein, and they provide a foundation for future investigations of the mechanisms underlying VHL regulation of oxygen-dependent gene expression.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpjwQDn-YYjRLVg90H21EOLACvtfcHk0lj6QqlPH1R3vw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXms1Crsb4%253D&md5=5ba458b01d352b6350e61c2dbdc074ca</span></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1073%2Fpnas.190332597&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.190332597%26sid%3Dliteratum%253Aachs%26aulast%3DKamura%26aufirst%3DT.%26aulast%3DSato%26aufirst%3DS.%26aulast%3DIwai%26aufirst%3DK.%26aulast%3DCzyzyk-Krzeska%26aufirst%3DM.%26aulast%3DConaway%26aufirst%3DR.%2BC.%26aulast%3DConaway%26aufirst%3DJ.%2BW.%26atitle%3DActivation%2520of%2520HIF1alpha%2520ubiquitination%2520by%2520a%2520reconstituted%2520von%2520Hippel-Lindau%2520%2528VHL%2529%2520tumor%2520suppressor%2520complex%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.S.A.%26date%3D2000%26volume%3D97%26spage%3D10430%26epage%3D10435%26doi%3D10.1073%2Fpnas.190332597" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref9"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref9'); return false;" data-citation="" class="refNumLink">9</a></strong><div class="NLM_citation" id="cit9"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Semenza, G. L.</span></span> <span> </span><span class="NLM_article-title">Defining the role of hypoxia-inducible factor 1 in cancer biology and therapeutics</span>. <i>Oncogene</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>29</i></span>,  <span class="NLM_fpage">625</span>– <span class="NLM_lpage">634</span>, <span class="refDoi"> DOI: 10.1038/onc.2009.441</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01313&amp;key=10.1038%2Fonc.2009.441" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01313&amp;key=19946328" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01313&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhsV2gt77N" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=29&publication_year=2010&pages=625-634&author=G.+L.+Semenza&title=Defining+the+role+of+hypoxia-inducible+factor+1+in+cancer+biology+and+therapeutics&doi=10.1038%2Fonc.2009.441"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit9R"><div class="casContent"><span class="casTitleNuber">9</span><div class="casTitle"><span class="NLM_cas:atitle">Defining the role of hypoxia-inducible factor 1 in cancer biology and therapeutics</span></div><div class="casAuthors">Semenza, G. L.</div><div class="citationInfo"><span class="NLM_cas:title">Oncogene</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">29</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">625-634</span>CODEN:
                <span class="NLM_cas:coden">ONCNES</span>;
        ISSN:<span class="NLM_cas:issn">0950-9232</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Adaptation of cancer cells to their microenvironment is an important driving force in the clonal selection that leads to invasive and metastatic disease.  O2 concns. are markedly reduced in many human cancers compared with normal tissue, and a major mechanism mediating adaptive responses to reduced O2 availability (hypoxia) is the regulation of transcription by hypoxia-inducible factor 1 (HIF-1).  This review summarizes the current state of knowledge regarding the mol. mechanisms by which HIF-1 contributes to cancer progression, focusing on (1) clin. data assocg. increased HIF-1 levels with patient mortality; (2) preclin. data linking HIF-1 activity with tumor growth; (3) mol. data linking specific HIF-1 target gene products to crit. aspects of cancer biol. and (4) pharmacol. data showing anticancer effects of HIF-1 inhibitors in mouse models of human cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqlXOi-2tydiLVg90H21EOLACvtfcHk0lj6QqlPH1R3vw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhsV2gt77N&md5=fb8c32b5f05bfad38f4a4ecef9bd98a7</span></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1038%2Fonc.2009.441&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fonc.2009.441%26sid%3Dliteratum%253Aachs%26aulast%3DSemenza%26aufirst%3DG.%2BL.%26atitle%3DDefining%2520the%2520role%2520of%2520hypoxia-inducible%2520factor%25201%2520in%2520cancer%2520biology%2520and%2520therapeutics%26jtitle%3DOncogene%26date%3D2010%26volume%3D29%26spage%3D625%26epage%3D634%26doi%3D10.1038%2Fonc.2009.441" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref10"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref10'); return false;" data-citation="" class="refNumLink">10</a></strong><div class="NLM_citation" id="cit10"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Koyasu, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kobayashi, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Goto, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hiraoka, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Harada, H.</span></span> <span> </span><span class="NLM_article-title">Regulatory mechanisms of hypoxia-inducible factor 1 activity: Two decades of knowledge</span>. <i>Cancer Sci.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>109</i></span>,  <span class="NLM_fpage">560</span>– <span class="NLM_lpage">571</span>, <span class="refDoi"> DOI: 10.1111/cas.13483</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01313&amp;key=10.1111%2Fcas.13483" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01313&amp;key=29285833" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01313&amp;key=1%3ACAS%3A528%3ADC%252BC1cXhvVeqtrg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=109&publication_year=2018&pages=560-571&author=S.+Koyasuauthor=M.+Kobayashiauthor=Y.+Gotoauthor=M.+Hiraokaauthor=H.+Harada&title=Regulatory+mechanisms+of+hypoxia-inducible+factor+1+activity%3A+Two+decades+of+knowledge&doi=10.1111%2Fcas.13483"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit10R"><div class="casContent"><span class="casTitleNuber">10</span><div class="casTitle"><span class="NLM_cas:atitle">Regulatory mechanisms of hypoxia-inducible factor 1 activity: Two decades of knowledge</span></div><div class="casAuthors">Koyasu, Sho; Kobayashi, Minoru; Goto, Yoko; Hiraoka, Masahiro; Harada, Hiroshi</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Science</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">109</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">560-571</span>CODEN:
                <span class="NLM_cas:coden">CSACCM</span>;
        ISSN:<span class="NLM_cas:issn">1349-7006</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">Hypoxia-inducible factor 1 (HIF-1) is a transcriptional activator of various genes related to cellular adaptive responses to hypoxia.  Dysfunctions in the regulatory systems of HIF-1 activity have been implicated in the pathogenesis of various diseases including malignant tumors and, thus, elucidating the mol. mechanisms underlying the activation of HIF-1 is eagerly desired for the development of novel anti-cancer strategies.  The importance of oxygen-dependent and ubiquitin-mediated proteolysis of the regulatory subunit of HIF-1 (HIF-1α) was first reported in 1997.  Since then, accumulating evidence has shown that HIF-1α may become stable and active even under normoxic conditions; for example, when disease-assocd. genetic and functional alterations in some genes trigger the aberrant activation of HIF-1 regardless of oxygen conditions.  We herein review the last two decades of knowledge, since 1997, on the regulatory mechanisms of HIF-1 activity from conventional oxygen- and proteolysis-dependent mechanisms to up-to-the-minute information on cancer-assocd. genetic and functional alteration-mediated mechanisms.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoszvKl39u117Vg90H21EOLACvtfcHk0liIKr-AVQi9dw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXhvVeqtrg%253D&md5=b5238f0c3e7d77d4871f149190a32d14</span></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1111%2Fcas.13483&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fcas.13483%26sid%3Dliteratum%253Aachs%26aulast%3DKoyasu%26aufirst%3DS.%26aulast%3DKobayashi%26aufirst%3DM.%26aulast%3DGoto%26aufirst%3DY.%26aulast%3DHiraoka%26aufirst%3DM.%26aulast%3DHarada%26aufirst%3DH.%26atitle%3DRegulatory%2520mechanisms%2520of%2520hypoxia-inducible%2520factor%25201%2520activity%253A%2520Two%2520decades%2520of%2520knowledge%26jtitle%3DCancer%2520Sci.%26date%3D2018%26volume%3D109%26spage%3D560%26epage%3D571%26doi%3D10.1111%2Fcas.13483" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref11"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref11'); return false;" data-citation="" class="refNumLink">11</a></strong><div class="NLM_citation" id="cit11"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Forsythe, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jiang, B. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Iyer, N. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Agani, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leung, S. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Koos, R. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Semenza, G. L.</span></span> <span> </span><span class="NLM_article-title">Activation of vascular endothelial growth factor gene transcription by hypoxia-inducible factor 1</span>. <i>Mol. Cell. Biol.</i> <span class="NLM_year" style="font-weight: bold;">1996</span>,  <span class="NLM_volume"><i>16</i></span>,  <span class="NLM_fpage">4604</span>– <span class="NLM_lpage">4613</span>, <span class="refDoi"> DOI: 10.1128/mcb.16.9.4604</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01313&amp;key=10.1128%2Fmcb.16.9.4604" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01313&amp;key=8756616" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01313&amp;key=1%3ACAS%3A528%3ADyaK28XltFKjsrc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=1996&pages=4604-4613&author=J.+A.+Forsytheauthor=B.+H.+Jiangauthor=N.+V.+Iyerauthor=F.+Aganiauthor=S.+W.+Leungauthor=R.+D.+Koosauthor=G.+L.+Semenza&title=Activation+of+vascular+endothelial+growth+factor+gene+transcription+by+hypoxia-inducible+factor+1&doi=10.1128%2Fmcb.16.9.4604"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit11R"><div class="casContent"><span class="casTitleNuber">11</span><div class="casTitle"><span class="NLM_cas:atitle">Activation of vascular endothelial growth factor gene transcription by hypoxia-inducible factor 1</span></div><div class="casAuthors">Forsythe, Jo A.; Jiang, Bing-Hua; Iyer, Narayan V.; Agani, Faton; Leung, Sandra W.; Koos, Robert D.; Semenza, Gregg L.</div><div class="citationInfo"><span class="NLM_cas:title">Molecular and Cellular Biology</span>
        (<span class="NLM_cas:date">1996</span>),
    <span class="NLM_cas:volume">16</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">4604-4613</span>CODEN:
                <span class="NLM_cas:coden">MCEBD4</span>;
        ISSN:<span class="NLM_cas:issn">0270-7306</span>.
    
            (<span class="NLM_cas:orgname">American Society for Microbiology</span>)
        </div><div class="casAbstract">Expression of vascular endothelial growth factor (VEGF) is induced in cells exposed to hypoxia or ischemia.  Neovascularization stimulated by VEGF occurs in severals important clin. contexts, including myocardial ischemia, retinal disease, and tumor growth.  Hypoxia-inducible factor 1 (HIF-1) is a heterodimeric basic helix-loop-helix protein that activates transcription of the human erythropoietin gene in hypoxic cells.  Here we demonstrate the involvement of HIF-1 in the activation of VEGF transcription.  VEGF 5'-flanking sequences mediated transcriptional activation of reporter gene expression in hypoxic Hep3B cells.  A 47-bp sequence located 985 to 939 bp 5' to the VEGF transcription initiation site mediated hypoxia-inducible reporter gene expression directed by a simian virus 40 promoter element that was otherwise minimally responsive to hypoxia.  When reporters contg. VEGF sequences, in the context of the native VEGF or heterologous simian virus 40 promoter, were cotransfected with expression vectors encoding HIF-1α and HIF-1β (ARNT [aryl hydrocarbon receptor nuclear translocator]), reporter gene transcription was much greater in both hypoxic and nonhypoxic cells than in cells transfected with the reporter alone.  A HIF-1 binding site was demonstrated in the 47-bp hypoxia response element, and a 3-bp substitution eliminated the ability of the element to bind HIF-1 and to activate transcription in response to hypoxia and/or recombinant HIF-1.  Cotransfection of cells with an expression vector encoding a dominant neg. form of HIF-1α inhibited the activation of reporter transcription in hypoxic cells in a dose-dependent manner.  VEGF mRNA was not induced by hypoxia in mutant cells that do not express the HIF-1β (ARNT) subunit.  These findings implicate HIF-1 in the activation of VEGF transcription in hypoxic cells.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoWR5k0flrm27Vg90H21EOLACvtfcHk0liIKr-AVQi9dw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK28XltFKjsrc%253D&md5=d699f194fc5edae7b2b6a5ce97359808</span></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1128%2Fmcb.16.9.4604&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252Fmcb.16.9.4604%26sid%3Dliteratum%253Aachs%26aulast%3DForsythe%26aufirst%3DJ.%2BA.%26aulast%3DJiang%26aufirst%3DB.%2BH.%26aulast%3DIyer%26aufirst%3DN.%2BV.%26aulast%3DAgani%26aufirst%3DF.%26aulast%3DLeung%26aufirst%3DS.%2BW.%26aulast%3DKoos%26aufirst%3DR.%2BD.%26aulast%3DSemenza%26aufirst%3DG.%2BL.%26atitle%3DActivation%2520of%2520vascular%2520endothelial%2520growth%2520factor%2520gene%2520transcription%2520by%2520hypoxia-inducible%2520factor%25201%26jtitle%3DMol.%2520Cell.%2520Biol.%26date%3D1996%26volume%3D16%26spage%3D4604%26epage%3D4613%26doi%3D10.1128%2Fmcb.16.9.4604" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref12"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref12'); return false;" data-citation="" class="refNumLink">12</a></strong><div class="NLM_citation" id="cit12"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Gilkes, D. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Semenza, G. L.</span></span> <span> </span><span class="NLM_article-title">Role of hypoxia-inducible factors in breast cancer metastasis</span>. <i>Future Oncol.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>9</i></span>,  <span class="NLM_fpage">1623</span>– <span class="NLM_lpage">1636</span>, <span class="refDoi"> DOI: 10.2217/fon.13.92</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01313&amp;key=10.2217%2Ffon.13.92" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01313&amp;key=24156323" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01313&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhs1KktbbJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2013&pages=1623-1636&author=D.+M.+Gilkesauthor=G.+L.+Semenza&title=Role+of+hypoxia-inducible+factors+in+breast+cancer+metastasis&doi=10.2217%2Ffon.13.92"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit12R"><div class="casContent"><span class="casTitleNuber">12</span><div class="casTitle"><span class="NLM_cas:atitle">Role of hypoxia-inducible factors in breast cancer metastasis</span></div><div class="casAuthors">Gilkes, Daniele M.; Semenza, Gregg L.</div><div class="citationInfo"><span class="NLM_cas:title">Future Oncology</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">1623-1636</span>CODEN:
                <span class="NLM_cas:coden">FOUNBN</span>;
        ISSN:<span class="NLM_cas:issn">1479-6694</span>.
    
            (<span class="NLM_cas:orgname">Future Medicine Ltd.</span>)
        </div><div class="casAbstract">A review.  Human breast tumors contain regions of hypoxia in which cells that are located far from a functional blood vessel have significantly reduced oxygen concns. when compared with normal mammary tissue.  Breast cancer cells adapt to hypoxic conditions by increasing levels of hypoxia-inducible factors (HIFs), which induce the expression of multiple genes involved in angiogenesis, glucose utilization, resistance to oxidative stress, cell proliferation, resistance to apoptosis, invasion and metastasis.  Breast cancer patients with increased HIF expression levels in primary tumor biopsies are at increased risk of metastasis.  This is an important finding since 90% of breast cancer deaths are the result of metastasis, primarily to the bone, lungs, liver, brain and regional lymph nodes.  Although the prognostic significance of reduced oxygen levels in primary breast tumors of cancer patients is well recognized, the mechanisms underlying hypoxia-induced, HIF-dependent breast cancer metastasis are just beginning to be uncovered.  Recent studies have implicated HIF target genes in every step of the metastatic process.  Drugs, such as digoxin, show the potential therapeutic effects of blocking HIF activity by decreasing primary tumor growth, vascularization, invasion and metastasis in animal models of breast cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqxOSas0fwKJ7Vg90H21EOLACvtfcHk0limr3bg0pe65w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhs1KktbbJ&md5=b08f55cb982519907625e23b5f40872b</span></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.2217%2Ffon.13.92&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2217%252Ffon.13.92%26sid%3Dliteratum%253Aachs%26aulast%3DGilkes%26aufirst%3DD.%2BM.%26aulast%3DSemenza%26aufirst%3DG.%2BL.%26atitle%3DRole%2520of%2520hypoxia-inducible%2520factors%2520in%2520breast%2520cancer%2520metastasis%26jtitle%3DFuture%2520Oncol.%26date%3D2013%26volume%3D9%26spage%3D1623%26epage%3D1636%26doi%3D10.2217%2Ffon.13.92" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref13"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref13'); return false;" data-citation="" class="refNumLink">13</a></strong><div class="NLM_citation" id="cit13"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fan, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, J.</span></span> <span> </span><span class="NLM_article-title">Expression and clinical significance of hypoxia-inducible factor 1alpha, Snail and E-cadherin in human ovarian cancer cell lines</span>. <i>Mol. Med. Rep.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>12</i></span>,  <span class="NLM_fpage">3393</span>– <span class="NLM_lpage">3399</span>, <span class="refDoi"> DOI: 10.3892/mmr.2015.3786</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01313&amp;key=10.3892%2Fmmr.2015.3786" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01313&amp;key=25975373" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01313&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhs1ems73P" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2015&pages=3393-3399&author=Y.+Zhangauthor=N.+Fanauthor=J.+Yang&title=Expression+and+clinical+significance+of+hypoxia-inducible+factor+1alpha%2C+Snail+and+E-cadherin+in+human+ovarian+cancer+cell+lines&doi=10.3892%2Fmmr.2015.3786"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit13R"><div class="casContent"><span class="casTitleNuber">13</span><div class="casTitle"><span class="NLM_cas:atitle">Expression and clinical significance of hypoxia-inducible factor 1α, Snail and E-cadherin in human ovarian cancer cell lines</span></div><div class="casAuthors">Zhang, Yan; Fan, Nina; Yang, Jing</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Medicine Reports</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue">3, Pt. A</span>),
    <span class="NLM_cas:pages">3393-3399</span>CODEN:
                <span class="NLM_cas:coden">MMROA5</span>;
        ISSN:<span class="NLM_cas:issn">1791-2997</span>.
    
            (<span class="NLM_cas:orgname">Spandidos Publications Ltd.</span>)
        </div><div class="casAbstract">The aim of the present study was to investigate the expression and clin. significance of hypoxia-inducible factor 1α (HIF-1α), Snail and E-cadherin in ovarian cancer.  The expression levels were assessed in a no. of ovarian cancer cell lines and ovarian cancer tissues, and correlations between the expression of the three proteins and clin. pathol. factors were analyzed.  Transwell assays showed that the invasive ability of the ovarian cancer cell lines SKOV3 and ES-2 were significantly higher than those of TYK and 3AO (P<0.01).  Furthermore, the expression levels of HIF-1α and Snail in SKOV3 and ES-2 were significantly higher than those in TYK and 3AO, whereas the expression levels of E-cadherin in SKOV3 and ES-2 were significantly lower than those in TYK and 3AO (P<0.05).  In ovarian cancer tissues, the expression levels of HIF-1α, Snail and E-cadherin were correlated with clin. pathol. factors (P<0.01); furthermore, there was a pos. correlation between the expression levels of HIF-1α and Snail (r = 0.231; P = 0.021), and a neg. correlation between the expression levels of Snail and that of E-cadherin (r = -0.225; P = 0.028).  HIF-1α was suggested to be able to suppress the expression of E-cadherin by upregulating Snail, thus serving an important role in invasion and metastasis of ovarian cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpKFtewwPIX37Vg90H21EOLACvtfcHk0limr3bg0pe65w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhs1ems73P&md5=16cd4c5e54278f7f5bed67a3ce81ff3a</span></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.3892%2Fmmr.2015.3786&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3892%252Fmmr.2015.3786%26sid%3Dliteratum%253Aachs%26aulast%3DZhang%26aufirst%3DY.%26aulast%3DFan%26aufirst%3DN.%26aulast%3DYang%26aufirst%3DJ.%26atitle%3DExpression%2520and%2520clinical%2520significance%2520of%2520hypoxia-inducible%2520factor%25201alpha%252C%2520Snail%2520and%2520E-cadherin%2520in%2520human%2520ovarian%2520cancer%2520cell%2520lines%26jtitle%3DMol.%2520Med.%2520Rep.%26date%3D2015%26volume%3D12%26spage%3D3393%26epage%3D3399%26doi%3D10.3892%2Fmmr.2015.3786" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref14"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref14'); return false;" data-citation="" class="refNumLink">14</a></strong><div class="NLM_citation" id="cit14"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Yang, M.-H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, M.-Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chiou, S.-H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, P.-M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chang, S.-Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, C.-J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Teng, S.-C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, K.-J.</span></span> <span> </span><span class="NLM_article-title">Direct regulation of TWIST by HIF-1alpha promotes metastasis</span>. <i>Nat. Cell Biol.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>10</i></span>,  <span class="NLM_fpage">295</span>– <span class="NLM_lpage">305</span>, <span class="refDoi"> DOI: 10.1038/ncb1691</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01313&amp;key=10.1038%2Fncb1691" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01313&amp;key=18297062" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01313&amp;key=1%3ACAS%3A528%3ADC%252BD1cXislaksrc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2008&pages=295-305&author=M.-H.+Yangauthor=M.-Z.+Wuauthor=S.-H.+Chiouauthor=P.-M.+Chenauthor=S.-Y.+Changauthor=C.-J.+Liuauthor=S.-C.+Tengauthor=K.-J.+Wu&title=Direct+regulation+of+TWIST+by+HIF-1alpha+promotes+metastasis&doi=10.1038%2Fncb1691"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit14R"><div class="casContent"><span class="casTitleNuber">14</span><div class="casTitle"><span class="NLM_cas:atitle">Direct regulation of TWIST by HIF-1α promotes metastasis</span></div><div class="casAuthors">Yang, Muh-Hwa; Wu, Min-Zu; Chiou, Shih-Hwa; Chen, Po-Min; Chang, Shyue-Yih; Liu, Chung-Ji; Teng, Shu-Chun; Wu, Kou-Juey</div><div class="citationInfo"><span class="NLM_cas:title">Nature Cell Biology</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">295-305</span>CODEN:
                <span class="NLM_cas:coden">NCBIFN</span>;
        ISSN:<span class="NLM_cas:issn">1465-7392</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Stabilization of the hypoxia-inducible factor-1α (HIF-1α) transcription complex, caused by intratumoral hypoxia, promotes tumor progression and metastasis, leading to treatment failure and mortality in different types of human cancers.  The transcription factor TWIST is a master regulator of gastrulation and mesoderm-specification and was implicated recently as an essential mediator of cancer metastasis.  Notably, HIF-1α- and TWIST-null mice show similarities in their phenotypes.  Here, we have shown that hypoxia or overexpression of HIF-1α promotes epithelial-mesenchymal transition (EMT) and metastastic phenotypes.  We also found that HIF-1 regulates the expression of TWIST by binding directly to the hypoxia-response element (HRE) in the TWIST proximal promoter.  However, siRNA-mediated repression of TWIST in HIF-1α-overexpressing or hypoxic cells reversed EMT and metastastic phenotypes.  Co-expression of HIF-1α, TWIST and Snail in primary tumors of patients with head and neck cancers correlated with metastasis and the worst prognosis.  These results provide evidence of a key signaling pathway involving HIF-1α and TWIST that promotes metastasis in response to intratumoral hypoxia.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrXoQyicb8skrVg90H21EOLACvtfcHk0limr3bg0pe65w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXislaksrc%253D&md5=492e76f95a453888ebd82b14273873ea</span></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1038%2Fncb1691&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fncb1691%26sid%3Dliteratum%253Aachs%26aulast%3DYang%26aufirst%3DM.-H.%26aulast%3DWu%26aufirst%3DM.-Z.%26aulast%3DChiou%26aufirst%3DS.-H.%26aulast%3DChen%26aufirst%3DP.-M.%26aulast%3DChang%26aufirst%3DS.-Y.%26aulast%3DLiu%26aufirst%3DC.-J.%26aulast%3DTeng%26aufirst%3DS.-C.%26aulast%3DWu%26aufirst%3DK.-J.%26atitle%3DDirect%2520regulation%2520of%2520TWIST%2520by%2520HIF-1alpha%2520promotes%2520metastasis%26jtitle%3DNat.%2520Cell%2520Biol.%26date%3D2008%26volume%3D10%26spage%3D295%26epage%3D305%26doi%3D10.1038%2Fncb1691" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref15"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref15'); return false;" data-citation="" class="refNumLink">15</a></strong><div class="NLM_citation" id="cit15"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kilic, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kasperczyk, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fulda, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Debatin, K.-M.</span></span> <span> </span><span class="NLM_article-title">Role of hypoxia inducible factor-1 alpha in modulation of apoptosis resistance</span>. <i>Oncogene</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>26</i></span>,  <span class="NLM_fpage">2027</span>– <span class="NLM_lpage">2038</span>, <span class="refDoi"> DOI: 10.1038/sj.onc.1210008</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01313&amp;key=10.1038%2Fsj.onc.1210008" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01313&amp;key=17043658" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01313&amp;key=1%3ACAS%3A528%3ADC%252BD2sXjsFSiu70%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=26&publication_year=2007&pages=2027-2038&author=M.+Kilicauthor=H.+Kasperczykauthor=S.+Fuldaauthor=K.-M.+Debatin&title=Role+of+hypoxia+inducible+factor-1+alpha+in+modulation+of+apoptosis+resistance&doi=10.1038%2Fsj.onc.1210008"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit15R"><div class="casContent"><span class="casTitleNuber">15</span><div class="casTitle"><span class="NLM_cas:atitle">Role of hypoxia inducible factor-1 alpha in modulation of apoptosis resistance</span></div><div class="casAuthors">Kilic, M.; Kasperczyk, H.; Fulda, S.; Debatin, K.-M.</div><div class="citationInfo"><span class="NLM_cas:title">Oncogene</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">26</span>
        (<span class="NLM_cas:issue">14</span>),
    <span class="NLM_cas:pages">2027-2038</span>CODEN:
                <span class="NLM_cas:coden">ONCNES</span>;
        ISSN:<span class="NLM_cas:issn">0950-9232</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Hypoxia inducible factor-1 (HIF-1) is the major transcription factor and key regulator of adoptive responses to hypoxia.  Although it usually promotes tumor cell survival under hypoxia, it has also been implied to trigger apoptosis.  Although the impact of hypoxia has been extensively studied in many adult solid tumors, its role in most childhood tumors, for example, in rhabdomyosarcoma (RMS) or Ewing sarcoma (ES), has not yet been addressed.  Here, we report that hypoxia protects A204 RMS and A673 ES cells against anticancer drug- or tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis and that Hif-1α plays a key role in conferring apoptosis resistance under hypoxia.  Although a functional HIF-1 pathway and proapoptotic proteins such as p53 and Bcl-2/E1B 19 kDa interacting protein 3 were activated under hypoxia in both A204 RMS and A673 ES cells, these cells remained refractory to apoptosis.  Concomitant anal. of antiapoptotic proteins revealed that hypoxia induced expression of Bcl-2 and inhibitor of apoptosis proteins (IAP)-2 as well as proteins assocd. with anaerobic metab. such as the glucose transporter protein GLUT-1 and the glycolytic enzyme Aldolase A.  Specific downregulation of Hif-1α by RNA interference significantly enhanced apoptosis under hypoxia by preventing the hypoxia-mediated increase in GLUT-1 expression without altering expression levels of the antiapoptotic proteins Bcl-2 or cIAP-2.  Moreover, glucose deprivation-induced apoptosis of A204 RMS and A673 ES cells was inhibited under hypoxic conditions in a Hif-1α-dependent manner.  As GLUT-1 was induced via Hif-1α under hypoxia in A204 RMS and A673 ES, these findings suggest that the Hif-1α-mediated increase in glucose uptake plays an important role in conferring apoptosis resistance.  Thus, hypoxia-inducible genes may represent novel targets for therapeutic intervention in some pediatric tumors, which warrants further investigation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrzZtyFtiJNKrVg90H21EOLACvtfcHk0liZVFxu76I-sA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXjsFSiu70%253D&md5=cbbbad640345852b13ff09cc45179630</span></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1038%2Fsj.onc.1210008&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fsj.onc.1210008%26sid%3Dliteratum%253Aachs%26aulast%3DKilic%26aufirst%3DM.%26aulast%3DKasperczyk%26aufirst%3DH.%26aulast%3DFulda%26aufirst%3DS.%26aulast%3DDebatin%26aufirst%3DK.-M.%26atitle%3DRole%2520of%2520hypoxia%2520inducible%2520factor-1%2520alpha%2520in%2520modulation%2520of%2520apoptosis%2520resistance%26jtitle%3DOncogene%26date%3D2007%26volume%3D26%26spage%3D2027%26epage%3D2038%26doi%3D10.1038%2Fsj.onc.1210008" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref16"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref16'); return false;" data-citation="" class="refNumLink">16</a></strong><div class="NLM_citation" id="cit16"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Semenza, G. L.</span></span> <span> </span><span class="NLM_article-title">Hypoxia-inducible factors: mediators of cancer progression and targets for cancer therapy</span>. <i>Trends Pharmacol. Sci.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>33</i></span>,  <span class="NLM_fpage">207</span>– <span class="NLM_lpage">214</span>, <span class="refDoi"> DOI: 10.1016/j.tips.2012.01.005</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01313&amp;key=10.1016%2Fj.tips.2012.01.005" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01313&amp;key=22398146" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01313&amp;key=1%3ACAS%3A528%3ADC%252BC38XjtlOrtbo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=33&publication_year=2012&pages=207-214&author=G.+L.+Semenza&title=Hypoxia-inducible+factors%3A+mediators+of+cancer+progression+and+targets+for+cancer+therapy&doi=10.1016%2Fj.tips.2012.01.005"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit16R"><div class="casContent"><span class="casTitleNuber">16</span><div class="casTitle"><span class="NLM_cas:atitle">Hypoxia-inducible factors: mediators of cancer progression and targets for cancer therapy</span></div><div class="casAuthors">Semenza, Gregg L.</div><div class="citationInfo"><span class="NLM_cas:title">Trends in Pharmacological Sciences</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">33</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">207-214</span>CODEN:
                <span class="NLM_cas:coden">TPHSDY</span>;
        ISSN:<span class="NLM_cas:issn">0165-6147</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">A review.  Hypoxia-inducible factors (HIFs) mediate adaptive physiol. responses to hypoxia.  In human cancers that are accessible for O2 electrode measurements, intratumoral hypoxia is common and severe hypoxia is assocd. with increased risk of mortality.  HIF activity in regions of intratumoral hypoxia mediates angiogenesis, epithelial-mesenchymal transition, stem-cell maintenance, invasion, metastasis, and resistance to radiation therapy and chemotherapy.  A growing no. of drugs have been identified that inhibit HIF activity by a variety of mol. mechanisms.  Because many of these drugs are already FDA-approved for other indications, clin. trials can (and should) be initiated to test the hypothesis that incorporation of HIF inhibitors into current std.-of-care therapy will increase the survival of cancer patients.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqPM2NYPLkLtLVg90H21EOLACvtfcHk0liZVFxu76I-sA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XjtlOrtbo%253D&md5=30c19dccf0af3af16f766e577c2397ee</span></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1016%2Fj.tips.2012.01.005&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.tips.2012.01.005%26sid%3Dliteratum%253Aachs%26aulast%3DSemenza%26aufirst%3DG.%2BL.%26atitle%3DHypoxia-inducible%2520factors%253A%2520mediators%2520of%2520cancer%2520progression%2520and%2520targets%2520for%2520cancer%2520therapy%26jtitle%3DTrends%2520Pharmacol.%2520Sci.%26date%3D2012%26volume%3D33%26spage%3D207%26epage%3D214%26doi%3D10.1016%2Fj.tips.2012.01.005" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref17"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref17'); return false;" data-citation="" class="refNumLink">17</a></strong><div class="NLM_citation" id="cit17"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wigerup, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Påhlman, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bexell, D.</span></span> <span> </span><span class="NLM_article-title">Therapeutic targeting of hypoxia and hypoxia-inducible factors in cancer</span>. <i>Pharmacol. Ther.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>164</i></span>,  <span class="NLM_fpage">152</span>– <span class="NLM_lpage">169</span>, <span class="refDoi"> DOI: 10.1016/j.pharmthera.2016.04.009</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01313&amp;key=10.1016%2Fj.pharmthera.2016.04.009" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01313&amp;key=27139518" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01313&amp;key=1%3ACAS%3A528%3ADC%252BC28XntlShsL4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=164&publication_year=2016&pages=152-169&author=C.+Wigerupauthor=S.+P%C3%A5hlmanauthor=D.+Bexell&title=Therapeutic+targeting+of+hypoxia+and+hypoxia-inducible+factors+in+cancer&doi=10.1016%2Fj.pharmthera.2016.04.009"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit17R"><div class="casContent"><span class="casTitleNuber">17</span><div class="casTitle"><span class="NLM_cas:atitle">Therapeutic targeting of hypoxia and hypoxia-inducible factors in cancer</span></div><div class="casAuthors">Wigerup, Caroline; Paahlman, Sven; Bexell, Daniel</div><div class="citationInfo"><span class="NLM_cas:title">Pharmacology & Therapeutics</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">164</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">152-169</span>CODEN:
                <span class="NLM_cas:coden">PHTHDT</span>;
        ISSN:<span class="NLM_cas:issn">0163-7258</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">Insufficient tissue oxygenation, or hypoxia, contributes to tumor aggressiveness and has a profound impact on clin. outcomes in cancer patients.  At decreased oxygen tensions, hypoxia-inducible factors (HIFs) 1 and 2 are stabilized and mediate a hypoxic response, primarily by acting as transcription factors.  HIFs exert differential effects on tumor growth and affect important cancer hallmarks including cell proliferation, apoptosis, differentiation, vascularization/angiogenesis, genetic instability, tumor metab., tumor immune responses, and invasion and metastasis.  As a consequence, HIFs mediate resistance to chemo- and radiotherapy and are assocd. with poor prognosis in cancer patients.  Intriguingly, perivascular tumor cells can also express HIF-2α, thereby forming a "pseudohypoxic" phenotype that further contributes to tumor aggressiveness.  Therefore, therapeutic targeting of HIFs in cancer has the potential to improve treatment efficacy.  Different strategies to target hypoxic cancer cells and/or HIFs include hypoxia-activated prodrugs and inhibition of HIF dimerization, mRNA or protein expression, DNA binding capacity, and transcriptional activity.  Here we review the functions of HIFs in the progression and treatment of malignant solid tumors.  We also highlight how HIFs may be targeted to improve the management of patients with therapy-resistant and metastatic cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpcq5JPjcEkgLVg90H21EOLACvtfcHk0liZVFxu76I-sA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XntlShsL4%253D&md5=dd665626b2d715b0222ca666f237a316</span></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.1016%2Fj.pharmthera.2016.04.009&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.pharmthera.2016.04.009%26sid%3Dliteratum%253Aachs%26aulast%3DWigerup%26aufirst%3DC.%26aulast%3DP%25C3%25A5hlman%26aufirst%3DS.%26aulast%3DBexell%26aufirst%3DD.%26atitle%3DTherapeutic%2520targeting%2520of%2520hypoxia%2520and%2520hypoxia-inducible%2520factors%2520in%2520cancer%26jtitle%3DPharmacol.%2520Ther.%26date%3D2016%26volume%3D164%26spage%3D152%26epage%3D169%26doi%3D10.1016%2Fj.pharmthera.2016.04.009" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref18"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref18'); return false;" data-citation="" class="refNumLink">18</a></strong><div class="NLM_citation" id="cit18"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Gao, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, J.-z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, C.-y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mao, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, L.-h.</span></span> <span> </span><span class="NLM_article-title">The mechanism between epithelial mesenchymal transition in breast cancer and hypoxia microenvironment</span>. <i>Biomed. Pharmacother.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>80</i></span>,  <span class="NLM_fpage">393</span>– <span class="NLM_lpage">405</span>, <span class="refDoi"> DOI: 10.1016/j.biopha.2016.02.044</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01313&amp;key=10.1016%2Fj.biopha.2016.02.044" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01313&amp;key=27133080" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01313&amp;key=1%3ACAS%3A528%3ADC%252BC28Xmt1Snt7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=80&publication_year=2016&pages=393-405&author=T.+Gaoauthor=J.-z.+Liauthor=Y.+Luauthor=C.-y.+Zhangauthor=Q.+Liauthor=J.+Maoauthor=L.-h.+Li&title=The+mechanism+between+epithelial+mesenchymal+transition+in+breast+cancer+and+hypoxia+microenvironment&doi=10.1016%2Fj.biopha.2016.02.044"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit18R"><div class="casContent"><span class="casTitleNuber">18</span><div class="casTitle"><span class="NLM_cas:atitle">The mechanism between epithelial mesenchymal transition in breast cancer and hypoxia microenvironment</span></div><div class="casAuthors">Gao, Tong; Li, Jia-zhi; Lu, Ying; Zhang, Chun-ying; Li, Qing; Mao, Jun; Li, Lian-hong</div><div class="citationInfo"><span class="NLM_cas:title">Biomedicine & Pharmacotherapy</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">80</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">393-405</span>CODEN:
                <span class="NLM_cas:coden">BIPHEX</span>;
        ISSN:<span class="NLM_cas:issn">0753-3322</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Masson SAS</span>)
        </div><div class="casAbstract">Hypoxia microenvironment widely exists in solid tumor tissues, which is mainly due to the rapid growth of cells within the tumor more than the speed of capillary in neoplasm, resulting in tumor tissue hypoxia.  In hypoxia, hypoxia inducible factor 1 (HIF-1) is activated and regulate the expression of a series of hypoxia inducible genes, resulting in a series of hypoxia adaptation reaction.  Researchs proved that, HIF-1 is closely related to the invasion, metastasis, prognosis of the tumor, and the expression of HIF-1 is higher in metastatic tissues compared with primary cancer tissues.  In the evolution process of breast cancer, epithelial mesenchymal transition (EMT) define the characteristics of migration and invasion of breast cancer cells, which can also allow cancer cells to acquire the ability of self-renewing and stemness, so as to promote the generation of breast cancer stem cells.  The incidence of EMT cancer stem cells are higher within the resistant to conventional treatment.  This review focuses on breast cancer (stem cells), targeting the mechanism between hypoxia and EMT in tumor (stem cells), with the purpose of finding the new therapy to breast cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr-cNeWyCyy5bVg90H21EOLACvtfcHk0liq4hB2ifsgTw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28Xmt1Snt7g%253D&md5=3265ab1c4a2fc837178c31a8af962b3d</span></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1016%2Fj.biopha.2016.02.044&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.biopha.2016.02.044%26sid%3Dliteratum%253Aachs%26aulast%3DGao%26aufirst%3DT.%26aulast%3DLi%26aufirst%3DJ.-z.%26aulast%3DLu%26aufirst%3DY.%26aulast%3DZhang%26aufirst%3DC.-y.%26aulast%3DLi%26aufirst%3DQ.%26aulast%3DMao%26aufirst%3DJ.%26aulast%3DLi%26aufirst%3DL.-h.%26atitle%3DThe%2520mechanism%2520between%2520epithelial%2520mesenchymal%2520transition%2520in%2520breast%2520cancer%2520and%2520hypoxia%2520microenvironment%26jtitle%3DBiomed.%2520Pharmacother.%26date%3D2016%26volume%3D80%26spage%3D393%26epage%3D405%26doi%3D10.1016%2Fj.biopha.2016.02.044" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref19"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref19'); return false;" data-citation="" class="refNumLink">19</a></strong><div class="NLM_citation" id="cit19"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Unwith, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhao, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hennah, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ma, D.</span></span> <span> </span><span class="NLM_article-title">The potential role of HIF on tumour progression and dissemination</span>. <i>Int. J. Cancer</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>136</i></span>,  <span class="NLM_fpage">2491</span>– <span class="NLM_lpage">2503</span>, <span class="refDoi"> DOI: 10.1002/ijc.28889</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01313&amp;key=10.1002%2Fijc.28889" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01313&amp;key=24729302" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01313&amp;key=1%3ACAS%3A528%3ADC%252BC2cXmvFSjtb8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=136&publication_year=2015&pages=2491-2503&author=S.+Unwithauthor=H.+Zhaoauthor=L.+Hennahauthor=D.+Ma&title=The+potential+role+of+HIF+on+tumour+progression+and+dissemination&doi=10.1002%2Fijc.28889"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit19R"><div class="casContent"><span class="casTitleNuber">19</span><div class="casTitle"><span class="NLM_cas:atitle">The potential role of HIF on tumour progression and dissemination</span></div><div class="casAuthors">Unwith, Sandeep; Zhao, Hailin; Hennah, Lindsay; Ma, Daqing</div><div class="citationInfo"><span class="NLM_cas:title">International Journal of Cancer</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">136</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">2491-2503</span>CODEN:
                <span class="NLM_cas:coden">IJCNAW</span>;
        ISSN:<span class="NLM_cas:issn">0020-7136</span>.
    
            (<span class="NLM_cas:orgname">John Wiley & Sons, Inc.</span>)
        </div><div class="casAbstract">A review.  Cancer is the second cause of mortality worldwide, primarily owing to failure to cure metastatic disease.  The need to target the metastatic process to reduce mortality is clear and research over the past decade has shown hypoxia-inducible factor-1 (HIF-1) to be one of the promising targets.  In order for metastatic disease to be established, multiple steps need to be taken whereby the tumor cells escape into the bloodstream and survive, disseminate and then establish at a premetastatic niche.  HIF-1 mediates hypoxia-induced proangiogenic factors such as vascular endothelial growth factor (VEGF) and platelet-derived growth factor (PDGF), which promote extravasation and chemotaxis.  The migration of tumor cells is mediated by loss of E-cadherin, which results in a more invasive phenotype; dissemination of the tumor cells by increased vascular permeability and survival in the bloodstream through resistance to apoptosis as well as adhesion at the premetastatic niche are all controlled by factors under the influence of HIF-1.  The overexpression of HIF in many aggressive cancer types as well as its role in the establishment of metastatic disease and treatment resistance demonstrate its potential target in therapeutics.  Taken together, the role of HIF-1 in cancer and metastatic disease is clear and the need for better treatment targeting metastases is paramount; more aggressive phenotypes with less response to treatment are assocd. with HIF-1 expression.  Our research has shown promise but many questions still remain to be answered.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq1wPlP2LNU9LVg90H21EOLACvtfcHk0ljg6fuls1GevQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXmvFSjtb8%253D&md5=f5ceebdee488affc039c6cde93c59523</span></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1002%2Fijc.28889&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fijc.28889%26sid%3Dliteratum%253Aachs%26aulast%3DUnwith%26aufirst%3DS.%26aulast%3DZhao%26aufirst%3DH.%26aulast%3DHennah%26aufirst%3DL.%26aulast%3DMa%26aufirst%3DD.%26atitle%3DThe%2520potential%2520role%2520of%2520HIF%2520on%2520tumour%2520progression%2520and%2520dissemination%26jtitle%3DInt.%2520J.%2520Cancer%26date%3D2015%26volume%3D136%26spage%3D2491%26epage%3D2503%26doi%3D10.1002%2Fijc.28889" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref20"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref20'); return false;" data-citation="" class="refNumLink">20</a></strong><div class="NLM_citation" id="cit20"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Moon, E. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brizel, D. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chi, J. T. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dewhirst, M. W.</span></span> <span> </span><span class="NLM_article-title">The potential role of intrinsic hypoxia markers as prognostic variables in cancer</span>. <i>Antioxid. Redox Signaling</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>9</i></span>,  <span class="NLM_fpage">1237</span>– <span class="NLM_lpage">1294</span>, <span class="refDoi"> DOI: 10.1089/ars.2007.1623</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01313&amp;key=10.1089%2Fars.2007.1623" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01313&amp;key=17571959" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01313&amp;key=1%3ACAS%3A528%3ADC%252BD2sXot1WktL8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2007&pages=1237-1294&author=E.+J.+Moonauthor=D.+M.+Brizelauthor=J.+T.+A.+Chiauthor=M.+W.+Dewhirst&title=The+potential+role+of+intrinsic+hypoxia+markers+as+prognostic+variables+in+cancer&doi=10.1089%2Fars.2007.1623"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit20R"><div class="casContent"><span class="casTitleNuber">20</span><div class="casTitle"><span class="NLM_cas:atitle">The potential role of intrinsic hypoxia markers as prognostic variables in cancer</span></div><div class="casAuthors">Moon, Eui Jung; Brizel, David M.; Chi, Jen-Tsan Ashley; Dewhirst, Mark W.</div><div class="citationInfo"><span class="NLM_cas:title">Antioxidants & Redox Signaling</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">1237-1294</span>CODEN:
                <span class="NLM_cas:coden">ARSIF2</span>;
        ISSN:<span class="NLM_cas:issn">1523-0864</span>.
    
            (<span class="NLM_cas:orgname">Mary Ann Liebert, Inc.</span>)
        </div><div class="casAbstract">A review.  Tumor hypoxia is related to tumor progression and therapy resistance, which leads to poor patient outcome.  It was suggested that measuring the hypoxic status of a tumor helps to predict patient outcome and to select more targeted treatment.  However, current methods using needle electrodes or exogenous markers have limitations due to their invasiveness or necessity for preinjection.  Recent studies showed that hypoxia-regulated genes could be alternatively used as endogenous hypoxia markers.  This is a review of 15 hypoxia-regulated genes, including hypoxia-inducible factor-1 and its targets, and their correlation with tumor hypoxia and patient outcome from 213 studies.  Though most of the studies showed significance of these genes in predicting prognosis, there was no definitive prognostic and hypoxia marker.  In conclusion, this review suggests the need for further studies with standardized methods to examine gene expression, as well as the use of multiple gene expressions.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpY758k83PGjbVg90H21EOLACvtfcHk0ljg6fuls1GevQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXot1WktL8%253D&md5=61a4f08cd5644ffdc91b45634f96b8af</span></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1089%2Fars.2007.1623&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1089%252Fars.2007.1623%26sid%3Dliteratum%253Aachs%26aulast%3DMoon%26aufirst%3DE.%2BJ.%26aulast%3DBrizel%26aufirst%3DD.%2BM.%26aulast%3DChi%26aufirst%3DJ.%2BT.%2BA.%26aulast%3DDewhirst%26aufirst%3DM.%2BW.%26atitle%3DThe%2520potential%2520role%2520of%2520intrinsic%2520hypoxia%2520markers%2520as%2520prognostic%2520variables%2520in%2520cancer%26jtitle%3DAntioxid.%2520Redox%2520Signaling%26date%3D2007%26volume%3D9%26spage%3D1237%26epage%3D1294%26doi%3D10.1089%2Fars.2007.1623" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref21"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref21'); return false;" data-citation="" class="refNumLink">21</a></strong><div class="NLM_citation" id="cit21"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Chen, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lou, T.</span></span> <span> </span><span class="NLM_article-title">Hypoxia inducible factors in hepatocellular carcinoma</span>. <i>OncoTarget</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>8</i></span>,  <span class="NLM_fpage">46691</span>– <span class="NLM_lpage">46703</span>, <span class="refDoi"> DOI: 10.18632/oncotarget.17358</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01313&amp;key=10.18632%2Foncotarget.17358" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01313&amp;key=28493839" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01313&amp;key=1%3ACAS%3A280%3ADC%252BC1crmt1ChtQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2017&pages=46691-46703&author=C.+Chenauthor=T.+Lou&title=Hypoxia+inducible+factors+in+hepatocellular+carcinoma&doi=10.18632%2Foncotarget.17358"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit21R"><div class="casContent"><span class="casTitleNuber">21</span><div class="casTitle"><span class="NLM_cas:atitle">Hypoxia inducible factors in hepatocellular carcinoma</span></div><div class="casAuthors">Chen Chu; Lou Tao</div><div class="citationInfo"><span class="NLM_cas:title">Oncotarget</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">28</span>),
    <span class="NLM_cas:pages">46691-46703</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Hepatocellular carcinoma is one of the most prevalent and lethal cancers with limited therapeutic options.  Pathogenesis of this disease involves tumor hypoxia and the activation of hypoxia inducible factors.  In this review, we describe the current understanding of hypoxia signaling pathway and summarize the expression, function and target genes of hypoxia inducible factors in hepatocellular carcinoma.  We also highlight the recent progress in hypoxia-targeted therapeutic strategies in hepatocellular carcinoma and discuss further the future efforts for the study of hypoxia and/or hypoxia inducible factors in this deadly disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRGR3Xe914MjnO4gDb7JggCfW6udTcc2eYYQSeMt6OIrLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC1crmt1ChtQ%253D%253D&md5=681c87740269e5f65b21bb082c2e789b</span></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.18632%2Foncotarget.17358&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.18632%252Foncotarget.17358%26sid%3Dliteratum%253Aachs%26aulast%3DChen%26aufirst%3DC.%26aulast%3DLou%26aufirst%3DT.%26atitle%3DHypoxia%2520inducible%2520factors%2520in%2520hepatocellular%2520carcinoma%26jtitle%3DOncoTarget%26date%3D2017%26volume%3D8%26spage%3D46691%26epage%3D46703%26doi%3D10.18632%2Foncotarget.17358" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref22"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref22'); return false;" data-citation="" class="refNumLink">22</a></strong><div class="NLM_citation" id="cit22"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kim, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cho, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chung, J.-Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Conway, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ylaya, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, J.-H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hewitt, S. M.</span></span> <span> </span><span class="NLM_article-title">Prognostic assessment of hypoxia and metabolic markers in cervical cancer using automated digital image analysis of immunohistochemistry</span>. <i>J. Transl. Med.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>11</i></span>,  <span class="NLM_fpage">185</span>, <span class="refDoi"> DOI: 10.1186/1479-5876-11-185</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01313&amp;key=10.1186%2F1479-5876-11-185" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01313&amp;key=23927384" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01313&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhtlaqtrrE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2013&pages=185&author=B.+Kimauthor=H.+Choauthor=J.-Y.+Chungauthor=C.+Conwayauthor=K.+Ylayaauthor=J.-H.+Kimauthor=S.+M.+Hewitt&title=Prognostic+assessment+of+hypoxia+and+metabolic+markers+in+cervical+cancer+using+automated+digital+image+analysis+of+immunohistochemistry&doi=10.1186%2F1479-5876-11-185"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit22R"><div class="casContent"><span class="casTitleNuber">22</span><div class="casTitle"><span class="NLM_cas:atitle">Prognostic assessment of hypoxia and metabolic markers in cervical cancer using automated digital image analysis of immunohistochemistry</span></div><div class="casAuthors">Kim, Bo Wook; Cho, Hanbyoul; Chung, Joon-Yong; Conway, Catherine; Ylaya, Kris; Kim, Jae-Hoon; Hewitt, Stephen M.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Translational Medicine</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">185</span>CODEN:
                <span class="NLM_cas:coden">JTMOBV</span>;
        ISSN:<span class="NLM_cas:issn">1479-5876</span>.
    
            (<span class="NLM_cas:orgname">BioMed Central Ltd.</span>)
        </div><div class="casAbstract">Background: Hypoxia inducible factor-1 alpha (HIF-1α), induced by tumor hypoxia, regulates tumor cell metab. and metastasis by up-regulation of c-Met, carbonic anhydrase 9 (CA9) and glucose transporter 1 (GLUT1).  The prognostic significance of hypoxia and metabolic markers is not clearly defined in cervical cancer.  Here, we have examd. the primary players in the hypoxia signaling pathway, by immunohistochem., but confirming their interactions, as well as defining which proteins are assocd. with outcome.  Methods: The study subjects were comprised of cervical intraepithelial neoplasia (CIN, n = 209), carcinoma in situ (CIS, n = 74), cervical cancer (n = 179), and matched nonadjacent normal tissues (n = 357).  Immunohistochem. (IHC) was performed to identify HIF-1α, c-Met, CA9, and GLUT1.  IHC scoring was performed using automated digital image anal. and the assocn. of hypoxic markers with prognostic outcome was evaluated.  Results: HIF-1α, c-Met, CA9 and GLUT1 expression were higher in cervical cancer than in CIN and normal cervix (all P < 0.001).  Among these markers, expression of HIF-1α and c-Met were significantly different in FIGO stage (P < 0.001 and P = 0.019, resp.) and patients with lymph node metastasis (P < 0.001 and P = 0.010, resp.).  HIF-1α expression was correlated with c-Met expression in cervical cancer (P < 0.001).  High expression of HIF-1α and c-Met showed worse 5-yr overall survival rate (P = 0.047 and P = 0.005, resp.) than low expression group, but CA9 and GLUT1 did not show significant survival difference.  After adjusting the prognostic covariates, c-Met was found to be an independent risk factor (HR = 3.27; 95% CI, 1.05-10.23, P = 0.041) for overall survival in cervical cancer.  Conclusions: We demonstrate that c-Met correlates with HIF-1α and is a poor prognostic factor in survival in cervical cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqQyodm2eH-0LVg90H21EOLACvtfcHk0lijS07arTV5_w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhtlaqtrrE&md5=0f6a2bc01e1caf3538b71111f859b204</span></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1186%2F1479-5876-11-185&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1186%252F1479-5876-11-185%26sid%3Dliteratum%253Aachs%26aulast%3DKim%26aufirst%3DB.%26aulast%3DCho%26aufirst%3DH.%26aulast%3DChung%26aufirst%3DJ.-Y.%26aulast%3DConway%26aufirst%3DC.%26aulast%3DYlaya%26aufirst%3DK.%26aulast%3DKim%26aufirst%3DJ.-H.%26aulast%3DHewitt%26aufirst%3DS.%2BM.%26atitle%3DPrognostic%2520assessment%2520of%2520hypoxia%2520and%2520metabolic%2520markers%2520in%2520cervical%2520cancer%2520using%2520automated%2520digital%2520image%2520analysis%2520of%2520immunohistochemistry%26jtitle%3DJ.%2520Transl.%2520Med.%26date%3D2013%26volume%3D11%26spage%3D185%26doi%3D10.1186%2F1479-5876-11-185" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref23"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref23'); return false;" data-citation="" class="refNumLink">23</a></strong><div class="NLM_citation" id="cit23"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Xia, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Choi, H.-K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, K.</span></span> <span> </span><span class="NLM_article-title">Recent advances in hypoxia-inducible factor (HIF)-1 inhibitors</span>. <i>Eur. J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>49</i></span>,  <span class="NLM_fpage">24</span>– <span class="NLM_lpage">40</span>, <span class="refDoi"> DOI: 10.1016/j.ejmech.2012.01.033</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01313&amp;key=10.1016%2Fj.ejmech.2012.01.033" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01313&amp;key=22305612" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01313&amp;key=1%3ACAS%3A528%3ADC%252BC38XisFOrs7w%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=49&publication_year=2012&pages=24-40&author=Y.+Xiaauthor=H.-K.+Choiauthor=K.+Lee&title=Recent+advances+in+hypoxia-inducible+factor+%28HIF%29-1+inhibitors&doi=10.1016%2Fj.ejmech.2012.01.033"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit23R"><div class="casContent"><span class="casTitleNuber">23</span><div class="casTitle"><span class="NLM_cas:atitle">Recent advances in hypoxia-inducible factor (HIF)-1 inhibitors</span></div><div class="casAuthors">Xia, Yan; Choi, Hyun-Kyung; Lee, Kyeong</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">49</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">24-40</span>CODEN:
                <span class="NLM_cas:coden">EJMCA5</span>;
        ISSN:<span class="NLM_cas:issn">0223-5234</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Masson SAS</span>)
        </div><div class="casAbstract">A review.  Tumor hypoxia has been recognized as a common feature of solid tumors and a neg. prognostic factor for response to treatment and survival of cancer patients.  The discovery of hypoxia-inducible factor-1 (HIF-1), a mol. determinant of responses to hypoxia in mammalian cells, has renewed enthusiasm for discovery and development of targeted therapies exploiting the hypoxic tumor microenvironment.  HIF-1 activity in tumors depends on availability of the HIF-1α subunit, the levels of which increase under hypoxic conditions and through activation of oncogenes and/or inactivation of tumor suppressor genes.  Increased HIF-1 has been correlated with increased angiogenesis, aggressive tumor growth, and poor patient prognosis, leading to current interest in HIF-1 as promising anticancer drug target.  In spite of an ever increasing no. of putative small mol. inhibitors of HIF-1, only a few are progressing through preclin. and early clin. development.  In this review, we will discuss recent advances in discovery and development of small mol. inhibitors that target the HIF-1 pathway as potential anticancer agents.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrV9MyS5Xicm7Vg90H21EOLACvtfcHk0lijS07arTV5_w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XisFOrs7w%253D&md5=04225108ab97c18845f7760ac4027185</span></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.1016%2Fj.ejmech.2012.01.033&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejmech.2012.01.033%26sid%3Dliteratum%253Aachs%26aulast%3DXia%26aufirst%3DY.%26aulast%3DChoi%26aufirst%3DH.-K.%26aulast%3DLee%26aufirst%3DK.%26atitle%3DRecent%2520advances%2520in%2520hypoxia-inducible%2520factor%2520%2528HIF%2529-1%2520inhibitors%26jtitle%3DEur.%2520J.%2520Med.%2520Chem.%26date%3D2012%26volume%3D49%26spage%3D24%26epage%3D40%26doi%3D10.1016%2Fj.ejmech.2012.01.033" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref24"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref24'); return false;" data-citation="" class="refNumLink">24</a></strong><div class="NLM_citation" id="cit24"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bhattarai, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, K.</span></span> <span> </span><span class="NLM_article-title">Hypoxia-inducible factor-1 (HIF-1) inhibitors from the last decade (2007 to 2016): A “structure-activity relationship” perspective</span>. <i>Med. Res. Rev.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>38</i></span>,  <span class="NLM_fpage">1404</span>– <span class="NLM_lpage">1442</span>, <span class="refDoi"> DOI: 10.1002/med.21477</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01313&amp;key=10.1002%2Fmed.21477" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01313&amp;key=29278273" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01313&amp;key=1%3ACAS%3A280%3ADC%252BC1MzltF2ntA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=38&publication_year=2018&pages=1404-1442&author=D.+Bhattaraiauthor=X.+Xuauthor=K.+Lee&title=Hypoxia-inducible+factor-1+%28HIF-1%29+inhibitors+from+the+last+decade+%282007+to+2016%29%3A+A+%E2%80%9Cstructure-activity+relationship%E2%80%9D+perspective&doi=10.1002%2Fmed.21477"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit24R"><div class="casContent"><span class="casTitleNuber">24</span><div class="casTitle"><span class="NLM_cas:atitle">Hypoxia-inducible factor-1 (HIF-1) inhibitors from the last decade (2007 to 2016): A "structure-activity relationship" perspective</span></div><div class="casAuthors">Bhattarai Deepak; Xu Xuezhen; Lee Kyeong</div><div class="citationInfo"><span class="NLM_cas:title">Medicinal research reviews</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">38</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">1404-1442</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Tumor hypoxia is a common feature in most solid tumors and is associated with overexpression of the hypoxia response pathway.  Overexpression of the hypoxia-inducible factor (HIF-1) protein leads to angiogenesis, metastasis, apoptosis resistance, and many other pro-tumorigenic responses in cancer development.  HIF-1 is a promising target in cancer drug development to increase the patient's response to chemotherapy and radiotherapy as well as the survival rate of cancer patients.  Since up to 1% of genes are hypoxia-sensitive, a target-specific HIF-1 inhibitor may be a better clinical candidate in cancer drug discovery.  Though no HIF-1 inhibitor is clinically available to date, a lot of effort has been applied during the last decade in search of potent HIF-1 inhibitors.  In this review, we will summarize the structure-activity relationship of ten different chemotypes reported to be HIF-1 inhibitors in the last decade (2007-2016), their mechanisms of action for HIF-1 inhibition, progress in the way of target-specific inhibitors, and problems associated with current inhibitors.  It is anticipated that the results of these research on the medicinal chemistry of HIF-1 inhibitors will provide decent information in the design and development of future inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTbzu6FaBO8zi-bLEOO4dYpfW6udTcc2eZvk4xQ37kLeLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC1MzltF2ntA%253D%253D&md5=c16ce6fa0369517b394adfb782551141</span></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.1002%2Fmed.21477&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fmed.21477%26sid%3Dliteratum%253Aachs%26aulast%3DBhattarai%26aufirst%3DD.%26aulast%3DXu%26aufirst%3DX.%26aulast%3DLee%26aufirst%3DK.%26atitle%3DHypoxia-inducible%2520factor-1%2520%2528HIF-1%2529%2520inhibitors%2520from%2520the%2520last%2520decade%2520%25282007%2520to%25202016%2529%253A%2520A%2520%25E2%2580%259Cstructure-activity%2520relationship%25E2%2580%259D%2520perspective%26jtitle%3DMed.%2520Res.%2520Rev.%26date%3D2018%26volume%3D38%26spage%3D1404%26epage%3D1442%26doi%3D10.1002%2Fmed.21477" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref25"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref25'); return false;" data-citation="" class="refNumLink">25</a></strong><div class="NLM_citation" id="cit25"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Li, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">You, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, X.</span></span> <span> </span><span class="NLM_article-title">Small-molecule modulators of the hypoxia-inducible factor pathway: development and therapeutic applications</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>62</i></span>,  <span class="NLM_fpage">5725</span>– <span class="NLM_lpage">5749</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.8b01596</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.8b01596" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01313&amp;key=1%3ACAS%3A528%3ADC%252BC1MXhvFGqtLg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=62&publication_year=2019&pages=5725-5749&author=Z.+Liauthor=Q.+Youauthor=X.+Zhang&title=Small-molecule+modulators+of+the+hypoxia-inducible+factor+pathway%3A+development+and+therapeutic+applications&doi=10.1021%2Facs.jmedchem.8b01596"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit25R"><div class="casContent"><span class="casTitleNuber">25</span><div class="casTitle"><span class="NLM_cas:atitle">Small-Molecule Modulators of the Hypoxia-Inducible Factor Pathway: Development and Therapeutic Applications</span></div><div class="casAuthors">Li, Zhihong; You, Qidong; Zhang, Xiaojin</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">62</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">5725-5749</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.  Hypoxia-inducible factor (HIF) is a central regulator involved in detection and adaptation to cellular oxygen stress through regulation of the hypoxic transcriptional program in angiogenesis, erythropoiesis, and metab.  The HIF pathway is involved in many diseases.  On one hand, overexpression of the HIF pathway is assocd. with solid tumors such as renal cell carcinoma (RCC).  On the other hand, suppression of the HIF pathway is correlated with inflammatory, anemia, and other hypoxic-ischemic diseases.  Therefore, modulation of the HIF pathway has been perceived as a promising strategy for treating HIF-related diseases.  Recent advances in understanding of the biochem. underlying the HIF pathway have stimulated small-mol. drugs development, and therapeutically, manipulation of the HIF-mediated response has been shown to have considerable medicinal potential.  This review will summarize and provide insight into recent advances in research that have expanded our knowledge of the HIF pathway, including its structural basis and biol., small-mol. modulators of the pathway, including inhibitors and activators, and the potential therapeutic applications of these modulators.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq1CIlpGTSGObVg90H21EOLACvtfcHk0ljiuWgh2yFdtA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXhvFGqtLg%253D&md5=69545930cfad7f091615f9b38d2661f3</span></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.8b01596&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.8b01596%26sid%3Dliteratum%253Aachs%26aulast%3DLi%26aufirst%3DZ.%26aulast%3DYou%26aufirst%3DQ.%26aulast%3DZhang%26aufirst%3DX.%26atitle%3DSmall-molecule%2520modulators%2520of%2520the%2520hypoxia-inducible%2520factor%2520pathway%253A%2520development%2520and%2520therapeutic%2520applications%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2019%26volume%3D62%26spage%3D5725%26epage%3D5749%26doi%3D10.1021%2Facs.jmedchem.8b01596" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref26"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref26'); return false;" data-citation="" class="refNumLink">26</a></strong><div class="NLM_citation" id="cit26"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lee, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, J. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Boovanahalli, S. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jin, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jin, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, J. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hong, Y.-S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, J. J.</span></span> <span> </span><span class="NLM_article-title">(Aryloxyacetylamino)benzoic acid analogues: a new class of hypoxia-inducible factor-1 inhibitors</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>50</i></span>,  <span class="NLM_fpage">1675</span>– <span class="NLM_lpage">1684</span>, <span class="refDoi"> DOI: 10.1021/jm0610292</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm0610292" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01313&amp;key=1%3ACAS%3A528%3ADC%252BD2sXitlSitbg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=50&publication_year=2007&pages=1675-1684&author=K.+Leeauthor=J.+H.+Leeauthor=S.+K.+Boovanahalliauthor=Y.+Jinauthor=M.+Leeauthor=X.+Jinauthor=J.+H.+Kimauthor=Y.-S.+Hongauthor=J.+J.+Lee&title=%28Aryloxyacetylamino%29benzoic+acid+analogues%3A+a+new+class+of+hypoxia-inducible+factor-1+inhibitors&doi=10.1021%2Fjm0610292"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit26R"><div class="casContent"><span class="casTitleNuber">26</span><div class="casTitle"><span class="NLM_cas:atitle">(Aryloxyacetylamino)benzoic Acid Analogues: A New Class of Hypoxia-Inducible Factor-1 Inhibitors</span></div><div class="casAuthors">Lee, Kyeong; Lee, Jeong Hyung; Boovanahalli, Shanthaveerappa K.; Jin, Yinglan; Lee, Mijeoung; Jin, Xuejun; Kim, Jin Hwan; Hong, Young-Soo; Lee, Jung Joon</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">50</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">1675-1684</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Structural modification of a compd. discovered during screening using an HRE-dependent reporter assay has revealed a novel class of HIF-1 inhibitors, which potently inhibit the HIF-1α protein accumulation and its target gene expression under hypoxic conditions in human hepatocellular carcinoma Hep3B cells.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoIHiJxa1MHHbVg90H21EOLACvtfcHk0ljiuWgh2yFdtA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXitlSitbg%253D&md5=62dac887df1c79fb8f4d3c87e50e0029</span></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.1021%2Fjm0610292&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm0610292%26sid%3Dliteratum%253Aachs%26aulast%3DLee%26aufirst%3DK.%26aulast%3DLee%26aufirst%3DJ.%2BH.%26aulast%3DBoovanahalli%26aufirst%3DS.%2BK.%26aulast%3DJin%26aufirst%3DY.%26aulast%3DLee%26aufirst%3DM.%26aulast%3DJin%26aufirst%3DX.%26aulast%3DKim%26aufirst%3DJ.%2BH.%26aulast%3DHong%26aufirst%3DY.-S.%26aulast%3DLee%26aufirst%3DJ.%2BJ.%26atitle%3D%2528Aryloxyacetylamino%2529benzoic%2520acid%2520analogues%253A%2520a%2520new%2520class%2520of%2520hypoxia-inducible%2520factor-1%2520inhibitors%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2007%26volume%3D50%26spage%3D1675%26epage%3D1684%26doi%3D10.1021%2Fjm0610292" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref27"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref27'); return false;" data-citation="" class="refNumLink">27</a></strong><div class="NLM_citation" id="cit27"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Naik, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Won, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, B.-K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xia, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Choi, H. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jin, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jung, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, H. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, K.</span></span> <span> </span><span class="NLM_article-title">Synthesis and structure-activity relationship of (<i>E</i>)-phenoxyacrylic amide derivatives as hypoxia-inducible factor (HIF) 1alpha inhibitors</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>55</i></span>,  <span class="NLM_fpage">10564</span>– <span class="NLM_lpage">10571</span>, <span class="refDoi"> DOI: 10.1021/jm301419d</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm301419d" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01313&amp;key=1%3ACAS%3A528%3ADC%252BC38Xhs1Ohs7vI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2012&pages=10564-10571&author=R.+Naikauthor=M.+Wonauthor=B.-K.+Kimauthor=Y.+Xiaauthor=H.+K.+Choiauthor=G.+Jinauthor=Y.+Jungauthor=H.+M.+Kimauthor=K.+Lee&title=Synthesis+and+structure-activity+relationship+of+%28E%29-phenoxyacrylic+amide+derivatives+as+hypoxia-inducible+factor+%28HIF%29+1alpha+inhibitors&doi=10.1021%2Fjm301419d"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit27R"><div class="casContent"><span class="casTitleNuber">27</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis and Structure-Activity Relationship of (E)-Phenoxyacrylic Amide Derivatives as Hypoxia-Inducible Factor (HIF) 1α Inhibitors</span></div><div class="casAuthors">Naik, Ravi; Won, Misun; Kim, Bo-Kyung; Xia, Yan; Choi, Hyun Kyung; Jin, Guanghai; Jung, Youngjin; Kim, Hwan Mook; Lee, Kyeong</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">55</span>
        (<span class="NLM_cas:issue">23</span>),
    <span class="NLM_cas:pages">10564-10571</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">(E)-phenoxyacrylamides such as I were prepd. and tested as inhibitors of the transcription factor hypoxia inducible factor-1α (HIF-1α) for potential use as antitumor agents; their toxicities to human cells and the aq. solubilities of selected compds. were detd.  I was a potent inhibitor of HIF-1α under hypoxic conditions (IC50 = 0.12 μM) in HCT116 cells.  I suppressed both hypoxia-induced HIF-1α accumulation and the expression of mRNAs for the genes for vascular endothelial growth factor, erythropoietin, and matrix metalloproteinase-9 in a dose-dependent manner.  I also inhibited tube formation (angiogenesis) and cell migration in vitro.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqzPCB8XH7HLrVg90H21EOLACvtfcHk0lhmAOQth6KdDA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38Xhs1Ohs7vI&md5=cc1c0da351a3e7d6b9ef0a97d8b2fcc6</span></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.1021%2Fjm301419d&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm301419d%26sid%3Dliteratum%253Aachs%26aulast%3DNaik%26aufirst%3DR.%26aulast%3DWon%26aufirst%3DM.%26aulast%3DKim%26aufirst%3DB.-K.%26aulast%3DXia%26aufirst%3DY.%26aulast%3DChoi%26aufirst%3DH.%2BK.%26aulast%3DJin%26aufirst%3DG.%26aulast%3DJung%26aufirst%3DY.%26aulast%3DKim%26aufirst%3DH.%2BM.%26aulast%3DLee%26aufirst%3DK.%26atitle%3DSynthesis%2520and%2520structure-activity%2520relationship%2520of%2520%2528E%2529-phenoxyacrylic%2520amide%2520derivatives%2520as%2520hypoxia-inducible%2520factor%2520%2528HIF%2529%25201alpha%2520inhibitors%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2012%26volume%3D55%26spage%3D10564%26epage%3D10571%26doi%3D10.1021%2Fjm301419d" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref28"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref28'); return false;" data-citation="" class="refNumLink">28</a></strong><div class="NLM_citation" id="cit28"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Shimizu, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maruyama, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yasui, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Minegishi, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ban, H. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nakamura, H.</span></span> <span> </span><span class="NLM_article-title">Boron-containing phenoxyacetanilide derivatives as hypoxia-inducible factor (HIF)-1α inhibitors</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>20</i></span>,  <span class="NLM_fpage">1453</span>– <span class="NLM_lpage">1456</span>, <span class="refDoi"> DOI: 10.1016/j.bmcl.2009.12.037</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01313&amp;key=10.1016%2Fj.bmcl.2009.12.037" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01313&amp;key=20083404" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01313&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhslSmtLc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2010&pages=1453-1456&author=K.+Shimizuauthor=M.+Maruyamaauthor=Y.+Yasuiauthor=H.+Minegishiauthor=H.+S.+Banauthor=H.+Nakamura&title=Boron-containing+phenoxyacetanilide+derivatives+as+hypoxia-inducible+factor+%28HIF%29-1%CE%B1+inhibitors&doi=10.1016%2Fj.bmcl.2009.12.037"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit28R"><div class="casContent"><span class="casTitleNuber">28</span><div class="casTitle"><span class="NLM_cas:atitle">Boron-containing phenoxyacetanilide derivatives as hypoxia-inducible factor (HIF)-1α inhibitors</span></div><div class="casAuthors">Shimizu, Kazuki; Maruyama, Minako; Yasui, Yuka; Minegishi, Hidemitsu; Ban, Hyun Seung; Nakamura, Hiroyuki</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">20</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">1453-1456</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A series of boron-contg. phenoxyacetanilide derivs. I [R1 = BPin, B(OH)2; R2 = Me, Et, Ph, Cy, 1-adamantyl, t-Bu, o-carboranyl] were synthesized as hypoxia-inducible factor (HIF)-1α inhibitors.  Among the compds. synthesized, carboranylphenoxyacetanilide I [R1 = B(OH)2; R2 = o-carboranyl (II)] was found to be a potent inhibitor against HIF-1α accumulation under hypoxic conditions and inhibited the hypoxia-induced HIF-1 transcriptional activity in HeLa cells (IC50 = 0.74 μM).  Compd. II (GN26361) suppressed hypoxia-induced HIF-1α accumulation and vascular endothelial growth factor mRNA expression in a concn.-dependent manner without affecting the expression of HIF-1α mRNA.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoUIHLf5RFJgLVg90H21EOLACvtfcHk0lhmAOQth6KdDA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhslSmtLc%253D&md5=18cb4c1f8e4b0212e8470c296adfa61d</span></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2009.12.037&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2009.12.037%26sid%3Dliteratum%253Aachs%26aulast%3DShimizu%26aufirst%3DK.%26aulast%3DMaruyama%26aufirst%3DM.%26aulast%3DYasui%26aufirst%3DY.%26aulast%3DMinegishi%26aufirst%3DH.%26aulast%3DBan%26aufirst%3DH.%2BS.%26aulast%3DNakamura%26aufirst%3DH.%26atitle%3DBoron-containing%2520phenoxyacetanilide%2520derivatives%2520as%2520hypoxia-inducible%2520factor%2520%2528HIF%2529-1%25CE%25B1%2520inhibitors%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2010%26volume%3D20%26spage%3D1453%26epage%3D1456%26doi%3D10.1016%2Fj.bmcl.2009.12.037" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref29"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref29'); return false;" data-citation="" class="refNumLink">29</a></strong><div class="NLM_citation" id="cit29"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kwon, D.-Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, H. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Weitzel, D. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Park, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, S. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, C.-T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stephenson, T. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Park, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fitzgerald, M. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chi, J.-T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mook, R. A.,  Jr.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dewhirst, M. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, Y. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hong, J.</span></span> <span> </span><span class="NLM_article-title">Synthesis and Biological Evaluation of Manassantin Analogues for Hypoxia-Inducible Factor 1α inhibition</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>58</i></span>,  <span class="NLM_fpage">7659</span>– <span class="NLM_lpage">7671</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.5b01220</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.5b01220" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01313&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhsFersrrM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=58&publication_year=2015&pages=7659-7671&author=D.-Y.+Kwonauthor=H.+E.+Leeauthor=D.+H.+Weitzelauthor=K.+Parkauthor=S.+H.+Leeauthor=C.-T.+Leeauthor=T.+N.+Stephensonauthor=H.+Parkauthor=M.+C.+Fitzgeraldauthor=J.-T.+Chiauthor=R.+A.+Mookauthor=M.+W.+Dewhirstauthor=Y.+M.+Leeauthor=J.+Hong&title=Synthesis+and+Biological+Evaluation+of+Manassantin+Analogues+for+Hypoxia-Inducible+Factor+1%CE%B1+inhibition&doi=10.1021%2Facs.jmedchem.5b01220"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit29R"><div class="casContent"><span class="casTitleNuber">29</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis and Biological Evaluation of Manassantin Analogues for Hypoxia-Inducible Factor 1α Inhibition</span></div><div class="casAuthors">Kwon, Do-Yeon; Lee, Hye Eun; Weitzel, Douglas H.; Park, Kyunghye; Lee, Sun Hee; Lee, Chen-Ting; Stephenson, Tesia N.; Park, Hyeri; Fitzgerald, Michael C.; Chi, Jen-Tsan; Mook, Robert A., Jr.; Dewhirst, Mark W.; Lee, You Mie; Hong, Jiyong</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">58</span>
        (<span class="NLM_cas:issue">19</span>),
    <span class="NLM_cas:pages">7659-7671</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">To cope with hypoxia, tumor cells have developed a no. of adaptive mechanisms mediated by hypoxia-inducible factor 1 (HIF-1) to promote angiogenesis and cell survival.  Due to significant roles of HIF-1 in the initiation, progression, metastasis, and resistance to treatment of most solid tumors, a considerable amt. of effort has been made to identify HIF-1 inhibitors for treatment of cancer.  Isolated from Saururus cernuus, manassantins A (I) and B (II) are potent inhibitors of HIF-1 activity.  To define the structural requirements of manassantins for HIF-1 inhibition, we prepd. and evaluated a series of manassantin analogs.  Our SAR studies examd. key regions of manassantin's structure in order to understand the impact of these regions on biol. activity and to define modifications that can lead to improved performance and drug-like properties.  Our efforts identified several manassantin analogs with reduced structural complexity as potential lead compds. for further development.  Some analogs, e.g., III, down-regulated hypoxia-induced expression of the HIF-1α protein and reduced the levels of HIF-1 target genes, including cyclin-dependent kinase 6 (Cdk6) and vascular endothelial growth factor (VEGF).  These findings provide an important framework to design potent and selective HIF-1α inhibitors, which is necessary to aid translation of manassantin-derived natural products to the clinic as novel therapeutics for cancers.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp4LzA8xQ0-LbVg90H21EOLACvtfcHk0liiXoas9hPE6A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhsFersrrM&md5=95a898b0ab734a00a2d7b2e685c816a8</span></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.5b01220&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.5b01220%26sid%3Dliteratum%253Aachs%26aulast%3DKwon%26aufirst%3DD.-Y.%26aulast%3DLee%26aufirst%3DH.%2BE.%26aulast%3DWeitzel%26aufirst%3DD.%2BH.%26aulast%3DPark%26aufirst%3DK.%26aulast%3DLee%26aufirst%3DS.%2BH.%26aulast%3DLee%26aufirst%3DC.-T.%26aulast%3DStephenson%26aufirst%3DT.%2BN.%26aulast%3DPark%26aufirst%3DH.%26aulast%3DFitzgerald%26aufirst%3DM.%2BC.%26aulast%3DChi%26aufirst%3DJ.-T.%26aulast%3DMook%26aufirst%3DR.%2BA.%26aulast%3DDewhirst%26aufirst%3DM.%2BW.%26aulast%3DLee%26aufirst%3DY.%2BM.%26aulast%3DHong%26aufirst%3DJ.%26atitle%3DSynthesis%2520and%2520Biological%2520Evaluation%2520of%2520Manassantin%2520Analogues%2520for%2520Hypoxia-Inducible%2520Factor%25201%25CE%25B1%2520inhibition%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2015%26volume%3D58%26spage%3D7659%26epage%3D7671%26doi%3D10.1021%2Facs.jmedchem.5b01220" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref30"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref30'); return false;" data-citation="" class="refNumLink">30</a></strong><div class="NLM_citation" id="cit30"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kim, H. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hong, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, S.-C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, H.-Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Suh, Y.-G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Oh, D.-C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Seo, J. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Choi, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, J. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, K.-W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, J. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, Y.-M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Park, S.-J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Park, H.-J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, J.</span></span> <span> </span><span class="NLM_article-title">Ring-truncated deguelin derivatives as potent Hypoxia Inducible Factor-1α (HIF-1α) inhibitors</span>. <i>Eur. J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>104</i></span>,  <span class="NLM_fpage">157</span>– <span class="NLM_lpage">164</span>, <span class="refDoi"> DOI: 10.1016/j.ejmech.2015.09.033</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01313&amp;key=10.1016%2Fj.ejmech.2015.09.033" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01313&amp;key=26457742" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01313&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhs1GktLnO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=104&publication_year=2015&pages=157-164&author=H.+S.+Kimauthor=M.+Hongauthor=S.-C.+Leeauthor=H.-Y.+Leeauthor=Y.-G.+Suhauthor=D.-C.+Ohauthor=J.+H.+Seoauthor=H.+Choiauthor=J.+Y.+Kimauthor=K.-W.+Kimauthor=J.+H.+Kimauthor=J.+Kimauthor=Y.-M.+Kimauthor=S.-J.+Parkauthor=H.-J.+Parkauthor=J.+Lee&title=Ring-truncated+deguelin+derivatives+as+potent+Hypoxia+Inducible+Factor-1%CE%B1+%28HIF-1%CE%B1%29+inhibitors&doi=10.1016%2Fj.ejmech.2015.09.033"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit30R"><div class="casContent"><span class="casTitleNuber">30</span><div class="casTitle"><span class="NLM_cas:atitle">Ring-truncated deguelin derivatives as potent Hypoxia Inducible Factor-1α (HIF-1α) inhibitors</span></div><div class="casAuthors">Kim, Ho Shin; Hong, Mannkyu; Lee, Su-Chan; Lee, Ho-Young; Suh, Young-Ger; Oh, Dong-Chan; Seo, Ji Hae; Choi, Hoon; Kim, Jun Yong; Kim, Kyu-Won; Kim, Jeong Hun; Kim, Joohwan; Kim, Young-Myeong; Park, So-Jung; Park, Hyun-Ju; Lee, Jeewoo</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">104</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">157-164</span>CODEN:
                <span class="NLM_cas:coden">EJMCA5</span>;
        ISSN:<span class="NLM_cas:issn">0223-5234</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Masson SAS</span>)
        </div><div class="casAbstract">A series of fluorophenyl and pyridine deguelin analogs were synthesized as ring-truncated deguelin surrogates and evaluated for their HIF-1α inhibition.  Their structure-activity relationship was systematically investigated based on the variation of the linker B-region moiety.  Among the inhibitors, compd. I exhibited potent HIF-1α inhibition in a dose-dependent manner and significant antitumor activity in H1299 with less toxicity than deguelin.  It also inhibited in vitro hypoxia-mediated angiogenic processes in HRMECs.  The docking study indicates that I occupied the C-terminal ATP-binding pocket of HSP90 in a similar mode as the original analog, which implies that the anticancer and antiangiogenic activities of I are derived from HIF-1α destabilization by binding to the C-terminal ATP-binding site of hHSP90.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrzOWGqCrZzTbVg90H21EOLACvtfcHk0liiXoas9hPE6A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhs1GktLnO&md5=df5425d3fa3e0e6e08d3d8ac1db1d128</span></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=10.1016%2Fj.ejmech.2015.09.033&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejmech.2015.09.033%26sid%3Dliteratum%253Aachs%26aulast%3DKim%26aufirst%3DH.%2BS.%26aulast%3DHong%26aufirst%3DM.%26aulast%3DLee%26aufirst%3DS.-C.%26aulast%3DLee%26aufirst%3DH.-Y.%26aulast%3DSuh%26aufirst%3DY.-G.%26aulast%3DOh%26aufirst%3DD.-C.%26aulast%3DSeo%26aufirst%3DJ.%2BH.%26aulast%3DChoi%26aufirst%3DH.%26aulast%3DKim%26aufirst%3DJ.%2BY.%26aulast%3DKim%26aufirst%3DK.-W.%26aulast%3DKim%26aufirst%3DJ.%2BH.%26aulast%3DKim%26aufirst%3DJ.%26aulast%3DKim%26aufirst%3DY.-M.%26aulast%3DPark%26aufirst%3DS.-J.%26aulast%3DPark%26aufirst%3DH.-J.%26aulast%3DLee%26aufirst%3DJ.%26atitle%3DRing-truncated%2520deguelin%2520derivatives%2520as%2520potent%2520Hypoxia%2520Inducible%2520Factor-1%25CE%25B1%2520%2528HIF-1%25CE%25B1%2529%2520inhibitors%26jtitle%3DEur.%2520J.%2520Med.%2520Chem.%26date%3D2015%26volume%3D104%26spage%3D157%26epage%3D164%26doi%3D10.1016%2Fj.ejmech.2015.09.033" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref31"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref31'); return false;" data-citation="" class="refNumLink">31</a></strong><div class="NLM_citation" id="cit31"><span><span class="NLM_contrib-group"><span class="NLM_string-name">An, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jo, D. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jeong, Y.-S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Heo, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cho, C. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Choi, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Seo, J. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hwang, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lim, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jun, H. O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sim, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lim, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hur, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ahn, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, H. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Seo, S.-Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Na, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, S.-H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chung, S.-J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, Y.-M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, K.-W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, S. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, J. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Suh, Y.-G.</span></span> <span> </span><span class="NLM_article-title">Novel hypoxia-inducible factor 1α (HIF-1α) inhibitors for angiogenesis-related ocular diseases: discovery of a novel scaffold via ring-truncation strategy</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>61</i></span>,  <span class="NLM_fpage">9266</span>– <span class="NLM_lpage">9286</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.8b00971</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.8b00971" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01313&amp;key=1%3ACAS%3A528%3ADC%252BC1cXhslOls77E" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=61&publication_year=2018&pages=9266-9286&author=H.+Anauthor=S.+Leeauthor=J.+M.+Leeauthor=D.+H.+Joauthor=J.+Kimauthor=Y.-S.+Jeongauthor=M.+J.+Heoauthor=C.+S.+Choauthor=H.+Choiauthor=J.+H.+Seoauthor=S.+Hwangauthor=J.+Limauthor=T.+Kimauthor=H.+O.+Junauthor=J.+Simauthor=C.+Limauthor=J.+Hurauthor=J.+Ahnauthor=H.+S.+Kimauthor=S.-Y.+Seoauthor=Y.+Naauthor=S.-H.+Kimauthor=J.+Leeauthor=J.+Leeauthor=S.-J.+Chungauthor=Y.-M.+Kimauthor=K.-W.+Kimauthor=S.+G.+Kimauthor=J.+H.+Kimauthor=Y.-G.+Suh&title=Novel+hypoxia-inducible+factor+1%CE%B1+%28HIF-1%CE%B1%29+inhibitors+for+angiogenesis-related+ocular+diseases%3A+discovery+of+a+novel+scaffold+via+ring-truncation+strategy&doi=10.1021%2Facs.jmedchem.8b00971"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit31R"><div class="casContent"><span class="casTitleNuber">31</span><div class="casTitle"><span class="NLM_cas:atitle">Novel Hypoxia-Inducible Factor 1α (HIF-1α) Inhibitors for Angiogenesis-Related Ocular Diseases: Discovery of a Novel Scaffold via Ring-Truncation Strategy</span></div><div class="casAuthors">An, Hongchan; Lee, Seungbeom; Lee, Jung Min; Jo, Dong Hyun; Kim, Joohwan; Jeong, Yoo-Seong; Heo, Mi Jeong; Cho, Chang Sik; Choi, Hoon; Seo, Ji Hae; Hwang, Seyeon; Lim, Jihye; Kim, Taewoo; Jun, Hyoung Oh; Sim, Jaehoon; Lim, Changjin; Hur, Joonseong; Ahn, Jungmin; Kim, Hyun Su; Seo, Seung-Yong; Na, Younghwa; Kim, Seok-Ho; Lee, Jeewoo; Lee, Jeeyeon; Chung, Suk-Jae; Kim, Young-Myeong; Kim, Kyu-Won; Kim, Sang Geon; Kim, Jeong Hun; Suh, Young-Ger</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">61</span>
        (<span class="NLM_cas:issue">20</span>),
    <span class="NLM_cas:pages">9266-9286</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Ocular diseases featuring pathol. neovascularization are the leading cause of blindness, and anti-VEGF agents have been conventionally used to treat these diseases.  Recently, regulating factors upstream of VEGF, such as HIF-1α, have emerged as a desirable therapeutic approach because the use of anti-VEGF agents is currently being reconsidered due to the VEGF action as a trophic factor.  Here, we report a novel scaffold discovered through the complete structure-activity relationship of ring-truncated deguelin analogs in HIF-1α inhibition.  Interestingly, analog 6i possessing a 2-fluorobenzene moiety instead of a dimethoxybenzene moiety exhibited excellent HIF-1α inhibitory activity, with an IC50 value of 100 nM.  In particular, the further ring-truncated analog 34f, which showed enhanced HIF-1α inhibitory activity compared to analog 2 previously reported by us, inhibited in vitro angiogenesis and effectively suppressed hypoxia-mediated retinal neovascularization.  Importantly, the heteroatom-substituted benzene ring as a key structural feature of analog 34f was identified as a novel scaffold for HIF-1α inhibitors that can be used in lieu of a chromene ring.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoy2LsTGWUU37Vg90H21EOLACvtfcHk0lg2OzWAFs6T4g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXhslOls77E&md5=01ae730c89b16149161931c6180955c2</span></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.8b00971&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.8b00971%26sid%3Dliteratum%253Aachs%26aulast%3DAn%26aufirst%3DH.%26aulast%3DLee%26aufirst%3DS.%26aulast%3DLee%26aufirst%3DJ.%2BM.%26aulast%3DJo%26aufirst%3DD.%2BH.%26aulast%3DKim%26aufirst%3DJ.%26aulast%3DJeong%26aufirst%3DY.-S.%26aulast%3DHeo%26aufirst%3DM.%2BJ.%26aulast%3DCho%26aufirst%3DC.%2BS.%26aulast%3DChoi%26aufirst%3DH.%26aulast%3DSeo%26aufirst%3DJ.%2BH.%26aulast%3DHwang%26aufirst%3DS.%26aulast%3DLim%26aufirst%3DJ.%26aulast%3DKim%26aufirst%3DT.%26aulast%3DJun%26aufirst%3DH.%2BO.%26aulast%3DSim%26aufirst%3DJ.%26aulast%3DLim%26aufirst%3DC.%26aulast%3DHur%26aufirst%3DJ.%26aulast%3DAhn%26aufirst%3DJ.%26aulast%3DKim%26aufirst%3DH.%2BS.%26aulast%3DSeo%26aufirst%3DS.-Y.%26aulast%3DNa%26aufirst%3DY.%26aulast%3DKim%26aufirst%3DS.-H.%26aulast%3DLee%26aufirst%3DJ.%26aulast%3DLee%26aufirst%3DJ.%26aulast%3DChung%26aufirst%3DS.-J.%26aulast%3DKim%26aufirst%3DY.-M.%26aulast%3DKim%26aufirst%3DK.-W.%26aulast%3DKim%26aufirst%3DS.%2BG.%26aulast%3DKim%26aufirst%3DJ.%2BH.%26aulast%3DSuh%26aufirst%3DY.-G.%26atitle%3DNovel%2520hypoxia-inducible%2520factor%25201%25CE%25B1%2520%2528HIF-1%25CE%25B1%2529%2520inhibitors%2520for%2520angiogenesis-related%2520ocular%2520diseases%253A%2520discovery%2520of%2520a%2520novel%2520scaffold%2520via%2520ring-truncation%2520strategy%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2018%26volume%3D61%26spage%3D9266%26epage%3D9286%26doi%3D10.1021%2Facs.jmedchem.8b00971" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref32"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref32'); return false;" data-citation="" class="refNumLink">32</a></strong><div class="NLM_citation" id="cit32"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Mooring, S. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jin, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Devi, N. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jabbar, A. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kaluz, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Van Meir, E. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, B.</span></span> <span> </span><span class="NLM_article-title">Design and synthesis of novel small-molecule inhibitors of the hypoxia inducible factor pathway</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>54</i></span>,  <span class="NLM_fpage">8471</span>– <span class="NLM_lpage">8489</span>, <span class="refDoi"> DOI: 10.1021/jm201018g</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm201018g" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01313&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhtlyjsrnO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=54&publication_year=2011&pages=8471-8489&author=S.+R.+Mooringauthor=H.+Jinauthor=N.+S.+Deviauthor=A.+A.+Jabbarauthor=S.+Kaluzauthor=Y.+Liuauthor=E.+G.+Van+Meirauthor=B.+Wang&title=Design+and+synthesis+of+novel+small-molecule+inhibitors+of+the+hypoxia+inducible+factor+pathway&doi=10.1021%2Fjm201018g"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit32R"><div class="casContent"><span class="casTitleNuber">32</span><div class="casTitle"><span class="NLM_cas:atitle">Design and Synthesis of Novel Small-Molecule Inhibitors of the Hypoxia Inducible Factor Pathway</span></div><div class="casAuthors">Mooring, Suazette Reid; Jin, Hui; Devi, Narra S.; Jabbar, Adnan A.; Kaluz, Stefan; Liu, Yuan; Van Meir, Erwin G.; Wang, Binghe</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">54</span>
        (<span class="NLM_cas:issue">24</span>),
    <span class="NLM_cas:pages">8471-8489</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Hypoxia, a redn. in partial oxygen pressure, is a salient property of solid tumors.  Hypoxia drives malignant progression and metastasis in tumors and participates in tumor resistance to radio- and chemotherapies.  Hypoxia activates the hypoxia-inducible factor (HIF) family of transcription factors, which induce target genes that regulate adaptive biol. processes such as anaerobic metab., cell motility, and angiogenesis.  Clin. evidence has demonstrated that expression of HIF-1 is strongly assocd. with poor patient prognosis and activation of HIF-1 contributes to malignant behavior and therapeutic resistance.  Consequently, HIF-1 has become an important therapeutic target for inhibition by small mols.  Herein, we describe the design and synthesis of small mols. that inhibit the HIF-1 signaling pathway.  Many of these compds. exhibit inhibitory activity in the nanomolar range.  Sep. mechanistic studies indicate that these inhibitors do not alter HIF-1 levels but interfere with the ability of HIF-1α/HIF-1β to interact with cofactors p300/CBP to form an active transcriptional complex.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoC3eSwxgvkCLVg90H21EOLACvtfcHk0ljPcSnaQjxc8Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhtlyjsrnO&md5=c21a16d41bf75cb886dc72753a880de9</span></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=10.1021%2Fjm201018g&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm201018g%26sid%3Dliteratum%253Aachs%26aulast%3DMooring%26aufirst%3DS.%2BR.%26aulast%3DJin%26aufirst%3DH.%26aulast%3DDevi%26aufirst%3DN.%2BS.%26aulast%3DJabbar%26aufirst%3DA.%2BA.%26aulast%3DKaluz%26aufirst%3DS.%26aulast%3DLiu%26aufirst%3DY.%26aulast%3DVan%2BMeir%26aufirst%3DE.%2BG.%26aulast%3DWang%26aufirst%3DB.%26atitle%3DDesign%2520and%2520synthesis%2520of%2520novel%2520small-molecule%2520inhibitors%2520of%2520the%2520hypoxia%2520inducible%2520factor%2520pathway%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2011%26volume%3D54%26spage%3D8471%26epage%3D8489%26doi%3D10.1021%2Fjm201018g" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref33"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref33'); return false;" data-citation="" class="refNumLink">33</a></strong><div class="NLM_citation" id="cit33"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Mun, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jabbar, A. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Devi, N. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yin, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tan, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Culver, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Snyder, J. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Van Meir, E. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Goodman, M. M.</span></span> <span> </span><span class="NLM_article-title">Design and in vitro activities of <i>N</i>-alkyl-<i>N</i>-[(8-<i>R</i>-2,2-dimethyl-2<i>H</i>-chromen-6-yl)methyl]heteroarylsulfonamides, novel, small-molecule hypoxia inducible factor-1 pathway inhibitors and anticancer agents</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>55</i></span>,  <span class="NLM_fpage">6738</span>– <span class="NLM_lpage">6750</span>, <span class="refDoi"> DOI: 10.1021/jm300752n</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm300752n" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01313&amp;key=1%3ACAS%3A528%3ADC%252BC38XpsV2gtL0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2012&pages=6738-6750&author=J.+Munauthor=A.+A.+Jabbarauthor=N.+S.+Deviauthor=S.+Yinauthor=Y.+Wangauthor=C.+Tanauthor=D.+Culverauthor=J.+P.+Snyderauthor=E.+G.+Van+Meirauthor=M.+M.+Goodman&title=Design+and+in+vitro+activities+of+N-alkyl-N-%5B%288-R-2%2C2-dimethyl-2H-chromen-6-yl%29methyl%5Dheteroarylsulfonamides%2C+novel%2C+small-molecule+hypoxia+inducible+factor-1+pathway+inhibitors+and+anticancer+agents&doi=10.1021%2Fjm300752n"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit33R"><div class="casContent"><span class="casTitleNuber">33</span><div class="casTitle"><span class="NLM_cas:atitle">Design and in Vitro Activities of N-Alkyl-N-[(8-R-2,2-dimethyl-2H-chromen-6-yl)methyl]heteroarylsulfonamides, Novel, Small-Molecule Hypoxia Inducible Factor-1 Pathway Inhibitors and Anticancer Agents</span></div><div class="casAuthors">Mun, Jiyoung; Jabbar, Adnan Abdul; Devi, Narra Sarojini; Yin, Shaoman; Wang, Yingzhe; Tan, Chalet; Culver, Deborah; Snyder, James P.; Van Meir, Erwin G.; Goodman, Mark M.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">55</span>
        (<span class="NLM_cas:issue">15</span>),
    <span class="NLM_cas:pages">6738-6750</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The hypoxia inducible factor (HIF) pathway is an attractive target for cancer, as it controls tumor adaptation to growth under hypoxia and mediates chemotherapy and radiation resistance.  We previously discovered 3,4-dimethoxy-N-[(2,2-dimethyl-2H-chromen-6-yl)methyl]-N-phenylbenzenesulfonamide as a novel, small-mol. HIF-1 pathway inhibitor in a high-throughput cell-based assay, but its in vivo delivery is hampered by poor aq. soly. (0.009 μM in water; log P7.4 = 3.7).  Here we describe the synthesis of 12 N-alkyl-N-[(8-R-2,2-dimethyl-2H-chromen-6-yl)methyl]heteroarylsulfonamides, which were designed to possess optimal lipophilicities and aq. solubilities by in silico calcns.  Exptl. log P7.4 values of 8 of the 12 new analogs ranged from 1.2-3.1.  Aq. solubilities of three analogs were measured, among which the most sol. N-[(8-methoxy-2,2-dimethyl-2H-chromen-6-yl)methyl]-N-(propan-2-yl)pyridine-2-sulfonamide had an aq. soly. of 80 μM, e.g., a soly. improvement of ∼9000-fold.  The pharmacol. optimization had limited impact on drug efficacy as the compds. retained IC50 values at or below 5 μM in our HIF-dependent reporter assay.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpVawJDxwPEs7Vg90H21EOLACvtfcHk0ljPcSnaQjxc8Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XpsV2gtL0%253D&md5=8598c06dcaf2dfa4faec14fb3820299e</span></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=10.1021%2Fjm300752n&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm300752n%26sid%3Dliteratum%253Aachs%26aulast%3DMun%26aufirst%3DJ.%26aulast%3DJabbar%26aufirst%3DA.%2BA.%26aulast%3DDevi%26aufirst%3DN.%2BS.%26aulast%3DYin%26aufirst%3DS.%26aulast%3DWang%26aufirst%3DY.%26aulast%3DTan%26aufirst%3DC.%26aulast%3DCulver%26aufirst%3DD.%26aulast%3DSnyder%26aufirst%3DJ.%2BP.%26aulast%3DVan%2BMeir%26aufirst%3DE.%2BG.%26aulast%3DGoodman%26aufirst%3DM.%2BM.%26atitle%3DDesign%2520and%2520in%2520vitro%2520activities%2520of%2520N-alkyl-N-%255B%25288-R-2%252C2-dimethyl-2H-chromen-6-yl%2529methyl%255Dheteroarylsulfonamides%252C%2520novel%252C%2520small-molecule%2520hypoxia%2520inducible%2520factor-1%2520pathway%2520inhibitors%2520and%2520anticancer%2520agents%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2012%26volume%3D55%26spage%3D6738%26epage%3D6750%26doi%3D10.1021%2Fjm300752n" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref34"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref34'); return false;" data-citation="" class="refNumLink">34</a></strong><div class="NLM_citation" id="cit34"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zhao, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wei, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Su, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhao, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hao, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhao, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cheng, M.</span></span> <span> </span><span class="NLM_article-title">Design, synthesis and evaluation of aromatic heterocyclic derivatives as potent antifungal agents</span>. <i>Eur. J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>137</i></span>,  <span class="NLM_fpage">96</span>– <span class="NLM_lpage">107</span>, <span class="refDoi"> DOI: 10.1016/j.ejmech.2017.05.043</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01313&amp;key=10.1016%2Fj.ejmech.2017.05.043" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01313&amp;key=28558334" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01313&amp;key=1%3ACAS%3A528%3ADC%252BC2sXos1Wnsrs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=137&publication_year=2017&pages=96-107&author=S.+Zhaoauthor=X.+Zhangauthor=P.+Weiauthor=X.+Suauthor=L.+Zhaoauthor=M.+Wuauthor=C.+Haoauthor=C.+Liuauthor=D.+Zhaoauthor=M.+Cheng&title=Design%2C+synthesis+and+evaluation+of+aromatic+heterocyclic+derivatives+as+potent+antifungal+agents&doi=10.1016%2Fj.ejmech.2017.05.043"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit34R"><div class="casContent"><span class="casTitleNuber">34</span><div class="casTitle"><span class="NLM_cas:atitle">Design, synthesis and evaluation of aromatic heterocyclic derivatives as potent antifungal agents</span></div><div class="casAuthors">Zhao, Shizhen; Zhang, Xiangqian; Wei, Peng; Su, Xin; Zhao, Liyu; Wu, Mengya; Hao, Chenzhou; Liu, Chunchi; Zhao, Dongmei; Cheng, Maosheng</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">137</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">96-107</span>CODEN:
                <span class="NLM_cas:coden">EJMCA5</span>;
        ISSN:<span class="NLM_cas:issn">0223-5234</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Masson SAS</span>)
        </div><div class="casAbstract">To further enhance the anti-Aspergillus efficacy of the authors' previously discovered antifungal lead compds. (1), a series of arom. heterocyclic derivs. were designed, synthesized and evaluated for in vitro antifungal activity.  Many of the target compds. showed good inhibitory activity against Candida albicans and Cryptococcus neoformans.  In particular, the isoxazole nuclei were more suited for improving the activity against Aspergillus spp.  Among these compds., 2-F substituted analogs isopropyl(S)-2-(5-(2-fluorophenyl)isoxazole-3-carboxamido)-3-(1H-imidazol-1-yl)propanoate and isobutyl(S)-2-(5-(2-fluorophenyl)isoxazole-3-carboxamido)-3-(1H-imidazol-1-yl)propanoate displayed the most remarkable in vitro activity against Candida spp., C. neoformans, A. fumigatus and fluconazole-resistant C.alb. strains, which is superior or comparable to the activity of the ref. drugs fluconazole and voriconazole.  Notably, the compds. isopropyl(S)-2-(5-(2-fluorophenyl)isoxazole-3-carboxamido)-3-(1H-imidazol-1-yl)propanoate and isobutyl(S)-2-(5-(2-fluorophenyl)isoxazole-3-carboxamido)-3-(1H-imidazol-1-yl)propanoate exhibited low inhibition profiles for various isoforms of human cytochrome P 450 and excellent blood plasma stability.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqtJRvJTjfWcbVg90H21EOLACvtfcHk0lirZLS1T8cKKg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXos1Wnsrs%253D&md5=29526c36c9ea980bcd0de971038fc679</span></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=10.1016%2Fj.ejmech.2017.05.043&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejmech.2017.05.043%26sid%3Dliteratum%253Aachs%26aulast%3DZhao%26aufirst%3DS.%26aulast%3DZhang%26aufirst%3DX.%26aulast%3DWei%26aufirst%3DP.%26aulast%3DSu%26aufirst%3DX.%26aulast%3DZhao%26aufirst%3DL.%26aulast%3DWu%26aufirst%3DM.%26aulast%3DHao%26aufirst%3DC.%26aulast%3DLiu%26aufirst%3DC.%26aulast%3DZhao%26aufirst%3DD.%26aulast%3DCheng%26aufirst%3DM.%26atitle%3DDesign%252C%2520synthesis%2520and%2520evaluation%2520of%2520aromatic%2520heterocyclic%2520derivatives%2520as%2520potent%2520antifungal%2520agents%26jtitle%3DEur.%2520J.%2520Med.%2520Chem.%26date%3D2017%26volume%3D137%26spage%3D96%26epage%3D107%26doi%3D10.1016%2Fj.ejmech.2017.05.043" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref35"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref35'); return false;" data-citation="" class="refNumLink">35</a></strong><div class="NLM_citation" id="cit35"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Huguet, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Melet, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Alves de Sousa, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lieutaud, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chevalier, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maigre, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Deschamps, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tomas, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leulliot, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pages, J.-M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Artaud, I.</span></span> <span> </span><span class="NLM_article-title">Hydroxamic acids as potent inhibitors of Fe(II) and Mn(II) E. coli methionine aminopeptidase: biological activities and X-ray structures of oxazole hydroxamate-EcMetAP-Mn complexes</span>. <i>ChemMedChem</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>7</i></span>,  <span class="NLM_fpage">1020</span>– <span class="NLM_lpage">1030</span>, <span class="refDoi"> DOI: 10.1002/cmdc.201200076</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01313&amp;key=10.1002%2Fcmdc.201200076" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01313&amp;key=22489069" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01313&amp;key=1%3ACAS%3A528%3ADC%252BC38XkvF2hs74%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2012&pages=1020-1030&author=F.+Huguetauthor=A.+Meletauthor=R.+Alves+de+Sousaauthor=A.+Lieutaudauthor=J.+Chevalierauthor=L.+Maigreauthor=P.+Deschampsauthor=A.+Tomasauthor=N.+Leulliotauthor=J.-M.+Pagesauthor=I.+Artaud&title=Hydroxamic+acids+as+potent+inhibitors+of+Fe%28II%29+and+Mn%28II%29+E.+coli+methionine+aminopeptidase%3A+biological+activities+and+X-ray+structures+of+oxazole+hydroxamate-EcMetAP-Mn+complexes&doi=10.1002%2Fcmdc.201200076"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit35R"><div class="casContent"><span class="casTitleNuber">35</span><div class="casTitle"><span class="NLM_cas:atitle">Hydroxamic Acids as Potent Inhibitors of FeII and MnII E. coli Methionine Aminopeptidase: Biological Activities and X-ray Structures of Oxazole Hydroxamate-EcMetAP-Mn Complexes</span></div><div class="casAuthors">Huguet, Florian; Melet, Armelle; Alves de Sousa, Rodolphe; Lieutaud, Aurelie; Chevalier, Jacqueline; Maigre, Laure; Deschamps, Patrick; Tomas, Alain; Leulliot, Nicolas; Pages, Jean-Marie; Artaud, Isabelle</div><div class="citationInfo"><span class="NLM_cas:title">ChemMedChem</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">1020-1030</span>CODEN:
                <span class="NLM_cas:coden">CHEMGX</span>;
        ISSN:<span class="NLM_cas:issn">1860-7179</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH & Co. KGaA</span>)
        </div><div class="casAbstract">New series of acids and hydroxamic acids linked to five-membered heterocycles including furan, oxazole, 1,2,4- or 1,3,4-oxadiazole, and imidazole were synthesized and tested as inhibitors against the FeII, CoII, and MnII forms of E. coli methionine aminopeptidase (MetAP) and as antibacterial agents against wild-type and acrAB E. coli strains.  2-Aryloxazol-4-ylcarboxylic acids appeared as potent and selective inhibitors of the CoII MetAP form, with IC50 values in the micromolar range, whereas 5-aryloxazol-2-ylcarboxylic acid regioisomers and 5-aryl-1,2,4-oxadiazol-3-ylcarboxylic acids were shown to be inefficient against all forms of EcMetAP.  Regardless of the heterocycle, all the hydroxamic acids are highly potent inhibitors and are selective for the MnII and FeII forms, with IC50 values between 1 and 2 μm.  One indole hydroxamic acid that we previously reported as a potent inhibitor of E. coli peptide deformylase also demonstrated efficiency against EcMetAP.  To gain insight into the positioning of the oxazole heterocycle with reversed substitutions at positions 2 and 5, X-ray crystal structures of EcMetAP-Mn complexed with two such oxazole hydroxamic acids were solved.  Irresp. of the [metal]/[apo-MetAP] ratio, the active site consistently contains a dinuclear manganese center, with the hydroxamate as bridging ligand.  Asp 97, which adopts a bidentate binding mode to the Mn2 site in the holoenzyme, is twisted in both structures toward the hydroxamate bridging ligand to favor the formation of a strong hydrogen bond.  Most of the compds. show weak antibacterial activity against a wild-type E. coli strain.  However, increased antibacterial activity was obsd. mainly for compds. with a 2-substituted Ph group in the presence of the nonapeptide polymyxin B and phenylalanine-arginine-β-naphthylamide as permeabilizer and efflux pump blocker, resp., which boost the intracellular uptake of the inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoWtb7WP9O-0LVg90H21EOLACvtfcHk0lirZLS1T8cKKg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XkvF2hs74%253D&md5=2aa1054cc48b2962bb56de5bab1f95a3</span></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=10.1002%2Fcmdc.201200076&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fcmdc.201200076%26sid%3Dliteratum%253Aachs%26aulast%3DHuguet%26aufirst%3DF.%26aulast%3DMelet%26aufirst%3DA.%26aulast%3DAlves%2Bde%2BSousa%26aufirst%3DR.%26aulast%3DLieutaud%26aufirst%3DA.%26aulast%3DChevalier%26aufirst%3DJ.%26aulast%3DMaigre%26aufirst%3DL.%26aulast%3DDeschamps%26aufirst%3DP.%26aulast%3DTomas%26aufirst%3DA.%26aulast%3DLeulliot%26aufirst%3DN.%26aulast%3DPages%26aufirst%3DJ.-M.%26aulast%3DArtaud%26aufirst%3DI.%26atitle%3DHydroxamic%2520acids%2520as%2520potent%2520inhibitors%2520of%2520Fe%2528II%2529%2520and%2520Mn%2528II%2529%2520E.%2520coli%2520methionine%2520aminopeptidase%253A%2520biological%2520activities%2520and%2520X-ray%2520structures%2520of%2520oxazole%2520hydroxamate-EcMetAP-Mn%2520complexes%26jtitle%3DChemMedChem%26date%3D2012%26volume%3D7%26spage%3D1020%26epage%3D1030%26doi%3D10.1002%2Fcmdc.201200076" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref36"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref36'); return false;" data-citation="" class="refNumLink">36</a></strong><div class="NLM_citation" id="cit36"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zhu, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tang, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhao, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zheng, P.</span></span> <span> </span><span class="NLM_article-title">Synthesis, and docking studies of phenylpyrimidine-carboxamide derivatives bearing 1<i>H</i>-pyrrolo[2,3-b]pyridine moiety as c-Met inhibitors</span>. <i>Bioorg. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>24</i></span>,  <span class="NLM_fpage">1749</span>– <span class="NLM_lpage">1756</span>, <span class="refDoi"> DOI: 10.1016/j.bmc.2016.02.046</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01313&amp;key=10.1016%2Fj.bmc.2016.02.046" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01313&amp;key=26964675" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01313&amp;key=1%3ACAS%3A528%3ADC%252BC28XjvVGltrg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=24&publication_year=2016&pages=1749-1756&author=W.+Zhuauthor=W.+Wangauthor=S.+Xuauthor=J.+Wangauthor=Q.+Tangauthor=C.+Wuauthor=Y.+Zhaoauthor=P.+Zheng&title=Synthesis%2C+and+docking+studies+of+phenylpyrimidine-carboxamide+derivatives+bearing+1H-pyrrolo%5B2%2C3-b%5Dpyridine+moiety+as+c-Met+inhibitors&doi=10.1016%2Fj.bmc.2016.02.046"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit36R"><div class="casContent"><span class="casTitleNuber">36</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis, and docking studies of phenylpyrimidine-carboxamide derivatives bearing 1H-pyrrolo[2,3-b]pyridine moiety as c-Met inhibitors</span></div><div class="casAuthors">Zhu, Wufu; Wang, Wenhui; Xu, Shan; Wang, Jianqiang; Tang, Qidong; Wu, Chunjiang; Zhao, Yanfang; Zheng, Pengwu</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">24</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">1749-1756</span>CODEN:
                <span class="NLM_cas:coden">BMECEP</span>;
        ISSN:<span class="NLM_cas:issn">0968-0896</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Four series of phenylpyrimidine-carboxamide derivs. bearing 1H-pyrrolo[2,3-b]pyridine moiety (14a-e, 15a-g, 16a-e and 17a-g) were designed, synthesized and evaluated for the IC50 values against three cancer cell lines (A549, PC-3 and MCF-7).  Four selected compds. (15e, 16a-b and 17a) were further evaluated for the activity against c-Met kinase, HepG2 and Hela cell lines.  Most of the compds. showed excellent cytotoxicity activity and selectivity with the IC50 valuables in single-digit μM to nanomole range.  Eleven of them are equal to more active than pos. control Foretinib against one or more cell lines.  The most promising compd. 15e showed superior activity to Foretinib against A549, PC-3 and MCF-7 cell lines, with the IC50 values of 0.14 ± 0.08 μM, 0.24 ± 0.07 μM and 0.02 ± 0.01 μM, which were 4.6, 1.6 and 473.5 times more active than Foretinib (0.64 ± 0.26 μM, 0.39 ± 0.11 μM, 9.47 ± 0.22 μM), resp.  Structure-activity relationships (SARs) and docking studies indicated that the replacement of phenylpicolinamide scaffold with phenylpyrimidine fragment of the target compds. was benefit for the activity.  What's more, the introduction of fluoro atom to the aminophenoxy part played no significant impact on the activity and any substituent group on aryl group is unfavorable for the activity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrmus_a92aE7bVg90H21EOLACvtfcHk0lip2gx3XKgUMA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XjvVGltrg%253D&md5=67b169710b011557afc8ad13f1ffebdb</span></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=10.1016%2Fj.bmc.2016.02.046&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmc.2016.02.046%26sid%3Dliteratum%253Aachs%26aulast%3DZhu%26aufirst%3DW.%26aulast%3DWang%26aufirst%3DW.%26aulast%3DXu%26aufirst%3DS.%26aulast%3DWang%26aufirst%3DJ.%26aulast%3DTang%26aufirst%3DQ.%26aulast%3DWu%26aufirst%3DC.%26aulast%3DZhao%26aufirst%3DY.%26aulast%3DZheng%26aufirst%3DP.%26atitle%3DSynthesis%252C%2520and%2520docking%2520studies%2520of%2520phenylpyrimidine-carboxamide%2520derivatives%2520bearing%25201H-pyrrolo%255B2%252C3-b%255Dpyridine%2520moiety%2520as%2520c-Met%2520inhibitors%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2016%26volume%3D24%26spage%3D1749%26epage%3D1756%26doi%3D10.1016%2Fj.bmc.2016.02.046" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref37"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref37'); return false;" data-citation="" class="refNumLink">37</a></strong><div class="NLM_citation" id="cit37"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lee, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kang, J. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Park, S.-K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jin, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chung, K.-S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, H.-M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kang, M. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, M. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Song, K. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, E.-G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, J.-J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Won, M.</span></span> <span> </span><span class="NLM_article-title">LW6, a novel HIF-1 inhibitor, promotes proteasomal degradation of HIF-1alpha via upregulation of VHL in a colon cancer cell line</span>. <i>Biochem. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>80</i></span>,  <span class="NLM_fpage">982</span>– <span class="NLM_lpage">989</span>, <span class="refDoi"> DOI: 10.1016/j.bcp.2010.06.018</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01313&amp;key=10.1016%2Fj.bcp.2010.06.018" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01313&amp;key=20599784" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01313&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhtVeku7fK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=80&publication_year=2010&pages=982-989&author=K.+Leeauthor=J.+E.+Kangauthor=S.-K.+Parkauthor=Y.+Jinauthor=K.-S.+Chungauthor=H.-M.+Kimauthor=K.+Leeauthor=M.+R.+Kangauthor=M.+K.+Leeauthor=K.+B.+Songauthor=E.-G.+Yangauthor=J.-J.+Leeauthor=M.+Won&title=LW6%2C+a+novel+HIF-1+inhibitor%2C+promotes+proteasomal+degradation+of+HIF-1alpha+via+upregulation+of+VHL+in+a+colon+cancer+cell+line&doi=10.1016%2Fj.bcp.2010.06.018"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit37R"><div class="casContent"><span class="casTitleNuber">37</span><div class="casTitle"><span class="NLM_cas:atitle">LW6, a novel HIF-1 inhibitor, promotes proteasomal degradation of HIF-1α via upregulation of VHL in a colon cancer cell line</span></div><div class="casAuthors">Lee, Kyeong; Kang, Jung-Eun; Park, Song-Kyu; Jin, Ying-Lan; Chung, Kyung-Sook; Kim, Hwan-Mook; Lee, Ki-Ho; Kang, Moo-Rim; Lee, Myung-Kyu; Song, Kyung-Bin; Yang, Eun-Gyeong; Lee, Jung-Jun; Won, Mi-Sun</div><div class="citationInfo"><span class="NLM_cas:title">Biochemical Pharmacology</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">80</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">982-989</span>CODEN:
                <span class="NLM_cas:coden">BCPCA6</span>;
        ISSN:<span class="NLM_cas:issn">0006-2952</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Hypoxia-inducible factor HIF-1 is responsible for radiation resistance and poor prognosis in cancer therapy.  As part of our drug discovery program, a novel HIF inhibitor, LW6, was identified as a small compd. that inhibits the accumulation of HIF-1α.  We found that LW6 decreased HIF-1α protein expression without affecting HIF-1β expression.  MG132, a proteasome inhibitor, protected HIF-1α from LW6-induced proteasomal degrdn., indicating that LW6 affects the stability of the HIF-1α protein.  We found that LW6 promoted the degrdn. of wild type HIF-1α, but not of a DM-HIF-1α with modifications of P402A and P564A, at hydroxylation sites in the oxygen-dependent degrdn. domain (ODDD).  LW6 did not affect the activity of prolyl hydroxylase (PHD), but induced the expression of von Hippel-Lindau (VHL), which interacts with prolyl-hydroxylated HIF-1α for proteasomal degrdn.  In the presence of LW6, knockdown of VHL did not abolish HIF-1α protein accumulation, indicating that LW6 degraded HIF-1α via regulation of VHL expression.  In mice carrying xenografts of human colon cancer HCT116 cells, LW6 demonstrated strong antitumor efficacy in vivo and caused a decrease in HIF-1α expression in frozen-tissue immunohistochem. staining.  These data suggest that LW6 may be valuable in the development of a HIF-1α inhibitor for cancer treatment.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq3Ksyrt_nbn7Vg90H21EOLACvtfcHk0lhmYtAFtTSgUw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhtVeku7fK&md5=4d6b427c3fc3e7d106fc9f7200802e9d</span></div><a href="/servlet/linkout?suffix=cit37&amp;dbid=16384&amp;doi=10.1016%2Fj.bcp.2010.06.018&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bcp.2010.06.018%26sid%3Dliteratum%253Aachs%26aulast%3DLee%26aufirst%3DK.%26aulast%3DKang%26aufirst%3DJ.%2BE.%26aulast%3DPark%26aufirst%3DS.-K.%26aulast%3DJin%26aufirst%3DY.%26aulast%3DChung%26aufirst%3DK.-S.%26aulast%3DKim%26aufirst%3DH.-M.%26aulast%3DLee%26aufirst%3DK.%26aulast%3DKang%26aufirst%3DM.%2BR.%26aulast%3DLee%26aufirst%3DM.%2BK.%26aulast%3DSong%26aufirst%3DK.%2BB.%26aulast%3DYang%26aufirst%3DE.-G.%26aulast%3DLee%26aufirst%3DJ.-J.%26aulast%3DWon%26aufirst%3DM.%26atitle%3DLW6%252C%2520a%2520novel%2520HIF-1%2520inhibitor%252C%2520promotes%2520proteasomal%2520degradation%2520of%2520HIF-1alpha%2520via%2520upregulation%2520of%2520VHL%2520in%2520a%2520colon%2520cancer%2520cell%2520line%26jtitle%3DBiochem.%2520Pharmacol.%26date%3D2010%26volume%3D80%26spage%3D982%26epage%3D989%26doi%3D10.1016%2Fj.bcp.2010.06.018" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref38"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref38'); return false;" data-citation="" class="refNumLink">38</a></strong><div class="NLM_citation" id="cit38"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jiang, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Feng, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ding, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Luo, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Y.</span></span> <span> </span><span class="NLM_article-title">Design, synthesis, biological evaluation and cocrystal structures with tubulin of chiral beta-lactam bridged combretastatin A-4 analogues as potent antitumor agents</span>. <i>Eur. J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>144</i></span>,  <span class="NLM_fpage">817</span>– <span class="NLM_lpage">842</span>, <span class="refDoi"> DOI: 10.1016/j.ejmech.2017.12.004</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01313&amp;key=10.1016%2Fj.ejmech.2017.12.004" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01313&amp;key=29306206" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01313&amp;key=1%3ACAS%3A528%3ADC%252BC1cXksFehug%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=144&publication_year=2018&pages=817-842&author=P.+Zhouauthor=Y.+Liangauthor=H.+Zhangauthor=H.+Jiangauthor=K.+Fengauthor=P.+Xuauthor=J.+Wangauthor=X.+Wangauthor=K.+Dingauthor=C.+Luoauthor=M.+Liuauthor=Y.+Wang&title=Design%2C+synthesis%2C+biological+evaluation+and+cocrystal+structures+with+tubulin+of+chiral+beta-lactam+bridged+combretastatin+A-4+analogues+as+potent+antitumor+agents&doi=10.1016%2Fj.ejmech.2017.12.004"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit38R"><div class="casContent"><span class="casTitleNuber">38</span><div class="casTitle"><span class="NLM_cas:atitle">Design, synthesis, biological evaluation and cocrystal structures with tubulin of chiral β-lactam bridged combretastatin A-4 analogues as potent antitumor agents</span></div><div class="casAuthors">Zhou, Pengfei; Liang, Yuru; Zhang, Hao; Jiang, Hao; Feng, Kechang; Xu, Pan; Wang, Jie; Wang, Xiaoming; Ding, Kuiling; Luo, Cheng; Liu, Mingming; Wang, Yang</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">144</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">817-842</span>CODEN:
                <span class="NLM_cas:coden">EJMCA5</span>;
        ISSN:<span class="NLM_cas:issn">0223-5234</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Masson SAS</span>)
        </div><div class="casAbstract">A diverse of chiral β-lactam bridged analogs of combretastatin A-4 (CA-4), 3-substituted 1,4-diaryl-2-azetidinones, were asym. synthesized and biol. evaluated, leading to identify a no. of potent anti-proliferative compds. represented by compds. I and II with IC50 values of 0.001-0.021 μM, against four human cancer cell lines (A2780, Hela, SKOV-3 and MDA-MB-231).  Structure-activity relationship (SAR) studies on all stereoisomers of compds. I and II revealed that the abs. configurations of the chiral centers at 3- and 4-position were critically important for the activity and generally a trans configuration between the "A" and "B" rings is optimal.  In addn., compds. I and II displayed less cytotoxicity on normal human oviduct epithelial cells than malignant cells indicating good selectivity in vitro.  Further biochem. evaluation and cocrystal structures with tubulin demonstrated that both compds. disrupted tubulin polymn. through interacting at the colchicine-binding site, suppressed angiogenesis in vitro and in vivo, blocked cell cycle progression at mitotic phase and induced cellular apoptosis.  The in vivo assays verified that both compds. inhibited xenograft tumor growth in nude mice with acceptable therapeutic window, showing promising potentials for further clin. development.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp-AkBbA6s_YLVg90H21EOLACvtfcHk0lhmYtAFtTSgUw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXksFehug%253D%253D&md5=d1c08d480a2f5d2976282076e7458839</span></div><a href="/servlet/linkout?suffix=cit38&amp;dbid=16384&amp;doi=10.1016%2Fj.ejmech.2017.12.004&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejmech.2017.12.004%26sid%3Dliteratum%253Aachs%26aulast%3DZhou%26aufirst%3DP.%26aulast%3DLiang%26aufirst%3DY.%26aulast%3DZhang%26aufirst%3DH.%26aulast%3DJiang%26aufirst%3DH.%26aulast%3DFeng%26aufirst%3DK.%26aulast%3DXu%26aufirst%3DP.%26aulast%3DWang%26aufirst%3DJ.%26aulast%3DWang%26aufirst%3DX.%26aulast%3DDing%26aufirst%3DK.%26aulast%3DLuo%26aufirst%3DC.%26aulast%3DLiu%26aufirst%3DM.%26aulast%3DWang%26aufirst%3DY.%26atitle%3DDesign%252C%2520synthesis%252C%2520biological%2520evaluation%2520and%2520cocrystal%2520structures%2520with%2520tubulin%2520of%2520chiral%2520beta-lactam%2520bridged%2520combretastatin%2520A-4%2520analogues%2520as%2520potent%2520antitumor%2520agents%26jtitle%3DEur.%2520J.%2520Med.%2520Chem.%26date%3D2018%26volume%3D144%26spage%3D817%26epage%3D842%26doi%3D10.1016%2Fj.ejmech.2017.12.004" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></div><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript">window.refViewer={'ref1':['cit1'],'ref2':['cit2'],'ref3':['cit3'],'ref4':['cit4'],'ref5':['cit5'],'ref6':['cit6'],'ref7':['cit7'],'ref8':['cit8'],'ref9':['cit9'],'ref10':['cit10'],'ref11':['cit11'],'ref12':['cit12'],'ref13':['cit13'],'ref14':['cit14'],'ref15':['cit15'],'ref16':['cit16'],'ref17':['cit17'],'ref18':['cit18'],'ref19':['cit19'],'ref20':['cit20'],'ref21':['cit21'],'ref22':['cit22'],'ref23':['cit23'],'ref24':['cit24'],'ref25':['cit25'],'ref26':['cit26'],'ref27':['cit27'],'ref28':['cit28'],'ref29':['cit29'],'ref30':['cit30'],'ref31':['cit31'],'ref32':['cit32'],'ref33':['cit33'],'ref34':['cit34'],'ref35':['cit35'],'ref36':['cit36'],'ref37':['cit37'],'ref38':['cit38']}</script><div class="articleCitedByDropzone" data-pb-dropzone="articleCitedByDropzone"><div class="cited-by"><div class="article_content-header cited-content_header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="citeThis">Cited By</h2></div></div></div><hr/></hr><div class="cited-by__content"><div class="cited-content hlFld-Abstract"><p>This article is cited by 4 publications.</p><ol class="cited-content_cbyCitation"><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Shaoqing  Du</span>, <span class="hlFld-ContribAuthor ">Jin  Li</span>, <span class="hlFld-ContribAuthor ">Wen  Fu</span>, <span class="hlFld-ContribAuthor ">Xiaoyong  Xu</span>, <span class="hlFld-ContribAuthor ">Xusheng  Shao</span>, <span class="hlFld-ContribAuthor ">Xuhong  Qian</span>. </span><span class="cited-content_cbyCitation_article-title">Acid-promoted reaction of N-(cyanomethyl) amide with nitrosation reagent: Facile synthesis of 1,2,4-oxadiazole-3-carboxamide. </span><span class="cited-content_cbyCitation_journal-name">Tetrahedron Letters</span><span> <strong>2021,</strong> <em>76 </em>, 153209. <a href="https://doi.org/10.1016/j.tetlet.2021.153209" title="DOI URL">https://doi.org/10.1016/j.tetlet.2021.153209</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.tetlet.2021.153209&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.tetlet.2021.153209%26sid%3Dliteratum%253Aachs%26jtitle%3DTetrahedron%2520Letters%26atitle%3DAcid-promoted%252Breaction%252Bof%252BN-%252528cyanomethyl%252529%252Bamide%252Bwith%252Bnitrosation%252Breagent%25253A%252BFacile%252Bsynthesis%252Bof%252B1%25252C2%25252C4-oxadiazole-3-carboxamide%26aulast%3DDu%26aufirst%3DShaoqing%26date%3D2021%26volume%3D76%26spage%3D153209" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Neha  Upadhyay</span>, <span class="hlFld-ContribAuthor ">Kalpana  Tilekar</span>, <span class="hlFld-ContribAuthor ">Sabreena  Safuan</span>, <span class="hlFld-ContribAuthor ">Alan P.  Kumar</span>, <span class="hlFld-ContribAuthor ">Jimmy  Stalin</span>, <span class="hlFld-ContribAuthor ">Curzio  Ruegg</span>, <span class="hlFld-ContribAuthor ">Ramaa C S</span>. </span><span class="cited-content_cbyCitation_article-title">Recent Anti‐angiogenic Drug Discovery Efforts To Combat Cancer. </span><span class="cited-content_cbyCitation_journal-name">ChemistrySelect</span><span> <strong>2021,</strong> <em>6 </em>
                                    (23)
                                     , 5689-5700. <a href="https://doi.org/10.1002/slct.202101792" title="DOI URL">https://doi.org/10.1002/slct.202101792</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/slct.202101792&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fslct.202101792%26sid%3Dliteratum%253Aachs%26jtitle%3DChemistrySelect%26atitle%3DRecent%252BAnti%2525E2%252580%252590angiogenic%252BDrug%252BDiscovery%252BEfforts%252BTo%252BCombat%252BCancer%26aulast%3DUpadhyay%26aufirst%3DNeha%26date%3D2021%26date%3D2021%26volume%3D6%26issue%3D23%26spage%3D5689%26epage%3D5700" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Kai  Yang</span>, <span class="hlFld-ContribAuthor ">Jian-Qiong  Yang</span>, <span class="hlFld-ContribAuthor ">Shi-He  Luo</span>, <span class="hlFld-ContribAuthor ">Wen-Jie  Mei</span>, <span class="hlFld-ContribAuthor ">Jian-Yun  Lin</span>, <span class="hlFld-ContribAuthor ">Jia-Qi  Zhan</span>, <span class="hlFld-ContribAuthor ">Zhao-Yang  Wang</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis of N-2(5H)-furanonyl sulfonyl hydrazone derivatives and their biological evaluation in vitro and in vivo activity against MCF-7 breast cancer cells. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic Chemistry</span><span> <strong>2021,</strong> <em>107 </em>, 104518. <a href="https://doi.org/10.1016/j.bioorg.2020.104518" title="DOI URL">https://doi.org/10.1016/j.bioorg.2020.104518</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bioorg.2020.104518&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bioorg.2020.104518%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520Chemistry%26atitle%3DSynthesis%252Bof%252BN-2%2525285H%252529-furanonyl%252Bsulfonyl%252Bhydrazone%252Bderivatives%252Band%252Btheir%252Bbiological%252Bevaluation%252Bin%252Bvitro%252Band%252Bin%252Bvivo%252Bactivity%252Bagainst%252BMCF-7%252Bbreast%252Bcancer%252Bcells%26aulast%3DYang%26aufirst%3DKai%26date%3D2021%26volume%3D107%26spage%3D104518" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Yitao  Li</span>, <span class="hlFld-ContribAuthor ">Wenqiang  Yao</span>, <span class="hlFld-ContribAuthor ">Jian  Lin</span>, <span class="hlFld-ContribAuthor ">Guoliang  Gao</span>, <span class="hlFld-ContribAuthor ">Chang  Huang</span>, <span class="hlFld-ContribAuthor ">Yang  Wu</span>. </span><span class="cited-content_cbyCitation_article-title">Design, synthesis, and biological evaluation of phenyloxadiazole derivatives as potential antifungal agents against phytopathogenic fungi. </span><span class="cited-content_cbyCitation_journal-name">Monatshefte für Chemie - Chemical Monthly</span><span> <strong>2021,</strong> <em>152 </em>
                                    (1)
                                     , 121-135. <a href="https://doi.org/10.1007/s00706-020-02717-z" title="DOI URL">https://doi.org/10.1007/s00706-020-02717-z</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/s00706-020-02717-z&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2Fs00706-020-02717-z%26sid%3Dliteratum%253Aachs%26jtitle%3DMonatshefte%2520f%25C3%25BCr%2520Chemie%2520-%2520Chemical%2520Monthly%26atitle%3DDesign%25252C%252Bsynthesis%25252C%252Band%252Bbiological%252Bevaluation%252Bof%252Bphenyloxadiazole%252Bderivatives%252Bas%252Bpotential%252Bantifungal%252Bagents%252Bagainst%252Bphytopathogenic%252Bfungi%26aulast%3DLi%26aufirst%3DYitao%26date%3D2021%26date%3D2021%26volume%3D152%26issue%3D1%26spage%3D121%26epage%3D135" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li></ol></div></div></div></div></div><div class="article_content-right" id="article_content-right" tabindex="0"><div class="tab tab--flex"><div class="tab__close"><i class="icon-close" tabindex="0" aria-label="close the sidebar."></i></div><ul role="tablist" class="rlist tab__nav"><li role="presentation" class="active"><a id="pane-m1con" href="#pane-m1" aria-controls="pane-m1" role="tab" data-toggle="tab" title="Figures" aria-selected="true" class="active empty" aria-label="Figures"><i class="icon-image"></i><span>Figures</span></a></li><li role="presentation"><a id="pane-m2con" href="#pane-m2" aria-controls="pane-m2" role="tab" data-toggle="tab" title="References" aria-selected="false" class="empty"><i class="icon-link"></i><span>References</span></a></li><li role="presentation"><a id="pane-m3con" href="#pane-m3" aria-controls="pane-m3" role="tab" data-toggle="tab" title="Support Info" aria-selected="false" class="empty tab__nav-suppInfo"><i class="icon-supporting-info"></i><span>Support Info</span></a></li></ul><div class="paneContainer"><ul class="rlist tab__content"><li id="pane-m1" aria-labelledby="pane-m1" class="tab__pane tab__pane-figures active empty"><figure data-id="_i1" data-index="0" class="article__inlineFigure"><h2 class="fig-label">Abstract</h2><img class="rightTab-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-20/acs.jmedchem.9b01313/20191018/images/medium/jm9b01313_0018.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-20/acs.jmedchem.9b01313/20191018/images/large/jm9b01313_0018.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b01313&amp;id=_i1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-20/acs.jmedchem.9b01313/20191018/images/medium/jm9b01313_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-20/acs.jmedchem.9b01313/20191018/images/large/jm9b01313_0001.jpeg" id="rightTab-gr1" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Structures of representative HIF-1α inhibitors.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-20/acs.jmedchem.9b01313/20191018/images/large/jm9b01313_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b01313&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig2" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-20/acs.jmedchem.9b01313/20191018/images/medium/jm9b01313_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-20/acs.jmedchem.9b01313/20191018/images/large/jm9b01313_0002.jpeg" id="rightTab-gr2" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Structural optimization step by step.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-20/acs.jmedchem.9b01313/20191018/images/large/jm9b01313_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b01313&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch1" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-20/acs.jmedchem.9b01313/20191018/images/medium/jm9b01313_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-20/acs.jmedchem.9b01313/20191018/images/large/jm9b01313_0007.jpeg" id="rightTab-gr7" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 1. Synthesis of <b>8</b>, <b>10a–h</b>, and <b>12a–f</b></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-20/acs.jmedchem.9b01313/20191018/images/large/jm9b01313_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b01313&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch2" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-20/acs.jmedchem.9b01313/20191018/images/medium/jm9b01313_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-20/acs.jmedchem.9b01313/20191018/images/large/jm9b01313_0008.jpeg" id="rightTab-gr8" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 2. Synthesis of <b>15a–f</b> and <b>18a–j</b></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-20/acs.jmedchem.9b01313/20191018/images/large/jm9b01313_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b01313&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch3" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Scheme 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-20/acs.jmedchem.9b01313/20191018/images/medium/jm9b01313_0009.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-20/acs.jmedchem.9b01313/20191018/images/large/jm9b01313_0009.jpeg" id="rightTab-gr9" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 3. Synthesis of <b>20a–b</b>, <b>24a–d</b>, and <b>27a–b</b></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-20/acs.jmedchem.9b01313/20191018/images/large/jm9b01313_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b01313&amp;id=sch3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch4" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Scheme 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-20/acs.jmedchem.9b01313/20191018/images/medium/jm9b01313_0010.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-20/acs.jmedchem.9b01313/20191018/images/large/jm9b01313_0010.jpeg" id="rightTab-gr10" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 4. Synthesis of <b>28a–l</b> and <b>30a–r</b></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-20/acs.jmedchem.9b01313/20191018/images/large/jm9b01313_0010.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b01313&amp;id=sch4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig3" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-20/acs.jmedchem.9b01313/20191018/images/medium/jm9b01313_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-20/acs.jmedchem.9b01313/20191018/images/large/jm9b01313_0003.jpeg" id="rightTab-gr3" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Effects of selected compounds on hypoxia-induced accumulation of HIF-1α. (A) Expression of HIF-1α was examined in LM3 cells treated with selected compounds, including compounds <b>30b</b>, <b>30f</b>, <b>30m</b> and <b>8</b> at the concentration of 10 μM under hypoxia. <b>1</b> (LW6) was used as positive control. (B) Effects of compound <b>30m</b> on hypoxia-induced HIF-1α accumulation were determined in various human cancer cell lines, including MDA-MB-231, SKOV3, and HeLa at indicated concentrations.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-20/acs.jmedchem.9b01313/20191018/images/large/jm9b01313_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b01313&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig4" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-20/acs.jmedchem.9b01313/20191018/images/medium/jm9b01313_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-20/acs.jmedchem.9b01313/20191018/images/large/jm9b01313_0004.jpeg" id="rightTab-gr4" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. Effects of compound <b>30m</b> on angiogenesis in vitro and in vivo. (A) Relative expression of VEGF mRNA was determined by real-time PCR after the treatment of HUVECs with 0.5 or 1 μM of compound <b>30m</b>. Relative expression of VEGF was normalized against GAPDH. Results represent the means ± standard deviation (SD) from three independent experiments. <sup>##</sup><i>p</i> < 0.01 vs normoxia group; *<i>p</i> < 0.05, **<i>p</i> < 0.01 vs untreated control. (B) Inhibition of hypoxia-induced capillary-like tube formation. HUVECs were seeded in the 96 well plate precoated with matrigel and incubated with 2 or 5 μM of compound <b>30m</b>. Tubule branches were photographed. A representative result from three independent experiments is shown. (C) Inhibitory effect of compound <b>30m</b> on the angiogenesis of transgenic zebrafish. Zebrafish was treated with <b>30m</b> (0.5 and 1 μM) or dimethyl sulfoxide (DMSO) (<i>n</i> = 10), and the SIVs of zebrafish were observed using confocal microscopy. Apatinib was used as a positive control. Representative images from three independent experiments were shown. White arrows indicated the destruction of SIVs. (D) Histogram showed the numbers of zebrafish SIVs per field under confocal microscopy. Results represented the means ± SD. *<i>p</i> < 0.05, **<i>p</i> < 0.01 vs untreated control.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-20/acs.jmedchem.9b01313/20191018/images/large/jm9b01313_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b01313&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig5" data-index="9" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-20/acs.jmedchem.9b01313/20191018/images/medium/jm9b01313_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-20/acs.jmedchem.9b01313/20191018/images/large/jm9b01313_0005.jpeg" id="rightTab-gr5" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. Effects of compound <b>30m</b> on cellular migration and invasion. (A) Inhibition of cellular migration by compound <b>30m</b> in wound-healing assay. After a single wound was scratched on a cellular monolayer, MDA-MB-231 cells were treated with compound <b>30m</b> (2, 5 and 10 μM) or DMSO under normoxia for 1 h and hypoxia for another 24 h. Representative images from three independent experiments are shown. (B) Inhibition of cellular migration and invasion by compound <b>30m</b> in transwell assays. MDA-MB-231 cells were seeded on chambers with or without precoated matrigel for invasion or migration assay, respectively. After incubated with compound <b>30m</b>, cells that migrated through the chambers were stained with crystal violet. Representative images from three independent experiments were shown. (C) Histogram shows the numbers of migrated and invasive cells. The experiments were repeated three times and results were indicated as means ± SD. *<i>p</i> < 0.05, **<i>p</i> < 0.01 vs untreated control. (D) Expression of E-cadherin, Vimentin, MMP-2, and MMP-9 were determined by western blotting assay. GAPDH was selected as loading control. Representative results from three independent experiments were shown.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-20/acs.jmedchem.9b01313/20191018/images/large/jm9b01313_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b01313&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig6" data-index="10" class="article__inlineFigure"><h2 class="fig-label">Figure 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-20/acs.jmedchem.9b01313/20191018/images/medium/jm9b01313_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-20/acs.jmedchem.9b01313/20191018/images/large/jm9b01313_0006.jpeg" id="rightTab-gr6" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 6. Compound <b>30m</b> inhibited the formation of metastasis of human breast cancer cells in the mice model. (A) MDA-MB-231 cells stably transfected with luciferase were injected directly into the tail vein of BALB/c nude mice. Mice then received vehicle or compound <b>30m</b> (15 and 30 mg/kg) starting 24 h after injection of cells. Animals received therapy every 2 days during 20 days. Bioluminescent images were acquired 24 h after the final dose of the inhibitor. (B) Quantification of bioluminescence. Data are expressed as the mean ± SD (<i>n</i> = 4 per group) *<i>p</i> < 0.05. (C) Body weights of the mice recorded at the end of the experiment. (D) Photomicrographs of mice lung tissue sections stained with H&E illustrated the formation of breast cancer metastasis. Black arrows indicate the metastatic nodules of breast cancer.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-20/acs.jmedchem.9b01313/20191018/images/large/jm9b01313_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b01313&amp;id=fig6"><span>Download MS PowerPoint Slide</span></a></div></div></figure></li><li id="pane-m2" aria-labelledby="pane-m2" class="tab__pane tab__pane-references empty"><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-_i111">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_87211" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_87211" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="rightTab-references-count">
            This article references 38 other publications.
        </p><ol id="rightTab-references" class="useLabel"><li id="rightTab-ref1"><div class="reference"><strong class="refLabel"><a href="#ref1" class="rightTabRefNumLink">1</a></strong><div class="NLM_citation" id="rightTab-cit1"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lambert, A. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pattabiraman, D. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Weinberg, R. A.</span></span> <span> </span><span class="NLM_article-title">Emerging Biological Principles of Metastasis</span>. <i>Cell</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>168</i></span>,  <span class="NLM_fpage">670</span>– <span class="NLM_lpage">691</span>, <span class="refDoi"> DOI: 10.1016/j.cell.2016.11.037</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01313&amp;key=10.1016%2Fj.cell.2016.11.037" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01313&amp;key=28187288" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01313&amp;key=1%3ACAS%3A528%3ADC%252BC2sXis1ygt7k%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=168&publication_year=2017&pages=670-691&author=A.+W.+Lambertauthor=D.+R.+Pattabiramanauthor=R.+A.+Weinberg&title=Emerging+Biological+Principles+of+Metastasis&doi=10.1016%2Fj.cell.2016.11.037"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit1R"><div class="casContent"><span class="casTitleNuber">1</span><div class="casTitle"><span class="NLM_cas:atitle">Emerging biological principles of metastasis</span></div><div class="casAuthors">Lambert, Arthur W.; Pattabiraman, Diwakar R.; Weinberg, Robert A.</div><div class="citationInfo"><span class="NLM_cas:title">Cell (Cambridge, MA, United States)</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">168</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">670-691</span>CODEN:
                <span class="NLM_cas:coden">CELLB5</span>;
        ISSN:<span class="NLM_cas:issn">0092-8674</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">A review.  Metastases account for the great majority of cancer-assocd. deaths, yet this complex process remains the least understood aspect of cancer biol.  As the body of research concerning metastasis continues to grow at a rapid rate, the biol. programs that underlie the dissemination and metastatic outgrowth of cancer cells are beginning to come into view.  In this review we summarize the cellular and mol. mechanisms involved in metastasis, with a focus on carcinomas where the most is known, and we highlight the general principles of metastasis that have begun to emerge.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo-uzuiS1fMU7Vg90H21EOLACvtfcHk0lhkBNhxk7BIUA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXis1ygt7k%253D&md5=d5ce0f203ea2c68a2cdd40e1315a7797</span></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.1016%2Fj.cell.2016.11.037&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.cell.2016.11.037%26sid%3Dliteratum%253Aachs%26aulast%3DLambert%26aufirst%3DA.%2BW.%26aulast%3DPattabiraman%26aufirst%3DD.%2BR.%26aulast%3DWeinberg%26aufirst%3DR.%2BA.%26atitle%3DEmerging%2520Biological%2520Principles%2520of%2520Metastasis%26jtitle%3DCell%26date%3D2017%26volume%3D168%26spage%3D670%26epage%3D691%26doi%3D10.1016%2Fj.cell.2016.11.037" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref2"><div class="reference"><strong class="refLabel"><a href="#ref2" class="rightTabRefNumLink">2</a></strong><div class="NLM_citation" id="rightTab-cit2"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Valastyan, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Weinberg, R. A.</span></span> <span> </span><span class="NLM_article-title">Tumor metastasis: molecular insights and evolving paradigms</span>. <i>Cell</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>147</i></span>,  <span class="NLM_fpage">275</span>– <span class="NLM_lpage">292</span>, <span class="refDoi"> DOI: 10.1016/j.cell.2011.09.024</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01313&amp;key=10.1016%2Fj.cell.2011.09.024" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01313&amp;key=22000009" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01313&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhtlaksb3N" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=147&publication_year=2011&pages=275-292&author=S.+Valastyanauthor=R.+A.+Weinberg&title=Tumor+metastasis%3A+molecular+insights+and+evolving+paradigms&doi=10.1016%2Fj.cell.2011.09.024"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit2R"><div class="casContent"><span class="casTitleNuber">2</span><div class="casTitle"><span class="NLM_cas:atitle">Tumor Metastasis: Molecular Insights and Evolving Paradigms</span></div><div class="casAuthors">Valastyan, Scott; Weinberg, Robert A.</div><div class="citationInfo"><span class="NLM_cas:title">Cell (Cambridge, MA, United States)</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">147</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">275-292</span>CODEN:
                <span class="NLM_cas:coden">CELLB5</span>;
        ISSN:<span class="NLM_cas:issn">0092-8674</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">A review.  Metastases represent the end products of a multistep cell-biol. process termed the invasion-metastasis cascade, which involves dissemination of cancer cells to anatomically distant organ sites and their subsequent adaptation to foreign tissue microenvironments.  Each of these events is driven by the acquisition of genetic and/or epigenetic alterations within tumor cells and the co-option of nonneoplastic stromal cells, which together endow incipient metastatic cells with traits needed to generate macroscopic metastases.  Recent advances provide provocative insights into these cell-biol. and mol. changes, which have implications regarding the steps of the invasion-metastasis cascade that appear amenable to therapeutic targeting.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpVqOPVKwPqtbVg90H21EOLACvtfcHk0lhkBNhxk7BIUA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhtlaksb3N&md5=fa62d15c6b61bf90cfcdc1d51bbe98b9</span></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.1016%2Fj.cell.2011.09.024&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.cell.2011.09.024%26sid%3Dliteratum%253Aachs%26aulast%3DValastyan%26aufirst%3DS.%26aulast%3DWeinberg%26aufirst%3DR.%2BA.%26atitle%3DTumor%2520metastasis%253A%2520molecular%2520insights%2520and%2520evolving%2520paradigms%26jtitle%3DCell%26date%3D2011%26volume%3D147%26spage%3D275%26epage%3D292%26doi%3D10.1016%2Fj.cell.2011.09.024" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref3"><div class="reference"><strong class="refLabel"><a href="#ref3" class="rightTabRefNumLink">3</a></strong><div class="NLM_citation" id="rightTab-cit3"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wan, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pantel, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kang, Y.</span></span> <span> </span><span class="NLM_article-title">Tumor metastasis: moving new biological insights into the clinic</span>. <i>Nat. Med.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>19</i></span>,  <span class="NLM_fpage">1450</span>– <span class="NLM_lpage">1464</span>, <span class="refDoi"> DOI: 10.1038/nm.3391</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01313&amp;key=10.1038%2Fnm.3391" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01313&amp;key=24202397" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01313&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhslCnt7zK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2013&pages=1450-1464&author=L.+Wanauthor=K.+Pantelauthor=Y.+Kang&title=Tumor+metastasis%3A+moving+new+biological+insights+into+the+clinic&doi=10.1038%2Fnm.3391"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit3R"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">Tumor metastasis: moving new biological insights into the clinic</span></div><div class="casAuthors">Wan, Liling; Pantel, Klaus; Kang, Yibin</div><div class="citationInfo"><span class="NLM_cas:title">Nature Medicine (New York, NY, United States)</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">19</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">1450-1464</span>CODEN:
                <span class="NLM_cas:coden">NAMEFI</span>;
        ISSN:<span class="NLM_cas:issn">1078-8956</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  As the culprit behind most cancer-related deaths, metastasis is the ultimate challenge in our effort to fight cancer as a life-threatening disease.  The explosive growth of metastasis research in the past decade has yielded an unprecedented wealth of information about the tumor-intrinsic and tumor-extrinsic mechanisms that dictate metastatic behaviors, the mol. and cellular basis underlying the distinct courses of metastatic progression in different cancers and what renders metastatic cancer refractory to available therapies.  However, integration of such new knowledge into an improved, metastasis-oriented oncol. drug development strategy is needed to thwart the development of metastatic disease at every stage of progression.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrthBY_OR1IkrVg90H21EOLACvtfcHk0lhsF7g-2eoeNg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhslCnt7zK&md5=4f499d29cd42a0073c98167d9573aa71</span></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1038%2Fnm.3391&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnm.3391%26sid%3Dliteratum%253Aachs%26aulast%3DWan%26aufirst%3DL.%26aulast%3DPantel%26aufirst%3DK.%26aulast%3DKang%26aufirst%3DY.%26atitle%3DTumor%2520metastasis%253A%2520moving%2520new%2520biological%2520insights%2520into%2520the%2520clinic%26jtitle%3DNat.%2520Med.%26date%3D2013%26volume%3D19%26spage%3D1450%26epage%3D1464%26doi%3D10.1038%2Fnm.3391" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref4"><div class="reference"><strong class="refLabel"><a href="#ref4" class="rightTabRefNumLink">4</a></strong><div class="NLM_citation" id="rightTab-cit4"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Guan, X.</span></span> <span> </span><span class="NLM_article-title">Cancer metastases: challenges and opportunities</span>. <i>Acta Pharm. Sin. B</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>5</i></span>,  <span class="NLM_fpage">402</span>– <span class="NLM_lpage">418</span>, <span class="refDoi"> DOI: 10.1016/j.apsb.2015.07.005</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01313&amp;key=10.1016%2Fj.apsb.2015.07.005" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01313&amp;key=26579471" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01313&amp;key=1%3ACAS%3A280%3ADC%252BC28rgtlOqsA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2015&pages=402-418&author=X.+Guan&title=Cancer+metastases%3A+challenges+and+opportunities&doi=10.1016%2Fj.apsb.2015.07.005"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit4R"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">Cancer metastases: challenges and opportunities</span></div><div class="casAuthors">Guan Xiangming</div><div class="citationInfo"><span class="NLM_cas:title">Acta pharmaceutica Sinica. B</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">402-18</span>
        ISSN:<span class="NLM_cas:issn">2211-3835</span>.
    </div><div class="casAbstract">Cancer metastasis is the major cause of cancer morbidity and mortality, and accounts for about 90% of cancer deaths.  Although cancer survival rate has been significantly improved over the years, the improvement is primarily due to early diagnosis and cancer growth inhibition.  Limited progress has been made in the treatment of cancer metastasis due to various factors.  Current treatments for cancer metastasis are mainly chemotherapy and radiotherapy, though the new generation anti-cancer drugs (predominantly neutralizing antibodies for growth factors and small molecule kinase inhibitors) do have the effects on cancer metastasis in addition to their effects on cancer growth.  Cancer metastasis begins with detachment of metastatic cells from the primary tumor, travel of the cells to different sites through blood/lymphatic vessels, settlement and growth of the cells at a distal site.  During the process, metastatic cells go through detachment, migration, invasion and adhesion.  These four essential, metastatic steps are inter-related and affected by multi-biochemical events and parameters.  Additionally, it is known that tumor microenvironment (such as extracellular matrix structure, growth factors, chemokines, matrix metalloproteinases) plays a significant role in cancer metastasis.  The biochemical events and parameters involved in the metastatic process and tumor microenvironment have been targeted or can be potential targets for metastasis prevention and inhibition.  This review provides an overview of these metastasis essential steps, related biochemical factors, and targets for intervention.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQ-qtzzXrDFl7xanA7vODO6fW6udTcc2eZQG0Nfde8Fx7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC28rgtlOqsA%253D%253D&md5=6c05f3977aa66da117e7373a7b77d387</span></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1016%2Fj.apsb.2015.07.005&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.apsb.2015.07.005%26sid%3Dliteratum%253Aachs%26aulast%3DGuan%26aufirst%3DX.%26atitle%3DCancer%2520metastases%253A%2520challenges%2520and%2520opportunities%26jtitle%3DActa%2520Pharm.%2520Sin.%2520B%26date%3D2015%26volume%3D5%26spage%3D402%26epage%3D418%26doi%3D10.1016%2Fj.apsb.2015.07.005" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref5"><div class="reference"><strong class="refLabel"><a href="#ref5" class="rightTabRefNumLink">5</a></strong><div class="NLM_citation" id="rightTab-cit5"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wells, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Grahovac, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wheeler, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ma, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lauffenburger, D.</span></span> <span> </span><span class="NLM_article-title">Targeting tumor cell motility as a strategy against invasion and metastasis</span>. <i>Trends Pharmacol. Sci.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>34</i></span>,  <span class="NLM_fpage">283</span>– <span class="NLM_lpage">289</span>, <span class="refDoi"> DOI: 10.1016/j.tips.2013.03.001</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01313&amp;key=10.1016%2Fj.tips.2013.03.001" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01313&amp;key=23571046" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01313&amp;key=1%3ACAS%3A528%3ADC%252BC3sXlsFaqtLs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=34&publication_year=2013&pages=283-289&author=A.+Wellsauthor=J.+Grahovacauthor=S.+Wheelerauthor=B.+Maauthor=D.+Lauffenburger&title=Targeting+tumor+cell+motility+as+a+strategy+against+invasion+and+metastasis&doi=10.1016%2Fj.tips.2013.03.001"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit5R"><div class="casContent"><span class="casTitleNuber">5</span><div class="casTitle"><span class="NLM_cas:atitle">Targeting tumor cell motility as a strategy against invasion and metastasis</span></div><div class="casAuthors">Wells, Alan; Grahovac, Jelena; Wheeler, Sarah; Ma, Bo; Lauffenburger, Douglas</div><div class="citationInfo"><span class="NLM_cas:title">Trends in Pharmacological Sciences</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">34</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">283-289</span>CODEN:
                <span class="NLM_cas:coden">TPHSDY</span>;
        ISSN:<span class="NLM_cas:issn">0165-6147</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">A review.  Advances in diagnosis and treatment have rendered most solid tumors largely curable if they are diagnosed and treated before dissemination.  However, once they spread beyond the initial primary location, these cancers are usually highly morbid, if not fatal.  Thus, current efforts focus on both limiting initial dissemination and preventing secondary spread.  There are two modes of tumor dissemination - invasion and metastasis - each leading to unique therapeutic challenges and likely to be driven by distinct mechanisms.  However, these two forms of dissemination utilize some common strategies to accomplish movement from the primary tumor, establishment in an ectopic site, and survival therein.  The adaptive behaviors of motile cancer cells provide an opening for therapeutic approaches if we understand the mol., cellular, and tissue biol. that underlie them.  Herein, we review the signaling cascades and organ reactions that lead to dissemination, as these are non-genetic in nature, focusing on cell migration as the key to tumor progression.  In this context, the cellular phenotype will also be discussed because the modes of migration are dictated by quant. and phys. aspects of the cell motility machinery.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrcnAq4y4QiJLVg90H21EOLACvtfcHk0liXbCO6BzK_ag"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXlsFaqtLs%253D&md5=a1434ebf9aa11f61f789ff8e9a3b52ef</span></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1016%2Fj.tips.2013.03.001&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.tips.2013.03.001%26sid%3Dliteratum%253Aachs%26aulast%3DWells%26aufirst%3DA.%26aulast%3DGrahovac%26aufirst%3DJ.%26aulast%3DWheeler%26aufirst%3DS.%26aulast%3DMa%26aufirst%3DB.%26aulast%3DLauffenburger%26aufirst%3DD.%26atitle%3DTargeting%2520tumor%2520cell%2520motility%2520as%2520a%2520strategy%2520against%2520invasion%2520and%2520metastasis%26jtitle%3DTrends%2520Pharmacol.%2520Sci.%26date%3D2013%26volume%3D34%26spage%3D283%26epage%3D289%26doi%3D10.1016%2Fj.tips.2013.03.001" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref6"><div class="reference"><strong class="refLabel"><a href="#ref6" class="rightTabRefNumLink">6</a></strong><div class="NLM_citation" id="rightTab-cit6"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sun, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ma, L.</span></span> <span> </span><span class="NLM_article-title">The emerging molecular machinery and therapeutic targets of metastasis</span>. <i>Trends Pharmacol. Sci.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>36</i></span>,  <span class="NLM_fpage">349</span>– <span class="NLM_lpage">359</span>, <span class="refDoi"> DOI: 10.1016/j.tips.2015.04.001</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01313&amp;key=10.1016%2Fj.tips.2015.04.001" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01313&amp;key=25939811" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01313&amp;key=1%3ACAS%3A528%3ADC%252BC2MXmvFaksLk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=36&publication_year=2015&pages=349-359&author=Y.+Sunauthor=L.+Ma&title=The+emerging+molecular+machinery+and+therapeutic+targets+of+metastasis&doi=10.1016%2Fj.tips.2015.04.001"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">The emerging molecular machinery and therapeutic targets of metastasis</span></div><div class="casAuthors">Sun, Yutong; Ma, Li</div><div class="citationInfo"><span class="NLM_cas:title">Trends in Pharmacological Sciences</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">36</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">349-359</span>CODEN:
                <span class="NLM_cas:coden">TPHSDY</span>;
        ISSN:<span class="NLM_cas:issn">0165-6147</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">Metastasis is a 100-yr-old research topic.  Technol. advances during the past few decades have led to significant progress in our understanding of metastatic disease.  However, metastasis remains the leading cause of cancer-related mortalities.  The lack of appropriate clin. trials for metastasis preventive drugs and incomplete understanding of the mol. machinery are major obstacles in metastasis prevention and treatment.  Numerous processes, factors, and signaling pathways are involved in regulating metastasis.  Here we discuss recent progress in metastasis research, including epithelial-mesenchymal plasticity, cancer stem cells, emerging mol. determinants and therapeutic targets, and the link between metastasis and therapy resistance.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrWbKMG8jaR0bVg90H21EOLACvtfcHk0liXbCO6BzK_ag"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXmvFaksLk%253D&md5=377ab410c450229134b7ec06755bb5ca</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1016%2Fj.tips.2015.04.001&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.tips.2015.04.001%26sid%3Dliteratum%253Aachs%26aulast%3DSun%26aufirst%3DY.%26aulast%3DMa%26aufirst%3DL.%26atitle%3DThe%2520emerging%2520molecular%2520machinery%2520and%2520therapeutic%2520targets%2520of%2520metastasis%26jtitle%3DTrends%2520Pharmacol.%2520Sci.%26date%3D2015%26volume%3D36%26spage%3D349%26epage%3D359%26doi%3D10.1016%2Fj.tips.2015.04.001" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref7"><div class="reference"><strong class="refLabel"><a href="#ref7" class="rightTabRefNumLink">7</a></strong><div class="NLM_citation" id="rightTab-cit7"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bruick, R. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McKnight, S. L.</span></span> <span> </span><span class="NLM_article-title">A conserved family of prolyl-4-hydroxylases that modify HIF</span>. <i>Science</i> <span class="NLM_year" style="font-weight: bold;">2001</span>,  <span class="NLM_volume"><i>294</i></span>,  <span class="NLM_fpage">1337</span>– <span class="NLM_lpage">1340</span>, <span class="refDoi"> DOI: 10.1126/science.1066373</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01313&amp;key=10.1126%2Fscience.1066373" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01313&amp;key=11598268" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01313&amp;key=1%3ACAS%3A528%3ADC%252BD3MXotlKmtbo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=294&publication_year=2001&pages=1337-1340&author=R.+K.+Bruickauthor=S.+L.+McKnight&title=A+conserved+family+of+prolyl-4-hydroxylases+that+modify+HIF&doi=10.1126%2Fscience.1066373"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit7R"><div class="casContent"><span class="casTitleNuber">7</span><div class="casTitle"><span class="NLM_cas:atitle">A conserved family of prolyl-4-hydroxylases that modify HIF</span></div><div class="casAuthors">Bruick, Richard K.; McKnight, Steven L.</div><div class="citationInfo"><span class="NLM_cas:title">Science (Washington, DC, United States)</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">294</span>
        (<span class="NLM_cas:issue">5545</span>),
    <span class="NLM_cas:pages">1337-1340</span>CODEN:
                <span class="NLM_cas:coden">SCIEAS</span>;
        ISSN:<span class="NLM_cas:issn">0036-8075</span>.
    
            (<span class="NLM_cas:orgname">American Association for the Advancement of Science</span>)
        </div><div class="casAbstract">Mammalian cells respond to changes in oxygen availability through a conserved pathway that is regulated by the hypoxia-inducible factor (HIF).  The alpha subunit of HIF is targeted for degrdn. under normoxic conditions by a ubiquitin-ligase complex that recognizes a hydroxylated proline residue in HIF.  The authors identified a conserved family of HIF prolyl hydroxylase (HPH) enzymes that appear to be responsible for this posttranslational modification.  In cultured mammalian cells, inappropriate accumulation of HIF caused by forced expression of the HIF-1α subunit under normoxic conditions was attenuated by coexpression of HPH.  Suppression of HPH in cultured Drosophila melanogaster cells by RNA interference resulted in elevated expression of a hypoxia-inducible gene (LDH, encoding lactate dehydrogenase) under normoxic conditions.  These findings indicate that HPH is an essential component of the pathway through which cells sense oxygen.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpH62syyo7QG7Vg90H21EOLACvtfcHk0ljMpJggUDXGLQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXotlKmtbo%253D&md5=e17b5094d300fc6e292cd063d5633502</span></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1126%2Fscience.1066373&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscience.1066373%26sid%3Dliteratum%253Aachs%26aulast%3DBruick%26aufirst%3DR.%2BK.%26aulast%3DMcKnight%26aufirst%3DS.%2BL.%26atitle%3DA%2520conserved%2520family%2520of%2520prolyl-4-hydroxylases%2520that%2520modify%2520HIF%26jtitle%3DScience%26date%3D2001%26volume%3D294%26spage%3D1337%26epage%3D1340%26doi%3D10.1126%2Fscience.1066373" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref8"><div class="reference"><strong class="refLabel"><a href="#ref8" class="rightTabRefNumLink">8</a></strong><div class="NLM_citation" id="rightTab-cit8"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kamura, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sato, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Iwai, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Czyzyk-Krzeska, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Conaway, R. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Conaway, J. W.</span></span> <span> </span><span class="NLM_article-title">Activation of HIF1alpha ubiquitination by a reconstituted von Hippel-Lindau (VHL) tumor suppressor complex</span>. <i>Proc. Natl. Acad. Sci. U.S.A.</i> <span class="NLM_year" style="font-weight: bold;">2000</span>,  <span class="NLM_volume"><i>97</i></span>,  <span class="NLM_fpage">10430</span>– <span class="NLM_lpage">10435</span>, <span class="refDoi"> DOI: 10.1073/pnas.190332597</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01313&amp;key=10.1073%2Fpnas.190332597" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01313&amp;key=10973499" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01313&amp;key=1%3ACAS%3A528%3ADC%252BD3cXms1Crsb4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=97&publication_year=2000&pages=10430-10435&author=T.+Kamuraauthor=S.+Satoauthor=K.+Iwaiauthor=M.+Czyzyk-Krzeskaauthor=R.+C.+Conawayauthor=J.+W.+Conaway&title=Activation+of+HIF1alpha+ubiquitination+by+a+reconstituted+von+Hippel-Lindau+%28VHL%29+tumor+suppressor+complex&doi=10.1073%2Fpnas.190332597"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit8R"><div class="casContent"><span class="casTitleNuber">8</span><div class="casTitle"><span class="NLM_cas:atitle">Activation of HIF1α ubiquitination by a reconstituted von Hippel-Lindau (VHL) tumor suppressor complex</span></div><div class="casAuthors">Kamura, Takumi; Sato, Shigeo; Iwai, Kazuhiro; Czyzyk-Krzeska, Maria; Conaway, Ronald C.; Conaway, Joan Weliky</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">97</span>
        (<span class="NLM_cas:issue">19</span>),
    <span class="NLM_cas:pages">10430-10435</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">Mutations in the VHL tumor suppressor gene result in constitutive expression of many hypoxia-inducible genes, at least in part because of increases in the cellular level of hypoxia-inducible transcription factor HIF1α, which in normal cells is rapidly ubiquitinated and degraded by the proteasome under normoxic conditions.  The recent observation that the VHL protein is a subunit of an Skp1-Cul1/Cdc53-F-box (SCF)-like E3 ubiquitin ligase raised the possibility that VHL may be directly responsible for regulating cellular levels of HIF1α by targeting it for ubiquitination and proteolysis.  In this report, we test this hypothesis directly.  We report development of methods for prodn. of the purified recombinant VHL complex and present direct biochem. evidence that it can function with an E1 ubiquitin-activating enzyme and E2 ubiquitin-conjugating enzyme to activate HIF1α ubiquitination in vitro.  Our findings provide new insight into the function of the VHL tumor suppressor protein, and they provide a foundation for future investigations of the mechanisms underlying VHL regulation of oxygen-dependent gene expression.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpjwQDn-YYjRLVg90H21EOLACvtfcHk0ljMpJggUDXGLQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXms1Crsb4%253D&md5=5ba458b01d352b6350e61c2dbdc074ca</span></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1073%2Fpnas.190332597&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.190332597%26sid%3Dliteratum%253Aachs%26aulast%3DKamura%26aufirst%3DT.%26aulast%3DSato%26aufirst%3DS.%26aulast%3DIwai%26aufirst%3DK.%26aulast%3DCzyzyk-Krzeska%26aufirst%3DM.%26aulast%3DConaway%26aufirst%3DR.%2BC.%26aulast%3DConaway%26aufirst%3DJ.%2BW.%26atitle%3DActivation%2520of%2520HIF1alpha%2520ubiquitination%2520by%2520a%2520reconstituted%2520von%2520Hippel-Lindau%2520%2528VHL%2529%2520tumor%2520suppressor%2520complex%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.S.A.%26date%3D2000%26volume%3D97%26spage%3D10430%26epage%3D10435%26doi%3D10.1073%2Fpnas.190332597" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref9"><div class="reference"><strong class="refLabel"><a href="#ref9" class="rightTabRefNumLink">9</a></strong><div class="NLM_citation" id="rightTab-cit9"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Semenza, G. L.</span></span> <span> </span><span class="NLM_article-title">Defining the role of hypoxia-inducible factor 1 in cancer biology and therapeutics</span>. <i>Oncogene</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>29</i></span>,  <span class="NLM_fpage">625</span>– <span class="NLM_lpage">634</span>, <span class="refDoi"> DOI: 10.1038/onc.2009.441</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01313&amp;key=10.1038%2Fonc.2009.441" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01313&amp;key=19946328" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01313&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhsV2gt77N" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=29&publication_year=2010&pages=625-634&author=G.+L.+Semenza&title=Defining+the+role+of+hypoxia-inducible+factor+1+in+cancer+biology+and+therapeutics&doi=10.1038%2Fonc.2009.441"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit9R"><div class="casContent"><span class="casTitleNuber">9</span><div class="casTitle"><span class="NLM_cas:atitle">Defining the role of hypoxia-inducible factor 1 in cancer biology and therapeutics</span></div><div class="casAuthors">Semenza, G. L.</div><div class="citationInfo"><span class="NLM_cas:title">Oncogene</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">29</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">625-634</span>CODEN:
                <span class="NLM_cas:coden">ONCNES</span>;
        ISSN:<span class="NLM_cas:issn">0950-9232</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Adaptation of cancer cells to their microenvironment is an important driving force in the clonal selection that leads to invasive and metastatic disease.  O2 concns. are markedly reduced in many human cancers compared with normal tissue, and a major mechanism mediating adaptive responses to reduced O2 availability (hypoxia) is the regulation of transcription by hypoxia-inducible factor 1 (HIF-1).  This review summarizes the current state of knowledge regarding the mol. mechanisms by which HIF-1 contributes to cancer progression, focusing on (1) clin. data assocg. increased HIF-1 levels with patient mortality; (2) preclin. data linking HIF-1 activity with tumor growth; (3) mol. data linking specific HIF-1 target gene products to crit. aspects of cancer biol. and (4) pharmacol. data showing anticancer effects of HIF-1 inhibitors in mouse models of human cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqlXOi-2tydiLVg90H21EOLACvtfcHk0lhnf2mKA8OGsw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhsV2gt77N&md5=fb8c32b5f05bfad38f4a4ecef9bd98a7</span></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1038%2Fonc.2009.441&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fonc.2009.441%26sid%3Dliteratum%253Aachs%26aulast%3DSemenza%26aufirst%3DG.%2BL.%26atitle%3DDefining%2520the%2520role%2520of%2520hypoxia-inducible%2520factor%25201%2520in%2520cancer%2520biology%2520and%2520therapeutics%26jtitle%3DOncogene%26date%3D2010%26volume%3D29%26spage%3D625%26epage%3D634%26doi%3D10.1038%2Fonc.2009.441" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref10"><div class="reference"><strong class="refLabel"><a href="#ref10" class="rightTabRefNumLink">10</a></strong><div class="NLM_citation" id="rightTab-cit10"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Koyasu, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kobayashi, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Goto, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hiraoka, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Harada, H.</span></span> <span> </span><span class="NLM_article-title">Regulatory mechanisms of hypoxia-inducible factor 1 activity: Two decades of knowledge</span>. <i>Cancer Sci.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>109</i></span>,  <span class="NLM_fpage">560</span>– <span class="NLM_lpage">571</span>, <span class="refDoi"> DOI: 10.1111/cas.13483</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01313&amp;key=10.1111%2Fcas.13483" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01313&amp;key=29285833" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01313&amp;key=1%3ACAS%3A528%3ADC%252BC1cXhvVeqtrg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=109&publication_year=2018&pages=560-571&author=S.+Koyasuauthor=M.+Kobayashiauthor=Y.+Gotoauthor=M.+Hiraokaauthor=H.+Harada&title=Regulatory+mechanisms+of+hypoxia-inducible+factor+1+activity%3A+Two+decades+of+knowledge&doi=10.1111%2Fcas.13483"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit10R"><div class="casContent"><span class="casTitleNuber">10</span><div class="casTitle"><span class="NLM_cas:atitle">Regulatory mechanisms of hypoxia-inducible factor 1 activity: Two decades of knowledge</span></div><div class="casAuthors">Koyasu, Sho; Kobayashi, Minoru; Goto, Yoko; Hiraoka, Masahiro; Harada, Hiroshi</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Science</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">109</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">560-571</span>CODEN:
                <span class="NLM_cas:coden">CSACCM</span>;
        ISSN:<span class="NLM_cas:issn">1349-7006</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">Hypoxia-inducible factor 1 (HIF-1) is a transcriptional activator of various genes related to cellular adaptive responses to hypoxia.  Dysfunctions in the regulatory systems of HIF-1 activity have been implicated in the pathogenesis of various diseases including malignant tumors and, thus, elucidating the mol. mechanisms underlying the activation of HIF-1 is eagerly desired for the development of novel anti-cancer strategies.  The importance of oxygen-dependent and ubiquitin-mediated proteolysis of the regulatory subunit of HIF-1 (HIF-1α) was first reported in 1997.  Since then, accumulating evidence has shown that HIF-1α may become stable and active even under normoxic conditions; for example, when disease-assocd. genetic and functional alterations in some genes trigger the aberrant activation of HIF-1 regardless of oxygen conditions.  We herein review the last two decades of knowledge, since 1997, on the regulatory mechanisms of HIF-1 activity from conventional oxygen- and proteolysis-dependent mechanisms to up-to-the-minute information on cancer-assocd. genetic and functional alteration-mediated mechanisms.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoszvKl39u117Vg90H21EOLACvtfcHk0lhnf2mKA8OGsw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXhvVeqtrg%253D&md5=b5238f0c3e7d77d4871f149190a32d14</span></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1111%2Fcas.13483&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fcas.13483%26sid%3Dliteratum%253Aachs%26aulast%3DKoyasu%26aufirst%3DS.%26aulast%3DKobayashi%26aufirst%3DM.%26aulast%3DGoto%26aufirst%3DY.%26aulast%3DHiraoka%26aufirst%3DM.%26aulast%3DHarada%26aufirst%3DH.%26atitle%3DRegulatory%2520mechanisms%2520of%2520hypoxia-inducible%2520factor%25201%2520activity%253A%2520Two%2520decades%2520of%2520knowledge%26jtitle%3DCancer%2520Sci.%26date%3D2018%26volume%3D109%26spage%3D560%26epage%3D571%26doi%3D10.1111%2Fcas.13483" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref11"><div class="reference"><strong class="refLabel"><a href="#ref11" class="rightTabRefNumLink">11</a></strong><div class="NLM_citation" id="rightTab-cit11"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Forsythe, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jiang, B. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Iyer, N. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Agani, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leung, S. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Koos, R. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Semenza, G. L.</span></span> <span> </span><span class="NLM_article-title">Activation of vascular endothelial growth factor gene transcription by hypoxia-inducible factor 1</span>. <i>Mol. Cell. Biol.</i> <span class="NLM_year" style="font-weight: bold;">1996</span>,  <span class="NLM_volume"><i>16</i></span>,  <span class="NLM_fpage">4604</span>– <span class="NLM_lpage">4613</span>, <span class="refDoi"> DOI: 10.1128/mcb.16.9.4604</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01313&amp;key=10.1128%2Fmcb.16.9.4604" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01313&amp;key=8756616" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01313&amp;key=1%3ACAS%3A528%3ADyaK28XltFKjsrc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=1996&pages=4604-4613&author=J.+A.+Forsytheauthor=B.+H.+Jiangauthor=N.+V.+Iyerauthor=F.+Aganiauthor=S.+W.+Leungauthor=R.+D.+Koosauthor=G.+L.+Semenza&title=Activation+of+vascular+endothelial+growth+factor+gene+transcription+by+hypoxia-inducible+factor+1&doi=10.1128%2Fmcb.16.9.4604"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit11R"><div class="casContent"><span class="casTitleNuber">11</span><div class="casTitle"><span class="NLM_cas:atitle">Activation of vascular endothelial growth factor gene transcription by hypoxia-inducible factor 1</span></div><div class="casAuthors">Forsythe, Jo A.; Jiang, Bing-Hua; Iyer, Narayan V.; Agani, Faton; Leung, Sandra W.; Koos, Robert D.; Semenza, Gregg L.</div><div class="citationInfo"><span class="NLM_cas:title">Molecular and Cellular Biology</span>
        (<span class="NLM_cas:date">1996</span>),
    <span class="NLM_cas:volume">16</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">4604-4613</span>CODEN:
                <span class="NLM_cas:coden">MCEBD4</span>;
        ISSN:<span class="NLM_cas:issn">0270-7306</span>.
    
            (<span class="NLM_cas:orgname">American Society for Microbiology</span>)
        </div><div class="casAbstract">Expression of vascular endothelial growth factor (VEGF) is induced in cells exposed to hypoxia or ischemia.  Neovascularization stimulated by VEGF occurs in severals important clin. contexts, including myocardial ischemia, retinal disease, and tumor growth.  Hypoxia-inducible factor 1 (HIF-1) is a heterodimeric basic helix-loop-helix protein that activates transcription of the human erythropoietin gene in hypoxic cells.  Here we demonstrate the involvement of HIF-1 in the activation of VEGF transcription.  VEGF 5'-flanking sequences mediated transcriptional activation of reporter gene expression in hypoxic Hep3B cells.  A 47-bp sequence located 985 to 939 bp 5' to the VEGF transcription initiation site mediated hypoxia-inducible reporter gene expression directed by a simian virus 40 promoter element that was otherwise minimally responsive to hypoxia.  When reporters contg. VEGF sequences, in the context of the native VEGF or heterologous simian virus 40 promoter, were cotransfected with expression vectors encoding HIF-1α and HIF-1β (ARNT [aryl hydrocarbon receptor nuclear translocator]), reporter gene transcription was much greater in both hypoxic and nonhypoxic cells than in cells transfected with the reporter alone.  A HIF-1 binding site was demonstrated in the 47-bp hypoxia response element, and a 3-bp substitution eliminated the ability of the element to bind HIF-1 and to activate transcription in response to hypoxia and/or recombinant HIF-1.  Cotransfection of cells with an expression vector encoding a dominant neg. form of HIF-1α inhibited the activation of reporter transcription in hypoxic cells in a dose-dependent manner.  VEGF mRNA was not induced by hypoxia in mutant cells that do not express the HIF-1β (ARNT) subunit.  These findings implicate HIF-1 in the activation of VEGF transcription in hypoxic cells.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoWR5k0flrm27Vg90H21EOLACvtfcHk0lhe2zg5uX9bnA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK28XltFKjsrc%253D&md5=d699f194fc5edae7b2b6a5ce97359808</span></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1128%2Fmcb.16.9.4604&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252Fmcb.16.9.4604%26sid%3Dliteratum%253Aachs%26aulast%3DForsythe%26aufirst%3DJ.%2BA.%26aulast%3DJiang%26aufirst%3DB.%2BH.%26aulast%3DIyer%26aufirst%3DN.%2BV.%26aulast%3DAgani%26aufirst%3DF.%26aulast%3DLeung%26aufirst%3DS.%2BW.%26aulast%3DKoos%26aufirst%3DR.%2BD.%26aulast%3DSemenza%26aufirst%3DG.%2BL.%26atitle%3DActivation%2520of%2520vascular%2520endothelial%2520growth%2520factor%2520gene%2520transcription%2520by%2520hypoxia-inducible%2520factor%25201%26jtitle%3DMol.%2520Cell.%2520Biol.%26date%3D1996%26volume%3D16%26spage%3D4604%26epage%3D4613%26doi%3D10.1128%2Fmcb.16.9.4604" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref12"><div class="reference"><strong class="refLabel"><a href="#ref12" class="rightTabRefNumLink">12</a></strong><div class="NLM_citation" id="rightTab-cit12"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Gilkes, D. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Semenza, G. L.</span></span> <span> </span><span class="NLM_article-title">Role of hypoxia-inducible factors in breast cancer metastasis</span>. <i>Future Oncol.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>9</i></span>,  <span class="NLM_fpage">1623</span>– <span class="NLM_lpage">1636</span>, <span class="refDoi"> DOI: 10.2217/fon.13.92</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01313&amp;key=10.2217%2Ffon.13.92" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01313&amp;key=24156323" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01313&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhs1KktbbJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2013&pages=1623-1636&author=D.+M.+Gilkesauthor=G.+L.+Semenza&title=Role+of+hypoxia-inducible+factors+in+breast+cancer+metastasis&doi=10.2217%2Ffon.13.92"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit12R"><div class="casContent"><span class="casTitleNuber">12</span><div class="casTitle"><span class="NLM_cas:atitle">Role of hypoxia-inducible factors in breast cancer metastasis</span></div><div class="casAuthors">Gilkes, Daniele M.; Semenza, Gregg L.</div><div class="citationInfo"><span class="NLM_cas:title">Future Oncology</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">1623-1636</span>CODEN:
                <span class="NLM_cas:coden">FOUNBN</span>;
        ISSN:<span class="NLM_cas:issn">1479-6694</span>.
    
            (<span class="NLM_cas:orgname">Future Medicine Ltd.</span>)
        </div><div class="casAbstract">A review.  Human breast tumors contain regions of hypoxia in which cells that are located far from a functional blood vessel have significantly reduced oxygen concns. when compared with normal mammary tissue.  Breast cancer cells adapt to hypoxic conditions by increasing levels of hypoxia-inducible factors (HIFs), which induce the expression of multiple genes involved in angiogenesis, glucose utilization, resistance to oxidative stress, cell proliferation, resistance to apoptosis, invasion and metastasis.  Breast cancer patients with increased HIF expression levels in primary tumor biopsies are at increased risk of metastasis.  This is an important finding since 90% of breast cancer deaths are the result of metastasis, primarily to the bone, lungs, liver, brain and regional lymph nodes.  Although the prognostic significance of reduced oxygen levels in primary breast tumors of cancer patients is well recognized, the mechanisms underlying hypoxia-induced, HIF-dependent breast cancer metastasis are just beginning to be uncovered.  Recent studies have implicated HIF target genes in every step of the metastatic process.  Drugs, such as digoxin, show the potential therapeutic effects of blocking HIF activity by decreasing primary tumor growth, vascularization, invasion and metastasis in animal models of breast cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqxOSas0fwKJ7Vg90H21EOLACvtfcHk0lhe2zg5uX9bnA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhs1KktbbJ&md5=b08f55cb982519907625e23b5f40872b</span></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.2217%2Ffon.13.92&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2217%252Ffon.13.92%26sid%3Dliteratum%253Aachs%26aulast%3DGilkes%26aufirst%3DD.%2BM.%26aulast%3DSemenza%26aufirst%3DG.%2BL.%26atitle%3DRole%2520of%2520hypoxia-inducible%2520factors%2520in%2520breast%2520cancer%2520metastasis%26jtitle%3DFuture%2520Oncol.%26date%3D2013%26volume%3D9%26spage%3D1623%26epage%3D1636%26doi%3D10.2217%2Ffon.13.92" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref13"><div class="reference"><strong class="refLabel"><a href="#ref13" class="rightTabRefNumLink">13</a></strong><div class="NLM_citation" id="rightTab-cit13"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fan, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, J.</span></span> <span> </span><span class="NLM_article-title">Expression and clinical significance of hypoxia-inducible factor 1alpha, Snail and E-cadherin in human ovarian cancer cell lines</span>. <i>Mol. Med. Rep.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>12</i></span>,  <span class="NLM_fpage">3393</span>– <span class="NLM_lpage">3399</span>, <span class="refDoi"> DOI: 10.3892/mmr.2015.3786</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01313&amp;key=10.3892%2Fmmr.2015.3786" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01313&amp;key=25975373" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01313&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhs1ems73P" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2015&pages=3393-3399&author=Y.+Zhangauthor=N.+Fanauthor=J.+Yang&title=Expression+and+clinical+significance+of+hypoxia-inducible+factor+1alpha%2C+Snail+and+E-cadherin+in+human+ovarian+cancer+cell+lines&doi=10.3892%2Fmmr.2015.3786"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit13R"><div class="casContent"><span class="casTitleNuber">13</span><div class="casTitle"><span class="NLM_cas:atitle">Expression and clinical significance of hypoxia-inducible factor 1α, Snail and E-cadherin in human ovarian cancer cell lines</span></div><div class="casAuthors">Zhang, Yan; Fan, Nina; Yang, Jing</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Medicine Reports</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue">3, Pt. A</span>),
    <span class="NLM_cas:pages">3393-3399</span>CODEN:
                <span class="NLM_cas:coden">MMROA5</span>;
        ISSN:<span class="NLM_cas:issn">1791-2997</span>.
    
            (<span class="NLM_cas:orgname">Spandidos Publications Ltd.</span>)
        </div><div class="casAbstract">The aim of the present study was to investigate the expression and clin. significance of hypoxia-inducible factor 1α (HIF-1α), Snail and E-cadherin in ovarian cancer.  The expression levels were assessed in a no. of ovarian cancer cell lines and ovarian cancer tissues, and correlations between the expression of the three proteins and clin. pathol. factors were analyzed.  Transwell assays showed that the invasive ability of the ovarian cancer cell lines SKOV3 and ES-2 were significantly higher than those of TYK and 3AO (P<0.01).  Furthermore, the expression levels of HIF-1α and Snail in SKOV3 and ES-2 were significantly higher than those in TYK and 3AO, whereas the expression levels of E-cadherin in SKOV3 and ES-2 were significantly lower than those in TYK and 3AO (P<0.05).  In ovarian cancer tissues, the expression levels of HIF-1α, Snail and E-cadherin were correlated with clin. pathol. factors (P<0.01); furthermore, there was a pos. correlation between the expression levels of HIF-1α and Snail (r = 0.231; P = 0.021), and a neg. correlation between the expression levels of Snail and that of E-cadherin (r = -0.225; P = 0.028).  HIF-1α was suggested to be able to suppress the expression of E-cadherin by upregulating Snail, thus serving an important role in invasion and metastasis of ovarian cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpKFtewwPIX37Vg90H21EOLACvtfcHk0ljYfMoScqlrWw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhs1ems73P&md5=16cd4c5e54278f7f5bed67a3ce81ff3a</span></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.3892%2Fmmr.2015.3786&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3892%252Fmmr.2015.3786%26sid%3Dliteratum%253Aachs%26aulast%3DZhang%26aufirst%3DY.%26aulast%3DFan%26aufirst%3DN.%26aulast%3DYang%26aufirst%3DJ.%26atitle%3DExpression%2520and%2520clinical%2520significance%2520of%2520hypoxia-inducible%2520factor%25201alpha%252C%2520Snail%2520and%2520E-cadherin%2520in%2520human%2520ovarian%2520cancer%2520cell%2520lines%26jtitle%3DMol.%2520Med.%2520Rep.%26date%3D2015%26volume%3D12%26spage%3D3393%26epage%3D3399%26doi%3D10.3892%2Fmmr.2015.3786" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref14"><div class="reference"><strong class="refLabel"><a href="#ref14" class="rightTabRefNumLink">14</a></strong><div class="NLM_citation" id="rightTab-cit14"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Yang, M.-H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, M.-Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chiou, S.-H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, P.-M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chang, S.-Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, C.-J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Teng, S.-C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, K.-J.</span></span> <span> </span><span class="NLM_article-title">Direct regulation of TWIST by HIF-1alpha promotes metastasis</span>. <i>Nat. Cell Biol.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>10</i></span>,  <span class="NLM_fpage">295</span>– <span class="NLM_lpage">305</span>, <span class="refDoi"> DOI: 10.1038/ncb1691</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01313&amp;key=10.1038%2Fncb1691" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01313&amp;key=18297062" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01313&amp;key=1%3ACAS%3A528%3ADC%252BD1cXislaksrc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2008&pages=295-305&author=M.-H.+Yangauthor=M.-Z.+Wuauthor=S.-H.+Chiouauthor=P.-M.+Chenauthor=S.-Y.+Changauthor=C.-J.+Liuauthor=S.-C.+Tengauthor=K.-J.+Wu&title=Direct+regulation+of+TWIST+by+HIF-1alpha+promotes+metastasis&doi=10.1038%2Fncb1691"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit14R"><div class="casContent"><span class="casTitleNuber">14</span><div class="casTitle"><span class="NLM_cas:atitle">Direct regulation of TWIST by HIF-1α promotes metastasis</span></div><div class="casAuthors">Yang, Muh-Hwa; Wu, Min-Zu; Chiou, Shih-Hwa; Chen, Po-Min; Chang, Shyue-Yih; Liu, Chung-Ji; Teng, Shu-Chun; Wu, Kou-Juey</div><div class="citationInfo"><span class="NLM_cas:title">Nature Cell Biology</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">295-305</span>CODEN:
                <span class="NLM_cas:coden">NCBIFN</span>;
        ISSN:<span class="NLM_cas:issn">1465-7392</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Stabilization of the hypoxia-inducible factor-1α (HIF-1α) transcription complex, caused by intratumoral hypoxia, promotes tumor progression and metastasis, leading to treatment failure and mortality in different types of human cancers.  The transcription factor TWIST is a master regulator of gastrulation and mesoderm-specification and was implicated recently as an essential mediator of cancer metastasis.  Notably, HIF-1α- and TWIST-null mice show similarities in their phenotypes.  Here, we have shown that hypoxia or overexpression of HIF-1α promotes epithelial-mesenchymal transition (EMT) and metastastic phenotypes.  We also found that HIF-1 regulates the expression of TWIST by binding directly to the hypoxia-response element (HRE) in the TWIST proximal promoter.  However, siRNA-mediated repression of TWIST in HIF-1α-overexpressing or hypoxic cells reversed EMT and metastastic phenotypes.  Co-expression of HIF-1α, TWIST and Snail in primary tumors of patients with head and neck cancers correlated with metastasis and the worst prognosis.  These results provide evidence of a key signaling pathway involving HIF-1α and TWIST that promotes metastasis in response to intratumoral hypoxia.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrXoQyicb8skrVg90H21EOLACvtfcHk0ljYfMoScqlrWw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXislaksrc%253D&md5=492e76f95a453888ebd82b14273873ea</span></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1038%2Fncb1691&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fncb1691%26sid%3Dliteratum%253Aachs%26aulast%3DYang%26aufirst%3DM.-H.%26aulast%3DWu%26aufirst%3DM.-Z.%26aulast%3DChiou%26aufirst%3DS.-H.%26aulast%3DChen%26aufirst%3DP.-M.%26aulast%3DChang%26aufirst%3DS.-Y.%26aulast%3DLiu%26aufirst%3DC.-J.%26aulast%3DTeng%26aufirst%3DS.-C.%26aulast%3DWu%26aufirst%3DK.-J.%26atitle%3DDirect%2520regulation%2520of%2520TWIST%2520by%2520HIF-1alpha%2520promotes%2520metastasis%26jtitle%3DNat.%2520Cell%2520Biol.%26date%3D2008%26volume%3D10%26spage%3D295%26epage%3D305%26doi%3D10.1038%2Fncb1691" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref15"><div class="reference"><strong class="refLabel"><a href="#ref15" class="rightTabRefNumLink">15</a></strong><div class="NLM_citation" id="rightTab-cit15"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kilic, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kasperczyk, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fulda, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Debatin, K.-M.</span></span> <span> </span><span class="NLM_article-title">Role of hypoxia inducible factor-1 alpha in modulation of apoptosis resistance</span>. <i>Oncogene</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>26</i></span>,  <span class="NLM_fpage">2027</span>– <span class="NLM_lpage">2038</span>, <span class="refDoi"> DOI: 10.1038/sj.onc.1210008</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01313&amp;key=10.1038%2Fsj.onc.1210008" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01313&amp;key=17043658" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01313&amp;key=1%3ACAS%3A528%3ADC%252BD2sXjsFSiu70%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=26&publication_year=2007&pages=2027-2038&author=M.+Kilicauthor=H.+Kasperczykauthor=S.+Fuldaauthor=K.-M.+Debatin&title=Role+of+hypoxia+inducible+factor-1+alpha+in+modulation+of+apoptosis+resistance&doi=10.1038%2Fsj.onc.1210008"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit15R"><div class="casContent"><span class="casTitleNuber">15</span><div class="casTitle"><span class="NLM_cas:atitle">Role of hypoxia inducible factor-1 alpha in modulation of apoptosis resistance</span></div><div class="casAuthors">Kilic, M.; Kasperczyk, H.; Fulda, S.; Debatin, K.-M.</div><div class="citationInfo"><span class="NLM_cas:title">Oncogene</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">26</span>
        (<span class="NLM_cas:issue">14</span>),
    <span class="NLM_cas:pages">2027-2038</span>CODEN:
                <span class="NLM_cas:coden">ONCNES</span>;
        ISSN:<span class="NLM_cas:issn">0950-9232</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Hypoxia inducible factor-1 (HIF-1) is the major transcription factor and key regulator of adoptive responses to hypoxia.  Although it usually promotes tumor cell survival under hypoxia, it has also been implied to trigger apoptosis.  Although the impact of hypoxia has been extensively studied in many adult solid tumors, its role in most childhood tumors, for example, in rhabdomyosarcoma (RMS) or Ewing sarcoma (ES), has not yet been addressed.  Here, we report that hypoxia protects A204 RMS and A673 ES cells against anticancer drug- or tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis and that Hif-1α plays a key role in conferring apoptosis resistance under hypoxia.  Although a functional HIF-1 pathway and proapoptotic proteins such as p53 and Bcl-2/E1B 19 kDa interacting protein 3 were activated under hypoxia in both A204 RMS and A673 ES cells, these cells remained refractory to apoptosis.  Concomitant anal. of antiapoptotic proteins revealed that hypoxia induced expression of Bcl-2 and inhibitor of apoptosis proteins (IAP)-2 as well as proteins assocd. with anaerobic metab. such as the glucose transporter protein GLUT-1 and the glycolytic enzyme Aldolase A.  Specific downregulation of Hif-1α by RNA interference significantly enhanced apoptosis under hypoxia by preventing the hypoxia-mediated increase in GLUT-1 expression without altering expression levels of the antiapoptotic proteins Bcl-2 or cIAP-2.  Moreover, glucose deprivation-induced apoptosis of A204 RMS and A673 ES cells was inhibited under hypoxic conditions in a Hif-1α-dependent manner.  As GLUT-1 was induced via Hif-1α under hypoxia in A204 RMS and A673 ES, these findings suggest that the Hif-1α-mediated increase in glucose uptake plays an important role in conferring apoptosis resistance.  Thus, hypoxia-inducible genes may represent novel targets for therapeutic intervention in some pediatric tumors, which warrants further investigation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrzZtyFtiJNKrVg90H21EOLACvtfcHk0lgYoM19RI_XUA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXjsFSiu70%253D&md5=cbbbad640345852b13ff09cc45179630</span></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1038%2Fsj.onc.1210008&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fsj.onc.1210008%26sid%3Dliteratum%253Aachs%26aulast%3DKilic%26aufirst%3DM.%26aulast%3DKasperczyk%26aufirst%3DH.%26aulast%3DFulda%26aufirst%3DS.%26aulast%3DDebatin%26aufirst%3DK.-M.%26atitle%3DRole%2520of%2520hypoxia%2520inducible%2520factor-1%2520alpha%2520in%2520modulation%2520of%2520apoptosis%2520resistance%26jtitle%3DOncogene%26date%3D2007%26volume%3D26%26spage%3D2027%26epage%3D2038%26doi%3D10.1038%2Fsj.onc.1210008" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref16"><div class="reference"><strong class="refLabel"><a href="#ref16" class="rightTabRefNumLink">16</a></strong><div class="NLM_citation" id="rightTab-cit16"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Semenza, G. L.</span></span> <span> </span><span class="NLM_article-title">Hypoxia-inducible factors: mediators of cancer progression and targets for cancer therapy</span>. <i>Trends Pharmacol. Sci.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>33</i></span>,  <span class="NLM_fpage">207</span>– <span class="NLM_lpage">214</span>, <span class="refDoi"> DOI: 10.1016/j.tips.2012.01.005</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01313&amp;key=10.1016%2Fj.tips.2012.01.005" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01313&amp;key=22398146" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01313&amp;key=1%3ACAS%3A528%3ADC%252BC38XjtlOrtbo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=33&publication_year=2012&pages=207-214&author=G.+L.+Semenza&title=Hypoxia-inducible+factors%3A+mediators+of+cancer+progression+and+targets+for+cancer+therapy&doi=10.1016%2Fj.tips.2012.01.005"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit16R"><div class="casContent"><span class="casTitleNuber">16</span><div class="casTitle"><span class="NLM_cas:atitle">Hypoxia-inducible factors: mediators of cancer progression and targets for cancer therapy</span></div><div class="casAuthors">Semenza, Gregg L.</div><div class="citationInfo"><span class="NLM_cas:title">Trends in Pharmacological Sciences</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">33</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">207-214</span>CODEN:
                <span class="NLM_cas:coden">TPHSDY</span>;
        ISSN:<span class="NLM_cas:issn">0165-6147</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">A review.  Hypoxia-inducible factors (HIFs) mediate adaptive physiol. responses to hypoxia.  In human cancers that are accessible for O2 electrode measurements, intratumoral hypoxia is common and severe hypoxia is assocd. with increased risk of mortality.  HIF activity in regions of intratumoral hypoxia mediates angiogenesis, epithelial-mesenchymal transition, stem-cell maintenance, invasion, metastasis, and resistance to radiation therapy and chemotherapy.  A growing no. of drugs have been identified that inhibit HIF activity by a variety of mol. mechanisms.  Because many of these drugs are already FDA-approved for other indications, clin. trials can (and should) be initiated to test the hypothesis that incorporation of HIF inhibitors into current std.-of-care therapy will increase the survival of cancer patients.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqPM2NYPLkLtLVg90H21EOLACvtfcHk0lgYoM19RI_XUA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XjtlOrtbo%253D&md5=30c19dccf0af3af16f766e577c2397ee</span></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1016%2Fj.tips.2012.01.005&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.tips.2012.01.005%26sid%3Dliteratum%253Aachs%26aulast%3DSemenza%26aufirst%3DG.%2BL.%26atitle%3DHypoxia-inducible%2520factors%253A%2520mediators%2520of%2520cancer%2520progression%2520and%2520targets%2520for%2520cancer%2520therapy%26jtitle%3DTrends%2520Pharmacol.%2520Sci.%26date%3D2012%26volume%3D33%26spage%3D207%26epage%3D214%26doi%3D10.1016%2Fj.tips.2012.01.005" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref17"><div class="reference"><strong class="refLabel"><a href="#ref17" class="rightTabRefNumLink">17</a></strong><div class="NLM_citation" id="rightTab-cit17"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wigerup, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Påhlman, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bexell, D.</span></span> <span> </span><span class="NLM_article-title">Therapeutic targeting of hypoxia and hypoxia-inducible factors in cancer</span>. <i>Pharmacol. Ther.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>164</i></span>,  <span class="NLM_fpage">152</span>– <span class="NLM_lpage">169</span>, <span class="refDoi"> DOI: 10.1016/j.pharmthera.2016.04.009</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01313&amp;key=10.1016%2Fj.pharmthera.2016.04.009" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01313&amp;key=27139518" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01313&amp;key=1%3ACAS%3A528%3ADC%252BC28XntlShsL4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=164&publication_year=2016&pages=152-169&author=C.+Wigerupauthor=S.+P%C3%A5hlmanauthor=D.+Bexell&title=Therapeutic+targeting+of+hypoxia+and+hypoxia-inducible+factors+in+cancer&doi=10.1016%2Fj.pharmthera.2016.04.009"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit17R"><div class="casContent"><span class="casTitleNuber">17</span><div class="casTitle"><span class="NLM_cas:atitle">Therapeutic targeting of hypoxia and hypoxia-inducible factors in cancer</span></div><div class="casAuthors">Wigerup, Caroline; Paahlman, Sven; Bexell, Daniel</div><div class="citationInfo"><span class="NLM_cas:title">Pharmacology & Therapeutics</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">164</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">152-169</span>CODEN:
                <span class="NLM_cas:coden">PHTHDT</span>;
        ISSN:<span class="NLM_cas:issn">0163-7258</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">Insufficient tissue oxygenation, or hypoxia, contributes to tumor aggressiveness and has a profound impact on clin. outcomes in cancer patients.  At decreased oxygen tensions, hypoxia-inducible factors (HIFs) 1 and 2 are stabilized and mediate a hypoxic response, primarily by acting as transcription factors.  HIFs exert differential effects on tumor growth and affect important cancer hallmarks including cell proliferation, apoptosis, differentiation, vascularization/angiogenesis, genetic instability, tumor metab., tumor immune responses, and invasion and metastasis.  As a consequence, HIFs mediate resistance to chemo- and radiotherapy and are assocd. with poor prognosis in cancer patients.  Intriguingly, perivascular tumor cells can also express HIF-2α, thereby forming a "pseudohypoxic" phenotype that further contributes to tumor aggressiveness.  Therefore, therapeutic targeting of HIFs in cancer has the potential to improve treatment efficacy.  Different strategies to target hypoxic cancer cells and/or HIFs include hypoxia-activated prodrugs and inhibition of HIF dimerization, mRNA or protein expression, DNA binding capacity, and transcriptional activity.  Here we review the functions of HIFs in the progression and treatment of malignant solid tumors.  We also highlight how HIFs may be targeted to improve the management of patients with therapy-resistant and metastatic cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpcq5JPjcEkgLVg90H21EOLACvtfcHk0li6a5Nch2jEWA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XntlShsL4%253D&md5=dd665626b2d715b0222ca666f237a316</span></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.1016%2Fj.pharmthera.2016.04.009&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.pharmthera.2016.04.009%26sid%3Dliteratum%253Aachs%26aulast%3DWigerup%26aufirst%3DC.%26aulast%3DP%25C3%25A5hlman%26aufirst%3DS.%26aulast%3DBexell%26aufirst%3DD.%26atitle%3DTherapeutic%2520targeting%2520of%2520hypoxia%2520and%2520hypoxia-inducible%2520factors%2520in%2520cancer%26jtitle%3DPharmacol.%2520Ther.%26date%3D2016%26volume%3D164%26spage%3D152%26epage%3D169%26doi%3D10.1016%2Fj.pharmthera.2016.04.009" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref18"><div class="reference"><strong class="refLabel"><a href="#ref18" class="rightTabRefNumLink">18</a></strong><div class="NLM_citation" id="rightTab-cit18"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Gao, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, J.-z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, C.-y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mao, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, L.-h.</span></span> <span> </span><span class="NLM_article-title">The mechanism between epithelial mesenchymal transition in breast cancer and hypoxia microenvironment</span>. <i>Biomed. Pharmacother.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>80</i></span>,  <span class="NLM_fpage">393</span>– <span class="NLM_lpage">405</span>, <span class="refDoi"> DOI: 10.1016/j.biopha.2016.02.044</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01313&amp;key=10.1016%2Fj.biopha.2016.02.044" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01313&amp;key=27133080" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01313&amp;key=1%3ACAS%3A528%3ADC%252BC28Xmt1Snt7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=80&publication_year=2016&pages=393-405&author=T.+Gaoauthor=J.-z.+Liauthor=Y.+Luauthor=C.-y.+Zhangauthor=Q.+Liauthor=J.+Maoauthor=L.-h.+Li&title=The+mechanism+between+epithelial+mesenchymal+transition+in+breast+cancer+and+hypoxia+microenvironment&doi=10.1016%2Fj.biopha.2016.02.044"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit18R"><div class="casContent"><span class="casTitleNuber">18</span><div class="casTitle"><span class="NLM_cas:atitle">The mechanism between epithelial mesenchymal transition in breast cancer and hypoxia microenvironment</span></div><div class="casAuthors">Gao, Tong; Li, Jia-zhi; Lu, Ying; Zhang, Chun-ying; Li, Qing; Mao, Jun; Li, Lian-hong</div><div class="citationInfo"><span class="NLM_cas:title">Biomedicine & Pharmacotherapy</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">80</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">393-405</span>CODEN:
                <span class="NLM_cas:coden">BIPHEX</span>;
        ISSN:<span class="NLM_cas:issn">0753-3322</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Masson SAS</span>)
        </div><div class="casAbstract">Hypoxia microenvironment widely exists in solid tumor tissues, which is mainly due to the rapid growth of cells within the tumor more than the speed of capillary in neoplasm, resulting in tumor tissue hypoxia.  In hypoxia, hypoxia inducible factor 1 (HIF-1) is activated and regulate the expression of a series of hypoxia inducible genes, resulting in a series of hypoxia adaptation reaction.  Researchs proved that, HIF-1 is closely related to the invasion, metastasis, prognosis of the tumor, and the expression of HIF-1 is higher in metastatic tissues compared with primary cancer tissues.  In the evolution process of breast cancer, epithelial mesenchymal transition (EMT) define the characteristics of migration and invasion of breast cancer cells, which can also allow cancer cells to acquire the ability of self-renewing and stemness, so as to promote the generation of breast cancer stem cells.  The incidence of EMT cancer stem cells are higher within the resistant to conventional treatment.  This review focuses on breast cancer (stem cells), targeting the mechanism between hypoxia and EMT in tumor (stem cells), with the purpose of finding the new therapy to breast cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr-cNeWyCyy5bVg90H21EOLACvtfcHk0li6a5Nch2jEWA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28Xmt1Snt7g%253D&md5=3265ab1c4a2fc837178c31a8af962b3d</span></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1016%2Fj.biopha.2016.02.044&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.biopha.2016.02.044%26sid%3Dliteratum%253Aachs%26aulast%3DGao%26aufirst%3DT.%26aulast%3DLi%26aufirst%3DJ.-z.%26aulast%3DLu%26aufirst%3DY.%26aulast%3DZhang%26aufirst%3DC.-y.%26aulast%3DLi%26aufirst%3DQ.%26aulast%3DMao%26aufirst%3DJ.%26aulast%3DLi%26aufirst%3DL.-h.%26atitle%3DThe%2520mechanism%2520between%2520epithelial%2520mesenchymal%2520transition%2520in%2520breast%2520cancer%2520and%2520hypoxia%2520microenvironment%26jtitle%3DBiomed.%2520Pharmacother.%26date%3D2016%26volume%3D80%26spage%3D393%26epage%3D405%26doi%3D10.1016%2Fj.biopha.2016.02.044" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref19"><div class="reference"><strong class="refLabel"><a href="#ref19" class="rightTabRefNumLink">19</a></strong><div class="NLM_citation" id="rightTab-cit19"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Unwith, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhao, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hennah, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ma, D.</span></span> <span> </span><span class="NLM_article-title">The potential role of HIF on tumour progression and dissemination</span>. <i>Int. J. Cancer</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>136</i></span>,  <span class="NLM_fpage">2491</span>– <span class="NLM_lpage">2503</span>, <span class="refDoi"> DOI: 10.1002/ijc.28889</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01313&amp;key=10.1002%2Fijc.28889" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01313&amp;key=24729302" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01313&amp;key=1%3ACAS%3A528%3ADC%252BC2cXmvFSjtb8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=136&publication_year=2015&pages=2491-2503&author=S.+Unwithauthor=H.+Zhaoauthor=L.+Hennahauthor=D.+Ma&title=The+potential+role+of+HIF+on+tumour+progression+and+dissemination&doi=10.1002%2Fijc.28889"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit19R"><div class="casContent"><span class="casTitleNuber">19</span><div class="casTitle"><span class="NLM_cas:atitle">The potential role of HIF on tumour progression and dissemination</span></div><div class="casAuthors">Unwith, Sandeep; Zhao, Hailin; Hennah, Lindsay; Ma, Daqing</div><div class="citationInfo"><span class="NLM_cas:title">International Journal of Cancer</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">136</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">2491-2503</span>CODEN:
                <span class="NLM_cas:coden">IJCNAW</span>;
        ISSN:<span class="NLM_cas:issn">0020-7136</span>.
    
            (<span class="NLM_cas:orgname">John Wiley & Sons, Inc.</span>)
        </div><div class="casAbstract">A review.  Cancer is the second cause of mortality worldwide, primarily owing to failure to cure metastatic disease.  The need to target the metastatic process to reduce mortality is clear and research over the past decade has shown hypoxia-inducible factor-1 (HIF-1) to be one of the promising targets.  In order for metastatic disease to be established, multiple steps need to be taken whereby the tumor cells escape into the bloodstream and survive, disseminate and then establish at a premetastatic niche.  HIF-1 mediates hypoxia-induced proangiogenic factors such as vascular endothelial growth factor (VEGF) and platelet-derived growth factor (PDGF), which promote extravasation and chemotaxis.  The migration of tumor cells is mediated by loss of E-cadherin, which results in a more invasive phenotype; dissemination of the tumor cells by increased vascular permeability and survival in the bloodstream through resistance to apoptosis as well as adhesion at the premetastatic niche are all controlled by factors under the influence of HIF-1.  The overexpression of HIF in many aggressive cancer types as well as its role in the establishment of metastatic disease and treatment resistance demonstrate its potential target in therapeutics.  Taken together, the role of HIF-1 in cancer and metastatic disease is clear and the need for better treatment targeting metastases is paramount; more aggressive phenotypes with less response to treatment are assocd. with HIF-1 expression.  Our research has shown promise but many questions still remain to be answered.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq1wPlP2LNU9LVg90H21EOLACvtfcHk0lhexvb60F7uIg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXmvFSjtb8%253D&md5=f5ceebdee488affc039c6cde93c59523</span></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1002%2Fijc.28889&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fijc.28889%26sid%3Dliteratum%253Aachs%26aulast%3DUnwith%26aufirst%3DS.%26aulast%3DZhao%26aufirst%3DH.%26aulast%3DHennah%26aufirst%3DL.%26aulast%3DMa%26aufirst%3DD.%26atitle%3DThe%2520potential%2520role%2520of%2520HIF%2520on%2520tumour%2520progression%2520and%2520dissemination%26jtitle%3DInt.%2520J.%2520Cancer%26date%3D2015%26volume%3D136%26spage%3D2491%26epage%3D2503%26doi%3D10.1002%2Fijc.28889" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref20"><div class="reference"><strong class="refLabel"><a href="#ref20" class="rightTabRefNumLink">20</a></strong><div class="NLM_citation" id="rightTab-cit20"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Moon, E. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brizel, D. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chi, J. T. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dewhirst, M. W.</span></span> <span> </span><span class="NLM_article-title">The potential role of intrinsic hypoxia markers as prognostic variables in cancer</span>. <i>Antioxid. Redox Signaling</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>9</i></span>,  <span class="NLM_fpage">1237</span>– <span class="NLM_lpage">1294</span>, <span class="refDoi"> DOI: 10.1089/ars.2007.1623</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01313&amp;key=10.1089%2Fars.2007.1623" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01313&amp;key=17571959" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01313&amp;key=1%3ACAS%3A528%3ADC%252BD2sXot1WktL8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2007&pages=1237-1294&author=E.+J.+Moonauthor=D.+M.+Brizelauthor=J.+T.+A.+Chiauthor=M.+W.+Dewhirst&title=The+potential+role+of+intrinsic+hypoxia+markers+as+prognostic+variables+in+cancer&doi=10.1089%2Fars.2007.1623"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit20R"><div class="casContent"><span class="casTitleNuber">20</span><div class="casTitle"><span class="NLM_cas:atitle">The potential role of intrinsic hypoxia markers as prognostic variables in cancer</span></div><div class="casAuthors">Moon, Eui Jung; Brizel, David M.; Chi, Jen-Tsan Ashley; Dewhirst, Mark W.</div><div class="citationInfo"><span class="NLM_cas:title">Antioxidants & Redox Signaling</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">1237-1294</span>CODEN:
                <span class="NLM_cas:coden">ARSIF2</span>;
        ISSN:<span class="NLM_cas:issn">1523-0864</span>.
    
            (<span class="NLM_cas:orgname">Mary Ann Liebert, Inc.</span>)
        </div><div class="casAbstract">A review.  Tumor hypoxia is related to tumor progression and therapy resistance, which leads to poor patient outcome.  It was suggested that measuring the hypoxic status of a tumor helps to predict patient outcome and to select more targeted treatment.  However, current methods using needle electrodes or exogenous markers have limitations due to their invasiveness or necessity for preinjection.  Recent studies showed that hypoxia-regulated genes could be alternatively used as endogenous hypoxia markers.  This is a review of 15 hypoxia-regulated genes, including hypoxia-inducible factor-1 and its targets, and their correlation with tumor hypoxia and patient outcome from 213 studies.  Though most of the studies showed significance of these genes in predicting prognosis, there was no definitive prognostic and hypoxia marker.  In conclusion, this review suggests the need for further studies with standardized methods to examine gene expression, as well as the use of multiple gene expressions.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpY758k83PGjbVg90H21EOLACvtfcHk0lhexvb60F7uIg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXot1WktL8%253D&md5=61a4f08cd5644ffdc91b45634f96b8af</span></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1089%2Fars.2007.1623&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1089%252Fars.2007.1623%26sid%3Dliteratum%253Aachs%26aulast%3DMoon%26aufirst%3DE.%2BJ.%26aulast%3DBrizel%26aufirst%3DD.%2BM.%26aulast%3DChi%26aufirst%3DJ.%2BT.%2BA.%26aulast%3DDewhirst%26aufirst%3DM.%2BW.%26atitle%3DThe%2520potential%2520role%2520of%2520intrinsic%2520hypoxia%2520markers%2520as%2520prognostic%2520variables%2520in%2520cancer%26jtitle%3DAntioxid.%2520Redox%2520Signaling%26date%3D2007%26volume%3D9%26spage%3D1237%26epage%3D1294%26doi%3D10.1089%2Fars.2007.1623" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref21"><div class="reference"><strong class="refLabel"><a href="#ref21" class="rightTabRefNumLink">21</a></strong><div class="NLM_citation" id="rightTab-cit21"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Chen, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lou, T.</span></span> <span> </span><span class="NLM_article-title">Hypoxia inducible factors in hepatocellular carcinoma</span>. <i>OncoTarget</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>8</i></span>,  <span class="NLM_fpage">46691</span>– <span class="NLM_lpage">46703</span>, <span class="refDoi"> DOI: 10.18632/oncotarget.17358</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01313&amp;key=10.18632%2Foncotarget.17358" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01313&amp;key=28493839" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01313&amp;key=1%3ACAS%3A280%3ADC%252BC1crmt1ChtQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2017&pages=46691-46703&author=C.+Chenauthor=T.+Lou&title=Hypoxia+inducible+factors+in+hepatocellular+carcinoma&doi=10.18632%2Foncotarget.17358"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit21R"><div class="casContent"><span class="casTitleNuber">21</span><div class="casTitle"><span class="NLM_cas:atitle">Hypoxia inducible factors in hepatocellular carcinoma</span></div><div class="casAuthors">Chen Chu; Lou Tao</div><div class="citationInfo"><span class="NLM_cas:title">Oncotarget</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">28</span>),
    <span class="NLM_cas:pages">46691-46703</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Hepatocellular carcinoma is one of the most prevalent and lethal cancers with limited therapeutic options.  Pathogenesis of this disease involves tumor hypoxia and the activation of hypoxia inducible factors.  In this review, we describe the current understanding of hypoxia signaling pathway and summarize the expression, function and target genes of hypoxia inducible factors in hepatocellular carcinoma.  We also highlight the recent progress in hypoxia-targeted therapeutic strategies in hepatocellular carcinoma and discuss further the future efforts for the study of hypoxia and/or hypoxia inducible factors in this deadly disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRGR3Xe914MjnO4gDb7JggCfW6udTcc2eaXhm2HpZ1MRrntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC1crmt1ChtQ%253D%253D&md5=681c87740269e5f65b21bb082c2e789b</span></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.18632%2Foncotarget.17358&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.18632%252Foncotarget.17358%26sid%3Dliteratum%253Aachs%26aulast%3DChen%26aufirst%3DC.%26aulast%3DLou%26aufirst%3DT.%26atitle%3DHypoxia%2520inducible%2520factors%2520in%2520hepatocellular%2520carcinoma%26jtitle%3DOncoTarget%26date%3D2017%26volume%3D8%26spage%3D46691%26epage%3D46703%26doi%3D10.18632%2Foncotarget.17358" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref22"><div class="reference"><strong class="refLabel"><a href="#ref22" class="rightTabRefNumLink">22</a></strong><div class="NLM_citation" id="rightTab-cit22"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kim, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cho, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chung, J.-Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Conway, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ylaya, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, J.-H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hewitt, S. M.</span></span> <span> </span><span class="NLM_article-title">Prognostic assessment of hypoxia and metabolic markers in cervical cancer using automated digital image analysis of immunohistochemistry</span>. <i>J. Transl. Med.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>11</i></span>,  <span class="NLM_fpage">185</span>, <span class="refDoi"> DOI: 10.1186/1479-5876-11-185</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01313&amp;key=10.1186%2F1479-5876-11-185" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01313&amp;key=23927384" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01313&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhtlaqtrrE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2013&pages=185&author=B.+Kimauthor=H.+Choauthor=J.-Y.+Chungauthor=C.+Conwayauthor=K.+Ylayaauthor=J.-H.+Kimauthor=S.+M.+Hewitt&title=Prognostic+assessment+of+hypoxia+and+metabolic+markers+in+cervical+cancer+using+automated+digital+image+analysis+of+immunohistochemistry&doi=10.1186%2F1479-5876-11-185"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit22R"><div class="casContent"><span class="casTitleNuber">22</span><div class="casTitle"><span class="NLM_cas:atitle">Prognostic assessment of hypoxia and metabolic markers in cervical cancer using automated digital image analysis of immunohistochemistry</span></div><div class="casAuthors">Kim, Bo Wook; Cho, Hanbyoul; Chung, Joon-Yong; Conway, Catherine; Ylaya, Kris; Kim, Jae-Hoon; Hewitt, Stephen M.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Translational Medicine</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">185</span>CODEN:
                <span class="NLM_cas:coden">JTMOBV</span>;
        ISSN:<span class="NLM_cas:issn">1479-5876</span>.
    
            (<span class="NLM_cas:orgname">BioMed Central Ltd.</span>)
        </div><div class="casAbstract">Background: Hypoxia inducible factor-1 alpha (HIF-1α), induced by tumor hypoxia, regulates tumor cell metab. and metastasis by up-regulation of c-Met, carbonic anhydrase 9 (CA9) and glucose transporter 1 (GLUT1).  The prognostic significance of hypoxia and metabolic markers is not clearly defined in cervical cancer.  Here, we have examd. the primary players in the hypoxia signaling pathway, by immunohistochem., but confirming their interactions, as well as defining which proteins are assocd. with outcome.  Methods: The study subjects were comprised of cervical intraepithelial neoplasia (CIN, n = 209), carcinoma in situ (CIS, n = 74), cervical cancer (n = 179), and matched nonadjacent normal tissues (n = 357).  Immunohistochem. (IHC) was performed to identify HIF-1α, c-Met, CA9, and GLUT1.  IHC scoring was performed using automated digital image anal. and the assocn. of hypoxic markers with prognostic outcome was evaluated.  Results: HIF-1α, c-Met, CA9 and GLUT1 expression were higher in cervical cancer than in CIN and normal cervix (all P < 0.001).  Among these markers, expression of HIF-1α and c-Met were significantly different in FIGO stage (P < 0.001 and P = 0.019, resp.) and patients with lymph node metastasis (P < 0.001 and P = 0.010, resp.).  HIF-1α expression was correlated with c-Met expression in cervical cancer (P < 0.001).  High expression of HIF-1α and c-Met showed worse 5-yr overall survival rate (P = 0.047 and P = 0.005, resp.) than low expression group, but CA9 and GLUT1 did not show significant survival difference.  After adjusting the prognostic covariates, c-Met was found to be an independent risk factor (HR = 3.27; 95% CI, 1.05-10.23, P = 0.041) for overall survival in cervical cancer.  Conclusions: We demonstrate that c-Met correlates with HIF-1α and is a poor prognostic factor in survival in cervical cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqQyodm2eH-0LVg90H21EOLACvtfcHk0lh37oAOvRMmlA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhtlaqtrrE&md5=0f6a2bc01e1caf3538b71111f859b204</span></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1186%2F1479-5876-11-185&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1186%252F1479-5876-11-185%26sid%3Dliteratum%253Aachs%26aulast%3DKim%26aufirst%3DB.%26aulast%3DCho%26aufirst%3DH.%26aulast%3DChung%26aufirst%3DJ.-Y.%26aulast%3DConway%26aufirst%3DC.%26aulast%3DYlaya%26aufirst%3DK.%26aulast%3DKim%26aufirst%3DJ.-H.%26aulast%3DHewitt%26aufirst%3DS.%2BM.%26atitle%3DPrognostic%2520assessment%2520of%2520hypoxia%2520and%2520metabolic%2520markers%2520in%2520cervical%2520cancer%2520using%2520automated%2520digital%2520image%2520analysis%2520of%2520immunohistochemistry%26jtitle%3DJ.%2520Transl.%2520Med.%26date%3D2013%26volume%3D11%26spage%3D185%26doi%3D10.1186%2F1479-5876-11-185" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref23"><div class="reference"><strong class="refLabel"><a href="#ref23" class="rightTabRefNumLink">23</a></strong><div class="NLM_citation" id="rightTab-cit23"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Xia, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Choi, H.-K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, K.</span></span> <span> </span><span class="NLM_article-title">Recent advances in hypoxia-inducible factor (HIF)-1 inhibitors</span>. <i>Eur. J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>49</i></span>,  <span class="NLM_fpage">24</span>– <span class="NLM_lpage">40</span>, <span class="refDoi"> DOI: 10.1016/j.ejmech.2012.01.033</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01313&amp;key=10.1016%2Fj.ejmech.2012.01.033" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01313&amp;key=22305612" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01313&amp;key=1%3ACAS%3A528%3ADC%252BC38XisFOrs7w%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=49&publication_year=2012&pages=24-40&author=Y.+Xiaauthor=H.-K.+Choiauthor=K.+Lee&title=Recent+advances+in+hypoxia-inducible+factor+%28HIF%29-1+inhibitors&doi=10.1016%2Fj.ejmech.2012.01.033"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit23R"><div class="casContent"><span class="casTitleNuber">23</span><div class="casTitle"><span class="NLM_cas:atitle">Recent advances in hypoxia-inducible factor (HIF)-1 inhibitors</span></div><div class="casAuthors">Xia, Yan; Choi, Hyun-Kyung; Lee, Kyeong</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">49</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">24-40</span>CODEN:
                <span class="NLM_cas:coden">EJMCA5</span>;
        ISSN:<span class="NLM_cas:issn">0223-5234</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Masson SAS</span>)
        </div><div class="casAbstract">A review.  Tumor hypoxia has been recognized as a common feature of solid tumors and a neg. prognostic factor for response to treatment and survival of cancer patients.  The discovery of hypoxia-inducible factor-1 (HIF-1), a mol. determinant of responses to hypoxia in mammalian cells, has renewed enthusiasm for discovery and development of targeted therapies exploiting the hypoxic tumor microenvironment.  HIF-1 activity in tumors depends on availability of the HIF-1α subunit, the levels of which increase under hypoxic conditions and through activation of oncogenes and/or inactivation of tumor suppressor genes.  Increased HIF-1 has been correlated with increased angiogenesis, aggressive tumor growth, and poor patient prognosis, leading to current interest in HIF-1 as promising anticancer drug target.  In spite of an ever increasing no. of putative small mol. inhibitors of HIF-1, only a few are progressing through preclin. and early clin. development.  In this review, we will discuss recent advances in discovery and development of small mol. inhibitors that target the HIF-1 pathway as potential anticancer agents.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrV9MyS5Xicm7Vg90H21EOLACvtfcHk0ljNe7IGk2u-qQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XisFOrs7w%253D&md5=04225108ab97c18845f7760ac4027185</span></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.1016%2Fj.ejmech.2012.01.033&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejmech.2012.01.033%26sid%3Dliteratum%253Aachs%26aulast%3DXia%26aufirst%3DY.%26aulast%3DChoi%26aufirst%3DH.-K.%26aulast%3DLee%26aufirst%3DK.%26atitle%3DRecent%2520advances%2520in%2520hypoxia-inducible%2520factor%2520%2528HIF%2529-1%2520inhibitors%26jtitle%3DEur.%2520J.%2520Med.%2520Chem.%26date%3D2012%26volume%3D49%26spage%3D24%26epage%3D40%26doi%3D10.1016%2Fj.ejmech.2012.01.033" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref24"><div class="reference"><strong class="refLabel"><a href="#ref24" class="rightTabRefNumLink">24</a></strong><div class="NLM_citation" id="rightTab-cit24"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bhattarai, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, K.</span></span> <span> </span><span class="NLM_article-title">Hypoxia-inducible factor-1 (HIF-1) inhibitors from the last decade (2007 to 2016): A “structure-activity relationship” perspective</span>. <i>Med. Res. Rev.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>38</i></span>,  <span class="NLM_fpage">1404</span>– <span class="NLM_lpage">1442</span>, <span class="refDoi"> DOI: 10.1002/med.21477</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01313&amp;key=10.1002%2Fmed.21477" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01313&amp;key=29278273" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01313&amp;key=1%3ACAS%3A280%3ADC%252BC1MzltF2ntA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=38&publication_year=2018&pages=1404-1442&author=D.+Bhattaraiauthor=X.+Xuauthor=K.+Lee&title=Hypoxia-inducible+factor-1+%28HIF-1%29+inhibitors+from+the+last+decade+%282007+to+2016%29%3A+A+%E2%80%9Cstructure-activity+relationship%E2%80%9D+perspective&doi=10.1002%2Fmed.21477"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit24R"><div class="casContent"><span class="casTitleNuber">24</span><div class="casTitle"><span class="NLM_cas:atitle">Hypoxia-inducible factor-1 (HIF-1) inhibitors from the last decade (2007 to 2016): A "structure-activity relationship" perspective</span></div><div class="casAuthors">Bhattarai Deepak; Xu Xuezhen; Lee Kyeong</div><div class="citationInfo"><span class="NLM_cas:title">Medicinal research reviews</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">38</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">1404-1442</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Tumor hypoxia is a common feature in most solid tumors and is associated with overexpression of the hypoxia response pathway.  Overexpression of the hypoxia-inducible factor (HIF-1) protein leads to angiogenesis, metastasis, apoptosis resistance, and many other pro-tumorigenic responses in cancer development.  HIF-1 is a promising target in cancer drug development to increase the patient's response to chemotherapy and radiotherapy as well as the survival rate of cancer patients.  Since up to 1% of genes are hypoxia-sensitive, a target-specific HIF-1 inhibitor may be a better clinical candidate in cancer drug discovery.  Though no HIF-1 inhibitor is clinically available to date, a lot of effort has been applied during the last decade in search of potent HIF-1 inhibitors.  In this review, we will summarize the structure-activity relationship of ten different chemotypes reported to be HIF-1 inhibitors in the last decade (2007-2016), their mechanisms of action for HIF-1 inhibition, progress in the way of target-specific inhibitors, and problems associated with current inhibitors.  It is anticipated that the results of these research on the medicinal chemistry of HIF-1 inhibitors will provide decent information in the design and development of future inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTbzu6FaBO8zi-bLEOO4dYpfW6udTcc2eZmh3-OpXBegbntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC1MzltF2ntA%253D%253D&md5=c16ce6fa0369517b394adfb782551141</span></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.1002%2Fmed.21477&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fmed.21477%26sid%3Dliteratum%253Aachs%26aulast%3DBhattarai%26aufirst%3DD.%26aulast%3DXu%26aufirst%3DX.%26aulast%3DLee%26aufirst%3DK.%26atitle%3DHypoxia-inducible%2520factor-1%2520%2528HIF-1%2529%2520inhibitors%2520from%2520the%2520last%2520decade%2520%25282007%2520to%25202016%2529%253A%2520A%2520%25E2%2580%259Cstructure-activity%2520relationship%25E2%2580%259D%2520perspective%26jtitle%3DMed.%2520Res.%2520Rev.%26date%3D2018%26volume%3D38%26spage%3D1404%26epage%3D1442%26doi%3D10.1002%2Fmed.21477" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref25"><div class="reference"><strong class="refLabel"><a href="#ref25" class="rightTabRefNumLink">25</a></strong><div class="NLM_citation" id="rightTab-cit25"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Li, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">You, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, X.</span></span> <span> </span><span class="NLM_article-title">Small-molecule modulators of the hypoxia-inducible factor pathway: development and therapeutic applications</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>62</i></span>,  <span class="NLM_fpage">5725</span>– <span class="NLM_lpage">5749</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.8b01596</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.8b01596" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01313&amp;key=1%3ACAS%3A528%3ADC%252BC1MXhvFGqtLg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=62&publication_year=2019&pages=5725-5749&author=Z.+Liauthor=Q.+Youauthor=X.+Zhang&title=Small-molecule+modulators+of+the+hypoxia-inducible+factor+pathway%3A+development+and+therapeutic+applications&doi=10.1021%2Facs.jmedchem.8b01596"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit25R"><div class="casContent"><span class="casTitleNuber">25</span><div class="casTitle"><span class="NLM_cas:atitle">Small-Molecule Modulators of the Hypoxia-Inducible Factor Pathway: Development and Therapeutic Applications</span></div><div class="casAuthors">Li, Zhihong; You, Qidong; Zhang, Xiaojin</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">62</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">5725-5749</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.  Hypoxia-inducible factor (HIF) is a central regulator involved in detection and adaptation to cellular oxygen stress through regulation of the hypoxic transcriptional program in angiogenesis, erythropoiesis, and metab.  The HIF pathway is involved in many diseases.  On one hand, overexpression of the HIF pathway is assocd. with solid tumors such as renal cell carcinoma (RCC).  On the other hand, suppression of the HIF pathway is correlated with inflammatory, anemia, and other hypoxic-ischemic diseases.  Therefore, modulation of the HIF pathway has been perceived as a promising strategy for treating HIF-related diseases.  Recent advances in understanding of the biochem. underlying the HIF pathway have stimulated small-mol. drugs development, and therapeutically, manipulation of the HIF-mediated response has been shown to have considerable medicinal potential.  This review will summarize and provide insight into recent advances in research that have expanded our knowledge of the HIF pathway, including its structural basis and biol., small-mol. modulators of the pathway, including inhibitors and activators, and the potential therapeutic applications of these modulators.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq1CIlpGTSGObVg90H21EOLACvtfcHk0ljcsn9CmisezQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXhvFGqtLg%253D&md5=69545930cfad7f091615f9b38d2661f3</span></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.8b01596&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.8b01596%26sid%3Dliteratum%253Aachs%26aulast%3DLi%26aufirst%3DZ.%26aulast%3DYou%26aufirst%3DQ.%26aulast%3DZhang%26aufirst%3DX.%26atitle%3DSmall-molecule%2520modulators%2520of%2520the%2520hypoxia-inducible%2520factor%2520pathway%253A%2520development%2520and%2520therapeutic%2520applications%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2019%26volume%3D62%26spage%3D5725%26epage%3D5749%26doi%3D10.1021%2Facs.jmedchem.8b01596" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref26"><div class="reference"><strong class="refLabel"><a href="#ref26" class="rightTabRefNumLink">26</a></strong><div class="NLM_citation" id="rightTab-cit26"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lee, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, J. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Boovanahalli, S. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jin, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jin, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, J. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hong, Y.-S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, J. J.</span></span> <span> </span><span class="NLM_article-title">(Aryloxyacetylamino)benzoic acid analogues: a new class of hypoxia-inducible factor-1 inhibitors</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>50</i></span>,  <span class="NLM_fpage">1675</span>– <span class="NLM_lpage">1684</span>, <span class="refDoi"> DOI: 10.1021/jm0610292</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm0610292" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01313&amp;key=1%3ACAS%3A528%3ADC%252BD2sXitlSitbg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=50&publication_year=2007&pages=1675-1684&author=K.+Leeauthor=J.+H.+Leeauthor=S.+K.+Boovanahalliauthor=Y.+Jinauthor=M.+Leeauthor=X.+Jinauthor=J.+H.+Kimauthor=Y.-S.+Hongauthor=J.+J.+Lee&title=%28Aryloxyacetylamino%29benzoic+acid+analogues%3A+a+new+class+of+hypoxia-inducible+factor-1+inhibitors&doi=10.1021%2Fjm0610292"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit26R"><div class="casContent"><span class="casTitleNuber">26</span><div class="casTitle"><span class="NLM_cas:atitle">(Aryloxyacetylamino)benzoic Acid Analogues: A New Class of Hypoxia-Inducible Factor-1 Inhibitors</span></div><div class="casAuthors">Lee, Kyeong; Lee, Jeong Hyung; Boovanahalli, Shanthaveerappa K.; Jin, Yinglan; Lee, Mijeoung; Jin, Xuejun; Kim, Jin Hwan; Hong, Young-Soo; Lee, Jung Joon</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">50</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">1675-1684</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Structural modification of a compd. discovered during screening using an HRE-dependent reporter assay has revealed a novel class of HIF-1 inhibitors, which potently inhibit the HIF-1α protein accumulation and its target gene expression under hypoxic conditions in human hepatocellular carcinoma Hep3B cells.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoIHiJxa1MHHbVg90H21EOLACvtfcHk0lhbpwbuEw-6VQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXitlSitbg%253D&md5=62dac887df1c79fb8f4d3c87e50e0029</span></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.1021%2Fjm0610292&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm0610292%26sid%3Dliteratum%253Aachs%26aulast%3DLee%26aufirst%3DK.%26aulast%3DLee%26aufirst%3DJ.%2BH.%26aulast%3DBoovanahalli%26aufirst%3DS.%2BK.%26aulast%3DJin%26aufirst%3DY.%26aulast%3DLee%26aufirst%3DM.%26aulast%3DJin%26aufirst%3DX.%26aulast%3DKim%26aufirst%3DJ.%2BH.%26aulast%3DHong%26aufirst%3DY.-S.%26aulast%3DLee%26aufirst%3DJ.%2BJ.%26atitle%3D%2528Aryloxyacetylamino%2529benzoic%2520acid%2520analogues%253A%2520a%2520new%2520class%2520of%2520hypoxia-inducible%2520factor-1%2520inhibitors%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2007%26volume%3D50%26spage%3D1675%26epage%3D1684%26doi%3D10.1021%2Fjm0610292" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref27"><div class="reference"><strong class="refLabel"><a href="#ref27" class="rightTabRefNumLink">27</a></strong><div class="NLM_citation" id="rightTab-cit27"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Naik, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Won, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, B.-K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xia, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Choi, H. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jin, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jung, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, H. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, K.</span></span> <span> </span><span class="NLM_article-title">Synthesis and structure-activity relationship of (<i>E</i>)-phenoxyacrylic amide derivatives as hypoxia-inducible factor (HIF) 1alpha inhibitors</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>55</i></span>,  <span class="NLM_fpage">10564</span>– <span class="NLM_lpage">10571</span>, <span class="refDoi"> DOI: 10.1021/jm301419d</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm301419d" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01313&amp;key=1%3ACAS%3A528%3ADC%252BC38Xhs1Ohs7vI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2012&pages=10564-10571&author=R.+Naikauthor=M.+Wonauthor=B.-K.+Kimauthor=Y.+Xiaauthor=H.+K.+Choiauthor=G.+Jinauthor=Y.+Jungauthor=H.+M.+Kimauthor=K.+Lee&title=Synthesis+and+structure-activity+relationship+of+%28E%29-phenoxyacrylic+amide+derivatives+as+hypoxia-inducible+factor+%28HIF%29+1alpha+inhibitors&doi=10.1021%2Fjm301419d"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit27R"><div class="casContent"><span class="casTitleNuber">27</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis and Structure-Activity Relationship of (E)-Phenoxyacrylic Amide Derivatives as Hypoxia-Inducible Factor (HIF) 1α Inhibitors</span></div><div class="casAuthors">Naik, Ravi; Won, Misun; Kim, Bo-Kyung; Xia, Yan; Choi, Hyun Kyung; Jin, Guanghai; Jung, Youngjin; Kim, Hwan Mook; Lee, Kyeong</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">55</span>
        (<span class="NLM_cas:issue">23</span>),
    <span class="NLM_cas:pages">10564-10571</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">(E)-phenoxyacrylamides such as I were prepd. and tested as inhibitors of the transcription factor hypoxia inducible factor-1α (HIF-1α) for potential use as antitumor agents; their toxicities to human cells and the aq. solubilities of selected compds. were detd.  I was a potent inhibitor of HIF-1α under hypoxic conditions (IC50 = 0.12 μM) in HCT116 cells.  I suppressed both hypoxia-induced HIF-1α accumulation and the expression of mRNAs for the genes for vascular endothelial growth factor, erythropoietin, and matrix metalloproteinase-9 in a dose-dependent manner.  I also inhibited tube formation (angiogenesis) and cell migration in vitro.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqzPCB8XH7HLrVg90H21EOLACvtfcHk0lhbpwbuEw-6VQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38Xhs1Ohs7vI&md5=cc1c0da351a3e7d6b9ef0a97d8b2fcc6</span></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.1021%2Fjm301419d&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm301419d%26sid%3Dliteratum%253Aachs%26aulast%3DNaik%26aufirst%3DR.%26aulast%3DWon%26aufirst%3DM.%26aulast%3DKim%26aufirst%3DB.-K.%26aulast%3DXia%26aufirst%3DY.%26aulast%3DChoi%26aufirst%3DH.%2BK.%26aulast%3DJin%26aufirst%3DG.%26aulast%3DJung%26aufirst%3DY.%26aulast%3DKim%26aufirst%3DH.%2BM.%26aulast%3DLee%26aufirst%3DK.%26atitle%3DSynthesis%2520and%2520structure-activity%2520relationship%2520of%2520%2528E%2529-phenoxyacrylic%2520amide%2520derivatives%2520as%2520hypoxia-inducible%2520factor%2520%2528HIF%2529%25201alpha%2520inhibitors%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2012%26volume%3D55%26spage%3D10564%26epage%3D10571%26doi%3D10.1021%2Fjm301419d" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref28"><div class="reference"><strong class="refLabel"><a href="#ref28" class="rightTabRefNumLink">28</a></strong><div class="NLM_citation" id="rightTab-cit28"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Shimizu, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maruyama, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yasui, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Minegishi, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ban, H. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nakamura, H.</span></span> <span> </span><span class="NLM_article-title">Boron-containing phenoxyacetanilide derivatives as hypoxia-inducible factor (HIF)-1α inhibitors</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>20</i></span>,  <span class="NLM_fpage">1453</span>– <span class="NLM_lpage">1456</span>, <span class="refDoi"> DOI: 10.1016/j.bmcl.2009.12.037</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01313&amp;key=10.1016%2Fj.bmcl.2009.12.037" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01313&amp;key=20083404" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01313&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhslSmtLc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2010&pages=1453-1456&author=K.+Shimizuauthor=M.+Maruyamaauthor=Y.+Yasuiauthor=H.+Minegishiauthor=H.+S.+Banauthor=H.+Nakamura&title=Boron-containing+phenoxyacetanilide+derivatives+as+hypoxia-inducible+factor+%28HIF%29-1%CE%B1+inhibitors&doi=10.1016%2Fj.bmcl.2009.12.037"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit28R"><div class="casContent"><span class="casTitleNuber">28</span><div class="casTitle"><span class="NLM_cas:atitle">Boron-containing phenoxyacetanilide derivatives as hypoxia-inducible factor (HIF)-1α inhibitors</span></div><div class="casAuthors">Shimizu, Kazuki; Maruyama, Minako; Yasui, Yuka; Minegishi, Hidemitsu; Ban, Hyun Seung; Nakamura, Hiroyuki</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">20</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">1453-1456</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A series of boron-contg. phenoxyacetanilide derivs. I [R1 = BPin, B(OH)2; R2 = Me, Et, Ph, Cy, 1-adamantyl, t-Bu, o-carboranyl] were synthesized as hypoxia-inducible factor (HIF)-1α inhibitors.  Among the compds. synthesized, carboranylphenoxyacetanilide I [R1 = B(OH)2; R2 = o-carboranyl (II)] was found to be a potent inhibitor against HIF-1α accumulation under hypoxic conditions and inhibited the hypoxia-induced HIF-1 transcriptional activity in HeLa cells (IC50 = 0.74 μM).  Compd. II (GN26361) suppressed hypoxia-induced HIF-1α accumulation and vascular endothelial growth factor mRNA expression in a concn.-dependent manner without affecting the expression of HIF-1α mRNA.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoUIHLf5RFJgLVg90H21EOLACvtfcHk0lhyusOVaxrbMg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhslSmtLc%253D&md5=18cb4c1f8e4b0212e8470c296adfa61d</span></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2009.12.037&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2009.12.037%26sid%3Dliteratum%253Aachs%26aulast%3DShimizu%26aufirst%3DK.%26aulast%3DMaruyama%26aufirst%3DM.%26aulast%3DYasui%26aufirst%3DY.%26aulast%3DMinegishi%26aufirst%3DH.%26aulast%3DBan%26aufirst%3DH.%2BS.%26aulast%3DNakamura%26aufirst%3DH.%26atitle%3DBoron-containing%2520phenoxyacetanilide%2520derivatives%2520as%2520hypoxia-inducible%2520factor%2520%2528HIF%2529-1%25CE%25B1%2520inhibitors%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2010%26volume%3D20%26spage%3D1453%26epage%3D1456%26doi%3D10.1016%2Fj.bmcl.2009.12.037" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref29"><div class="reference"><strong class="refLabel"><a href="#ref29" class="rightTabRefNumLink">29</a></strong><div class="NLM_citation" id="rightTab-cit29"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kwon, D.-Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, H. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Weitzel, D. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Park, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, S. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, C.-T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stephenson, T. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Park, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fitzgerald, M. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chi, J.-T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mook, R. A.,  Jr.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dewhirst, M. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, Y. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hong, J.</span></span> <span> </span><span class="NLM_article-title">Synthesis and Biological Evaluation of Manassantin Analogues for Hypoxia-Inducible Factor 1α inhibition</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>58</i></span>,  <span class="NLM_fpage">7659</span>– <span class="NLM_lpage">7671</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.5b01220</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.5b01220" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01313&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhsFersrrM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=58&publication_year=2015&pages=7659-7671&author=D.-Y.+Kwonauthor=H.+E.+Leeauthor=D.+H.+Weitzelauthor=K.+Parkauthor=S.+H.+Leeauthor=C.-T.+Leeauthor=T.+N.+Stephensonauthor=H.+Parkauthor=M.+C.+Fitzgeraldauthor=J.-T.+Chiauthor=R.+A.+Mookauthor=M.+W.+Dewhirstauthor=Y.+M.+Leeauthor=J.+Hong&title=Synthesis+and+Biological+Evaluation+of+Manassantin+Analogues+for+Hypoxia-Inducible+Factor+1%CE%B1+inhibition&doi=10.1021%2Facs.jmedchem.5b01220"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit29R"><div class="casContent"><span class="casTitleNuber">29</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis and Biological Evaluation of Manassantin Analogues for Hypoxia-Inducible Factor 1α Inhibition</span></div><div class="casAuthors">Kwon, Do-Yeon; Lee, Hye Eun; Weitzel, Douglas H.; Park, Kyunghye; Lee, Sun Hee; Lee, Chen-Ting; Stephenson, Tesia N.; Park, Hyeri; Fitzgerald, Michael C.; Chi, Jen-Tsan; Mook, Robert A., Jr.; Dewhirst, Mark W.; Lee, You Mie; Hong, Jiyong</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">58</span>
        (<span class="NLM_cas:issue">19</span>),
    <span class="NLM_cas:pages">7659-7671</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">To cope with hypoxia, tumor cells have developed a no. of adaptive mechanisms mediated by hypoxia-inducible factor 1 (HIF-1) to promote angiogenesis and cell survival.  Due to significant roles of HIF-1 in the initiation, progression, metastasis, and resistance to treatment of most solid tumors, a considerable amt. of effort has been made to identify HIF-1 inhibitors for treatment of cancer.  Isolated from Saururus cernuus, manassantins A (I) and B (II) are potent inhibitors of HIF-1 activity.  To define the structural requirements of manassantins for HIF-1 inhibition, we prepd. and evaluated a series of manassantin analogs.  Our SAR studies examd. key regions of manassantin's structure in order to understand the impact of these regions on biol. activity and to define modifications that can lead to improved performance and drug-like properties.  Our efforts identified several manassantin analogs with reduced structural complexity as potential lead compds. for further development.  Some analogs, e.g., III, down-regulated hypoxia-induced expression of the HIF-1α protein and reduced the levels of HIF-1 target genes, including cyclin-dependent kinase 6 (Cdk6) and vascular endothelial growth factor (VEGF).  These findings provide an important framework to design potent and selective HIF-1α inhibitors, which is necessary to aid translation of manassantin-derived natural products to the clinic as novel therapeutics for cancers.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp4LzA8xQ0-LbVg90H21EOLACvtfcHk0lhyusOVaxrbMg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhsFersrrM&md5=95a898b0ab734a00a2d7b2e685c816a8</span></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.5b01220&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.5b01220%26sid%3Dliteratum%253Aachs%26aulast%3DKwon%26aufirst%3DD.-Y.%26aulast%3DLee%26aufirst%3DH.%2BE.%26aulast%3DWeitzel%26aufirst%3DD.%2BH.%26aulast%3DPark%26aufirst%3DK.%26aulast%3DLee%26aufirst%3DS.%2BH.%26aulast%3DLee%26aufirst%3DC.-T.%26aulast%3DStephenson%26aufirst%3DT.%2BN.%26aulast%3DPark%26aufirst%3DH.%26aulast%3DFitzgerald%26aufirst%3DM.%2BC.%26aulast%3DChi%26aufirst%3DJ.-T.%26aulast%3DMook%26aufirst%3DR.%2BA.%26aulast%3DDewhirst%26aufirst%3DM.%2BW.%26aulast%3DLee%26aufirst%3DY.%2BM.%26aulast%3DHong%26aufirst%3DJ.%26atitle%3DSynthesis%2520and%2520Biological%2520Evaluation%2520of%2520Manassantin%2520Analogues%2520for%2520Hypoxia-Inducible%2520Factor%25201%25CE%25B1%2520inhibition%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2015%26volume%3D58%26spage%3D7659%26epage%3D7671%26doi%3D10.1021%2Facs.jmedchem.5b01220" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref30"><div class="reference"><strong class="refLabel"><a href="#ref30" class="rightTabRefNumLink">30</a></strong><div class="NLM_citation" id="rightTab-cit30"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kim, H. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hong, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, S.-C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, H.-Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Suh, Y.-G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Oh, D.-C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Seo, J. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Choi, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, J. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, K.-W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, J. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, Y.-M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Park, S.-J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Park, H.-J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, J.</span></span> <span> </span><span class="NLM_article-title">Ring-truncated deguelin derivatives as potent Hypoxia Inducible Factor-1α (HIF-1α) inhibitors</span>. <i>Eur. J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>104</i></span>,  <span class="NLM_fpage">157</span>– <span class="NLM_lpage">164</span>, <span class="refDoi"> DOI: 10.1016/j.ejmech.2015.09.033</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01313&amp;key=10.1016%2Fj.ejmech.2015.09.033" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01313&amp;key=26457742" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01313&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhs1GktLnO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=104&publication_year=2015&pages=157-164&author=H.+S.+Kimauthor=M.+Hongauthor=S.-C.+Leeauthor=H.-Y.+Leeauthor=Y.-G.+Suhauthor=D.-C.+Ohauthor=J.+H.+Seoauthor=H.+Choiauthor=J.+Y.+Kimauthor=K.-W.+Kimauthor=J.+H.+Kimauthor=J.+Kimauthor=Y.-M.+Kimauthor=S.-J.+Parkauthor=H.-J.+Parkauthor=J.+Lee&title=Ring-truncated+deguelin+derivatives+as+potent+Hypoxia+Inducible+Factor-1%CE%B1+%28HIF-1%CE%B1%29+inhibitors&doi=10.1016%2Fj.ejmech.2015.09.033"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit30R"><div class="casContent"><span class="casTitleNuber">30</span><div class="casTitle"><span class="NLM_cas:atitle">Ring-truncated deguelin derivatives as potent Hypoxia Inducible Factor-1α (HIF-1α) inhibitors</span></div><div class="casAuthors">Kim, Ho Shin; Hong, Mannkyu; Lee, Su-Chan; Lee, Ho-Young; Suh, Young-Ger; Oh, Dong-Chan; Seo, Ji Hae; Choi, Hoon; Kim, Jun Yong; Kim, Kyu-Won; Kim, Jeong Hun; Kim, Joohwan; Kim, Young-Myeong; Park, So-Jung; Park, Hyun-Ju; Lee, Jeewoo</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">104</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">157-164</span>CODEN:
                <span class="NLM_cas:coden">EJMCA5</span>;
        ISSN:<span class="NLM_cas:issn">0223-5234</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Masson SAS</span>)
        </div><div class="casAbstract">A series of fluorophenyl and pyridine deguelin analogs were synthesized as ring-truncated deguelin surrogates and evaluated for their HIF-1α inhibition.  Their structure-activity relationship was systematically investigated based on the variation of the linker B-region moiety.  Among the inhibitors, compd. I exhibited potent HIF-1α inhibition in a dose-dependent manner and significant antitumor activity in H1299 with less toxicity than deguelin.  It also inhibited in vitro hypoxia-mediated angiogenic processes in HRMECs.  The docking study indicates that I occupied the C-terminal ATP-binding pocket of HSP90 in a similar mode as the original analog, which implies that the anticancer and antiangiogenic activities of I are derived from HIF-1α destabilization by binding to the C-terminal ATP-binding site of hHSP90.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrzOWGqCrZzTbVg90H21EOLACvtfcHk0lh3P--8gfM6-w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhs1GktLnO&md5=df5425d3fa3e0e6e08d3d8ac1db1d128</span></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=10.1016%2Fj.ejmech.2015.09.033&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejmech.2015.09.033%26sid%3Dliteratum%253Aachs%26aulast%3DKim%26aufirst%3DH.%2BS.%26aulast%3DHong%26aufirst%3DM.%26aulast%3DLee%26aufirst%3DS.-C.%26aulast%3DLee%26aufirst%3DH.-Y.%26aulast%3DSuh%26aufirst%3DY.-G.%26aulast%3DOh%26aufirst%3DD.-C.%26aulast%3DSeo%26aufirst%3DJ.%2BH.%26aulast%3DChoi%26aufirst%3DH.%26aulast%3DKim%26aufirst%3DJ.%2BY.%26aulast%3DKim%26aufirst%3DK.-W.%26aulast%3DKim%26aufirst%3DJ.%2BH.%26aulast%3DKim%26aufirst%3DJ.%26aulast%3DKim%26aufirst%3DY.-M.%26aulast%3DPark%26aufirst%3DS.-J.%26aulast%3DPark%26aufirst%3DH.-J.%26aulast%3DLee%26aufirst%3DJ.%26atitle%3DRing-truncated%2520deguelin%2520derivatives%2520as%2520potent%2520Hypoxia%2520Inducible%2520Factor-1%25CE%25B1%2520%2528HIF-1%25CE%25B1%2529%2520inhibitors%26jtitle%3DEur.%2520J.%2520Med.%2520Chem.%26date%3D2015%26volume%3D104%26spage%3D157%26epage%3D164%26doi%3D10.1016%2Fj.ejmech.2015.09.033" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref31"><div class="reference"><strong class="refLabel"><a href="#ref31" class="rightTabRefNumLink">31</a></strong><div class="NLM_citation" id="rightTab-cit31"><span><span class="NLM_contrib-group"><span class="NLM_string-name">An, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jo, D. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jeong, Y.-S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Heo, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cho, C. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Choi, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Seo, J. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hwang, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lim, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jun, H. O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sim, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lim, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hur, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ahn, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, H. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Seo, S.-Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Na, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, S.-H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chung, S.-J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, Y.-M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, K.-W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, S. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, J. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Suh, Y.-G.</span></span> <span> </span><span class="NLM_article-title">Novel hypoxia-inducible factor 1α (HIF-1α) inhibitors for angiogenesis-related ocular diseases: discovery of a novel scaffold via ring-truncation strategy</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>61</i></span>,  <span class="NLM_fpage">9266</span>– <span class="NLM_lpage">9286</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.8b00971</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.8b00971" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01313&amp;key=1%3ACAS%3A528%3ADC%252BC1cXhslOls77E" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=61&publication_year=2018&pages=9266-9286&author=H.+Anauthor=S.+Leeauthor=J.+M.+Leeauthor=D.+H.+Joauthor=J.+Kimauthor=Y.-S.+Jeongauthor=M.+J.+Heoauthor=C.+S.+Choauthor=H.+Choiauthor=J.+H.+Seoauthor=S.+Hwangauthor=J.+Limauthor=T.+Kimauthor=H.+O.+Junauthor=J.+Simauthor=C.+Limauthor=J.+Hurauthor=J.+Ahnauthor=H.+S.+Kimauthor=S.-Y.+Seoauthor=Y.+Naauthor=S.-H.+Kimauthor=J.+Leeauthor=J.+Leeauthor=S.-J.+Chungauthor=Y.-M.+Kimauthor=K.-W.+Kimauthor=S.+G.+Kimauthor=J.+H.+Kimauthor=Y.-G.+Suh&title=Novel+hypoxia-inducible+factor+1%CE%B1+%28HIF-1%CE%B1%29+inhibitors+for+angiogenesis-related+ocular+diseases%3A+discovery+of+a+novel+scaffold+via+ring-truncation+strategy&doi=10.1021%2Facs.jmedchem.8b00971"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit31R"><div class="casContent"><span class="casTitleNuber">31</span><div class="casTitle"><span class="NLM_cas:atitle">Novel Hypoxia-Inducible Factor 1α (HIF-1α) Inhibitors for Angiogenesis-Related Ocular Diseases: Discovery of a Novel Scaffold via Ring-Truncation Strategy</span></div><div class="casAuthors">An, Hongchan; Lee, Seungbeom; Lee, Jung Min; Jo, Dong Hyun; Kim, Joohwan; Jeong, Yoo-Seong; Heo, Mi Jeong; Cho, Chang Sik; Choi, Hoon; Seo, Ji Hae; Hwang, Seyeon; Lim, Jihye; Kim, Taewoo; Jun, Hyoung Oh; Sim, Jaehoon; Lim, Changjin; Hur, Joonseong; Ahn, Jungmin; Kim, Hyun Su; Seo, Seung-Yong; Na, Younghwa; Kim, Seok-Ho; Lee, Jeewoo; Lee, Jeeyeon; Chung, Suk-Jae; Kim, Young-Myeong; Kim, Kyu-Won; Kim, Sang Geon; Kim, Jeong Hun; Suh, Young-Ger</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">61</span>
        (<span class="NLM_cas:issue">20</span>),
    <span class="NLM_cas:pages">9266-9286</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Ocular diseases featuring pathol. neovascularization are the leading cause of blindness, and anti-VEGF agents have been conventionally used to treat these diseases.  Recently, regulating factors upstream of VEGF, such as HIF-1α, have emerged as a desirable therapeutic approach because the use of anti-VEGF agents is currently being reconsidered due to the VEGF action as a trophic factor.  Here, we report a novel scaffold discovered through the complete structure-activity relationship of ring-truncated deguelin analogs in HIF-1α inhibition.  Interestingly, analog 6i possessing a 2-fluorobenzene moiety instead of a dimethoxybenzene moiety exhibited excellent HIF-1α inhibitory activity, with an IC50 value of 100 nM.  In particular, the further ring-truncated analog 34f, which showed enhanced HIF-1α inhibitory activity compared to analog 2 previously reported by us, inhibited in vitro angiogenesis and effectively suppressed hypoxia-mediated retinal neovascularization.  Importantly, the heteroatom-substituted benzene ring as a key structural feature of analog 34f was identified as a novel scaffold for HIF-1α inhibitors that can be used in lieu of a chromene ring.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoy2LsTGWUU37Vg90H21EOLACvtfcHk0liD-4Ts-SlsUg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXhslOls77E&md5=01ae730c89b16149161931c6180955c2</span></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.8b00971&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.8b00971%26sid%3Dliteratum%253Aachs%26aulast%3DAn%26aufirst%3DH.%26aulast%3DLee%26aufirst%3DS.%26aulast%3DLee%26aufirst%3DJ.%2BM.%26aulast%3DJo%26aufirst%3DD.%2BH.%26aulast%3DKim%26aufirst%3DJ.%26aulast%3DJeong%26aufirst%3DY.-S.%26aulast%3DHeo%26aufirst%3DM.%2BJ.%26aulast%3DCho%26aufirst%3DC.%2BS.%26aulast%3DChoi%26aufirst%3DH.%26aulast%3DSeo%26aufirst%3DJ.%2BH.%26aulast%3DHwang%26aufirst%3DS.%26aulast%3DLim%26aufirst%3DJ.%26aulast%3DKim%26aufirst%3DT.%26aulast%3DJun%26aufirst%3DH.%2BO.%26aulast%3DSim%26aufirst%3DJ.%26aulast%3DLim%26aufirst%3DC.%26aulast%3DHur%26aufirst%3DJ.%26aulast%3DAhn%26aufirst%3DJ.%26aulast%3DKim%26aufirst%3DH.%2BS.%26aulast%3DSeo%26aufirst%3DS.-Y.%26aulast%3DNa%26aufirst%3DY.%26aulast%3DKim%26aufirst%3DS.-H.%26aulast%3DLee%26aufirst%3DJ.%26aulast%3DLee%26aufirst%3DJ.%26aulast%3DChung%26aufirst%3DS.-J.%26aulast%3DKim%26aufirst%3DY.-M.%26aulast%3DKim%26aufirst%3DK.-W.%26aulast%3DKim%26aufirst%3DS.%2BG.%26aulast%3DKim%26aufirst%3DJ.%2BH.%26aulast%3DSuh%26aufirst%3DY.-G.%26atitle%3DNovel%2520hypoxia-inducible%2520factor%25201%25CE%25B1%2520%2528HIF-1%25CE%25B1%2529%2520inhibitors%2520for%2520angiogenesis-related%2520ocular%2520diseases%253A%2520discovery%2520of%2520a%2520novel%2520scaffold%2520via%2520ring-truncation%2520strategy%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2018%26volume%3D61%26spage%3D9266%26epage%3D9286%26doi%3D10.1021%2Facs.jmedchem.8b00971" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref32"><div class="reference"><strong class="refLabel"><a href="#ref32" class="rightTabRefNumLink">32</a></strong><div class="NLM_citation" id="rightTab-cit32"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Mooring, S. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jin, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Devi, N. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jabbar, A. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kaluz, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Van Meir, E. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, B.</span></span> <span> </span><span class="NLM_article-title">Design and synthesis of novel small-molecule inhibitors of the hypoxia inducible factor pathway</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>54</i></span>,  <span class="NLM_fpage">8471</span>– <span class="NLM_lpage">8489</span>, <span class="refDoi"> DOI: 10.1021/jm201018g</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm201018g" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01313&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhtlyjsrnO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=54&publication_year=2011&pages=8471-8489&author=S.+R.+Mooringauthor=H.+Jinauthor=N.+S.+Deviauthor=A.+A.+Jabbarauthor=S.+Kaluzauthor=Y.+Liuauthor=E.+G.+Van+Meirauthor=B.+Wang&title=Design+and+synthesis+of+novel+small-molecule+inhibitors+of+the+hypoxia+inducible+factor+pathway&doi=10.1021%2Fjm201018g"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit32R"><div class="casContent"><span class="casTitleNuber">32</span><div class="casTitle"><span class="NLM_cas:atitle">Design and Synthesis of Novel Small-Molecule Inhibitors of the Hypoxia Inducible Factor Pathway</span></div><div class="casAuthors">Mooring, Suazette Reid; Jin, Hui; Devi, Narra S.; Jabbar, Adnan A.; Kaluz, Stefan; Liu, Yuan; Van Meir, Erwin G.; Wang, Binghe</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">54</span>
        (<span class="NLM_cas:issue">24</span>),
    <span class="NLM_cas:pages">8471-8489</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Hypoxia, a redn. in partial oxygen pressure, is a salient property of solid tumors.  Hypoxia drives malignant progression and metastasis in tumors and participates in tumor resistance to radio- and chemotherapies.  Hypoxia activates the hypoxia-inducible factor (HIF) family of transcription factors, which induce target genes that regulate adaptive biol. processes such as anaerobic metab., cell motility, and angiogenesis.  Clin. evidence has demonstrated that expression of HIF-1 is strongly assocd. with poor patient prognosis and activation of HIF-1 contributes to malignant behavior and therapeutic resistance.  Consequently, HIF-1 has become an important therapeutic target for inhibition by small mols.  Herein, we describe the design and synthesis of small mols. that inhibit the HIF-1 signaling pathway.  Many of these compds. exhibit inhibitory activity in the nanomolar range.  Sep. mechanistic studies indicate that these inhibitors do not alter HIF-1 levels but interfere with the ability of HIF-1α/HIF-1β to interact with cofactors p300/CBP to form an active transcriptional complex.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoC3eSwxgvkCLVg90H21EOLACvtfcHk0liD-4Ts-SlsUg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhtlyjsrnO&md5=c21a16d41bf75cb886dc72753a880de9</span></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=10.1021%2Fjm201018g&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm201018g%26sid%3Dliteratum%253Aachs%26aulast%3DMooring%26aufirst%3DS.%2BR.%26aulast%3DJin%26aufirst%3DH.%26aulast%3DDevi%26aufirst%3DN.%2BS.%26aulast%3DJabbar%26aufirst%3DA.%2BA.%26aulast%3DKaluz%26aufirst%3DS.%26aulast%3DLiu%26aufirst%3DY.%26aulast%3DVan%2BMeir%26aufirst%3DE.%2BG.%26aulast%3DWang%26aufirst%3DB.%26atitle%3DDesign%2520and%2520synthesis%2520of%2520novel%2520small-molecule%2520inhibitors%2520of%2520the%2520hypoxia%2520inducible%2520factor%2520pathway%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2011%26volume%3D54%26spage%3D8471%26epage%3D8489%26doi%3D10.1021%2Fjm201018g" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref33"><div class="reference"><strong class="refLabel"><a href="#ref33" class="rightTabRefNumLink">33</a></strong><div class="NLM_citation" id="rightTab-cit33"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Mun, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jabbar, A. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Devi, N. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yin, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tan, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Culver, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Snyder, J. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Van Meir, E. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Goodman, M. M.</span></span> <span> </span><span class="NLM_article-title">Design and in vitro activities of <i>N</i>-alkyl-<i>N</i>-[(8-<i>R</i>-2,2-dimethyl-2<i>H</i>-chromen-6-yl)methyl]heteroarylsulfonamides, novel, small-molecule hypoxia inducible factor-1 pathway inhibitors and anticancer agents</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>55</i></span>,  <span class="NLM_fpage">6738</span>– <span class="NLM_lpage">6750</span>, <span class="refDoi"> DOI: 10.1021/jm300752n</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm300752n" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01313&amp;key=1%3ACAS%3A528%3ADC%252BC38XpsV2gtL0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2012&pages=6738-6750&author=J.+Munauthor=A.+A.+Jabbarauthor=N.+S.+Deviauthor=S.+Yinauthor=Y.+Wangauthor=C.+Tanauthor=D.+Culverauthor=J.+P.+Snyderauthor=E.+G.+Van+Meirauthor=M.+M.+Goodman&title=Design+and+in+vitro+activities+of+N-alkyl-N-%5B%288-R-2%2C2-dimethyl-2H-chromen-6-yl%29methyl%5Dheteroarylsulfonamides%2C+novel%2C+small-molecule+hypoxia+inducible+factor-1+pathway+inhibitors+and+anticancer+agents&doi=10.1021%2Fjm300752n"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit33R"><div class="casContent"><span class="casTitleNuber">33</span><div class="casTitle"><span class="NLM_cas:atitle">Design and in Vitro Activities of N-Alkyl-N-[(8-R-2,2-dimethyl-2H-chromen-6-yl)methyl]heteroarylsulfonamides, Novel, Small-Molecule Hypoxia Inducible Factor-1 Pathway Inhibitors and Anticancer Agents</span></div><div class="casAuthors">Mun, Jiyoung; Jabbar, Adnan Abdul; Devi, Narra Sarojini; Yin, Shaoman; Wang, Yingzhe; Tan, Chalet; Culver, Deborah; Snyder, James P.; Van Meir, Erwin G.; Goodman, Mark M.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">55</span>
        (<span class="NLM_cas:issue">15</span>),
    <span class="NLM_cas:pages">6738-6750</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The hypoxia inducible factor (HIF) pathway is an attractive target for cancer, as it controls tumor adaptation to growth under hypoxia and mediates chemotherapy and radiation resistance.  We previously discovered 3,4-dimethoxy-N-[(2,2-dimethyl-2H-chromen-6-yl)methyl]-N-phenylbenzenesulfonamide as a novel, small-mol. HIF-1 pathway inhibitor in a high-throughput cell-based assay, but its in vivo delivery is hampered by poor aq. soly. (0.009 μM in water; log P7.4 = 3.7).  Here we describe the synthesis of 12 N-alkyl-N-[(8-R-2,2-dimethyl-2H-chromen-6-yl)methyl]heteroarylsulfonamides, which were designed to possess optimal lipophilicities and aq. solubilities by in silico calcns.  Exptl. log P7.4 values of 8 of the 12 new analogs ranged from 1.2-3.1.  Aq. solubilities of three analogs were measured, among which the most sol. N-[(8-methoxy-2,2-dimethyl-2H-chromen-6-yl)methyl]-N-(propan-2-yl)pyridine-2-sulfonamide had an aq. soly. of 80 μM, e.g., a soly. improvement of ∼9000-fold.  The pharmacol. optimization had limited impact on drug efficacy as the compds. retained IC50 values at or below 5 μM in our HIF-dependent reporter assay.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpVawJDxwPEs7Vg90H21EOLACvtfcHk0ljD1-GXB0wVQA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XpsV2gtL0%253D&md5=8598c06dcaf2dfa4faec14fb3820299e</span></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=10.1021%2Fjm300752n&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm300752n%26sid%3Dliteratum%253Aachs%26aulast%3DMun%26aufirst%3DJ.%26aulast%3DJabbar%26aufirst%3DA.%2BA.%26aulast%3DDevi%26aufirst%3DN.%2BS.%26aulast%3DYin%26aufirst%3DS.%26aulast%3DWang%26aufirst%3DY.%26aulast%3DTan%26aufirst%3DC.%26aulast%3DCulver%26aufirst%3DD.%26aulast%3DSnyder%26aufirst%3DJ.%2BP.%26aulast%3DVan%2BMeir%26aufirst%3DE.%2BG.%26aulast%3DGoodman%26aufirst%3DM.%2BM.%26atitle%3DDesign%2520and%2520in%2520vitro%2520activities%2520of%2520N-alkyl-N-%255B%25288-R-2%252C2-dimethyl-2H-chromen-6-yl%2529methyl%255Dheteroarylsulfonamides%252C%2520novel%252C%2520small-molecule%2520hypoxia%2520inducible%2520factor-1%2520pathway%2520inhibitors%2520and%2520anticancer%2520agents%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2012%26volume%3D55%26spage%3D6738%26epage%3D6750%26doi%3D10.1021%2Fjm300752n" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref34"><div class="reference"><strong class="refLabel"><a href="#ref34" class="rightTabRefNumLink">34</a></strong><div class="NLM_citation" id="rightTab-cit34"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zhao, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wei, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Su, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhao, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hao, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhao, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cheng, M.</span></span> <span> </span><span class="NLM_article-title">Design, synthesis and evaluation of aromatic heterocyclic derivatives as potent antifungal agents</span>. <i>Eur. J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>137</i></span>,  <span class="NLM_fpage">96</span>– <span class="NLM_lpage">107</span>, <span class="refDoi"> DOI: 10.1016/j.ejmech.2017.05.043</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01313&amp;key=10.1016%2Fj.ejmech.2017.05.043" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01313&amp;key=28558334" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01313&amp;key=1%3ACAS%3A528%3ADC%252BC2sXos1Wnsrs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=137&publication_year=2017&pages=96-107&author=S.+Zhaoauthor=X.+Zhangauthor=P.+Weiauthor=X.+Suauthor=L.+Zhaoauthor=M.+Wuauthor=C.+Haoauthor=C.+Liuauthor=D.+Zhaoauthor=M.+Cheng&title=Design%2C+synthesis+and+evaluation+of+aromatic+heterocyclic+derivatives+as+potent+antifungal+agents&doi=10.1016%2Fj.ejmech.2017.05.043"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit34R"><div class="casContent"><span class="casTitleNuber">34</span><div class="casTitle"><span class="NLM_cas:atitle">Design, synthesis and evaluation of aromatic heterocyclic derivatives as potent antifungal agents</span></div><div class="casAuthors">Zhao, Shizhen; Zhang, Xiangqian; Wei, Peng; Su, Xin; Zhao, Liyu; Wu, Mengya; Hao, Chenzhou; Liu, Chunchi; Zhao, Dongmei; Cheng, Maosheng</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">137</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">96-107</span>CODEN:
                <span class="NLM_cas:coden">EJMCA5</span>;
        ISSN:<span class="NLM_cas:issn">0223-5234</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Masson SAS</span>)
        </div><div class="casAbstract">To further enhance the anti-Aspergillus efficacy of the authors' previously discovered antifungal lead compds. (1), a series of arom. heterocyclic derivs. were designed, synthesized and evaluated for in vitro antifungal activity.  Many of the target compds. showed good inhibitory activity against Candida albicans and Cryptococcus neoformans.  In particular, the isoxazole nuclei were more suited for improving the activity against Aspergillus spp.  Among these compds., 2-F substituted analogs isopropyl(S)-2-(5-(2-fluorophenyl)isoxazole-3-carboxamido)-3-(1H-imidazol-1-yl)propanoate and isobutyl(S)-2-(5-(2-fluorophenyl)isoxazole-3-carboxamido)-3-(1H-imidazol-1-yl)propanoate displayed the most remarkable in vitro activity against Candida spp., C. neoformans, A. fumigatus and fluconazole-resistant C.alb. strains, which is superior or comparable to the activity of the ref. drugs fluconazole and voriconazole.  Notably, the compds. isopropyl(S)-2-(5-(2-fluorophenyl)isoxazole-3-carboxamido)-3-(1H-imidazol-1-yl)propanoate and isobutyl(S)-2-(5-(2-fluorophenyl)isoxazole-3-carboxamido)-3-(1H-imidazol-1-yl)propanoate exhibited low inhibition profiles for various isoforms of human cytochrome P 450 and excellent blood plasma stability.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqtJRvJTjfWcbVg90H21EOLACvtfcHk0ljD1-GXB0wVQA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXos1Wnsrs%253D&md5=29526c36c9ea980bcd0de971038fc679</span></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=10.1016%2Fj.ejmech.2017.05.043&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejmech.2017.05.043%26sid%3Dliteratum%253Aachs%26aulast%3DZhao%26aufirst%3DS.%26aulast%3DZhang%26aufirst%3DX.%26aulast%3DWei%26aufirst%3DP.%26aulast%3DSu%26aufirst%3DX.%26aulast%3DZhao%26aufirst%3DL.%26aulast%3DWu%26aufirst%3DM.%26aulast%3DHao%26aufirst%3DC.%26aulast%3DLiu%26aufirst%3DC.%26aulast%3DZhao%26aufirst%3DD.%26aulast%3DCheng%26aufirst%3DM.%26atitle%3DDesign%252C%2520synthesis%2520and%2520evaluation%2520of%2520aromatic%2520heterocyclic%2520derivatives%2520as%2520potent%2520antifungal%2520agents%26jtitle%3DEur.%2520J.%2520Med.%2520Chem.%26date%3D2017%26volume%3D137%26spage%3D96%26epage%3D107%26doi%3D10.1016%2Fj.ejmech.2017.05.043" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref35"><div class="reference"><strong class="refLabel"><a href="#ref35" class="rightTabRefNumLink">35</a></strong><div class="NLM_citation" id="rightTab-cit35"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Huguet, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Melet, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Alves de Sousa, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lieutaud, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chevalier, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maigre, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Deschamps, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tomas, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leulliot, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pages, J.-M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Artaud, I.</span></span> <span> </span><span class="NLM_article-title">Hydroxamic acids as potent inhibitors of Fe(II) and Mn(II) E. coli methionine aminopeptidase: biological activities and X-ray structures of oxazole hydroxamate-EcMetAP-Mn complexes</span>. <i>ChemMedChem</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>7</i></span>,  <span class="NLM_fpage">1020</span>– <span class="NLM_lpage">1030</span>, <span class="refDoi"> DOI: 10.1002/cmdc.201200076</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01313&amp;key=10.1002%2Fcmdc.201200076" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01313&amp;key=22489069" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01313&amp;key=1%3ACAS%3A528%3ADC%252BC38XkvF2hs74%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2012&pages=1020-1030&author=F.+Huguetauthor=A.+Meletauthor=R.+Alves+de+Sousaauthor=A.+Lieutaudauthor=J.+Chevalierauthor=L.+Maigreauthor=P.+Deschampsauthor=A.+Tomasauthor=N.+Leulliotauthor=J.-M.+Pagesauthor=I.+Artaud&title=Hydroxamic+acids+as+potent+inhibitors+of+Fe%28II%29+and+Mn%28II%29+E.+coli+methionine+aminopeptidase%3A+biological+activities+and+X-ray+structures+of+oxazole+hydroxamate-EcMetAP-Mn+complexes&doi=10.1002%2Fcmdc.201200076"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit35R"><div class="casContent"><span class="casTitleNuber">35</span><div class="casTitle"><span class="NLM_cas:atitle">Hydroxamic Acids as Potent Inhibitors of FeII and MnII E. coli Methionine Aminopeptidase: Biological Activities and X-ray Structures of Oxazole Hydroxamate-EcMetAP-Mn Complexes</span></div><div class="casAuthors">Huguet, Florian; Melet, Armelle; Alves de Sousa, Rodolphe; Lieutaud, Aurelie; Chevalier, Jacqueline; Maigre, Laure; Deschamps, Patrick; Tomas, Alain; Leulliot, Nicolas; Pages, Jean-Marie; Artaud, Isabelle</div><div class="citationInfo"><span class="NLM_cas:title">ChemMedChem</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">1020-1030</span>CODEN:
                <span class="NLM_cas:coden">CHEMGX</span>;
        ISSN:<span class="NLM_cas:issn">1860-7179</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH & Co. KGaA</span>)
        </div><div class="casAbstract">New series of acids and hydroxamic acids linked to five-membered heterocycles including furan, oxazole, 1,2,4- or 1,3,4-oxadiazole, and imidazole were synthesized and tested as inhibitors against the FeII, CoII, and MnII forms of E. coli methionine aminopeptidase (MetAP) and as antibacterial agents against wild-type and acrAB E. coli strains.  2-Aryloxazol-4-ylcarboxylic acids appeared as potent and selective inhibitors of the CoII MetAP form, with IC50 values in the micromolar range, whereas 5-aryloxazol-2-ylcarboxylic acid regioisomers and 5-aryl-1,2,4-oxadiazol-3-ylcarboxylic acids were shown to be inefficient against all forms of EcMetAP.  Regardless of the heterocycle, all the hydroxamic acids are highly potent inhibitors and are selective for the MnII and FeII forms, with IC50 values between 1 and 2 μm.  One indole hydroxamic acid that we previously reported as a potent inhibitor of E. coli peptide deformylase also demonstrated efficiency against EcMetAP.  To gain insight into the positioning of the oxazole heterocycle with reversed substitutions at positions 2 and 5, X-ray crystal structures of EcMetAP-Mn complexed with two such oxazole hydroxamic acids were solved.  Irresp. of the [metal]/[apo-MetAP] ratio, the active site consistently contains a dinuclear manganese center, with the hydroxamate as bridging ligand.  Asp 97, which adopts a bidentate binding mode to the Mn2 site in the holoenzyme, is twisted in both structures toward the hydroxamate bridging ligand to favor the formation of a strong hydrogen bond.  Most of the compds. show weak antibacterial activity against a wild-type E. coli strain.  However, increased antibacterial activity was obsd. mainly for compds. with a 2-substituted Ph group in the presence of the nonapeptide polymyxin B and phenylalanine-arginine-β-naphthylamide as permeabilizer and efflux pump blocker, resp., which boost the intracellular uptake of the inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoWtb7WP9O-0LVg90H21EOLACvtfcHk0lhq02N0g6LOcA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XkvF2hs74%253D&md5=2aa1054cc48b2962bb56de5bab1f95a3</span></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=10.1002%2Fcmdc.201200076&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fcmdc.201200076%26sid%3Dliteratum%253Aachs%26aulast%3DHuguet%26aufirst%3DF.%26aulast%3DMelet%26aufirst%3DA.%26aulast%3DAlves%2Bde%2BSousa%26aufirst%3DR.%26aulast%3DLieutaud%26aufirst%3DA.%26aulast%3DChevalier%26aufirst%3DJ.%26aulast%3DMaigre%26aufirst%3DL.%26aulast%3DDeschamps%26aufirst%3DP.%26aulast%3DTomas%26aufirst%3DA.%26aulast%3DLeulliot%26aufirst%3DN.%26aulast%3DPages%26aufirst%3DJ.-M.%26aulast%3DArtaud%26aufirst%3DI.%26atitle%3DHydroxamic%2520acids%2520as%2520potent%2520inhibitors%2520of%2520Fe%2528II%2529%2520and%2520Mn%2528II%2529%2520E.%2520coli%2520methionine%2520aminopeptidase%253A%2520biological%2520activities%2520and%2520X-ray%2520structures%2520of%2520oxazole%2520hydroxamate-EcMetAP-Mn%2520complexes%26jtitle%3DChemMedChem%26date%3D2012%26volume%3D7%26spage%3D1020%26epage%3D1030%26doi%3D10.1002%2Fcmdc.201200076" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref36"><div class="reference"><strong class="refLabel"><a href="#ref36" class="rightTabRefNumLink">36</a></strong><div class="NLM_citation" id="rightTab-cit36"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zhu, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tang, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhao, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zheng, P.</span></span> <span> </span><span class="NLM_article-title">Synthesis, and docking studies of phenylpyrimidine-carboxamide derivatives bearing 1<i>H</i>-pyrrolo[2,3-b]pyridine moiety as c-Met inhibitors</span>. <i>Bioorg. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>24</i></span>,  <span class="NLM_fpage">1749</span>– <span class="NLM_lpage">1756</span>, <span class="refDoi"> DOI: 10.1016/j.bmc.2016.02.046</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01313&amp;key=10.1016%2Fj.bmc.2016.02.046" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01313&amp;key=26964675" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01313&amp;key=1%3ACAS%3A528%3ADC%252BC28XjvVGltrg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=24&publication_year=2016&pages=1749-1756&author=W.+Zhuauthor=W.+Wangauthor=S.+Xuauthor=J.+Wangauthor=Q.+Tangauthor=C.+Wuauthor=Y.+Zhaoauthor=P.+Zheng&title=Synthesis%2C+and+docking+studies+of+phenylpyrimidine-carboxamide+derivatives+bearing+1H-pyrrolo%5B2%2C3-b%5Dpyridine+moiety+as+c-Met+inhibitors&doi=10.1016%2Fj.bmc.2016.02.046"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit36R"><div class="casContent"><span class="casTitleNuber">36</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis, and docking studies of phenylpyrimidine-carboxamide derivatives bearing 1H-pyrrolo[2,3-b]pyridine moiety as c-Met inhibitors</span></div><div class="casAuthors">Zhu, Wufu; Wang, Wenhui; Xu, Shan; Wang, Jianqiang; Tang, Qidong; Wu, Chunjiang; Zhao, Yanfang; Zheng, Pengwu</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">24</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">1749-1756</span>CODEN:
                <span class="NLM_cas:coden">BMECEP</span>;
        ISSN:<span class="NLM_cas:issn">0968-0896</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Four series of phenylpyrimidine-carboxamide derivs. bearing 1H-pyrrolo[2,3-b]pyridine moiety (14a-e, 15a-g, 16a-e and 17a-g) were designed, synthesized and evaluated for the IC50 values against three cancer cell lines (A549, PC-3 and MCF-7).  Four selected compds. (15e, 16a-b and 17a) were further evaluated for the activity against c-Met kinase, HepG2 and Hela cell lines.  Most of the compds. showed excellent cytotoxicity activity and selectivity with the IC50 valuables in single-digit μM to nanomole range.  Eleven of them are equal to more active than pos. control Foretinib against one or more cell lines.  The most promising compd. 15e showed superior activity to Foretinib against A549, PC-3 and MCF-7 cell lines, with the IC50 values of 0.14 ± 0.08 μM, 0.24 ± 0.07 μM and 0.02 ± 0.01 μM, which were 4.6, 1.6 and 473.5 times more active than Foretinib (0.64 ± 0.26 μM, 0.39 ± 0.11 μM, 9.47 ± 0.22 μM), resp.  Structure-activity relationships (SARs) and docking studies indicated that the replacement of phenylpicolinamide scaffold with phenylpyrimidine fragment of the target compds. was benefit for the activity.  What's more, the introduction of fluoro atom to the aminophenoxy part played no significant impact on the activity and any substituent group on aryl group is unfavorable for the activity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrmus_a92aE7bVg90H21EOLACvtfcHk0lhq02N0g6LOcA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XjvVGltrg%253D&md5=67b169710b011557afc8ad13f1ffebdb</span></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=10.1016%2Fj.bmc.2016.02.046&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmc.2016.02.046%26sid%3Dliteratum%253Aachs%26aulast%3DZhu%26aufirst%3DW.%26aulast%3DWang%26aufirst%3DW.%26aulast%3DXu%26aufirst%3DS.%26aulast%3DWang%26aufirst%3DJ.%26aulast%3DTang%26aufirst%3DQ.%26aulast%3DWu%26aufirst%3DC.%26aulast%3DZhao%26aufirst%3DY.%26aulast%3DZheng%26aufirst%3DP.%26atitle%3DSynthesis%252C%2520and%2520docking%2520studies%2520of%2520phenylpyrimidine-carboxamide%2520derivatives%2520bearing%25201H-pyrrolo%255B2%252C3-b%255Dpyridine%2520moiety%2520as%2520c-Met%2520inhibitors%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2016%26volume%3D24%26spage%3D1749%26epage%3D1756%26doi%3D10.1016%2Fj.bmc.2016.02.046" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref37"><div class="reference"><strong class="refLabel"><a href="#ref37" class="rightTabRefNumLink">37</a></strong><div class="NLM_citation" id="rightTab-cit37"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lee, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kang, J. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Park, S.-K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jin, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chung, K.-S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, H.-M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kang, M. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, M. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Song, K. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, E.-G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, J.-J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Won, M.</span></span> <span> </span><span class="NLM_article-title">LW6, a novel HIF-1 inhibitor, promotes proteasomal degradation of HIF-1alpha via upregulation of VHL in a colon cancer cell line</span>. <i>Biochem. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>80</i></span>,  <span class="NLM_fpage">982</span>– <span class="NLM_lpage">989</span>, <span class="refDoi"> DOI: 10.1016/j.bcp.2010.06.018</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01313&amp;key=10.1016%2Fj.bcp.2010.06.018" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01313&amp;key=20599784" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01313&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhtVeku7fK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=80&publication_year=2010&pages=982-989&author=K.+Leeauthor=J.+E.+Kangauthor=S.-K.+Parkauthor=Y.+Jinauthor=K.-S.+Chungauthor=H.-M.+Kimauthor=K.+Leeauthor=M.+R.+Kangauthor=M.+K.+Leeauthor=K.+B.+Songauthor=E.-G.+Yangauthor=J.-J.+Leeauthor=M.+Won&title=LW6%2C+a+novel+HIF-1+inhibitor%2C+promotes+proteasomal+degradation+of+HIF-1alpha+via+upregulation+of+VHL+in+a+colon+cancer+cell+line&doi=10.1016%2Fj.bcp.2010.06.018"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit37R"><div class="casContent"><span class="casTitleNuber">37</span><div class="casTitle"><span class="NLM_cas:atitle">LW6, a novel HIF-1 inhibitor, promotes proteasomal degradation of HIF-1α via upregulation of VHL in a colon cancer cell line</span></div><div class="casAuthors">Lee, Kyeong; Kang, Jung-Eun; Park, Song-Kyu; Jin, Ying-Lan; Chung, Kyung-Sook; Kim, Hwan-Mook; Lee, Ki-Ho; Kang, Moo-Rim; Lee, Myung-Kyu; Song, Kyung-Bin; Yang, Eun-Gyeong; Lee, Jung-Jun; Won, Mi-Sun</div><div class="citationInfo"><span class="NLM_cas:title">Biochemical Pharmacology</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">80</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">982-989</span>CODEN:
                <span class="NLM_cas:coden">BCPCA6</span>;
        ISSN:<span class="NLM_cas:issn">0006-2952</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Hypoxia-inducible factor HIF-1 is responsible for radiation resistance and poor prognosis in cancer therapy.  As part of our drug discovery program, a novel HIF inhibitor, LW6, was identified as a small compd. that inhibits the accumulation of HIF-1α.  We found that LW6 decreased HIF-1α protein expression without affecting HIF-1β expression.  MG132, a proteasome inhibitor, protected HIF-1α from LW6-induced proteasomal degrdn., indicating that LW6 affects the stability of the HIF-1α protein.  We found that LW6 promoted the degrdn. of wild type HIF-1α, but not of a DM-HIF-1α with modifications of P402A and P564A, at hydroxylation sites in the oxygen-dependent degrdn. domain (ODDD).  LW6 did not affect the activity of prolyl hydroxylase (PHD), but induced the expression of von Hippel-Lindau (VHL), which interacts with prolyl-hydroxylated HIF-1α for proteasomal degrdn.  In the presence of LW6, knockdown of VHL did not abolish HIF-1α protein accumulation, indicating that LW6 degraded HIF-1α via regulation of VHL expression.  In mice carrying xenografts of human colon cancer HCT116 cells, LW6 demonstrated strong antitumor efficacy in vivo and caused a decrease in HIF-1α expression in frozen-tissue immunohistochem. staining.  These data suggest that LW6 may be valuable in the development of a HIF-1α inhibitor for cancer treatment.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq3Ksyrt_nbn7Vg90H21EOLACvtfcHk0lgl2rtDYmuzmg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhtVeku7fK&md5=4d6b427c3fc3e7d106fc9f7200802e9d</span></div><a href="/servlet/linkout?suffix=cit37&amp;dbid=16384&amp;doi=10.1016%2Fj.bcp.2010.06.018&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bcp.2010.06.018%26sid%3Dliteratum%253Aachs%26aulast%3DLee%26aufirst%3DK.%26aulast%3DKang%26aufirst%3DJ.%2BE.%26aulast%3DPark%26aufirst%3DS.-K.%26aulast%3DJin%26aufirst%3DY.%26aulast%3DChung%26aufirst%3DK.-S.%26aulast%3DKim%26aufirst%3DH.-M.%26aulast%3DLee%26aufirst%3DK.%26aulast%3DKang%26aufirst%3DM.%2BR.%26aulast%3DLee%26aufirst%3DM.%2BK.%26aulast%3DSong%26aufirst%3DK.%2BB.%26aulast%3DYang%26aufirst%3DE.-G.%26aulast%3DLee%26aufirst%3DJ.-J.%26aulast%3DWon%26aufirst%3DM.%26atitle%3DLW6%252C%2520a%2520novel%2520HIF-1%2520inhibitor%252C%2520promotes%2520proteasomal%2520degradation%2520of%2520HIF-1alpha%2520via%2520upregulation%2520of%2520VHL%2520in%2520a%2520colon%2520cancer%2520cell%2520line%26jtitle%3DBiochem.%2520Pharmacol.%26date%3D2010%26volume%3D80%26spage%3D982%26epage%3D989%26doi%3D10.1016%2Fj.bcp.2010.06.018" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref38"><div class="reference"><strong class="refLabel"><a href="#ref38" class="rightTabRefNumLink">38</a></strong><div class="NLM_citation" id="rightTab-cit38"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jiang, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Feng, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ding, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Luo, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Y.</span></span> <span> </span><span class="NLM_article-title">Design, synthesis, biological evaluation and cocrystal structures with tubulin of chiral beta-lactam bridged combretastatin A-4 analogues as potent antitumor agents</span>. <i>Eur. J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>144</i></span>,  <span class="NLM_fpage">817</span>– <span class="NLM_lpage">842</span>, <span class="refDoi"> DOI: 10.1016/j.ejmech.2017.12.004</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01313&amp;key=10.1016%2Fj.ejmech.2017.12.004" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01313&amp;key=29306206" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01313&amp;key=1%3ACAS%3A528%3ADC%252BC1cXksFehug%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=144&publication_year=2018&pages=817-842&author=P.+Zhouauthor=Y.+Liangauthor=H.+Zhangauthor=H.+Jiangauthor=K.+Fengauthor=P.+Xuauthor=J.+Wangauthor=X.+Wangauthor=K.+Dingauthor=C.+Luoauthor=M.+Liuauthor=Y.+Wang&title=Design%2C+synthesis%2C+biological+evaluation+and+cocrystal+structures+with+tubulin+of+chiral+beta-lactam+bridged+combretastatin+A-4+analogues+as+potent+antitumor+agents&doi=10.1016%2Fj.ejmech.2017.12.004"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit38R"><div class="casContent"><span class="casTitleNuber">38</span><div class="casTitle"><span class="NLM_cas:atitle">Design, synthesis, biological evaluation and cocrystal structures with tubulin of chiral β-lactam bridged combretastatin A-4 analogues as potent antitumor agents</span></div><div class="casAuthors">Zhou, Pengfei; Liang, Yuru; Zhang, Hao; Jiang, Hao; Feng, Kechang; Xu, Pan; Wang, Jie; Wang, Xiaoming; Ding, Kuiling; Luo, Cheng; Liu, Mingming; Wang, Yang</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">144</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">817-842</span>CODEN:
                <span class="NLM_cas:coden">EJMCA5</span>;
        ISSN:<span class="NLM_cas:issn">0223-5234</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Masson SAS</span>)
        </div><div class="casAbstract">A diverse of chiral β-lactam bridged analogs of combretastatin A-4 (CA-4), 3-substituted 1,4-diaryl-2-azetidinones, were asym. synthesized and biol. evaluated, leading to identify a no. of potent anti-proliferative compds. represented by compds. I and II with IC50 values of 0.001-0.021 μM, against four human cancer cell lines (A2780, Hela, SKOV-3 and MDA-MB-231).  Structure-activity relationship (SAR) studies on all stereoisomers of compds. I and II revealed that the abs. configurations of the chiral centers at 3- and 4-position were critically important for the activity and generally a trans configuration between the "A" and "B" rings is optimal.  In addn., compds. I and II displayed less cytotoxicity on normal human oviduct epithelial cells than malignant cells indicating good selectivity in vitro.  Further biochem. evaluation and cocrystal structures with tubulin demonstrated that both compds. disrupted tubulin polymn. through interacting at the colchicine-binding site, suppressed angiogenesis in vitro and in vivo, blocked cell cycle progression at mitotic phase and induced cellular apoptosis.  The in vivo assays verified that both compds. inhibited xenograft tumor growth in nude mice with acceptable therapeutic window, showing promising potentials for further clin. development.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp-AkBbA6s_YLVg90H21EOLACvtfcHk0lgl2rtDYmuzmg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXksFehug%253D%253D&md5=d1c08d480a2f5d2976282076e7458839</span></div><a href="/servlet/linkout?suffix=cit38&amp;dbid=16384&amp;doi=10.1016%2Fj.ejmech.2017.12.004&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejmech.2017.12.004%26sid%3Dliteratum%253Aachs%26aulast%3DZhou%26aufirst%3DP.%26aulast%3DLiang%26aufirst%3DY.%26aulast%3DZhang%26aufirst%3DH.%26aulast%3DJiang%26aufirst%3DH.%26aulast%3DFeng%26aufirst%3DK.%26aulast%3DXu%26aufirst%3DP.%26aulast%3DWang%26aufirst%3DJ.%26aulast%3DWang%26aufirst%3DX.%26aulast%3DDing%26aufirst%3DK.%26aulast%3DLuo%26aufirst%3DC.%26aulast%3DLiu%26aufirst%3DM.%26aulast%3DWang%26aufirst%3DY.%26atitle%3DDesign%252C%2520synthesis%252C%2520biological%2520evaluation%2520and%2520cocrystal%2520structures%2520with%2520tubulin%2520of%2520chiral%2520beta-lactam%2520bridged%2520combretastatin%2520A-4%2520analogues%2520as%2520potent%2520antitumor%2520agents%26jtitle%3DEur.%2520J.%2520Med.%2520Chem.%26date%3D2018%26volume%3D144%26spage%3D817%26epage%3D842%26doi%3D10.1016%2Fj.ejmech.2017.12.004" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></li><li id="pane-m3" aria-labelledby="pane-m3" class="tab__pane tab__pane-suppInfo empty"><h2 class="supp-info-label">Supporting Information</h2><div class="article_supporting-info" id="rightTab-notes1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-rightTab-_i107"><a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.9b01313">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a class="" href="#"><span>Jump To</span><i class="icon-angle-down"></i></a><div class="dropBlock__holder" data-db-target-of="sectionsDB_21488"></div></div></div></div></div><hr /></hr><p class="last">The Supporting Information is available free of charge on the <a class="ext-link" href="/">ACS Publications website</a> at DOI: <a class="ext-link" href="/doi/abs/10.1021/acs.jmedchem.9b01313">10.1021/acs.jmedchem.9b01313</a>.<ul id="rightTab-silist" class="NLM_list-list_type-label"><li><p class="inline">Molecular formula strings and some data (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.9b01313/suppl_file/jm9b01313_si_002.csv">CSV</a>)</p></li><li><p class="inline">Synthesis of intermediates <b>13a–c</b>, <b>16a–e</b>, <b>25a–b</b>; <sup>1</sup>H NMR, <sup>13</sup>C NMR spectra and the purity table of target compounds; and element analysis of representative compounds (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.9b01313/suppl_file/jm9b01313_si_003.pdf">PDF</a>)</p></li></ul></p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.9b01313/suppl_file/jm9b01313_si_002.csv">jm9b01313_si_002.csv (4.38 kb)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.9b01313/suppl_file/jm9b01313_si_003.pdf">jm9b01313_si_003.pdf (10.87 MB)</a></li></ul></div></div><div id="rightTab-figshare-widget"></div><br /></br><div class="TermsAndConditionsDropzoneRight" data-pb-dropzone="TermsAndConditionsDropzoneRight"><div data-widget-def="UX3HTMLWidget" data-widget-id="b84e6b6c-b4d0-4427-b286-3cf14d52d013" class="mb-4">
        



        
        <h2 style="font-size: 1rem;margin-bottom: 10px;">Terms & Conditions</h2>
<p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system:
<a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div></div></li></ul><div class="recommendedDropzone7" data-pb-dropzone="recommendedDropzone7"><div data-ajaxurl="/pb/widgets/ux3/ux3-showRecommend?widgetId=b272b1fe-ab4e-454f-940c-a3deaf223d23&amp;doi=10.1021%2Facs.jmedchem.9b01313&amp;pbContext=%3BrequestedJournal%3Ajournal%3Ajmcmar%3Bjournal%3Ajournal%3Ajmcmar%3Bpage%3Astring%3AArticle%2FChapter+View%3Bctype%3Astring%3AJournal+Content%3Bwgroup%3Astring%3AACHS+website+Group%3Bwebsite%3Awebsite%3Aacspubs%3Barticle%3Aarticle%3A10.1021%2Facs.jmedchem.9b01313%3Bissue%3Aissue%3A10.1021%2Fjmcmar.2019.62.issue-20%3BpageGroup%3Astring%3APublication+Pages%3BsubPage%3Astring%3AFull+Text" class="show-recommended-placeholder"></div>




        
        <script>
$(document).ready(function() {
  setTimeout(function() {
    var myLink = $(".show-recommended").find("a").not("[href='http://acsmediakit.org']").not("[href='javascript:void(0);']");
    myLink.attr("href", function(i, href) {
        return href + '?ref=recommended';
    });
  }, 5000);
});
</script></div></div></div></div></div></div></div><div class="col-xs-12.clearfix"><div class="article_qv-xs-container"><div class="article_qv-xs"><ul><li><a href="#" title="In This Article"><span>In This Article</span></a></li><li><a href="#" title="Figures" data-slide-target=".tab__pane-figures" class="w-slide__btn slide-active"><i class="icon-image"></i><span>Figures</span></a></li><li><a href="#" title="References" data-slide-target=".tab__pane-references" class="w-slide__btn slide-active"><i class="icon-link"></i><span>References</span></a></li><li><a href="#" title="Supporting Information" data-slide-target=".tab__pane-suppInfo" class="w-slide__btn slide-active"><i class="icon-supporting-info"></i><span>Supporting Information</span></a></li><li><a href="#" title="Recommended Articles" data-slide-target=".recommendedDropzone7" class="show-recommended-qv w-slide__btn slide-active" target="_self"><i class="icon-newspaper-o"></i><span>Recommended Articles</span></a></li></ul><a title="PDF" href="/doi/pdf/10.1021/acs.jmedchem.9b01313" class="button_primary"><i class="icon-file-pdf-o"></i>PDF  <span class="filesize">[
                5MB]
            </span></a></div></div></div></div></div></div></article></main>




        
        <footer class="footer">



        
        <div class="footer_first-row" id="partners">
	<div class="container">
		<div class="row">
			<div class="col-xs-12">
				<div class="footer_first-row_title">
					<h2>
						Partners
					</h2>
				</div>
				<div class="footer_first-row_logos">
					<div>
						<a href="http://www.atypon.com/">
							<img src="/pb-assets/images/footer_logos/logo-atypon-1525376610217.png" alt="Atypon">
						</a>
					</div>
					<div>
						<a href="http://www.chorusaccess.org/">
							<img src="/pb-assets/images/footer_logos/logo-chorus-1525375622947.png" alt="Chorus">
						</a>
					</div>
					<div>
						<a href="http://publicationethics.org/">
							<img src="/pb-assets/images/footer_logos/logo-cope-1525375622977.png" alt="Cope publication ethics">
						</a>
					</div>
					<div>
						<a href="http://www.projectcounter.org/">
							<img src="/pb-assets/images/footer_logos/logo-counter-1523044519173.jpg" alt="Project Counter">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/">
							<img src="/pb-assets/images/footer_logos/logo-crossref-1525377362093.png" alt="Crossref">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/crosscheck/index.html">
							<img src="/pb-assets/images/footer_logos/logo-crosscheck-1525375623000.png" alt="Crossref similarity check">
						</a>
					</div>
					<div>
						<a href="http://www.orcid.org/">
							<img src="/pb-assets/images/footer_logos/logo-orcid-1525375623187.png" alt="Orcid Connecting Research and Researchers">
						</a>
					</div>
					<div>
						<a href="http://www.portico.org/">
							<img src="/pb-assets/images/footer_logos/logo-portico-1525375623203.png" alt="Portico digital preservation service">
						</a>
					</div>
				</div>
			</div>
		</div>
	</div>
</div>





        
        <div class="footer_second-row col-xs-12 gutterless ">









        <div data-widget-def="ux3-layout-widget" data-widget-id="f963f9aa-5ade-4a09-8515-e6cd8e6364cf" class="row container">
        



        
        <div class="col-xs-12">



        
        <div class="footer_second-row_left col-md-2 gutterless ">



        
        <a href="/"><img src="/pb-assets/images/pubslogo-small-1444685090580.png" alt="ACS Publications"></a>
<div class="footer_menu">
	<ul>
		<li class="footer_menu_address">
			<span>
				1155 Sixteenth Street N.W.
			</span>
		</li>
		<li class="footer_menu_address">
			<span>
				Washington, DC 20036
			</span>
		</li>

		<li class="footer_menu_copyright">
			<a href="http://www.acs.org/content/acs/en/copyright.html">
				Copyright © 2021<br>
				American Chemical Society
			</a>
		</li>
	</ul>
</div>
</div><div class="footer_second-row_middle col-md-2 gutterless "></div><div class="footer_second-row_right col-md-8 gutterless ">



        
        <div class="footer_second-row_about col-xs-4">



        
        <h2>About</h2>
<ul>
    <li><a href="/page/about-us.html">About ACS Publications</a></li>
    <li><a href="http://acsopenscience.org">ACS & Open Access</a></li>
    <li><a href="https://www.acs.org/content/acs/en/membership/member-benefits/publications-discounts.html">ACS Membership</a></li>
</ul>
</div><div class="footer_second-row_resources col-xs-5">



        
        <h2>Resources and Information</h2>
<ul>
	<li><a href="/action/showPublications?pubType=journal">Journals A-Z</a></li>
	<li><a href="/action/showPublications?pubType=book">Books and Reference</a></li>
    <li><a href="http://acsmediakit.org/digital/acs-pubs/?utm_source=Footer&amp;utm_medium=Pubs&amp;utm_campaign=CEN">Advertising Media Kit</a></li>
    <li><a href="https://solutions.acs.org">Institutional Sales</a></li>
    <li><a href="https://publish.acs.org/publish/">ACS Publishing Center</a></li>
    <li><a href="http://www.acs.org/content/acs/en/privacy.html">Privacy Policy</a></li>
    <li><a href="https://www.acs.org/content/acs/en/terms.html">Terms of Use</a></li>
</ul>
</div><div class="footer_second-row_support col-xs-3">



        
        <h2>Support & Contact</h2>
<ul>
    <li><a href="https://acs.service-now.com/acs">Help</a></li>
    <li><a href="#" onclick="SnapEngage.startLink();return false;" class="help help-chat">Live Chat</a></li>
    <li><a href="https://acs.service-now.com/acs">FAQ</a></li>
</ul>
</div>
</div>




        
        <div class="footer_social_section col-xs-12">



        
        <div class="footer_social_header">
	<h2>Connect with ACS Publications</h2>
</div>
<div class="footer_social">
	<ul>
		<li>
			<a href="https://preferences.acspubs.org/journals" class="icon-envelope-o" aria-label="email">
			</a>
		</li>
		<li>
			<a href="https://www.facebook.com/ACSPublications/" class="icon-facebook" aria-label="facebook" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://twitter.com/ACSPublications" class="icon-twitter" aria-label="twitter" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://www.youtube.com/user/AmerChemSoc" class="icon-youtube-play" aria-label="youtube" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="/page/follow.html?widget=follow-pane-rss" class="icon-rss" aria-label="rss feed">
			</a>
		</li>
	</ul>
</div>

</div>
</div>

        </div>
    
</div>
</footer>




        
        <script>
(function(){
	
	/*Event Tracking for RIS menu dropdown - Article pages*/

	$('.cit-download-dropdown_button').on('click',function(e)
	{	
		e.preventDefault();
	    ga('send', 'event', 'Citation', 'Export', 'Main');
	});


	$('.cit-download-dropdown_content ul li').on('click',function(e)
	{	
	//	e.preventDefault();
	    var idx = $(this).index();
	    
	    var label = '';
	    if (idx === 0 ) {
	    	label = 'Citation';
	    } else if (idx === 1 ) {
	    	label = 'Abstract';
	    } else if (idx === 2 ) {
	    	label = 'Reference';
	    } else if (idx === 3 ) {
	    	label = 'More Options';
	    }
	   ga('send', 'event', 'Citation', 'Export', label);
	});

	$('.header_contnav-next a').on('click', function(e){
        e.preventDefault();
        ga('send', 'event', 'Article', 'Top', 'Right Arrow');
	}); 

 	$('.header_contnav-pre a').on('click', function(e){
	    e.preventDefault();
	     ga('send', 'event', 'Article', 'Top', 'Left Arrow');
	}); 

	$('.share_button').on('click', function(e){
		e.preventDefault();
		ga('send', 'event', 'Article', 'Top', 'Share');
	});

	$("#pane-m1con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Figures');
	});

	$("#pane-m2con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'References');
	});

	$("#pane-m3con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Supporting Info');
	});

	$('.tab__close').on('click', function(){
		ga('send', 'event', 'Article', 'Sidebar', 'Close');
	}); 



})();

</script>






        
        <div aria-live="polite" aria-atomic="true" class="achs-mendeley"><input type="hidden" name="tokenEndpoint" value="https://sso.acs.org/mendeley/token" class="tokenEndpoint"/></input><input type="hidden" name="appID" value="literatum" class="appID"/></input><input type="hidden" name="reopen-mendeley-modal-after-reload" class="reopen-mendeley-modal-after-reload"/></input><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><div class="achs-mendeley_table"><div class="achs-mendeley_row"><div class="achs-mendeley_cell loop-trap"><div class="achs-mendeley_container"><a title="Close" aria-label="close" tabindex="0" class="achs-mendeley_close"><i aria-hidden="true" class="icon-close"></i></a><div class="achs-mendeley_dropzone1"><div class="achs-mendeley_dropzone1_state1">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state2">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state3">



        
        <p style="font-weight: bold;">You’ve supercharged your research process with ACS and Mendeley!</p>
</div></div><div class="achs-mendeley_continue-header"><button class="achs-mendeley_continue-btn"><span class="achs-mendeley_buttonText">Continue</span></button></div><div class="achs-mendeley_steps"><div class="achs-mendeley_steps_row"><div class="achs-mendeley_steps_cell achs-mendeley_acsLogin"><h6>STEP 1:</h6><button class="button_primary achs-mendeley_acsLogin_button"><span class="achs-mendeley_buttonText">Login with ACS ID</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><span class="achs-mendeley_acsLogin_label">Click to create an ACS ID</span><i class="icon-if-arrow-right"></i></div><div class="achs-mendeley_steps_cell achs-mendeley_login"><h6>STEP 2:</h6><button class="button_primary achs-mendeley_login_button"><i class="icon-mendeley"></i><span class="achs-mendeley_buttonText">Login with Mendeley</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><a href="https://id.elsevier.com/as/authorization.oauth2?state=c33c27125763433d4d32a15accaacc18&amp;prompt=login&amp;scope=openid%20email%20profile%20els_auth_info&amp;authType=SINGLE_SIGN_IN&amp;response_type=code&amp;platSite=MDY%2Fmendeley&amp;redirect_uri=https%3A%2F%2Fwww.mendeley.com%2Fcallback%2F&amp;client_id=MENDELEY" title="Create a Mendeley account">Create a Mendeley account</a></div></div></div><div class="achs-mendeley_dropzone2"><div class="achs-mendeley_dropzone2_state1">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state2">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state3">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div></div></div></div></div></div></div><div class="achs-mendeley_alert"><div class="achs-mendeley_alert_table"><div class="achs-mendeley_alert_row"><div class="achs-mendeley_alert_cell"><div class="achs-mendeley_alert_container"><a title="Close" aria-label="close" class="achs-mendeley_alert_close"><i aria-hidden="true" class="icon-close"></i></a><div role="alert" aria-live="polite" aria-atomic="true" class="achs-mendeley_alert_dropzone">



        
        <p>Please login with your ACS ID before connecting to your Mendeley account.</p><button class="button_tertiary achs-mendeley_acsLogin_button mendeley-acs-custom-login-btn" onclick="loginToAcsSso(event); return false;">Login with ACS ID</button>

<script>
 function loginToAcsSso(event){
 event.preventDefault();
 $('.achs-mendeley_acsLogin .achs-mendeley_acsLogin_button').trigger('click');
 }
</script>
</div><div class="achs-mendeley_alert_error-msg"></div></div></div></div></div><div class="pairing-expired-dialog-container"><div class="pairing-expired-dialog"><div class="pairing-expired-dialog_top-btns"><span class="pairing-expired-dialog_heading">MENDELEY PAIRING EXPIRED</span><button onClick="UX.achsMendeley.reconnectOnClickHandler();" class="pairing-expired-dialog_reconnect">Reconnect</button></div><div class="pairing-expired-dialog_content"><span>Your Mendeley pairing has expired. Please reconnect</span></div></div></div></div>




        
        <style type="text/css">
#gdpr-message-modal {
    display: none;
    /* Hidden by default */
    position: fixed;
    /* Stay in place */
    z-index: 2;
    /* Sit on top */
    /*padding-top: 100px;*/
    /* Location of the box */
    left: 0;
    bottom: 0;
    width: 100%;
    /* Full width */
    /*height: 100%;*/
    /* Full height */
    overflow: auto;
    /* Enable scroll if needed */
    /*background-color: rgb(0,0,0);*/
    /* Fallback color */
    /*background-color: rgba(0,0,0,0.4);*/
    /* Black w/ opacity */
}
#gdpr-message-content {
    font-family: Arial;
    background-color: #005083;
    color: #fff;
    margin: auto;
    padding: 5px 0 10px 0;
    /*border: 1px solid #888;*/
    box-shadow: 0 -1px 3px #666;
    width: 100%;
    display: block;
    bottom: 0;
}
#gdpr-message-container {
    /*width: 1130px;*/
    margin: 0 auto;
}
.gdpr-innerwrap {
    display: block;
    /*width: 1100px;*/
    margin: 0 auto;
    text-align: center;
}
#gdpr-message-content h1 {
    color: #0629b5;
    font-size: 26px;
    margin: 0.5em 0 0 0;
    border-bottom: solid 2px #4c7fb9;
    display: inline;
    padding-bottom: 10px;
}
#gdpr-message-content h4 {
    display: inline-block;
    margin-left: 0;
    margin-right: 14px;
    margin-top: 13px;
    /*width: 980px;*/
    font-size: 14px;
    font-weight: normal;
}
#gdpr-message-content p {
    font-size: 14px;
    margin: 2em 2em 0.5em 0em;
    text-align: left;
    font-weight: bold;
}
#gdpr-message-content a,
#gdpr-message-content a:hover {
    color: #9bcfff;
}
.gdpr-listwrap {
    display: block;
    margin-bottom: 10px;
    min-height: 100px;
    min-width: 200px;
}
#gdpr-message-content ul {
    margin-top: 20px;
    font-size: 13px;
}
#gdpr-ul1 {
    display: inline-block;
    float: left;
}
#gdpr-ul2 {
    display: inline-block;
    margin-left: 10px;
}
#gdpr-message-content ul li {
    margin-top: 4px;
}
a#gdpr-con-btn,
a#gdpr-con-btn:hover {
    width: 110px;
    height: 35px;
    background: #fec82a;
    background-image: none;
    background-image: -webkit-gradient(linear, 50% 0%, 50% 100%, color-stop(0%, #fec82a), color-stop(100%, #daa301));
    background-image: -webkit-linear-gradient(top, #fec82a, #daa301);
    background-image: -moz-linear-gradient(top, #fec82a, #daa301);
    background-image: -o-linear-gradient(top, #fec82a, #daa301);
    background-image: linear-gradient(top, #fec82a, #daa301);
    border-radius: 4px;
    color: #004a7b;
    display: inline-block;
    text-decoration: none;
    line-height: 35px;
    text-align: center;
    margin-top: 5px;
    /*margin-right: 14px;*/
    /*float: right;*/
    font-weight: bold;
}
#gdpr-message-btn {
    width: 60px;
    height: 38px;
    background: #4b8fc2;
    border-radius: 4px;
    color: white;
    display: inline-block;
    margin-top: -4px;
    font-size: 12px;
}
a#closebtn {
    float: right;
    color: #d4e5ef;
}
#gdpr-input {
    width: 200px;
    height: 30px;
    border-radius: 3px;
    border-width: 1px;
    box-shadow: none;
    margin-right: 10px;
    font-size: 14px;
    outline: none;
    padding-left: 2px;
    display: inline-block;
    float: left;
}
#gdpr-message-content p.gdpr_err {
    font-size: 15px;
    margin-top: 10px;
}
#gdpr-message-modal.mobile, #gdpr-message-modal.mobile .gdpr-message-content {
    height: 160px;
}
@media only screen and (min-width: 1026px) and (max-width: 1368px) {
	#gdpr-message-content h4 {
		width: 80%;
		text-align: left;
	}
}
</style>

<div id="gdpr-message-modal">
    <div id="gdpr-message-content">
        
	        <div class="gdpr-innerwrap container">
	            <h4>This website uses cookies to improve your user experience. By continuing to use the site, you are accepting our use of cookies. <a href="http://www.acs.org/content/acs/en/privacy.html">Read the ACS privacy policy</a>.</h4>
	            <a href="#" id="gdpr-con-btn">CONTINUE</a>
	        </div>
        
    </div>
</div>

<script type="text/javascript">
"use strict"
//Script checks gdpr cookie and submits form
	/* 
	Create an in-page pop-up message, only for the InfoCentral homepage, that will gather email registrants for the library marketing list.
	 
	Needs the end point
	*/

var infoCentralCapture = (function() {

    //Detect mobile device
    window.mobilecheck = function() {
        var check = false;
        (function(a){if(/(android|bb\d+|meego).+mobile|avantgo|bada\/|blackberry|blazer|compal|elaine|fennec|hiptop|iemobile|ip(hone|od)|iris|kindle|lge |maemo|midp|mmp|mobile.+firefox|netfront|opera m(ob|in)i|palm( os)?|phone|p(ixi|re)\/|plucker|pocket|psp|series(4|6)0|symbian|treo|up\.(browser|link)|vodafone|wap|windows ce|xda|xiino/i.test(a)||/1207|6310|6590|3gso|4thp|50[1-6]i|770s|802s|a wa|abac|ac(er|oo|s\-)|ai(ko|rn)|al(av|ca|co)|amoi|an(ex|ny|yw)|aptu|ar(ch|go)|as(te|us)|attw|au(di|\-m|r |s )|avan|be(ck|ll|nq)|bi(lb|rd)|bl(ac|az)|br(e|v)w|bumb|bw\-(n|u)|c55\/|capi|ccwa|cdm\-|cell|chtm|cldc|cmd\-|co(mp|nd)|craw|da(it|ll|ng)|dbte|dc\-s|devi|dica|dmob|do(c|p)o|ds(12|\-d)|el(49|ai)|em(l2|ul)|er(ic|k0)|esl8|ez([4-7]0|os|wa|ze)|fetc|fly(\-|_)|g1 u|g560|gene|gf\-5|g\-mo|go(\.w|od)|gr(ad|un)|haie|hcit|hd\-(m|p|t)|hei\-|hi(pt|ta)|hp( i|ip)|hs\-c|ht(c(\-| |_|a|g|p|s|t)|tp)|hu(aw|tc)|i\-(20|go|ma)|i230|iac( |\-|\/)|ibro|idea|ig01|ikom|im1k|inno|ipaq|iris|ja(t|v)a|jbro|jemu|jigs|kddi|keji|kgt( |\/)|klon|kpt |kwc\-|kyo(c|k)|le(no|xi)|lg( g|\/(k|l|u)|50|54|\-[a-w])|libw|lynx|m1\-w|m3ga|m50\/|ma(te|ui|xo)|mc(01|21|ca)|m\-cr|me(rc|ri)|mi(o8|oa|ts)|mmef|mo(01|02|bi|de|do|t(\-| |o|v)|zz)|mt(50|p1|v )|mwbp|mywa|n10[0-2]|n20[2-3]|n30(0|2)|n50(0|2|5)|n7(0(0|1)|10)|ne((c|m)\-|on|tf|wf|wg|wt)|nok(6|i)|nzph|o2im|op(ti|wv)|oran|owg1|p800|pan(a|d|t)|pdxg|pg(13|\-([1-8]|c))|phil|pire|pl(ay|uc)|pn\-2|po(ck|rt|se)|prox|psio|pt\-g|qa\-a|qc(07|12|21|32|60|\-[2-7]|i\-)|qtek|r380|r600|raks|rim9|ro(ve|zo)|s55\/|sa(ge|ma|mm|ms|ny|va)|sc(01|h\-|oo|p\-)|sdk\/|se(c(\-|0|1)|47|mc|nd|ri)|sgh\-|shar|sie(\-|m)|sk\-0|sl(45|id)|sm(al|ar|b3|it|t5)|so(ft|ny)|sp(01|h\-|v\-|v )|sy(01|mb)|t2(18|50)|t6(00|10|18)|ta(gt|lk)|tcl\-|tdg\-|tel(i|m)|tim\-|t\-mo|to(pl|sh)|ts(70|m\-|m3|m5)|tx\-9|up(\.b|g1|si)|utst|v400|v750|veri|vi(rg|te)|vk(40|5[0-3]|\-v)|vm40|voda|vulc|vx(52|53|60|61|70|80|81|83|85|98)|w3c(\-| )|webc|whit|wi(g |nc|nw)|wmlb|wonu|x700|yas\-|your|zeto|zte\-/i.test(a.substr(0,4))) check = true;})(navigator.userAgent||navigator.vendor||window.opera);
              return check;
        };

    var _isMobile = window.mobilecheck();
    if (_isMobile) {
        $('#gdpr-message-modal').addClass('mobile');
    }

    var emailValid = "",
        time = 3000,
        btnStatus = true,
        errorStatus = false,
        errormessage = "<p class='gdpr_err'><b>Please Enter a valid email address<b><p>";

    function init() {
        setTimeout(function() {
            var cookieExist = getCookie("gdpr");
            if (cookieExist) {
                //console.log("gdpr cookie exist");
                return false;
            } else {
                //console.log("gdpr cookie does not exist")
                gdprMessage();
            }
            //Events
            $('#closebtn').on("click", hideForm);

            //Handle submit
            $('#gdpr-message-btn').on("click", function(event) {
                handleClick();
            });

            // //Hide if clicked outside div - TO DO stop handling click after submit
            // $(document).click(function(event) {
            // 	event.stopPropagation();
            //   console.log(event.target);
            //   if (!$(event.target).closest("#gdpr-message-content").length) {
            //     $("body").find("#gdpr-message-modal").hide();
            //     $(this).off();
            //   }
            // });
            $('#gdpr-con-btn').click(function() {
                setCookie("gdpr", "true");
                hideForm();
            });
        }, time);
    }

    //Show the message
    function gdprMessage() {
        //console.log("Show GDPR Message");
        var tMessage, emailInput, messageButton, ewrap;

        $('#gdpr-message-modal').show();
    }

    function handleClick() {
        //console.log($("#gdpr-input").val());
        emailValid = validateEmail($("#gdpr-input").val());
        if (emailValid) {
            //Submit the form
            //Hide form
            if ($('.gdpr_err')) {
                $('.gdpr_err').hide();
            }

            $("#gdpr-message-content")
                //If successful then...
            setCookie("gdpr", "true");
            //console.log("emailValid " + emailValid + " submiting form");
        } else {
            //Show error message
            gdprErrorMessage();
            //console.log("emailValid " + emailValid);
        }
    }

    function gdprErrorMessage() {
        if (errorStatus) {
            return false;
        } else {
            errorStatus = true;
            $("#gdpr-message-content").append(errormessage);
        }
    }

    function validateEmail(email) {
        var re = /^(([^<>()\[\]\\.,;:\s@"]+(\.[^<>()\[\]\\.,;:\s@"]+)*)|(".+"))@((\[[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\])|(([a-zA-Z\-0-9]+\.)+[a-zA-Z]{2,}))$/;
        return re.test(String(email).toLowerCase());
    }

    function setCookie(name, value) {
        var expires = "";
        expires = "; expires=Fri, 31 Dec 9999 23:59:59 GMT";
        document.cookie = name + "=" + (value || "") + expires + "; path=/";
    }

    function getCookie(name) {
        var match = document.cookie.match(new RegExp(name + '=([^;]+)'));
        if (match) return match[1];
    }

    function hideForm() { //And set cookie
        $('#gdpr-message-modal').hide();
        setCookie("gdpr", "false");
        ga('send', 'event', 'Pubs GDPR', 'GDPR Modal', 'GDPR Dismissal');
    }

    return {
        init: init
    }
})();

$(document).ready(infoCentralCapture.init);
</script>





        
        <script>
    //Top nav tracking

    (function(){
        $('.header_my-activity a:first').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Activity')
            ga('send', 'event', 'Top Nav', 'Button', 'Activity');
        })


        $('.pubModal_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Publications')
            ga('send', 'event', 'Top Nav', 'Button', 'Publications');
        }) 

        $('.header_burger-menu_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Hamburger');
            ga('send', 'event', 'Top Nav', 'Button', 'Hamburger');
        }) 

        // $('.header_burger-menu_content ul li').on('click', function(e){
        //     // e.preventDefault();
        //     var idx = $(this).index();
        //     console.log('Menu item' + idx)
        // })
    })();
    
    
</script>




        
        
<script type="text/javascript">
    adroll_adv_id = "3LBZJ4KXKBF2PJ46QCMT3X";
    adroll_pix_id = "6EITYRDI4FFGJPSZQ62UJJ";

    (function () {
        var _onload = function(){
            if (document.readyState && !/loaded|complete/.test(document.readyState)){setTimeout(_onload, 10);return}
            if (!window.__adroll_loaded){__adroll_loaded=true;setTimeout(_onload, 50);return}
            var scr = document.createElement("script");
            var host = (("https:" == document.location.protocol) ? "https://s.adroll.com" : "http://a.adroll.com");
            scr.setAttribute('async', 'true');
            scr.type = "text/javascript";
            scr.src = host + "/j/roundtrip.js";
            ((document.getElementsByTagName('head') || [null])[0] ||
                document.getElementsByTagName('script')[0].parentNode).appendChild(scr);
        };
        if (window.addEventListener) {window.addEventListener('load', _onload, false);}
        else {window.attachEvent('onload', _onload)}
    }());
</script>










        
        <div class="activity-container hidden-lg hidden-md"><div class="recentlyViewed" style="right: -100%;"><div class="activity_title_container"><span class="activity_title">Recently Viewed</span><a href="javascript:void(0)" class="activity_back"><i class="icon-angle-left"></i></a></div></div></div>




        
        <script>
$(document).ready(function(){
    var cookie = "";
    var uri = "/doi/full/10.1021/html_original_uri?id=123";
    console.log("ACSPubs2 start");
    $.getJSON('https://extreme-ip-lookup.com/json/', function(data, status) {
            if ( status == 'success' ) {
                $.each(data, function(i, field){
                    cookie=cookie.concat(i+' = '+field+" - ");
                });
                
            } else {
                    cookie=status;
            }

            cookie1 = cookie;
            cookie = cookie1 + "; path=/; domain=.acs.org";
            //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
            $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
            //TODO send cookie val to the controller for logging
            console.log("ACSPubs2 success");
    })
    .fail(function(xx, status, err){
        cookie="error: 127.0.0.1";
        //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
        $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
        console.log("ACSPubs2 failed");
        //TODO send cookie val to the controller for logging
    });
});    
</script>





        
        



        
    

        </div>
    </div>





	

    <script>if (typeof define !== 'undefined')
    if (define.amd)
        define.amd = false</script><script src="/products/achs/releasedAssets/js/build.lazyload.bundle-191cb5c7d88ed9894acd.js"></script><script src="/products/achs/releasedAssets/js/main.bundle-524acd43b3dccf6df3df.js"></script>

<script type="text/javascript" src="/wro/kfa7~product.js"></script>































    












<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"6799fa652df73d0c","token":"d4e766cffbf14806ad37e095398b9c5f","version":"2021.7.0","si":10}'></script>
</body>
</html>
